id	sid	tid	token	lemma	pos
ajmri-3091	1	1	pa	pa	PROPN
ajmri-3091	1	2	ge	ge	PROPN
ajmri-3091	1	3	1	1	NUM
ajmri-3091	1	4	6	6	NUM
ajmri-3091	1	5	pa	pa	PROPN
ajmri-3091	1	6	ge	ge	PROPN
ajmri-3091	1	7	12	12	NUM
ajmri-3091	1	8	american	american	PROPN
ajmri-3091	1	9	journal	journal	PROPN
ajmri-3091	1	10	of	of	ADP
ajmri-3091	1	11	multidisciplinary	multidisciplinary	ADJ
ajmri-3091	1	12	research	research	NOUN
ajmri-3091	1	13	and	and	CCONJ
ajmri-3091	1	14	innovation	innovation	NOUN
ajmri-3091	1	15	(	(	PUNCT
ajmri-3091	1	16	ajmri	ajmri	NOUN
ajmri-3091	1	17	)	)	PUNCT
ajmri-3091	1	18	does	do	VERB
ajmri-3091	1	19	the	the	DET
ajmri-3091	1	20	covid-19	covid-19	PROPN
ajmri-3091	1	21	vaccines	vaccine	NOUN
ajmri-3091	1	22	effect	effect	NOUN
ajmri-3091	1	23	on	on	ADP
ajmri-3091	1	24	the	the	DET
ajmri-3091	1	25	menstrual	menstrual	ADJ
ajmri-3091	1	26	cycle	cycle	NOUN
ajmri-3091	1	27	,	,	PUNCT
ajmri-3091	1	28	cross	cross	ADJ
ajmri-3091	1	29	-	-	ADJ
ajmri-3091	1	30	sectional	sectional	ADJ
ajmri-3091	1	31	study	study	NOUN
ajmri-3091	1	32	among	among	ADP
ajmri-3091	1	33	adult	adult	NOUN
ajmri-3091	1	34	females	female	NOUN
ajmri-3091	1	35	at	at	ADP
ajmri-3091	1	36	king	king	PROPN
ajmri-3091	1	37	saud	saud	PROPN
ajmri-3091	1	38	university	university	PROPN
ajmri-3091	1	39	taghread	taghread	ADV
ajmri-3091	1	40	saadi	saadi	PROPN
ajmri-3091	1	41	alghamdi1	alghamdi1	PROPN
ajmri-3091	1	42	*	*	PROPN
ajmri-3091	1	43	,	,	PUNCT
ajmri-3091	1	44	eltigani	eltigani	ADJ
ajmri-3091	1	45	o.	o.	PROPN
ajmri-3091	1	46	m.	m.	PROPN
ajmri-3091	1	47	omer2	omer2	PROPN
ajmri-3091	2	1	volume	volume	NOUN
ajmri-3091	2	2	3	3	NUM
ajmri-3091	2	3	issue	issue	NOUN
ajmri-3091	2	4	6	6	NUM
ajmri-3091	2	5	,	,	PUNCT
ajmri-3091	2	6	year	year	NOUN
ajmri-3091	2	7	2024	2024	NUM
ajmri-3091	2	8	issn	issn	X
ajmri-3091	2	9	:	:	PUNCT
ajmri-3091	2	10	2158	2158	NUM
ajmri-3091	2	11	-	-	SYM
ajmri-3091	2	12	8155	8155	NUM
ajmri-3091	2	13	(	(	PUNCT
ajmri-3091	2	14	online	online	NOUN
ajmri-3091	2	15	)	)	PUNCT
ajmri-3091	2	16	,	,	PUNCT
ajmri-3091	2	17	2832	2832	NUM
ajmri-3091	2	18	-	-	SYM
ajmri-3091	2	19	4854	4854	NUM
ajmri-3091	2	20	(	(	PUNCT
ajmri-3091	2	21	print	print	NOUN
ajmri-3091	2	22	)	)	PUNCT
ajmri-3091	2	23	doi	doi	NOUN
ajmri-3091	2	24	:	:	PUNCT
ajmri-3091	2	25	https://doi.org/10.54536/ajmri.v3i6.3091	https://doi.org/10.54536/ajmri.v3i6.3091	NOUN
ajmri-3091	2	26	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	ADJ
ajmri-3091	2	27	article	article	NOUN
ajmri-3091	2	28	information	information	NOUN
ajmri-3091	2	29	abstract	abstract	ADJ
ajmri-3091	2	30	received	receive	VERB
ajmri-3091	2	31	:	:	PUNCT
ajmri-3091	2	32	may	may	AUX
ajmri-3091	2	33	08	08	NUM
ajmri-3091	2	34	,	,	PUNCT
ajmri-3091	2	35	2024	2024	NUM
ajmri-3091	2	36	accepted	accept	VERB
ajmri-3091	2	37	:	:	PUNCT
ajmri-3091	2	38	june	june	PROPN
ajmri-3091	2	39	12	12	NUM
ajmri-3091	2	40	,	,	PUNCT
ajmri-3091	2	41	2024	2024	NUM
ajmri-3091	2	42	published	publish	VERB
ajmri-3091	2	43	:	:	PUNCT
ajmri-3091	2	44	november	november	PROPN
ajmri-3091	2	45	13	13	NUM
ajmri-3091	2	46	,	,	PUNCT
ajmri-3091	2	47	2024	2024	NUM
ajmri-3091	2	48	covid-19	covid-19	PROPN
ajmri-3091	2	49	vaccinations	vaccination	NOUN
ajmri-3091	2	50	have	have	AUX
ajmri-3091	2	51	been	be	AUX
ajmri-3091	2	52	associated	associate	VERB
ajmri-3091	2	53	with	with	ADP
ajmri-3091	2	54	irregularities	irregularity	NOUN
ajmri-3091	2	55	in	in	ADP
ajmri-3091	2	56	the	the	DET
ajmri-3091	2	57	menstrual	menstrual	ADJ
ajmri-3091	2	58	cycle	cycle	NOUN
ajmri-3091	2	59	and	and	CCONJ
ajmri-3091	2	60	symptoms	symptom	NOUN
ajmri-3091	2	61	occurring	occur	VERB
ajmri-3091	2	62	pre	pre	ADJ
ajmri-3091	2	63	and	and	CCONJ
ajmri-3091	2	64	post	post	ADJ
ajmri-3091	2	65	-	-	ADJ
ajmri-3091	2	66	menstruation	menstruation	NOUN
ajmri-3091	2	67	,	,	PUNCT
ajmri-3091	2	68	affecting	affect	VERB
ajmri-3091	2	69	women	woman	NOUN
ajmri-3091	2	70	’s	’s	PART
ajmri-3091	2	71	reproductive	reproductive	ADJ
ajmri-3091	2	72	health	health	NOUN
ajmri-3091	2	73	.	.	PUNCT
ajmri-3091	3	1	this	this	DET
ajmri-3091	3	2	study	study	NOUN
ajmri-3091	3	3	aimed	aim	VERB
ajmri-3091	3	4	to	to	PART
ajmri-3091	3	5	demonstrate	demonstrate	VERB
ajmri-3091	3	6	the	the	DET
ajmri-3091	3	7	impact	impact	NOUN
ajmri-3091	3	8	of	of	ADP
ajmri-3091	3	9	covid-19	covid-19	PROPN
ajmri-3091	3	10	vaccines	vaccine	NOUN
ajmri-3091	3	11	on	on	ADP
ajmri-3091	3	12	women	woman	NOUN
ajmri-3091	3	13	’s	’s	PART
ajmri-3091	3	14	reproductive	reproductive	ADJ
ajmri-3091	3	15	health	health	NOUN
ajmri-3091	3	16	by	by	ADP
ajmri-3091	3	17	examining	examine	VERB
ajmri-3091	3	18	the	the	DET
ajmri-3091	3	19	association	association	NOUN
ajmri-3091	3	20	between	between	ADP
ajmri-3091	3	21	covid-19	covid-19	PROPN
ajmri-3091	3	22	vaccines	vaccine	NOUN
ajmri-3091	3	23	and	and	CCONJ
ajmri-3091	3	24	disturbed	disturb	VERB
ajmri-3091	3	25	menstrual	menstrual	ADJ
ajmri-3091	3	26	cycles	cycle	NOUN
ajmri-3091	3	27	.	.	PUNCT
ajmri-3091	4	1	this	this	DET
ajmri-3091	4	2	cross	cross	ADJ
ajmri-3091	4	3	-	-	ADJ
ajmri-3091	4	4	sectional	sectional	ADJ
ajmri-3091	4	5	survey	survey	NOUN
ajmri-3091	4	6	-	-	PUNCT
ajmri-3091	4	7	based	base	VERB
ajmri-3091	4	8	study	study	NOUN
ajmri-3091	4	9	was	be	AUX
ajmri-3091	4	10	conducted	conduct	VERB
ajmri-3091	4	11	among	among	ADP
ajmri-3091	4	12	adult	adult	NOUN
ajmri-3091	4	13	females	female	NOUN
ajmri-3091	4	14	at	at	ADP
ajmri-3091	4	15	king	king	PROPN
ajmri-3091	4	16	saud	saud	PROPN
ajmri-3091	4	17	university	university	PROPN
ajmri-3091	4	18	,	,	PUNCT
ajmri-3091	4	19	saudi	saudi	PROPN
ajmri-3091	4	20	arabia	arabia	PROPN
ajmri-3091	4	21	,	,	PUNCT
ajmri-3091	4	22	from	from	ADP
ajmri-3091	4	23	april	april	PROPN
ajmri-3091	4	24	2022	2022	NUM
ajmri-3091	4	25	to	to	ADP
ajmri-3091	4	26	august	august	PROPN
ajmri-3091	4	27	2022	2022	NUM
ajmri-3091	4	28	.	.	PUNCT
ajmri-3091	5	1	a	a	DET
ajmri-3091	5	2	total	total	NOUN
ajmri-3091	5	3	of	of	ADP
ajmri-3091	5	4	380	380	NUM
ajmri-3091	5	5	participants	participant	NOUN
ajmri-3091	5	6	were	be	AUX
ajmri-3091	5	7	selected	select	VERB
ajmri-3091	5	8	through	through	ADP
ajmri-3091	5	9	a	a	DET
ajmri-3091	5	10	stratified	stratified	ADJ
ajmri-3091	5	11	random	random	ADJ
ajmri-3091	5	12	sampling	sampling	NOUN
ajmri-3091	5	13	technique	technique	NOUN
ajmri-3091	5	14	.	.	PUNCT
ajmri-3091	6	1	ethical	ethical	ADJ
ajmri-3091	6	2	approval	approval	NOUN
ajmri-3091	6	3	was	be	AUX
ajmri-3091	6	4	obtained	obtain	VERB
ajmri-3091	6	5	from	from	ADP
ajmri-3091	6	6	the	the	DET
ajmri-3091	6	7	deanship	deanship	NOUN
ajmri-3091	6	8	of	of	ADP
ajmri-3091	6	9	scientific	scientific	ADJ
ajmri-3091	6	10	research	research	NOUN
ajmri-3091	6	11	at	at	ADP
ajmri-3091	6	12	king	king	PROPN
ajmri-3091	6	13	saud	saud	PROPN
ajmri-3091	6	14	university	university	PROPN
ajmri-3091	6	15	.	.	PUNCT
ajmri-3091	7	1	the	the	DET
ajmri-3091	7	2	data	datum	NOUN
ajmri-3091	7	3	were	be	AUX
ajmri-3091	7	4	analysed	analyse	VERB
ajmri-3091	7	5	using	use	VERB
ajmri-3091	7	6	descriptive	descriptive	ADJ
ajmri-3091	7	7	statistics	statistic	NOUN
ajmri-3091	7	8	and	and	CCONJ
ajmri-3091	7	9	appropriate	appropriate	ADJ
ajmri-3091	7	10	statistical	statistical	ADJ
ajmri-3091	7	11	tests	test	NOUN
ajmri-3091	7	12	.	.	PUNCT
ajmri-3091	8	1	the	the	DET
ajmri-3091	8	2	results	result	NOUN
ajmri-3091	8	3	revealed	reveal	VERB
ajmri-3091	8	4	that	that	SCONJ
ajmri-3091	8	5	53.9	53.9	NUM
ajmri-3091	8	6	%	%	NOUN
ajmri-3091	8	7	of	of	ADP
ajmri-3091	8	8	the	the	DET
ajmri-3091	8	9	participants	participant	NOUN
ajmri-3091	8	10	experienced	experience	VERB
ajmri-3091	8	11	disturbances	disturbance	NOUN
ajmri-3091	8	12	in	in	ADP
ajmri-3091	8	13	the	the	DET
ajmri-3091	8	14	menstrual	menstrual	ADJ
ajmri-3091	8	15	cycle	cycle	NOUN
ajmri-3091	8	16	after	after	ADP
ajmri-3091	8	17	receiving	receive	VERB
ajmri-3091	8	18	the	the	DET
ajmri-3091	8	19	covid-19	covid-19	PROPN
ajmri-3091	8	20	vaccination	vaccination	NOUN
ajmri-3091	8	21	.	.	PUNCT
ajmri-3091	9	1	adult	adult	NOUN
ajmri-3091	9	2	females	female	NOUN
ajmri-3091	9	3	aged	age	VERB
ajmri-3091	9	4	18	18	NUM
ajmri-3091	9	5	-	-	SYM
ajmri-3091	9	6	25	25	NUM
ajmri-3091	9	7	showed	show	VERB
ajmri-3091	9	8	the	the	DET
ajmri-3091	9	9	highest	high	ADJ
ajmri-3091	9	10	rate	rate	NOUN
ajmri-3091	9	11	of	of	ADP
ajmri-3091	9	12	disorders	disorder	NOUN
ajmri-3091	9	13	.	.	PUNCT
ajmri-3091	10	1	menstrual	menstrual	ADJ
ajmri-3091	10	2	disruptions	disruption	NOUN
ajmri-3091	10	3	were	be	AUX
ajmri-3091	10	4	substantially	substantially	ADV
ajmri-3091	10	5	correlated	correlate	VERB
ajmri-3091	10	6	with	with	ADP
ajmri-3091	10	7	marital	marital	ADJ
ajmri-3091	10	8	status	status	NOUN
ajmri-3091	10	9	(	(	PUNCT
ajmri-3091	10	10	p	p	X
ajmri-3091	10	11	=	=	NOUN
ajmri-3091	10	12	0.05	0.05	NUM
ajmri-3091	10	13	)	)	PUNCT
ajmri-3091	10	14	,	,	PUNCT
ajmri-3091	10	15	with	with	ADP
ajmri-3091	10	16	a	a	DET
ajmri-3091	10	17	significant	significant	ADJ
ajmri-3091	10	18	association	association	NOUN
ajmri-3091	10	19	between	between	ADP
ajmri-3091	10	20	the	the	DET
ajmri-3091	10	21	number	number	NOUN
ajmri-3091	10	22	of	of	ADP
ajmri-3091	10	23	covid-19	covid-19	PROPN
ajmri-3091	10	24	vaccine	vaccine	NOUN
ajmri-3091	10	25	doses	dose	NOUN
ajmri-3091	10	26	and	and	CCONJ
ajmri-3091	10	27	the	the	DET
ajmri-3091	10	28	occurrence	occurrence	NOUN
ajmri-3091	10	29	of	of	ADP
ajmri-3091	10	30	menstrual	menstrual	ADJ
ajmri-3091	10	31	disturbances	disturbance	NOUN
ajmri-3091	10	32	(	(	PUNCT
ajmri-3091	10	33	p	p	NOUN
ajmri-3091	10	34	=	=	NOUN
ajmri-3091	10	35	0.001	0.001	NUM
ajmri-3091	10	36	)	)	PUNCT
ajmri-3091	10	37	.	.	PUNCT
ajmri-3091	11	1	the	the	DET
ajmri-3091	11	2	administration	administration	NOUN
ajmri-3091	11	3	of	of	ADP
ajmri-3091	11	4	the	the	DET
ajmri-3091	11	5	vaccination	vaccination	NOUN
ajmri-3091	11	6	during	during	ADP
ajmri-3091	11	7	menstruation	menstruation	NOUN
ajmri-3091	11	8	was	be	AUX
ajmri-3091	11	9	linked	link	VERB
ajmri-3091	11	10	to	to	ADP
ajmri-3091	11	11	a	a	DET
ajmri-3091	11	12	notable	notable	ADJ
ajmri-3091	11	13	occurrence	occurrence	NOUN
ajmri-3091	11	14	of	of	ADP
ajmri-3091	11	15	menstrual	menstrual	ADJ
ajmri-3091	11	16	disturbances	disturbance	NOUN
ajmri-3091	11	17	,	,	PUNCT
ajmri-3091	11	18	although	although	SCONJ
ajmri-3091	11	19	the	the	DET
ajmri-3091	11	20	p	p	NOUN
ajmri-3091	11	21	-	-	PUNCT
ajmri-3091	11	22	value	value	NOUN
ajmri-3091	11	23	showed	show	VERB
ajmri-3091	11	24	no	no	DET
ajmri-3091	11	25	statistical	statistical	ADJ
ajmri-3091	11	26	significance	significance	NOUN
ajmri-3091	11	27	.	.	PUNCT
ajmri-3091	12	1	a	a	DET
ajmri-3091	12	2	significant	significant	ADJ
ajmri-3091	12	3	correlation	correlation	NOUN
ajmri-3091	12	4	was	be	AUX
ajmri-3091	12	5	examined	examine	VERB
ajmri-3091	12	6	(	(	PUNCT
ajmri-3091	12	7	p	p	X
ajmri-3091	12	8	<	<	X
ajmri-3091	12	9	0.05	0.05	NUM
ajmri-3091	12	10	)	)	PUNCT
ajmri-3091	12	11	between	between	ADP
ajmri-3091	12	12	pre	pre	ADJ
ajmri-3091	12	13	-	-	ADJ
ajmri-3091	12	14	existing	exist	VERB
ajmri-3091	12	15	menstrual	menstrual	ADJ
ajmri-3091	12	16	problems	problem	NOUN
ajmri-3091	12	17	and	and	CCONJ
ajmri-3091	12	18	the	the	DET
ajmri-3091	12	19	occurrence	occurrence	NOUN
ajmri-3091	12	20	of	of	ADP
ajmri-3091	12	21	disorders	disorder	NOUN
ajmri-3091	12	22	after	after	ADP
ajmri-3091	12	23	receiving	receive	VERB
ajmri-3091	12	24	the	the	DET
ajmri-3091	12	25	covid-19	covid-19	PROPN
ajmri-3091	12	26	vaccine	vaccine	NOUN
ajmri-3091	12	27	(	(	PUNCT
ajmri-3091	12	28	p	p	X
ajmri-3091	12	29	<	<	X
ajmri-3091	12	30	0.05	0.05	NUM
ajmri-3091	12	31	)	)	PUNCT
ajmri-3091	12	32	.	.	PUNCT
ajmri-3091	13	1	the	the	DET
ajmri-3091	13	2	study	study	NOUN
ajmri-3091	13	3	emphasised	emphasise	VERB
ajmri-3091	13	4	the	the	DET
ajmri-3091	13	5	importance	importance	NOUN
ajmri-3091	13	6	of	of	ADP
ajmri-3091	13	7	tailored	tailor	VERB
ajmri-3091	13	8	healthcare	healthcare	NOUN
ajmri-3091	13	9	treatments	treatment	NOUN
ajmri-3091	13	10	for	for	ADP
ajmri-3091	13	11	women	woman	NOUN
ajmri-3091	13	12	following	follow	VERB
ajmri-3091	13	13	covid-19	covid-19	PROPN
ajmri-3091	13	14	vaccination	vaccination	NOUN
ajmri-3091	13	15	and	and	CCONJ
ajmri-3091	13	16	the	the	DET
ajmri-3091	13	17	need	need	NOUN
ajmri-3091	13	18	for	for	ADP
ajmri-3091	13	19	regular	regular	ADJ
ajmri-3091	13	20	evaluation	evaluation	NOUN
ajmri-3091	13	21	of	of	ADP
ajmri-3091	13	22	reproductive	reproductive	ADJ
ajmri-3091	13	23	health	health	NOUN
ajmri-3091	13	24	outcomes	outcome	NOUN
ajmri-3091	13	25	post	post	ADJ
ajmri-3091	13	26	-	-	ADJ
ajmri-3091	13	27	covid-19	covid-19	ADJ
ajmri-3091	13	28	vaccination	vaccination	NOUN
ajmri-3091	13	29	.	.	PUNCT
ajmri-3091	14	1	keywords	keyword	VERB
ajmri-3091	14	2	contraceptive	contraceptive	ADJ
ajmri-3091	14	3	pills	pill	NOUN
ajmri-3091	14	4	,	,	PUNCT
ajmri-3091	14	5	covid-19	covid-19	PROPN
ajmri-3091	14	6	vaccine	vaccine	NOUN
ajmri-3091	14	7	,	,	PUNCT
ajmri-3091	14	8	menstrual	menstrual	ADJ
ajmri-3091	14	9	cycle	cycle	NOUN
ajmri-3091	14	10	,	,	PUNCT
ajmri-3091	14	11	oligomenorrhea	oligomenorrhea	PROPN
ajmri-3091	14	12	,	,	PUNCT
ajmri-3091	14	13	polycystic	polycystic	ADJ
ajmri-3091	14	14	ovaries	ovary	NOUN
ajmri-3091	14	15	introduction	introduction	NOUN
ajmri-3091	14	16	the	the	DET
ajmri-3091	14	17	menstrual	menstrual	ADJ
ajmri-3091	14	18	cycle	cycle	NOUN
ajmri-3091	14	19	is	be	AUX
ajmri-3091	14	20	a	a	DET
ajmri-3091	14	21	regular	regular	ADJ
ajmri-3091	14	22	and	and	CCONJ
ajmri-3091	14	23	natural	natural	ADJ
ajmri-3091	14	24	process	process	NOUN
ajmri-3091	14	25	that	that	PRON
ajmri-3091	14	26	occurs	occur	VERB
ajmri-3091	14	27	within	within	ADP
ajmri-3091	14	28	the	the	DET
ajmri-3091	14	29	female	female	ADJ
ajmri-3091	14	30	reproductive	reproductive	ADJ
ajmri-3091	14	31	system	system	NOUN
ajmri-3091	14	32	(	(	PUNCT
ajmri-3091	14	33	schmalenberger	schmalenberger	NOUN
ajmri-3091	14	34	et	et	PROPN
ajmri-3091	14	35	al	al	PROPN
ajmri-3091	14	36	.	.	PROPN
ajmri-3091	14	37	,	,	PUNCT
ajmri-3091	14	38	2021	2021	NUM
ajmri-3091	14	39	)	)	PUNCT
ajmri-3091	14	40	.	.	PUNCT
ajmri-3091	15	1	the	the	DET
ajmri-3091	15	2	reproductive	reproductive	ADJ
ajmri-3091	15	3	cycle	cycle	NOUN
ajmri-3091	15	4	starts	start	VERB
ajmri-3091	15	5	with	with	ADP
ajmri-3091	15	6	menarche	menarche	NOUN
ajmri-3091	15	7	,	,	PUNCT
ajmri-3091	15	8	the	the	DET
ajmri-3091	15	9	initial	initial	ADJ
ajmri-3091	15	10	occurrence	occurrence	NOUN
ajmri-3091	15	11	of	of	ADP
ajmri-3091	15	12	menstruation	menstruation	NOUN
ajmri-3091	15	13	in	in	ADP
ajmri-3091	15	14	adolescence	adolescence	NOUN
ajmri-3091	15	15	,	,	PUNCT
ajmri-3091	15	16	and	and	CCONJ
ajmri-3091	15	17	ends	end	VERB
ajmri-3091	15	18	with	with	ADP
ajmri-3091	15	19	menopause	menopause	NOUN
ajmri-3091	15	20	,	,	PUNCT
ajmri-3091	15	21	a	a	DET
ajmri-3091	15	22	stage	stage	NOUN
ajmri-3091	15	23	that	that	PRON
ajmri-3091	15	24	facilitates	facilitate	VERB
ajmri-3091	15	25	fertilisation	fertilisation	NOUN
ajmri-3091	15	26	and	and	CCONJ
ajmri-3091	15	27	potential	potential	ADJ
ajmri-3091	15	28	pregnancy	pregnancy	NOUN
ajmri-3091	15	29	(	(	PUNCT
ajmri-3091	15	30	patricio	patricio	PROPN
ajmri-3091	15	31	&	&	CCONJ
ajmri-3091	15	32	sergio	sergio	PROPN
ajmri-3091	15	33	,	,	PUNCT
ajmri-3091	15	34	2019	2019	NUM
ajmri-3091	15	35	;	;	PUNCT
ajmri-3091	15	36	vogazianou	vogazianou	ADJ
ajmri-3091	15	37	,	,	PUNCT
ajmri-3091	15	38	2019	2019	NUM
ajmri-3091	15	39	)	)	PUNCT
ajmri-3091	15	40	.	.	PUNCT
ajmri-3091	16	1	the	the	DET
ajmri-3091	16	2	duration	duration	NOUN
ajmri-3091	16	3	of	of	ADP
ajmri-3091	16	4	healthy	healthy	ADJ
ajmri-3091	16	5	menstrual	menstrual	ADJ
ajmri-3091	16	6	cycles	cycle	NOUN
ajmri-3091	16	7	can	can	AUX
ajmri-3091	16	8	range	range	VERB
ajmri-3091	16	9	from	from	ADP
ajmri-3091	16	10	21	21	NUM
ajmri-3091	16	11	to	to	PART
ajmri-3091	16	12	37	37	NUM
ajmri-3091	16	13	days	day	NOUN
ajmri-3091	16	14	,	,	PUNCT
ajmri-3091	16	15	with	with	ADP
ajmri-3091	16	16	cycles	cycle	NOUN
ajmri-3091	16	17	<	<	X
ajmri-3091	16	18	21	21	NUM
ajmri-3091	16	19	days	day	NOUN
ajmri-3091	16	20	being	be	AUX
ajmri-3091	16	21	identified	identify	VERB
ajmri-3091	16	22	as	as	ADP
ajmri-3091	16	23	polymenorrhea	polymenorrhea	PROPN
ajmri-3091	16	24	and	and	CCONJ
ajmri-3091	16	25	cycles	cycle	NOUN
ajmri-3091	16	26	>	>	X
ajmri-3091	16	27	37	37	NUM
ajmri-3091	16	28	days	day	NOUN
ajmri-3091	16	29	as	as	ADP
ajmri-3091	16	30	oligomenorrhea	oligomenorrhea	PROPN
ajmri-3091	16	31	(	(	PUNCT
ajmri-3091	16	32	de	de	X
ajmri-3091	16	33	sanctis	sanctis	PROPN
ajmri-3091	16	34	et	et	PROPN
ajmri-3091	16	35	al	al	PROPN
ajmri-3091	16	36	.	.	PROPN
ajmri-3091	16	37	,	,	PUNCT
ajmri-3091	16	38	2014	2014	NUM
ajmri-3091	16	39	)	)	PUNCT
ajmri-3091	16	40	.	.	PUNCT
ajmri-3091	17	1	typically	typically	ADV
ajmri-3091	17	2	,	,	PUNCT
ajmri-3091	17	3	a	a	DET
ajmri-3091	17	4	normal	normal	ADJ
ajmri-3091	17	5	menstrual	menstrual	ADJ
ajmri-3091	17	6	cycle	cycle	NOUN
ajmri-3091	17	7	lasts	last	VERB
ajmri-3091	17	8	for	for	ADP
ajmri-3091	17	9	28	28	NUM
ajmri-3091	17	10	days	day	NOUN
ajmri-3091	17	11	,	,	PUNCT
ajmri-3091	17	12	starting	start	VERB
ajmri-3091	17	13	from	from	ADP
ajmri-3091	17	14	the	the	DET
ajmri-3091	17	15	beginning	beginning	NOUN
ajmri-3091	17	16	of	of	ADP
ajmri-3091	17	17	menstruation	menstruation	NOUN
ajmri-3091	17	18	and	and	CCONJ
ajmri-3091	17	19	ending	end	VERB
ajmri-3091	17	20	the	the	DET
ajmri-3091	17	21	day	day	NOUN
ajmri-3091	17	22	before	before	ADP
ajmri-3091	17	23	the	the	DET
ajmri-3091	17	24	next	next	ADJ
ajmri-3091	17	25	period	period	NOUN
ajmri-3091	17	26	onset	onset	NOUN
ajmri-3091	17	27	(	(	PUNCT
ajmri-3091	17	28	thiyagarajan	thiyagarajan	NOUN
ajmri-3091	17	29	et	et	PROPN
ajmri-3091	17	30	al	al	PROPN
ajmri-3091	17	31	.	.	PROPN
ajmri-3091	17	32	,	,	PUNCT
ajmri-3091	17	33	2022	2022	NUM
ajmri-3091	17	34	)	)	PUNCT
ajmri-3091	17	35	.	.	PUNCT
ajmri-3091	18	1	estradiol	estradiol	PROPN
ajmri-3091	18	2	or	or	CCONJ
ajmri-3091	18	3	estrogen	estrogen	NOUN
ajmri-3091	18	4	(	(	PUNCT
ajmri-3091	18	5	e2	e2	PROPN
ajmri-3091	18	6	)	)	PUNCT
ajmri-3091	18	7	and	and	CCONJ
ajmri-3091	18	8	progesterone	progesterone	NOUN
ajmri-3091	18	9	(	(	PUNCT
ajmri-3091	18	10	p4	p4	ADJ
ajmri-3091	18	11	)	)	PUNCT
ajmri-3091	18	12	exhibit	exhibit	VERB
ajmri-3091	18	13	regular	regular	ADJ
ajmri-3091	18	14	variations	variation	NOUN
ajmri-3091	18	15	in	in	ADP
ajmri-3091	18	16	hormone	hormone	NOUN
ajmri-3091	18	17	levels	level	NOUN
ajmri-3091	18	18	that	that	PRON
ajmri-3091	18	19	regulate	regulate	VERB
ajmri-3091	18	20	this	this	DET
ajmri-3091	18	21	cyclic	cyclic	ADJ
ajmri-3091	18	22	process	process	NOUN
ajmri-3091	18	23	(	(	PUNCT
ajmri-3091	18	24	schmalenberger	schmalenberger	NOUN
ajmri-3091	18	25	et	et	PROPN
ajmri-3091	18	26	al	al	PROPN
ajmri-3091	18	27	.	.	PROPN
ajmri-3091	18	28	,	,	PUNCT
ajmri-3091	18	29	2021	2021	NUM
ajmri-3091	18	30	)	)	PUNCT
ajmri-3091	18	31	.	.	PUNCT
ajmri-3091	19	1	the	the	DET
ajmri-3091	19	2	follicular	follicular	ADJ
ajmri-3091	19	3	phase	phase	NOUN
ajmri-3091	19	4	,	,	PUNCT
ajmri-3091	19	5	originating	originate	VERB
ajmri-3091	19	6	with	with	ADP
ajmri-3091	19	7	menstruation	menstruation	NOUN
ajmri-3091	19	8	and	and	CCONJ
ajmri-3091	19	9	extending	extend	VERB
ajmri-3091	19	10	until	until	ADP
ajmri-3091	19	11	ovulation	ovulation	NOUN
ajmri-3091	19	12	,	,	PUNCT
ajmri-3091	19	13	can	can	AUX
ajmri-3091	19	14	be	be	AUX
ajmri-3091	19	15	identified	identify	VERB
ajmri-3091	19	16	by	by	ADP
ajmri-3091	19	17	the	the	DET
ajmri-3091	19	18	development	development	NOUN
ajmri-3091	19	19	of	of	ADP
ajmri-3091	19	20	ovarian	ovarian	ADJ
ajmri-3091	19	21	follicles	follicle	NOUN
ajmri-3091	19	22	containing	contain	VERB
ajmri-3091	19	23	oocytes	oocyte	NOUN
ajmri-3091	19	24	.	.	PUNCT
ajmri-3091	20	1	during	during	ADP
ajmri-3091	20	2	this	this	DET
ajmri-3091	20	3	stage	stage	NOUN
ajmri-3091	20	4	,	,	PUNCT
ajmri-3091	20	5	the	the	DET
ajmri-3091	20	6	levels	level	NOUN
ajmri-3091	20	7	of	of	ADP
ajmri-3091	20	8	p4	p4	ADJ
ajmri-3091	20	9	remain	remain	VERB
ajmri-3091	20	10	low	low	ADJ
ajmri-3091	20	11	,	,	PUNCT
ajmri-3091	20	12	while	while	SCONJ
ajmri-3091	20	13	the	the	DET
ajmri-3091	20	14	levels	level	NOUN
ajmri-3091	20	15	of	of	ADP
ajmri-3091	20	16	e2	e2	PROPN
ajmri-3091	20	17	gradually	gradually	ADV
ajmri-3091	20	18	increase	increase	VERB
ajmri-3091	20	19	as	as	SCONJ
ajmri-3091	20	20	they	they	PRON
ajmri-3091	20	21	achieve	achieve	VERB
ajmri-3091	20	22	a	a	DET
ajmri-3091	20	23	preovulatory	preovulatory	ADJ
ajmri-3091	20	24	surge	surge	NOUN
ajmri-3091	20	25	(	(	PUNCT
ajmri-3091	20	26	murray	murray	PROPN
ajmri-3091	20	27	&	&	CCONJ
ajmri-3091	20	28	orr	orr	PROPN
ajmri-3091	20	29	,	,	PUNCT
ajmri-3091	20	30	2020	2020	NUM
ajmri-3091	20	31	)	)	PUNCT
ajmri-3091	20	32	.	.	PUNCT
ajmri-3091	21	1	in	in	ADP
ajmri-3091	21	2	the	the	DET
ajmri-3091	21	3	following	follow	VERB
ajmri-3091	21	4	luteal	luteal	ADJ
ajmri-3091	21	5	phase	phase	NOUN
ajmri-3091	21	6	,	,	PUNCT
ajmri-3091	21	7	which	which	PRON
ajmri-3091	21	8	occurs	occur	VERB
ajmri-3091	21	9	after	after	ADP
ajmri-3091	21	10	ovulation	ovulation	NOUN
ajmri-3091	21	11	until	until	ADP
ajmri-3091	21	12	the	the	DET
ajmri-3091	21	13	start	start	NOUN
ajmri-3091	21	14	of	of	ADP
ajmri-3091	21	15	menstruation	menstruation	NOUN
ajmri-3091	21	16	,	,	PUNCT
ajmri-3091	21	17	the	the	DET
ajmri-3091	21	18	primary	primary	ADJ
ajmri-3091	21	19	follicle	follicle	NOUN
ajmri-3091	21	20	transforms	transform	VERB
ajmri-3091	21	21	into	into	ADP
ajmri-3091	21	22	the	the	DET
ajmri-3091	21	23	corpus	corpus	NOUN
ajmri-3091	21	24	luteum	luteum	NOUN
ajmri-3091	21	25	,	,	PUNCT
ajmri-3091	21	26	which	which	PRON
ajmri-3091	21	27	releases	release	VERB
ajmri-3091	21	28	progesterone	progesterone	NOUN
ajmri-3091	21	29	and	and	CCONJ
ajmri-3091	21	30	estrogen	estrogen	NOUN
ajmri-3091	21	31	(	(	PUNCT
ajmri-3091	21	32	barbieri	barbieri	PROPN
ajmri-3091	21	33	,	,	PUNCT
ajmri-3091	21	34	2014	2014	NUM
ajmri-3091	21	35	;	;	PUNCT
ajmri-3091	21	36	k.	k.	PROPN
ajmri-3091	21	37	schmalenberger	schmalenberger	PROPN
ajmri-3091	21	38	et	et	PROPN
ajmri-3091	21	39	al	al	PROPN
ajmri-3091	21	40	.	.	PROPN
ajmri-3091	21	41	,	,	PUNCT
ajmri-3091	21	42	2021	2021	NUM
ajmri-3091	21	43	)	)	PUNCT
ajmri-3091	21	44	.	.	PUNCT
ajmri-3091	22	1	during	during	ADP
ajmri-3091	22	2	the	the	DET
ajmri-3091	22	3	mid	mid	ADJ
ajmri-3091	22	4	-	-	ADJ
ajmri-3091	22	5	luteal	luteal	ADJ
ajmri-3091	22	6	phase	phase	NOUN
ajmri-3091	22	7	,	,	PUNCT
ajmri-3091	22	8	there	there	PRON
ajmri-3091	22	9	is	be	VERB
ajmri-3091	22	10	a	a	DET
ajmri-3091	22	11	noticeable	noticeable	ADJ
ajmri-3091	22	12	increase	increase	NOUN
ajmri-3091	22	13	in	in	ADP
ajmri-3091	22	14	p4	p4	ADJ
ajmri-3091	22	15	levels	level	NOUN
ajmri-3091	22	16	,	,	PUNCT
ajmri-3091	22	17	reaching	reach	VERB
ajmri-3091	22	18	their	their	PRON
ajmri-3091	22	19	highest	high	ADJ
ajmri-3091	22	20	point	point	NOUN
ajmri-3091	22	21	,	,	PUNCT
ajmri-3091	22	22	as	as	ADV
ajmri-3091	22	23	well	well	ADV
ajmri-3091	22	24	as	as	ADP
ajmri-3091	22	25	a	a	DET
ajmri-3091	22	26	subsequent	subsequent	ADJ
ajmri-3091	22	27	spike	spike	NOUN
ajmri-3091	22	28	in	in	ADP
ajmri-3091	22	29	e2	e2	PROPN
ajmri-3091	22	30	levels	level	NOUN
ajmri-3091	22	31	.	.	PUNCT
ajmri-3091	23	1	the	the	DET
ajmri-3091	23	2	corpus	corpus	NOUN
ajmri-3091	23	3	luteum	luteum	NOUN
ajmri-3091	23	4	is	be	AUX
ajmri-3091	23	5	involved	involve	VERB
ajmri-3091	23	6	in	in	ADP
ajmri-3091	23	7	the	the	DET
ajmri-3091	23	8	event	event	NOUN
ajmri-3091	23	9	that	that	SCONJ
ajmri-3091	23	10	fertilisation	fertilisation	NOUN
ajmri-3091	23	11	is	be	AUX
ajmri-3091	23	12	unsuccessful	unsuccessful	ADJ
ajmri-3091	23	13	,	,	PUNCT
ajmri-3091	23	14	which	which	PRON
ajmri-3091	23	15	results	result	VERB
ajmri-3091	23	16	in	in	ADP
ajmri-3091	23	17	a	a	DET
ajmri-3091	23	18	perimenstrual	perimenstrual	ADJ
ajmri-3091	23	19	decline	decline	NOUN
ajmri-3091	23	20	in	in	ADP
ajmri-3091	23	21	e2	e2	PROPN
ajmri-3091	23	22	and	and	CCONJ
ajmri-3091	23	23	p4	p4	NOUN
ajmri-3091	23	24	and	and	CCONJ
ajmri-3091	23	25	the	the	DET
ajmri-3091	23	26	start	start	NOUN
ajmri-3091	23	27	of	of	ADP
ajmri-3091	23	28	menstruation	menstruation	NOUN
ajmri-3091	23	29	(	(	PUNCT
ajmri-3091	23	30	reed	reed	PROPN
ajmri-3091	23	31	&	&	CCONJ
ajmri-3091	23	32	carr	carr	PROPN
ajmri-3091	23	33	,	,	PUNCT
ajmri-3091	23	34	2015	2015	NUM
ajmri-3091	23	35	)	)	PUNCT
ajmri-3091	23	36	.	.	PUNCT
ajmri-3091	24	1	this	this	DET
ajmri-3091	24	2	cycle	cycle	NOUN
ajmri-3091	24	3	continues	continue	VERB
ajmri-3091	24	4	with	with	ADP
ajmri-3091	24	5	the	the	DET
ajmri-3091	24	6	onset	onset	NOUN
ajmri-3091	24	7	of	of	ADP
ajmri-3091	24	8	the	the	DET
ajmri-3091	24	9	subsequent	subsequent	ADJ
ajmri-3091	24	10	menstrual	menstrual	ADJ
ajmri-3091	24	11	period	period	NOUN
ajmri-3091	24	12	(	(	PUNCT
ajmri-3091	24	13	schmalenberger	schmalenberger	NOUN
ajmri-3091	24	14	et	et	PROPN
ajmri-3091	24	15	al	al	PROPN
ajmri-3091	24	16	.	.	PROPN
ajmri-3091	24	17	,	,	PUNCT
ajmri-3091	24	18	2021	2021	NUM
ajmri-3091	24	19	)	)	PUNCT
ajmri-3091	24	20	.	.	PUNCT
ajmri-3091	25	1	numerous	numerous	ADJ
ajmri-3091	25	2	experimental	experimental	ADJ
ajmri-3091	25	3	and	and	CCONJ
ajmri-3091	25	4	long	long	ADJ
ajmri-3091	25	5	-	-	PUNCT
ajmri-3091	25	6	term	term	NOUN
ajmri-3091	25	7	studies	study	NOUN
ajmri-3091	25	8	validate	validate	VERB
ajmri-3091	25	9	the	the	DET
ajmri-3091	25	10	presence	presence	NOUN
ajmri-3091	25	11	of	of	ADP
ajmri-3091	25	12	a	a	DET
ajmri-3091	25	13	particular	particular	ADJ
ajmri-3091	25	14	subset	subset	NOUN
ajmri-3091	25	15	of	of	ADP
ajmri-3091	25	16	females	female	NOUN
ajmri-3091	25	17	who	who	PRON
ajmri-3091	25	18	exhibit	exhibit	VERB
ajmri-3091	25	19	an	an	DET
ajmri-3091	25	20	abnormal	abnormal	ADJ
ajmri-3091	25	21	response	response	NOUN
ajmri-3091	25	22	to	to	ADP
ajmri-3091	25	23	regular	regular	ADJ
ajmri-3091	25	24	changes	change	NOUN
ajmri-3091	25	25	in	in	ADP
ajmri-3091	25	26	ovarian	ovarian	ADJ
ajmri-3091	25	27	hormone	hormone	NOUN
ajmri-3091	25	28	levels	level	NOUN
ajmri-3091	25	29	(	(	PUNCT
ajmri-3091	25	30	berga	berga	NOUN
ajmri-3091	25	31	,	,	PUNCT
ajmri-3091	25	32	2020	2020	NUM
ajmri-3091	25	33	;	;	PUNCT
ajmri-3091	25	34	wei	wei	PROPN
ajmri-3091	25	35	et	et	PROPN
ajmri-3091	25	36	al	al	PROPN
ajmri-3091	25	37	.	.	PROPN
ajmri-3091	25	38	,	,	PUNCT
ajmri-3091	25	39	2018	2018	NUM
ajmri-3091	25	40	)	)	PUNCT
ajmri-3091	25	41	.	.	PUNCT
ajmri-3091	26	1	the	the	DET
ajmri-3091	26	2	condition	condition	NOUN
ajmri-3091	26	3	manifests	manifest	VERB
ajmri-3091	26	4	as	as	ADP
ajmri-3091	26	5	behavioural	behavioural	ADJ
ajmri-3091	26	6	,	,	PUNCT
ajmri-3091	26	7	emotional	emotional	ADJ
ajmri-3091	26	8	,	,	PUNCT
ajmri-3091	26	9	and	and	CCONJ
ajmri-3091	26	10	cognitive	cognitive	ADJ
ajmri-3091	26	11	symptoms	symptom	NOUN
ajmri-3091	26	12	that	that	PRON
ajmri-3091	26	13	primarily	primarily	ADV
ajmri-3091	26	14	occur	occur	VERB
ajmri-3091	26	15	during	during	ADP
ajmri-3091	26	16	the	the	DET
ajmri-3091	26	17	usual	usual	ADJ
ajmri-3091	26	18	hormonal	hormonal	ADJ
ajmri-3091	26	19	changes	change	NOUN
ajmri-3091	26	20	observed	observe	VERB
ajmri-3091	26	21	in	in	ADP
ajmri-3091	26	22	the	the	DET
ajmri-3091	26	23	premenstrual	premenstrual	ADJ
ajmri-3091	26	24	and	and	CCONJ
ajmri-3091	26	25	mid	mid	ADJ
ajmri-3091	26	26	-	-	ADJ
ajmri-3091	26	27	luteal	luteal	ADJ
ajmri-3091	26	28	phases	phase	NOUN
ajmri-3091	26	29	of	of	ADP
ajmri-3091	26	30	the	the	DET
ajmri-3091	26	31	menstrual	menstrual	ADJ
ajmri-3091	26	32	cycle	cycle	NOUN
ajmri-3091	26	33	(	(	PUNCT
ajmri-3091	26	34	schmalenberger	schmalenberger	NOUN
ajmri-3091	26	35	et	et	PROPN
ajmri-3091	26	36	al	al	PROPN
ajmri-3091	26	37	.	.	PROPN
ajmri-3091	26	38	,	,	PUNCT
ajmri-3091	26	39	2021	2021	NUM
ajmri-3091	26	40	)	)	PUNCT
ajmri-3091	26	41	.	.	PUNCT
ajmri-3091	27	1	a	a	DET
ajmri-3091	27	2	woman	woman	NOUN
ajmri-3091	27	3	’s	’s	PART
ajmri-3091	27	4	menstrual	menstrual	ADJ
ajmri-3091	27	5	cycle	cycle	NOUN
ajmri-3091	27	6	may	may	AUX
ajmri-3091	27	7	exhibit	exhibit	VERB
ajmri-3091	27	8	abnormal	abnormal	ADJ
ajmri-3091	27	9	or	or	CCONJ
ajmri-3091	27	10	unusual	unusual	ADJ
ajmri-3091	27	11	characteristics	characteristic	NOUN
ajmri-3091	27	12	.	.	PUNCT
ajmri-3091	28	1	menstrual	menstrual	ADJ
ajmri-3091	28	2	cycle	cycle	NOUN
ajmri-3091	28	3	disorders	disorder	NOUN
ajmri-3091	28	4	encompass	encompass	VERB
ajmri-3091	28	5	dysmenorrhea	dysmenorrhea	ADJ
ajmri-3091	28	6	,	,	PUNCT
ajmri-3091	28	7	amenorrhea	amenorrhea	PROPN
ajmri-3091	28	8	lasting	last	VERB
ajmri-3091	28	9	at	at	ADP
ajmri-3091	28	10	least	least	ADV
ajmri-3091	28	11	three	three	NUM
ajmri-3091	28	12	months	month	NOUN
ajmri-3091	28	13	in	in	ADP
ajmri-3091	28	14	the	the	DET
ajmri-3091	28	15	absence	absence	NOUN
ajmri-3091	28	16	of	of	ADP
ajmri-3091	28	17	pregnancy	pregnancy	NOUN
ajmri-3091	28	18	,	,	PUNCT
ajmri-3091	28	19	and	and	CCONJ
ajmri-3091	28	20	menorrhagia	menorrhagia	NOUN
ajmri-3091	28	21	,	,	PUNCT
ajmri-3091	28	22	which	which	PRON
ajmri-3091	28	23	refers	refer	VERB
ajmri-3091	28	24	to	to	ADP
ajmri-3091	28	25	heavy	heavy	ADJ
ajmri-3091	28	26	bleeding	bleeding	NOUN
ajmri-3091	28	27	.	.	PUNCT
ajmri-3091	29	1	approximately	approximately	ADV
ajmri-3091	29	2	14	14	NUM
ajmri-3091	29	3	%	%	NOUN
ajmri-3091	29	4	to	to	PART
ajmri-3091	29	5	25	25	NUM
ajmri-3091	29	6	%	%	NOUN
ajmri-3091	29	7	of	of	ADP
ajmri-3091	29	8	women	woman	NOUN
ajmri-3091	29	9	experience	experience	VERB
ajmri-3091	29	10	menstrual	menstrual	ADJ
ajmri-3091	29	11	irregularities	irregularity	NOUN
ajmri-3091	29	12	during	during	ADP
ajmri-3091	29	13	childbearing	childbearing	NOUN
ajmri-3091	29	14	,	,	PUNCT
ajmri-3091	29	15	and	and	CCONJ
ajmri-3091	29	16	these	these	DET
ajmri-3091	29	17	irregularities	irregularity	NOUN
ajmri-3091	29	18	may	may	AUX
ajmri-3091	29	19	differ	differ	VERB
ajmri-3091	29	20	between	between	ADP
ajmri-3091	29	21	women	woman	NOUN
ajmri-3091	29	22	(	(	PUNCT
ajmri-3091	29	23	male	male	NOUN
ajmri-3091	29	24	,	,	PUNCT
ajmri-3091	29	25	2021	2021	NUM
ajmri-3091	29	26	)	)	PUNCT
ajmri-3091	29	27	.	.	PUNCT
ajmri-3091	30	1	however	however	ADV
ajmri-3091	30	2	,	,	PUNCT
ajmri-3091	30	3	irregular	irregular	ADJ
ajmri-3091	30	4	menstruation	menstruation	NOUN
ajmri-3091	30	5	can	can	AUX
ajmri-3091	30	6	occur	occur	VERB
ajmri-3091	30	7	due	due	ADJ
ajmri-3091	30	8	to	to	ADP
ajmri-3091	30	9	hormonal	hormonal	ADJ
ajmri-3091	30	10	imbalances	imbalance	NOUN
ajmri-3091	30	11	,	,	PUNCT
ajmri-3091	30	12	pregnancy	pregnancy	NOUN
ajmri-3091	30	13	,	,	PUNCT
ajmri-3091	30	14	trauma	trauma	NOUN
ajmri-3091	30	15	,	,	PUNCT
ajmri-3091	30	16	inflammation	inflammation	NOUN
ajmri-3091	30	17	,	,	PUNCT
ajmri-3091	30	18	and	and	CCONJ
ajmri-3091	30	19	infections	infection	NOUN
ajmri-3091	30	20	(	(	PUNCT
ajmri-3091	30	21	critchley	critchley	NOUN
ajmri-3091	30	22	et	et	PROPN
ajmri-3091	30	23	al	al	PROPN
ajmri-3091	30	24	.	.	PROPN
ajmri-3091	30	25	,	,	PUNCT
ajmri-3091	30	26	2020	2020	NUM
ajmri-3091	30	27	)	)	PUNCT
ajmri-3091	30	28	.	.	PUNCT
ajmri-3091	31	1	1	1	NUM
ajmri-3091	31	2	public	public	ADJ
ajmri-3091	31	3	health	health	NOUN
ajmri-3091	31	4	department	department	PROPN
ajmri-3091	31	5	,	,	PUNCT
ajmri-3091	31	6	college	college	NOUN
ajmri-3091	31	7	of	of	ADP
ajmri-3091	31	8	public	public	ADJ
ajmri-3091	31	9	health	health	NOUN
ajmri-3091	31	10	,	,	PUNCT
ajmri-3091	31	11	imam	imam	NOUN
ajmri-3091	31	12	abdurrahman	abdurrahman	NOUN
ajmri-3091	31	13	bin	bin	PROPN
ajmri-3091	31	14	fisal	fisal	PROPN
ajmri-3091	31	15	university	university	PROPN
ajmri-3091	31	16	,	,	PUNCT
ajmri-3091	31	17	dammam	dammam	PROPN
ajmri-3091	31	18	,	,	PUNCT
ajmri-3091	31	19	saudi	saudi	PROPN
ajmri-3091	31	20	arabia	arabia	PROPN
ajmri-3091	31	21	2	2	NUM
ajmri-3091	31	22	community	community	NOUN
ajmri-3091	31	23	health	health	NOUN
ajmri-3091	31	24	department	department	NOUN
ajmri-3091	31	25	,	,	PUNCT
ajmri-3091	31	26	college	college	NOUN
ajmri-3091	31	27	of	of	ADP
ajmri-3091	31	28	applied	apply	VERB
ajmri-3091	31	29	medical	medical	ADJ
ajmri-3091	31	30	sciences	science	NOUN
ajmri-3091	31	31	,	,	PUNCT
ajmri-3091	31	32	northern	northern	ADJ
ajmri-3091	31	33	border	border	NOUN
ajmri-3091	31	34	university	university	PROPN
ajmri-3091	31	35	,	,	PUNCT
ajmri-3091	31	36	arar	arar	PROPN
ajmri-3091	31	37	,	,	PUNCT
ajmri-3091	31	38	saudi	saudi	PROPN
ajmri-3091	31	39	arabia	arabia	PROPN
ajmri-3091	31	40	*	*	PUNCT
ajmri-3091	31	41	corresponding	correspond	VERB
ajmri-3091	31	42	author	author	NOUN
ajmri-3091	31	43	’s	’s	PART
ajmri-3091	31	44	e	e	NOUN
ajmri-3091	31	45	-	-	NOUN
ajmri-3091	31	46	mail	mail	NOUN
ajmri-3091	31	47	:	:	PUNCT
ajmri-3091	31	48	taghread.sa@gmail.com	taghread.sa@gmail.com	PROPN
ajmri-3091	32	1	pa	pa	PROPN
ajmri-3091	32	2	ge	ge	PROPN
ajmri-3091	32	3	13	13	NUM
ajmri-3091	32	4	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	32	5	am	am	NOUN
ajmri-3091	32	6	.	.	PUNCT
ajmri-3091	33	1	j.	j.	PROPN
ajmri-3091	33	2	multidis	multidis	PROPN
ajmri-3091	33	3	.	.	PUNCT
ajmri-3091	34	1	res	re	NOUN
ajmri-3091	34	2	.	.	PUNCT
ajmri-3091	35	1	innov	innov	PROPN
ajmri-3091	35	2	.	.	PUNCT
ajmri-3091	36	1	3(6	3(6	PROPN
ajmri-3091	36	2	)	)	PUNCT
ajmri-3091	36	3	12	12	NUM
ajmri-3091	36	4	-	-	SYM
ajmri-3091	36	5	24	24	NUM
ajmri-3091	36	6	,	,	PUNCT
ajmri-3091	36	7	2024	2024	NUM
ajmri-3091	36	8	additionally	additionally	ADV
ajmri-3091	36	9	,	,	PUNCT
ajmri-3091	36	10	physical	physical	ADJ
ajmri-3091	36	11	factors	factor	NOUN
ajmri-3091	36	12	like	like	ADP
ajmri-3091	36	13	excessive	excessive	ADJ
ajmri-3091	36	14	exercise	exercise	NOUN
ajmri-3091	36	15	,	,	PUNCT
ajmri-3091	36	16	unhealthy	unhealthy	ADJ
ajmri-3091	36	17	food	food	NOUN
ajmri-3091	36	18	,	,	PUNCT
ajmri-3091	36	19	and	and	CCONJ
ajmri-3091	36	20	stress	stress	NOUN
ajmri-3091	36	21	can	can	AUX
ajmri-3091	36	22	impact	impact	VERB
ajmri-3091	36	23	the	the	DET
ajmri-3091	36	24	menstrual	menstrual	ADJ
ajmri-3091	36	25	cycle	cycle	NOUN
ajmri-3091	36	26	(	(	PUNCT
ajmri-3091	36	27	huhmann	huhmann	NOUN
ajmri-3091	36	28	,	,	PUNCT
ajmri-3091	36	29	2020	2020	NUM
ajmri-3091	36	30	)	)	PUNCT
ajmri-3091	36	31	.	.	PUNCT
ajmri-3091	37	1	other	other	ADJ
ajmri-3091	37	2	health	health	NOUN
ajmri-3091	37	3	issues	issue	NOUN
ajmri-3091	37	4	like	like	ADP
ajmri-3091	37	5	thyroid	thyroid	NOUN
ajmri-3091	37	6	disorders	disorder	NOUN
ajmri-3091	37	7	,	,	PUNCT
ajmri-3091	37	8	liver	liver	NOUN
ajmri-3091	37	9	and	and	CCONJ
ajmri-3091	37	10	kidney	kidney	NOUN
ajmri-3091	37	11	diseases	disease	NOUN
ajmri-3091	37	12	,	,	PUNCT
ajmri-3091	37	13	and	and	CCONJ
ajmri-3091	37	14	certain	certain	ADJ
ajmri-3091	37	15	medications	medication	NOUN
ajmri-3091	37	16	like	like	ADP
ajmri-3091	37	17	anticoagulants	anticoagulant	NOUN
ajmri-3091	37	18	can	can	AUX
ajmri-3091	37	19	also	also	ADV
ajmri-3091	37	20	cause	cause	VERB
ajmri-3091	37	21	menstrual	menstrual	ADJ
ajmri-3091	37	22	changes	change	NOUN
ajmri-3091	37	23	(	(	PUNCT
ajmri-3091	37	24	gray	gray	ADJ
ajmri-3091	37	25	,	,	PUNCT
ajmri-3091	37	26	2013	2013	NUM
ajmri-3091	37	27	)	)	PUNCT
ajmri-3091	37	28	.	.	PUNCT
ajmri-3091	38	1	therefore	therefore	ADV
ajmri-3091	38	2	,	,	PUNCT
ajmri-3091	38	3	understanding	understand	VERB
ajmri-3091	38	4	these	these	DET
ajmri-3091	38	5	factors	factor	NOUN
ajmri-3091	38	6	is	be	AUX
ajmri-3091	38	7	crucial	crucial	ADJ
ajmri-3091	38	8	for	for	ADP
ajmri-3091	38	9	managing	manage	VERB
ajmri-3091	38	10	menstrual	menstrual	ADJ
ajmri-3091	38	11	cycles	cycle	NOUN
ajmri-3091	38	12	(	(	PUNCT
ajmri-3091	38	13	vladimirovna	vladimirovna	NOUN
ajmri-3091	38	14	et	et	PROPN
ajmri-3091	38	15	al	al	PROPN
ajmri-3091	38	16	.	.	PROPN
ajmri-3091	38	17	,	,	PUNCT
ajmri-3091	38	18	2023	2023	NUM
ajmri-3091	38	19	)	)	PUNCT
ajmri-3091	38	20	.	.	PUNCT
ajmri-3091	39	1	a	a	DET
ajmri-3091	39	2	gynaecologist	gynaecologist	NOUN
ajmri-3091	39	3	can	can	AUX
ajmri-3091	39	4	address	address	VERB
ajmri-3091	39	5	menstrual	menstrual	ADJ
ajmri-3091	39	6	issues	issue	NOUN
ajmri-3091	39	7	,	,	PUNCT
ajmri-3091	39	8	but	but	CCONJ
ajmri-3091	39	9	factors	factor	NOUN
ajmri-3091	39	10	like	like	ADP
ajmri-3091	39	11	medication	medication	NOUN
ajmri-3091	39	12	use	use	NOUN
ajmri-3091	39	13	,	,	PUNCT
ajmri-3091	39	14	cycle	cycle	NOUN
ajmri-3091	39	15	duration	duration	NOUN
ajmri-3091	39	16	,	,	PUNCT
ajmri-3091	39	17	and	and	CCONJ
ajmri-3091	39	18	gynaecological	gynaecological	ADJ
ajmri-3091	39	19	surgery	surgery	NOUN
ajmri-3091	39	20	increase	increase	VERB
ajmri-3091	39	21	the	the	DET
ajmri-3091	39	22	risk	risk	NOUN
ajmri-3091	39	23	.	.	PUNCT
ajmri-3091	40	1	symptoms	symptom	NOUN
ajmri-3091	40	2	can	can	AUX
ajmri-3091	40	3	be	be	AUX
ajmri-3091	40	4	alleviated	alleviate	VERB
ajmri-3091	40	5	with	with	ADP
ajmri-3091	40	6	dietary	dietary	ADJ
ajmri-3091	40	7	adjustments	adjustment	NOUN
ajmri-3091	40	8	,	,	PUNCT
ajmri-3091	40	9	hormone	hormone	NOUN
ajmri-3091	40	10	supplementation	supplementation	NOUN
ajmri-3091	40	11	,	,	PUNCT
ajmri-3091	40	12	oral	oral	ADJ
ajmri-3091	40	13	contraceptives	contraceptive	NOUN
ajmri-3091	40	14	,	,	PUNCT
ajmri-3091	40	15	diuretics	diuretic	NOUN
ajmri-3091	40	16	,	,	PUNCT
ajmri-3091	40	17	tranquillisers	tranquilliser	NOUN
ajmri-3091	40	18	,	,	PUNCT
ajmri-3091	40	19	antidepressants	antidepressant	NOUN
ajmri-3091	40	20	,	,	PUNCT
ajmri-3091	40	21	and	and	CCONJ
ajmri-3091	40	22	regular	regular	ADJ
ajmri-3091	40	23	physical	physical	ADJ
ajmri-3091	40	24	activity	activity	NOUN
ajmri-3091	40	25	(	(	PUNCT
ajmri-3091	40	26	roos	roo	NOUN
ajmri-3091	40	27	et	et	PROPN
ajmri-3091	40	28	al	al	PROPN
ajmri-3091	40	29	.	.	PROPN
ajmri-3091	40	30	,	,	PUNCT
ajmri-3091	40	31	2022	2022	NUM
ajmri-3091	40	32	)	)	PUNCT
ajmri-3091	40	33	.	.	PUNCT
ajmri-3091	41	1	vaccination	vaccination	NOUN
ajmri-3091	41	2	has	have	AUX
ajmri-3091	41	3	played	play	VERB
ajmri-3091	41	4	a	a	DET
ajmri-3091	41	5	major	major	ADJ
ajmri-3091	41	6	role	role	NOUN
ajmri-3091	41	7	in	in	ADP
ajmri-3091	41	8	keeping	keep	VERB
ajmri-3091	41	9	infectious	infectious	ADJ
ajmri-3091	41	10	diseases	disease	NOUN
ajmri-3091	41	11	under	under	ADP
ajmri-3091	41	12	control	control	NOUN
ajmri-3091	41	13	.	.	PUNCT
ajmri-3091	42	1	the	the	DET
ajmri-3091	42	2	emergence	emergence	NOUN
ajmri-3091	42	3	of	of	ADP
ajmri-3091	42	4	covid-19	covid-19	PROPN
ajmri-3091	42	5	triggered	trigger	VERB
ajmri-3091	42	6	a	a	DET
ajmri-3091	42	7	worldwide	worldwide	ADJ
ajmri-3091	42	8	health	health	NOUN
ajmri-3091	42	9	crisis	crisis	NOUN
ajmri-3091	42	10	,	,	PUNCT
ajmri-3091	42	11	prompting	prompt	VERB
ajmri-3091	42	12	the	the	DET
ajmri-3091	42	13	development	development	NOUN
ajmri-3091	42	14	of	of	ADP
ajmri-3091	42	15	numerous	numerous	ADJ
ajmri-3091	42	16	vaccines	vaccine	NOUN
ajmri-3091	42	17	and	and	CCONJ
ajmri-3091	42	18	the	the	DET
ajmri-3091	42	19	implementation	implementation	NOUN
ajmri-3091	42	20	of	of	ADP
ajmri-3091	42	21	widespread	widespread	ADJ
ajmri-3091	42	22	immunisation	immunisation	NOUN
ajmri-3091	42	23	programs	program	NOUN
ajmri-3091	42	24	across	across	ADP
ajmri-3091	42	25	the	the	DET
ajmri-3091	42	26	world	world	NOUN
ajmri-3091	42	27	(	(	PUNCT
ajmri-3091	42	28	sualeh	sualeh	PROPN
ajmri-3091	42	29	et	et	PROPN
ajmri-3091	42	30	al	al	PROPN
ajmri-3091	42	31	.	.	PROPN
ajmri-3091	42	32	,	,	PUNCT
ajmri-3091	42	33	2022	2022	NUM
ajmri-3091	42	34	)	)	PUNCT
ajmri-3091	42	35	.	.	PUNCT
ajmri-3091	43	1	several	several	ADJ
ajmri-3091	43	2	vaccines	vaccine	NOUN
ajmri-3091	43	3	were	be	AUX
ajmri-3091	43	4	developed	develop	VERB
ajmri-3091	43	5	to	to	PART
ajmri-3091	43	6	control	control	VERB
ajmri-3091	43	7	the	the	DET
ajmri-3091	43	8	infection	infection	NOUN
ajmri-3091	43	9	announced	announce	VERB
ajmri-3091	43	10	by	by	ADP
ajmri-3091	43	11	the	the	DET
ajmri-3091	43	12	world	world	PROPN
ajmri-3091	43	13	health	health	NOUN
ajmri-3091	43	14	organisation	organisation	NOUN
ajmri-3091	43	15	(	(	PUNCT
ajmri-3091	43	16	who	who	PRON
ajmri-3091	43	17	)	)	PUNCT
ajmri-3091	43	18	,	,	PUNCT
ajmri-3091	43	19	such	such	ADJ
ajmri-3091	43	20	as	as	ADP
ajmri-3091	43	21	sinopharm	sinopharm	NOUN
ajmri-3091	43	22	,	,	PUNCT
ajmri-3091	43	23	sinovac	sinovac	NOUN
ajmri-3091	43	24	,	,	PUNCT
ajmri-3091	43	25	novavax	novavax	NOUN
ajmri-3091	43	26	,	,	PUNCT
ajmri-3091	43	27	and	and	CCONJ
ajmri-3091	43	28	pfizer	pfizer	NOUN
ajmri-3091	43	29	(	(	PUNCT
ajmri-3091	43	30	bnt162b2	bnt162b2	PROPN
ajmri-3091	43	31	)	)	PUNCT
ajmri-3091	43	32	(	(	PUNCT
ajmri-3091	43	33	polack	polack	PROPN
ajmri-3091	43	34	et	et	PROPN
ajmri-3091	43	35	al	al	PROPN
ajmri-3091	43	36	.	.	PROPN
ajmri-3091	43	37	,	,	PUNCT
ajmri-3091	43	38	2020	2020	NUM
ajmri-3091	43	39	)	)	PUNCT
ajmri-3091	43	40	.	.	PUNCT
ajmri-3091	44	1	however	however	ADV
ajmri-3091	44	2	,	,	PUNCT
ajmri-3091	44	3	there	there	PRON
ajmri-3091	44	4	was	be	VERB
ajmri-3091	44	5	evidence	evidence	NOUN
ajmri-3091	44	6	of	of	ADP
ajmri-3091	44	7	vaccine	vaccine	NOUN
ajmri-3091	44	8	hesitation	hesitation	NOUN
ajmri-3091	44	9	,	,	PUNCT
ajmri-3091	44	10	particularly	particularly	ADV
ajmri-3091	44	11	among	among	ADP
ajmri-3091	44	12	women	woman	NOUN
ajmri-3091	44	13	of	of	ADP
ajmri-3091	44	14	reproductive	reproductive	ADJ
ajmri-3091	44	15	age	age	NOUN
ajmri-3091	44	16	who	who	PRON
ajmri-3091	44	17	were	be	AUX
ajmri-3091	44	18	concerned	concern	VERB
ajmri-3091	44	19	that	that	SCONJ
ajmri-3091	44	20	the	the	DET
ajmri-3091	44	21	vaccination	vaccination	NOUN
ajmri-3091	44	22	may	may	AUX
ajmri-3091	44	23	interfere	interfere	VERB
ajmri-3091	44	24	with	with	ADP
ajmri-3091	44	25	their	their	PRON
ajmri-3091	44	26	menstrual	menstrual	ADJ
ajmri-3091	44	27	cycle	cycle	NOUN
ajmri-3091	44	28	(	(	PUNCT
ajmri-3091	44	29	sualeh	sualeh	NOUN
ajmri-3091	44	30	et	et	PROPN
ajmri-3091	44	31	al	al	PROPN
ajmri-3091	44	32	.	.	PROPN
ajmri-3091	44	33	,	,	PUNCT
ajmri-3091	44	34	2022	2022	NUM
ajmri-3091	44	35	)	)	PUNCT
ajmri-3091	44	36	.	.	PUNCT
ajmri-3091	45	1	a	a	DET
ajmri-3091	45	2	study	study	NOUN
ajmri-3091	45	3	by	by	ADP
ajmri-3091	45	4	li	li	PROPN
ajmri-3091	45	5	et	et	PROPN
ajmri-3091	45	6	al	al	PROPN
ajmri-3091	45	7	.	.	PROPN
ajmri-3091	45	8	(	(	PUNCT
ajmri-3091	45	9	2021	2021	NUM
ajmri-3091	45	10	)	)	PUNCT
ajmri-3091	45	11	showed	show	VERB
ajmri-3091	45	12	that	that	SCONJ
ajmri-3091	45	13	about	about	ADV
ajmri-3091	45	14	20	20	NUM
ajmri-3091	45	15	%	%	NOUN
ajmri-3091	45	16	of	of	ADP
ajmri-3091	45	17	covid-19	covid-19	PROPN
ajmri-3091	45	18	patients	patient	NOUN
ajmri-3091	45	19	had	have	AUX
ajmri-3091	45	20	shortened	shorten	VERB
ajmri-3091	45	21	menstrual	menstrual	ADJ
ajmri-3091	45	22	cycles	cycle	NOUN
ajmri-3091	45	23	,	,	PUNCT
ajmri-3091	45	24	while	while	SCONJ
ajmri-3091	45	25	19	19	NUM
ajmri-3091	45	26	%	%	NOUN
ajmri-3091	45	27	experienced	experience	VERB
ajmri-3091	45	28	prolonged	prolonged	ADJ
ajmri-3091	45	29	cycles	cycle	NOUN
ajmri-3091	45	30	and	and	CCONJ
ajmri-3091	45	31	28	28	NUM
ajmri-3091	45	32	%	%	NOUN
ajmri-3091	45	33	experienced	experienced	ADJ
ajmri-3091	45	34	changes	change	NOUN
ajmri-3091	45	35	in	in	ADP
ajmri-3091	45	36	menstruation	menstruation	NOUN
ajmri-3091	45	37	(	(	PUNCT
ajmri-3091	45	38	li	li	PROPN
ajmri-3091	45	39	et	et	PROPN
ajmri-3091	45	40	al	al	PROPN
ajmri-3091	45	41	.	.	PROPN
ajmri-3091	45	42	,	,	PUNCT
ajmri-3091	45	43	2021	2021	NUM
ajmri-3091	45	44	)	)	PUNCT
ajmri-3091	45	45	.	.	PUNCT
ajmri-3091	46	1	in	in	ADP
ajmri-3091	46	2	another	another	DET
ajmri-3091	46	3	study	study	NOUN
ajmri-3091	46	4	,	,	PUNCT
ajmri-3091	46	5	naina	naina	PROPN
ajmri-3091	46	6	kumar	kumar	PROPN
ajmri-3091	46	7	et	et	PROPN
ajmri-3091	46	8	al	al	PROPN
ajmri-3091	46	9	.	.	PROPN
ajmri-3091	46	10	2023	2023	NUM
ajmri-3091	46	11	demonstrated	demonstrate	VERB
ajmri-3091	46	12	that	that	SCONJ
ajmri-3091	46	13	covishield	covishield	NOUN
ajmri-3091	46	14	and	and	CCONJ
ajmri-3091	46	15	covaxin	covaxin	NOUN
ajmri-3091	46	16	vaccinations	vaccination	NOUN
ajmri-3091	46	17	were	be	AUX
ajmri-3091	46	18	linked	link	VERB
ajmri-3091	46	19	to	to	ADP
ajmri-3091	46	20	irregularities	irregularity	NOUN
ajmri-3091	46	21	in	in	ADP
ajmri-3091	46	22	the	the	DET
ajmri-3091	46	23	menstrual	menstrual	ADJ
ajmri-3091	46	24	cycle	cycle	NOUN
ajmri-3091	46	25	and	and	CCONJ
ajmri-3091	46	26	preand	preand	VERB
ajmri-3091	46	27	post	post	ADJ
ajmri-3091	46	28	-	-	ADJ
ajmri-3091	46	29	menstrual	menstrual	ADJ
ajmri-3091	46	30	symptoms	symptom	NOUN
ajmri-3091	46	31	in	in	ADP
ajmri-3091	46	32	a	a	DET
ajmri-3091	46	33	small	small	ADJ
ajmri-3091	46	34	subset	subset	NOUN
ajmri-3091	46	35	of	of	ADP
ajmri-3091	46	36	patients	patient	NOUN
ajmri-3091	46	37	(	(	PUNCT
ajmri-3091	46	38	kumar	kumar	PROPN
ajmri-3091	46	39	et	et	PROPN
ajmri-3091	46	40	al	al	PROPN
ajmri-3091	46	41	.	.	PROPN
ajmri-3091	46	42	,	,	PUNCT
ajmri-3091	46	43	2023	2023	NUM
ajmri-3091	46	44	)	)	PUNCT
ajmri-3091	46	45	.	.	PUNCT
ajmri-3091	47	1	the	the	DET
ajmri-3091	47	2	reluctance	reluctance	NOUN
ajmri-3091	47	3	regarding	regard	VERB
ajmri-3091	47	4	vaccination	vaccination	NOUN
ajmri-3091	47	5	could	could	AUX
ajmri-3091	47	6	result	result	VERB
ajmri-3091	47	7	from	from	ADP
ajmri-3091	47	8	the	the	DET
ajmri-3091	47	9	association	association	NOUN
ajmri-3091	47	10	between	between	ADP
ajmri-3091	47	11	the	the	DET
ajmri-3091	47	12	vaccine	vaccine	NOUN
ajmri-3091	47	13	and	and	CCONJ
ajmri-3091	47	14	menstruation	menstruation	NOUN
ajmri-3091	47	15	complications	complication	NOUN
ajmri-3091	47	16	(	(	PUNCT
ajmri-3091	47	17	sualeh	sualeh	PROPN
ajmri-3091	47	18	et	et	PROPN
ajmri-3091	47	19	al	al	PROPN
ajmri-3091	47	20	.	.	PROPN
ajmri-3091	47	21	,	,	PUNCT
ajmri-3091	47	22	2022	2022	NUM
ajmri-3091	47	23	)	)	PUNCT
ajmri-3091	47	24	.	.	PUNCT
ajmri-3091	48	1	literature	literature	PROPN
ajmri-3091	48	2	review	review	VERB
ajmri-3091	48	3	a	a	DET
ajmri-3091	48	4	regular	regular	ADJ
ajmri-3091	48	5	menstrual	menstrual	ADJ
ajmri-3091	48	6	cycle	cycle	NOUN
ajmri-3091	48	7	serves	serve	VERB
ajmri-3091	48	8	as	as	ADP
ajmri-3091	48	9	a	a	DET
ajmri-3091	48	10	reliable	reliable	ADJ
ajmri-3091	48	11	indicator	indicator	NOUN
ajmri-3091	48	12	of	of	ADP
ajmri-3091	48	13	a	a	DET
ajmri-3091	48	14	well	well	ADV
ajmri-3091	48	15	-	-	PUNCT
ajmri-3091	48	16	functioning	function	VERB
ajmri-3091	48	17	hypothalamic	hypothalamic	ADJ
ajmri-3091	48	18	-	-	PUNCT
ajmri-3091	48	19	pituitary	pituitary	ADJ
ajmri-3091	48	20	-	-	PUNCT
ajmri-3091	48	21	ovarian	ovarian	NOUN
ajmri-3091	48	22	(	(	PUNCT
ajmri-3091	48	23	hpo	hpo	NOUN
ajmri-3091	48	24	)	)	PUNCT
ajmri-3091	48	25	system	system	NOUN
ajmri-3091	48	26	and	and	CCONJ
ajmri-3091	48	27	a	a	DET
ajmri-3091	48	28	woman	woman	NOUN
ajmri-3091	48	29	’s	’s	PART
ajmri-3091	48	30	state	state	NOUN
ajmri-3091	48	31	of	of	ADP
ajmri-3091	48	32	health	health	NOUN
ajmri-3091	48	33	.	.	PUNCT
ajmri-3091	49	1	the	the	DET
ajmri-3091	49	2	menstrual	menstrual	ADJ
ajmri-3091	49	3	characteristics	characteristic	NOUN
ajmri-3091	49	4	exhibit	exhibit	VERB
ajmri-3091	49	5	variability	variability	NOUN
ajmri-3091	49	6	on	on	ADP
ajmri-3091	49	7	a	a	DET
ajmri-3091	49	8	monthly	monthly	ADJ
ajmri-3091	49	9	basis	basis	NOUN
ajmri-3091	49	10	throughout	throughout	ADP
ajmri-3091	49	11	an	an	DET
ajmri-3091	49	12	individual	individual	NOUN
ajmri-3091	49	13	’s	’s	PART
ajmri-3091	49	14	lifespan	lifespan	NOUN
ajmri-3091	49	15	(	(	PUNCT
ajmri-3091	49	16	bull	bull	NOUN
ajmri-3091	49	17	et	et	PROPN
ajmri-3091	49	18	al	al	PROPN
ajmri-3091	49	19	.	.	PROPN
ajmri-3091	49	20	,	,	PUNCT
ajmri-3091	49	21	2019	2019	NUM
ajmri-3091	49	22	)	)	PUNCT
ajmri-3091	49	23	.	.	PUNCT
ajmri-3091	50	1	changes	change	NOUN
ajmri-3091	50	2	in	in	ADP
ajmri-3091	50	3	frequency	frequency	NOUN
ajmri-3091	50	4	,	,	PUNCT
ajmri-3091	50	5	intensity	intensity	NOUN
ajmri-3091	50	6	,	,	PUNCT
ajmri-3091	50	7	duration	duration	NOUN
ajmri-3091	50	8	,	,	PUNCT
ajmri-3091	50	9	or	or	CCONJ
ajmri-3091	50	10	regularity	regularity	NOUN
ajmri-3091	50	11	can	can	AUX
ajmri-3091	50	12	identify	identify	VERB
ajmri-3091	50	13	menstrual	menstrual	ADJ
ajmri-3091	50	14	irregularities	irregularity	NOUN
ajmri-3091	50	15	(	(	PUNCT
ajmri-3091	50	16	jung	jung	PROPN
ajmri-3091	50	17	et	et	PROPN
ajmri-3091	50	18	al	al	PROPN
ajmri-3091	50	19	.	.	PROPN
ajmri-3091	50	20	,	,	PUNCT
ajmri-3091	50	21	2018	2018	NUM
ajmri-3091	50	22	)	)	PUNCT
ajmri-3091	50	23	.	.	PUNCT
ajmri-3091	51	1	these	these	DET
ajmri-3091	51	2	variations	variation	NOUN
ajmri-3091	51	3	arise	arise	VERB
ajmri-3091	51	4	due	due	ADP
ajmri-3091	51	5	to	to	ADP
ajmri-3091	51	6	several	several	ADJ
ajmri-3091	51	7	reasons	reason	NOUN
ajmri-3091	51	8	,	,	PUNCT
ajmri-3091	51	9	including	include	VERB
ajmri-3091	51	10	coagulopathy	coagulopathy	ADJ
ajmri-3091	51	11	,	,	PUNCT
ajmri-3091	51	12	ovulatory	ovulatory	ADJ
ajmri-3091	51	13	dysfunction	dysfunction	NOUN
ajmri-3091	51	14	,	,	PUNCT
ajmri-3091	51	15	medication	medication	NOUN
ajmri-3091	51	16	usage	usage	NOUN
ajmri-3091	51	17	,	,	PUNCT
ajmri-3091	51	18	and	and	CCONJ
ajmri-3091	51	19	modifiable	modifiable	ADJ
ajmri-3091	51	20	elements	element	NOUN
ajmri-3091	51	21	such	such	ADJ
ajmri-3091	51	22	as	as	ADP
ajmri-3091	51	23	abrupt	abrupt	ADJ
ajmri-3091	51	24	weight	weight	NOUN
ajmri-3091	51	25	loss	loss	NOUN
ajmri-3091	51	26	,	,	PUNCT
ajmri-3091	51	27	severe	severe	ADJ
ajmri-3091	51	28	exercise	exercise	NOUN
ajmri-3091	51	29	,	,	PUNCT
ajmri-3091	51	30	obesity	obesity	NOUN
ajmri-3091	51	31	,	,	PUNCT
ajmri-3091	51	32	and	and	CCONJ
ajmri-3091	51	33	psychological	psychological	ADJ
ajmri-3091	51	34	disorders	disorder	NOUN
ajmri-3091	51	35	(	(	PUNCT
ajmri-3091	51	36	polack	polack	PROPN
ajmri-3091	51	37	et	et	PROPN
ajmri-3091	51	38	al	al	PROPN
ajmri-3091	51	39	.	.	PROPN
ajmri-3091	51	40	,	,	PUNCT
ajmri-3091	51	41	2020	2020	NUM
ajmri-3091	51	42	)	)	PUNCT
ajmri-3091	51	43	.	.	PUNCT
ajmri-3091	52	1	however	however	ADV
ajmri-3091	52	2	,	,	PUNCT
ajmri-3091	52	3	mental	mental	ADJ
ajmri-3091	52	4	stress	stress	NOUN
ajmri-3091	52	5	is	be	AUX
ajmri-3091	52	6	considered	consider	VERB
ajmri-3091	52	7	a	a	DET
ajmri-3091	52	8	significant	significant	ADJ
ajmri-3091	52	9	factor	factor	NOUN
ajmri-3091	52	10	;	;	PUNCT
ajmri-3091	52	11	recent	recent	ADJ
ajmri-3091	52	12	research	research	NOUN
ajmri-3091	52	13	has	have	AUX
ajmri-3091	52	14	linked	link	VERB
ajmri-3091	52	15	irregular	irregular	ADJ
ajmri-3091	52	16	menstrual	menstrual	ADJ
ajmri-3091	52	17	cycles	cycle	NOUN
ajmri-3091	52	18	to	to	ADP
ajmri-3091	52	19	increased	increase	VERB
ajmri-3091	52	20	levels	level	NOUN
ajmri-3091	52	21	of	of	ADP
ajmri-3091	52	22	stress	stress	NOUN
ajmri-3091	52	23	and	and	CCONJ
ajmri-3091	52	24	anxiety	anxiety	NOUN
ajmri-3091	52	25	during	during	ADP
ajmri-3091	52	26	the	the	DET
ajmri-3091	52	27	covid-19	covid-19	PROPN
ajmri-3091	52	28	pandemic	pandemic	NOUN
ajmri-3091	52	29	(	(	PUNCT
ajmri-3091	52	30	demir	demir	PROPN
ajmri-3091	52	31	et	et	PROPN
ajmri-3091	52	32	al	al	PROPN
ajmri-3091	52	33	.	.	PROPN
ajmri-3091	52	34	,	,	PUNCT
ajmri-3091	52	35	2021	2021	NUM
ajmri-3091	52	36	)	)	PUNCT
ajmri-3091	52	37	.	.	PUNCT
ajmri-3091	53	1	recent	recent	ADJ
ajmri-3091	53	2	studies	study	NOUN
ajmri-3091	53	3	suggest	suggest	VERB
ajmri-3091	53	4	that	that	SCONJ
ajmri-3091	53	5	covid-19	covid-19	PROPN
ajmri-3091	53	6	infection	infection	NOUN
ajmri-3091	53	7	and	and	CCONJ
ajmri-3091	53	8	vaccination	vaccination	NOUN
ajmri-3091	53	9	can	can	AUX
ajmri-3091	53	10	impact	impact	VERB
ajmri-3091	53	11	menstrual	menstrual	ADJ
ajmri-3091	53	12	cycles	cycle	NOUN
ajmri-3091	53	13	(	(	PUNCT
ajmri-3091	53	14	alvergne	alvergne	ADV
ajmri-3091	53	15	et	et	PROPN
ajmri-3091	53	16	al	al	PROPN
ajmri-3091	53	17	.	.	PROPN
ajmri-3091	53	18	,	,	PUNCT
ajmri-3091	53	19	2021	2021	NUM
ajmri-3091	53	20	;	;	PUNCT
ajmri-3091	53	21	male	male	NOUN
ajmri-3091	53	22	,	,	PUNCT
ajmri-3091	53	23	2021	2021	NUM
ajmri-3091	53	24	;	;	PUNCT
ajmri-3091	53	25	taşkaldıran	taşkaldıran	VERB
ajmri-3091	53	26	et	et	PROPN
ajmri-3091	53	27	al	al	PROPN
ajmri-3091	53	28	.	.	PROPN
ajmri-3091	53	29	,	,	PUNCT
ajmri-3091	53	30	2022	2022	NUM
ajmri-3091	53	31	)	)	PUNCT
ajmri-3091	53	32	.	.	PUNCT
ajmri-3091	54	1	in	in	ADP
ajmri-3091	54	2	a	a	DET
ajmri-3091	54	3	casecontrol	casecontrol	NOUN
ajmri-3091	54	4	study	study	NOUN
ajmri-3091	54	5	conducted	conduct	VERB
ajmri-3091	54	6	in	in	ADP
ajmri-3091	54	7	the	the	DET
ajmri-3091	54	8	united	united	ADJ
ajmri-3091	54	9	kingdom	kingdom	NOUN
ajmri-3091	54	10	,	,	PUNCT
ajmri-3091	54	11	20	20	NUM
ajmri-3091	54	12	%	%	NOUN
ajmri-3091	54	13	of	of	ADP
ajmri-3091	54	14	the	the	DET
ajmri-3091	54	15	female	female	ADJ
ajmri-3091	54	16	participants	participant	NOUN
ajmri-3091	54	17	reported	report	VERB
ajmri-3091	54	18	experiencing	experience	VERB
ajmri-3091	54	19	irregular	irregular	ADJ
ajmri-3091	54	20	menstrual	menstrual	ADJ
ajmri-3091	54	21	cycles	cycle	NOUN
ajmri-3091	54	22	post	post	NOUN
ajmri-3091	54	23	-	-	NOUN
ajmri-3091	54	24	vaccination	vaccination	NOUN
ajmri-3091	54	25	(	(	PUNCT
ajmri-3091	54	26	alzahrani	alzahrani	NOUN
ajmri-3091	54	27	et	et	PROPN
ajmri-3091	54	28	al	al	PROPN
ajmri-3091	54	29	.	.	PROPN
ajmri-3091	54	30	,	,	PUNCT
ajmri-3091	54	31	2023	2023	NUM
ajmri-3091	54	32	)	)	PUNCT
ajmri-3091	54	33	.	.	PUNCT
ajmri-3091	55	1	covid-19	covid-19	PROPN
ajmri-3091	55	2	vaccination	vaccination	NOUN
ajmri-3091	55	3	and	and	CCONJ
ajmri-3091	55	4	its	its	PRON
ajmri-3091	55	5	side	side	NOUN
ajmri-3091	55	6	effects	effect	NOUN
ajmri-3091	55	7	vaccines	vaccine	NOUN
ajmri-3091	55	8	are	be	AUX
ajmri-3091	55	9	constantly	constantly	ADV
ajmri-3091	55	10	monitored	monitor	VERB
ajmri-3091	55	11	and	and	CCONJ
ajmri-3091	55	12	managed	manage	VERB
ajmri-3091	55	13	for	for	ADP
ajmri-3091	55	14	safety	safety	NOUN
ajmri-3091	55	15	and	and	CCONJ
ajmri-3091	55	16	efficacy	efficacy	NOUN
ajmri-3091	55	17	,	,	PUNCT
ajmri-3091	55	18	but	but	CCONJ
ajmri-3091	55	19	they	they	PRON
ajmri-3091	55	20	can	can	AUX
ajmri-3091	55	21	still	still	ADV
ajmri-3091	55	22	cause	cause	VERB
ajmri-3091	55	23	side	side	NOUN
ajmri-3091	55	24	effects	effect	NOUN
ajmri-3091	55	25	.	.	PUNCT
ajmri-3091	56	1	these	these	DET
ajmri-3091	56	2	symptoms	symptom	NOUN
ajmri-3091	56	3	often	often	ADV
ajmri-3091	56	4	manifest	manifest	VERB
ajmri-3091	56	5	as	as	ADP
ajmri-3091	56	6	minor	minor	ADJ
ajmri-3091	56	7	pain	pain	NOUN
ajmri-3091	56	8	and	and	CCONJ
ajmri-3091	56	9	redness	redness	NOUN
ajmri-3091	56	10	at	at	ADP
ajmri-3091	56	11	the	the	DET
ajmri-3091	56	12	injection	injection	NOUN
ajmri-3091	56	13	site	site	NOUN
ajmri-3091	56	14	or	or	CCONJ
ajmri-3091	56	15	a	a	DET
ajmri-3091	56	16	fever	fever	NOUN
ajmri-3091	56	17	,	,	PUNCT
ajmri-3091	56	18	and	and	CCONJ
ajmri-3091	56	19	they	they	PRON
ajmri-3091	56	20	usually	usually	ADV
ajmri-3091	56	21	disappear	disappear	VERB
ajmri-3091	56	22	within	within	ADP
ajmri-3091	56	23	a	a	DET
ajmri-3091	56	24	few	few	ADJ
ajmri-3091	56	25	days	day	NOUN
ajmri-3091	56	26	(	(	PUNCT
ajmri-3091	56	27	hatmal	hatmal	PROPN
ajmri-3091	56	28	et	et	PROPN
ajmri-3091	56	29	al	al	PROPN
ajmri-3091	56	30	.	.	PROPN
ajmri-3091	56	31	,	,	PUNCT
ajmri-3091	56	32	2021	2021	NUM
ajmri-3091	56	33	)	)	PUNCT
ajmri-3091	56	34	.	.	PUNCT
ajmri-3091	57	1	in	in	ADP
ajmri-3091	57	2	2022	2022	NUM
ajmri-3091	57	3	,	,	PUNCT
ajmri-3091	57	4	approximately	approximately	ADV
ajmri-3091	57	5	1,871,932,835	1,871,932,835	ADJ
ajmri-3091	57	6	people	people	NOUN
ajmri-3091	57	7	(	(	PUNCT
ajmri-3091	57	8	23.61	23.61	NUM
ajmri-3091	57	9	%	%	NOUN
ajmri-3091	57	10	of	of	ADP
ajmri-3091	57	11	the	the	DET
ajmri-3091	57	12	global	global	ADJ
ajmri-3091	57	13	population	population	NOUN
ajmri-3091	57	14	)	)	PUNCT
ajmri-3091	57	15	received	receive	VERB
ajmri-3091	57	16	two	two	NUM
ajmri-3091	57	17	doses	dose	NOUN
ajmri-3091	57	18	of	of	ADP
ajmri-3091	57	19	a	a	DET
ajmri-3091	57	20	covid-19	covid-19	PROPN
ajmri-3091	57	21	vaccine	vaccine	NOUN
ajmri-3091	57	22	;	;	PUNCT
ajmri-3091	57	23	meanwhile	meanwhile	ADV
ajmri-3091	57	24	,	,	PUNCT
ajmri-3091	57	25	in	in	ADP
ajmri-3091	57	26	saudi	saudi	PROPN
ajmri-3091	57	27	arabia	arabia	PROPN
ajmri-3091	57	28	,	,	PUNCT
ajmri-3091	57	29	21,449,067	21,449,067	NUM
ajmri-3091	57	30	people	people	NOUN
ajmri-3091	57	31	(	(	PUNCT
ajmri-3091	57	32	60.69	60.69	NUM
ajmri-3091	57	33	%	%	NOUN
ajmri-3091	57	34	of	of	ADP
ajmri-3091	57	35	the	the	DET
ajmri-3091	57	36	population	population	NOUN
ajmri-3091	57	37	)	)	PUNCT
ajmri-3091	57	38	were	be	AUX
ajmri-3091	57	39	fully	fully	ADV
ajmri-3091	57	40	vaccinated	vaccinate	VERB
ajmri-3091	57	41	with	with	ADP
ajmri-3091	57	42	two	two	NUM
ajmri-3091	57	43	doses	dose	NOUN
ajmri-3091	57	44	(	(	PUNCT
ajmri-3091	57	45	organization	organization	NOUN
ajmri-3091	57	46	,	,	PUNCT
ajmri-3091	57	47	2022	2022	NUM
ajmri-3091	57	48	)	)	PUNCT
ajmri-3091	57	49	.	.	PUNCT
ajmri-3091	58	1	a	a	DET
ajmri-3091	58	2	third	third	ADJ
ajmri-3091	58	3	dose	dose	NOUN
ajmri-3091	58	4	of	of	ADP
ajmri-3091	58	5	covid-19	covid-19	PROPN
ajmri-3091	58	6	vaccine	vaccine	NOUN
ajmri-3091	58	7	was	be	AUX
ajmri-3091	58	8	given	give	VERB
ajmri-3091	58	9	to	to	ADP
ajmri-3091	58	10	low	low	ADJ
ajmri-3091	58	11	-	-	PUNCT
ajmri-3091	58	12	immunity	immunity	NOUN
ajmri-3091	58	13	individuals	individual	NOUN
ajmri-3091	58	14	after	after	ADP
ajmri-3091	58	15	10	10	NUM
ajmri-3091	58	16	months	month	NOUN
ajmri-3091	58	17	of	of	ADP
ajmri-3091	58	18	the	the	DET
ajmri-3091	58	19	first	first	ADJ
ajmri-3091	58	20	dose	dose	PROPN
ajmri-3091	58	21	(	(	PUNCT
ajmri-3091	58	22	moreira	moreira	PROPN
ajmri-3091	58	23	jr	jr	PROPN
ajmri-3091	58	24	et	et	PROPN
ajmri-3091	58	25	al	al	PROPN
ajmri-3091	58	26	.	.	PROPN
ajmri-3091	58	27	,	,	PUNCT
ajmri-3091	58	28	2022	2022	NUM
ajmri-3091	58	29	)	)	PUNCT
ajmri-3091	58	30	.	.	PUNCT
ajmri-3091	59	1	despite	despite	SCONJ
ajmri-3091	59	2	fda	fda	PROPN
ajmri-3091	59	3	approval	approval	NOUN
ajmri-3091	59	4	and	and	CCONJ
ajmri-3091	59	5	difficulty	difficulty	NOUN
ajmri-3091	59	6	in	in	ADP
ajmri-3091	59	7	predicting	predict	VERB
ajmri-3091	59	8	side	side	NOUN
ajmri-3091	59	9	effects	effect	NOUN
ajmri-3091	59	10	,	,	PUNCT
ajmri-3091	59	11	many	many	ADJ
ajmri-3091	59	12	have	have	AUX
ajmri-3091	59	13	been	be	AUX
ajmri-3091	59	14	reported	report	VERB
ajmri-3091	59	15	through	through	ADP
ajmri-3091	59	16	surveillance	surveillance	NOUN
ajmri-3091	59	17	systems	system	NOUN
ajmri-3091	59	18	issued	issue	VERB
ajmri-3091	59	19	by	by	ADP
ajmri-3091	59	20	the	the	DET
ajmri-3091	59	21	centers	center	NOUN
ajmri-3091	59	22	for	for	ADP
ajmri-3091	59	23	disease	disease	NOUN
ajmri-3091	59	24	control	control	PROPN
ajmri-3091	59	25	&	&	CCONJ
ajmri-3091	59	26	prevention	prevention	PROPN
ajmri-3091	59	27	(	(	PUNCT
ajmri-3091	59	28	cdc	cdc	PROPN
ajmri-3091	59	29	)	)	PUNCT
ajmri-3091	59	30	for	for	ADP
ajmri-3091	59	31	the	the	DET
ajmri-3091	59	32	vaccine	vaccine	NOUN
ajmri-3091	59	33	adverse	adverse	ADJ
ajmri-3091	59	34	events	event	NOUN
ajmri-3091	59	35	reporting	reporting	NOUN
ajmri-3091	59	36	system	system	NOUN
ajmri-3091	59	37	(	(	PUNCT
ajmri-3091	59	38	vaers	vaer	NOUN
ajmri-3091	59	39	)	)	PUNCT
ajmri-3091	59	40	and	and	CCONJ
ajmri-3091	59	41	after	after	ADP
ajmri-3091	59	42	vaccination	vaccination	NOUN
ajmri-3091	59	43	health	health	NOUN
ajmri-3091	59	44	checker	checker	NOUN
ajmri-3091	59	45	(	(	PUNCT
ajmri-3091	59	46	v	v	NOUN
ajmri-3091	59	47	-	-	PUNCT
ajmri-3091	59	48	safe	safe	ADJ
ajmri-3091	59	49	)	)	PUNCT
ajmri-3091	59	50	(	(	PUNCT
ajmri-3091	59	51	organization	organization	NOUN
ajmri-3091	59	52	,	,	PUNCT
ajmri-3091	59	53	2022	2022	NUM
ajmri-3091	59	54	)	)	PUNCT
ajmri-3091	59	55	.	.	PUNCT
ajmri-3091	60	1	side	side	NOUN
ajmri-3091	60	2	effects	effect	NOUN
ajmri-3091	60	3	range	range	VERB
ajmri-3091	60	4	from	from	ADP
ajmri-3091	60	5	mild	mild	ADJ
ajmri-3091	60	6	to	to	ADP
ajmri-3091	60	7	severe	severe	ADJ
ajmri-3091	60	8	and	and	CCONJ
ajmri-3091	60	9	include	include	VERB
ajmri-3091	60	10	redness	redness	NOUN
ajmri-3091	60	11	,	,	PUNCT
ajmri-3091	60	12	chest	chest	NOUN
ajmri-3091	60	13	pain	pain	NOUN
ajmri-3091	60	14	,	,	PUNCT
ajmri-3091	60	15	swelling	swelling	NOUN
ajmri-3091	60	16	,	,	PUNCT
ajmri-3091	60	17	fatigue	fatigue	NOUN
ajmri-3091	60	18	,	,	PUNCT
ajmri-3091	60	19	headache	headache	NOUN
ajmri-3091	60	20	,	,	PUNCT
ajmri-3091	60	21	muscle	muscle	NOUN
ajmri-3091	60	22	ache	ache	NOUN
ajmri-3091	60	23	,	,	PUNCT
ajmri-3091	60	24	nausea	nausea	NOUN
ajmri-3091	60	25	,	,	PUNCT
ajmri-3091	60	26	fever	fever	NOUN
ajmri-3091	60	27	,	,	PUNCT
ajmri-3091	60	28	chills	chill	NOUN
ajmri-3091	60	29	,	,	PUNCT
ajmri-3091	60	30	difficulty	difficulty	NOUN
ajmri-3091	60	31	in	in	ADP
ajmri-3091	60	32	breathing	breathing	NOUN
ajmri-3091	60	33	,	,	PUNCT
ajmri-3091	60	34	and	and	CCONJ
ajmri-3091	60	35	menstrual	menstrual	ADJ
ajmri-3091	60	36	irregularities	irregularity	NOUN
ajmri-3091	60	37	in	in	ADP
ajmri-3091	60	38	women	woman	NOUN
ajmri-3091	60	39	(	(	PUNCT
ajmri-3091	60	40	beatty	beatty	PROPN
ajmri-3091	60	41	et	et	PROPN
ajmri-3091	60	42	al	al	PROPN
ajmri-3091	60	43	.	.	PROPN
ajmri-3091	60	44	,	,	PUNCT
ajmri-3091	60	45	2021	2021	NUM
ajmri-3091	60	46	)	)	PUNCT
ajmri-3091	60	47	.	.	PUNCT
ajmri-3091	61	1	a	a	DET
ajmri-3091	61	2	report	report	NOUN
ajmri-3091	61	3	by	by	ADP
ajmri-3091	61	4	cdc	cdc	PROPN
ajmri-3091	61	5	2023	2023	NUM
ajmri-3091	61	6	showed	show	VERB
ajmri-3091	61	7	2,403,628	2,403,628	NUM
ajmri-3091	61	8	cases	case	NOUN
ajmri-3091	61	9	of	of	ADP
ajmri-3091	61	10	side	side	NOUN
ajmri-3091	61	11	effects	effect	NOUN
ajmri-3091	61	12	due	due	ADJ
ajmri-3091	61	13	to	to	ADP
ajmri-3091	61	14	covid-19	covid-19	PROPN
ajmri-3091	61	15	vaccines	vaccine	NOUN
ajmri-3091	61	16	,	,	PUNCT
ajmri-3091	61	17	including	include	VERB
ajmri-3091	61	18	98,163	98,163	NUM
ajmri-3091	61	19	cases	case	NOUN
ajmri-3091	61	20	of	of	ADP
ajmri-3091	61	21	blood	blood	NOUN
ajmri-3091	61	22	and	and	CCONJ
ajmri-3091	61	23	lymphatic	lymphatic	ADJ
ajmri-3091	61	24	disorders	disorder	NOUN
ajmri-3091	61	25	,	,	PUNCT
ajmri-3091	61	26	124,613	124,613	NUM
ajmri-3091	61	27	cases	case	NOUN
ajmri-3091	61	28	of	of	ADP
ajmri-3091	61	29	heart	heart	NOUN
ajmri-3091	61	30	disorders	disorder	NOUN
ajmri-3091	61	31	,	,	PUNCT
ajmri-3091	61	32	and	and	CCONJ
ajmri-3091	61	33	103,310	103,310	NUM
ajmri-3091	61	34	cases	case	NOUN
ajmri-3091	61	35	of	of	ADP
ajmri-3091	61	36	reproductive	reproductive	ADJ
ajmri-3091	61	37	system	system	NOUN
ajmri-3091	61	38	and	and	CCONJ
ajmri-3091	61	39	breast	breast	NOUN
ajmri-3091	61	40	disorders	disorder	NOUN
ajmri-3091	61	41	(	(	PUNCT
ajmri-3091	61	42	centers	center	NOUN
ajmri-3091	61	43	for	for	ADP
ajmri-3091	61	44	disease	disease	NOUN
ajmri-3091	61	45	control	control	NOUN
ajmri-3091	61	46	and	and	CCONJ
ajmri-3091	61	47	prevention	prevention	NOUN
ajmri-3091	61	48	.	.	PUNCT
ajmri-3091	61	49	,	,	PUNCT
ajmri-3091	61	50	2023	2023	NUM
ajmri-3091	61	51	)	)	PUNCT
ajmri-3091	61	52	.	.	PUNCT
ajmri-3091	62	1	a	a	DET
ajmri-3091	62	2	study	study	NOUN
ajmri-3091	62	3	conducted	conduct	VERB
ajmri-3091	62	4	in	in	ADP
ajmri-3091	62	5	saudi	saudi	PROPN
ajmri-3091	62	6	arabia	arabia	PROPN
ajmri-3091	62	7	by	by	ADP
ajmri-3091	62	8	alghamdi	alghamdi	PROPN
ajmri-3091	62	9	et	et	PROPN
ajmri-3091	62	10	al	al	PROPN
ajmri-3091	62	11	.	.	PROPN
ajmri-3091	62	12	(	(	PUNCT
ajmri-3091	62	13	2021	2021	NUM
ajmri-3091	62	14	)	)	PUNCT
ajmri-3091	62	15	reported	report	VERB
ajmri-3091	62	16	that	that	SCONJ
ajmri-3091	62	17	adverse	adverse	ADJ
ajmri-3091	62	18	side	side	NOUN
ajmri-3091	62	19	effects	effect	NOUN
ajmri-3091	62	20	were	be	AUX
ajmri-3091	62	21	observed	observe	VERB
ajmri-3091	62	22	by	by	ADP
ajmri-3091	62	23	the	the	DET
ajmri-3091	62	24	pfizer	pfizer	NOUN
ajmri-3091	62	25	vaccine	vaccine	NOUN
ajmri-3091	62	26	after	after	ADP
ajmri-3091	62	27	the	the	DET
ajmri-3091	62	28	second	second	ADJ
ajmri-3091	62	29	dose	dose	NOUN
ajmri-3091	62	30	(	(	PUNCT
ajmri-3091	62	31	13.22	13.22	NUM
ajmri-3091	62	32	%	%	NOUN
ajmri-3091	62	33	)	)	PUNCT
ajmri-3091	62	34	compared	compare	VERB
ajmri-3091	62	35	to	to	ADP
ajmri-3091	62	36	the	the	DET
ajmri-3091	62	37	first	first	ADJ
ajmri-3091	62	38	dose	dose	NOUN
ajmri-3091	62	39	(	(	PUNCT
ajmri-3091	62	40	4.17	4.17	NUM
ajmri-3091	62	41	%	%	NOUN
ajmri-3091	62	42	)	)	PUNCT
ajmri-3091	62	43	.	.	PUNCT
ajmri-3091	63	1	breathlessness	breathlessness	NOUN
ajmri-3091	63	2	and	and	CCONJ
ajmri-3091	63	3	chest	chest	NOUN
ajmri-3091	63	4	pain	pain	NOUN
ajmri-3091	63	5	were	be	AUX
ajmri-3091	63	6	recorded	record	VERB
ajmri-3091	63	7	following	follow	VERB
ajmri-3091	63	8	the	the	DET
ajmri-3091	63	9	administration	administration	NOUN
ajmri-3091	63	10	of	of	ADP
ajmri-3091	63	11	the	the	DET
ajmri-3091	63	12	oxford	oxford	PROPN
ajmri-3091	63	13	-	-	PUNCT
ajmri-3091	63	14	astrazeneca	astrazeneca	PROPN
ajmri-3091	63	15	(	(	PUNCT
ajmri-3091	63	16	chadox1	chadox1	ADJ
ajmri-3091	63	17	)	)	PUNCT
ajmri-3091	63	18	vaccine	vaccine	NOUN
ajmri-3091	63	19	and	and	CCONJ
ajmri-3091	63	20	less	less	ADV
ajmri-3091	63	21	frequently	frequently	ADV
ajmri-3091	63	22	through	through	ADP
ajmri-3091	63	23	the	the	DET
ajmri-3091	63	24	pfizer	pfizer	NOUN
ajmri-3091	63	25	vaccine	vaccine	NOUN
ajmri-3091	63	26	(	(	PUNCT
ajmri-3091	63	27	alghamdi	alghamdi	NOUN
ajmri-3091	63	28	et	et	PROPN
ajmri-3091	63	29	al	al	PROPN
ajmri-3091	63	30	.	.	PROPN
ajmri-3091	63	31	,	,	PUNCT
ajmri-3091	63	32	2021	2021	NUM
ajmri-3091	63	33	)	)	PUNCT
ajmri-3091	63	34	.	.	PUNCT
ajmri-3091	64	1	another	another	DET
ajmri-3091	64	2	study	study	NOUN
ajmri-3091	64	3	by	by	ADP
ajmri-3091	64	4	alhazmi	alhazmi	PROPN
ajmri-3091	64	5	et	et	PROPN
ajmri-3091	64	6	al	al	PROPN
ajmri-3091	64	7	.	.	PROPN
ajmri-3091	64	8	(	(	PUNCT
ajmri-3091	64	9	2021	2021	NUM
ajmri-3091	64	10	)	)	PUNCT
ajmri-3091	64	11	found	find	VERB
ajmri-3091	64	12	that	that	SCONJ
ajmri-3091	64	13	60	60	NUM
ajmri-3091	64	14	%	%	NOUN
ajmri-3091	64	15	of	of	ADP
ajmri-3091	64	16	participants	participant	NOUN
ajmri-3091	64	17	experienced	experience	VERB
ajmri-3091	64	18	adverse	adverse	ADJ
ajmri-3091	64	19	effects	effect	NOUN
ajmri-3091	64	20	from	from	ADP
ajmri-3091	64	21	covid-19	covid-19	PROPN
ajmri-3091	64	22	vaccines	vaccine	NOUN
ajmri-3091	64	23	,	,	PUNCT
ajmri-3091	64	24	with	with	ADP
ajmri-3091	64	25	fatigue	fatigue	NOUN
ajmri-3091	64	26	(	(	PUNCT
ajmri-3091	64	27	90	90	NUM
ajmri-3091	64	28	%	%	NOUN
ajmri-3091	64	29	)	)	PUNCT
ajmri-3091	64	30	and	and	CCONJ
ajmri-3091	64	31	soreness	soreness	NOUN
ajmri-3091	64	32	at	at	ADP
ajmri-3091	64	33	the	the	DET
ajmri-3091	64	34	injection	injection	NOUN
ajmri-3091	64	35	site	site	NOUN
ajmri-3091	64	36	(	(	PUNCT
ajmri-3091	64	37	85	85	NUM
ajmri-3091	64	38	%	%	NOUN
ajmri-3091	64	39	)	)	PUNCT
ajmri-3091	64	40	being	be	AUX
ajmri-3091	64	41	common	common	ADJ
ajmri-3091	64	42	(	(	PUNCT
ajmri-3091	64	43	alhazmi	alhazmi	PROPN
ajmri-3091	64	44	et	et	NOUN
ajmri-3091	64	45	al	al	PROPN
ajmri-3091	64	46	.	.	PROPN
ajmri-3091	64	47	,	,	PUNCT
ajmri-3091	64	48	2021	2021	NUM
ajmri-3091	64	49	)	)	PUNCT
ajmri-3091	64	50	.	.	PUNCT
ajmri-3091	65	1	covid-19	covid-19	PROPN
ajmri-3091	65	2	vaccination	vaccination	NOUN
ajmri-3091	65	3	and	and	CCONJ
ajmri-3091	65	4	menstrual	menstrual	ADJ
ajmri-3091	65	5	cycle	cycle	NOUN
ajmri-3091	65	6	disturbances	disturbance	NOUN
ajmri-3091	65	7	according	accord	VERB
ajmri-3091	65	8	to	to	ADP
ajmri-3091	65	9	a	a	DET
ajmri-3091	65	10	cdc	cdc	PROPN
ajmri-3091	65	11	report	report	NOUN
ajmri-3091	65	12	,	,	PUNCT
ajmri-3091	65	13	26,450	26,450	NUM
ajmri-3091	65	14	(	(	PUNCT
ajmri-3091	65	15	19.19	19.19	NUM
ajmri-3091	65	16	%	%	NOUN
ajmri-3091	65	17	)	)	PUNCT
ajmri-3091	65	18	cases	case	NOUN
ajmri-3091	65	19	among	among	ADP
ajmri-3091	65	20	adult	adult	NOUN
ajmri-3091	65	21	females	female	NOUN
ajmri-3091	65	22	experienced	experience	VERB
ajmri-3091	65	23	heavy	heavy	ADJ
ajmri-3091	65	24	menstrual	menstrual	ADJ
ajmri-3091	65	25	bleeding	bleeding	NOUN
ajmri-3091	65	26	,	,	PUNCT
ajmri-3091	65	27	14,835	14,835	NUM
ajmri-3091	65	28	(	(	PUNCT
ajmri-3091	65	29	10.76	10.76	NUM
ajmri-3091	65	30	%	%	NOUN
ajmri-3091	65	31	)	)	PUNCT
ajmri-3091	65	32	cases	case	NOUN
ajmri-3091	65	33	suffered	suffer	VERB
ajmri-3091	65	34	from	from	ADP
ajmri-3091	65	35	delayed	delay	VERB
ajmri-3091	65	36	menstruation	menstruation	NOUN
ajmri-3091	65	37	,	,	PUNCT
ajmri-3091	65	38	and	and	CCONJ
ajmri-3091	65	39	14,560	14,560	NUM
ajmri-3091	65	40	cases	case	NOUN
ajmri-3091	65	41	had	have	VERB
ajmri-3091	65	42	menstrual	menstrual	ADJ
ajmri-3091	65	43	disorders	disorder	NOUN
ajmri-3091	65	44	and	and	CCONJ
ajmri-3091	65	45	several	several	ADJ
ajmri-3091	65	46	other	other	ADJ
ajmri-3091	65	47	side	side	NOUN
ajmri-3091	65	48	effects	effect	NOUN
ajmri-3091	65	49	related	relate	VERB
ajmri-3091	65	50	to	to	ADP
ajmri-3091	65	51	breast	breast	NOUN
ajmri-3091	65	52	injuries	injury	NOUN
ajmri-3091	65	53	(	(	PUNCT
ajmri-3091	65	54	centers	center	NOUN
ajmri-3091	65	55	for	for	ADP
ajmri-3091	65	56	disease	disease	NOUN
ajmri-3091	65	57	control	control	NOUN
ajmri-3091	65	58	and	and	CCONJ
ajmri-3091	65	59	prevention	prevention	NOUN
ajmri-3091	65	60	,	,	PUNCT
ajmri-3091	65	61	2023	2023	NUM
ajmri-3091	65	62	)	)	PUNCT
ajmri-3091	65	63	.	.	PUNCT
ajmri-3091	66	1	a	a	DET
ajmri-3091	66	2	study	study	NOUN
ajmri-3091	66	3	conducted	conduct	VERB
ajmri-3091	66	4	by	by	ADP
ajmri-3091	66	5	al	al	PROPN
ajmri-3091	66	6	-	-	PUNCT
ajmri-3091	66	7	mousa	mousa	PROPN
ajmri-3091	66	8	et	et	PROPN
ajmri-3091	66	9	al	al	PROPN
ajmri-3091	66	10	.	.	PROPN
ajmri-3091	66	11	(	(	PUNCT
ajmri-3091	66	12	2022	2022	NUM
ajmri-3091	66	13	)	)	PUNCT
ajmri-3091	66	14	in	in	ADP
ajmri-3091	66	15	saudi	saudi	PROPN
ajmri-3091	66	16	arabia	arabia	PROPN
ajmri-3091	66	17	found	find	VERB
ajmri-3091	66	18	that	that	SCONJ
ajmri-3091	66	19	the	the	DET
ajmri-3091	66	20	covid-19	covid-19	PROPN
ajmri-3091	66	21	vaccine	vaccine	NOUN
ajmri-3091	66	22	caused	cause	VERB
ajmri-3091	66	23	changes	change	NOUN
ajmri-3091	66	24	in	in	ADP
ajmri-3091	66	25	the	the	DET
ajmri-3091	66	26	menstrual	menstrual	ADJ
ajmri-3091	66	27	cycle	cycle	NOUN
ajmri-3091	66	28	,	,	PUNCT
ajmri-3091	66	29	including	include	VERB
ajmri-3091	66	30	increased	increase	VERB
ajmri-3091	66	31	duration	duration	NOUN
ajmri-3091	66	32	,	,	PUNCT
ajmri-3091	66	33	abundance	abundance	NOUN
ajmri-3091	66	34	,	,	PUNCT
ajmri-3091	66	35	and	and	CCONJ
ajmri-3091	66	36	pain	pain	NOUN
ajmri-3091	66	37	.	.	PUNCT
ajmri-3091	67	1	around	around	ADV
ajmri-3091	67	2	60	60	NUM
ajmri-3091	67	3	%	%	NOUN
ajmri-3091	67	4	of	of	ADP
ajmri-3091	67	5	cases	case	NOUN
ajmri-3091	67	6	experienced	experience	VERB
ajmri-3091	67	7	these	these	DET
ajmri-3091	67	8	disorders	disorder	NOUN
ajmri-3091	67	9	after	after	ADP
ajmri-3091	67	10	the	the	DET
ajmri-3091	67	11	vaccine	vaccine	NOUN
ajmri-3091	67	12	.	.	PUNCT
ajmri-3091	68	1	females	female	NOUN
ajmri-3091	68	2	aged	age	VERB
ajmri-3091	68	3	15	15	NUM
ajmri-3091	68	4	-	-	SYM
ajmri-3091	68	5	24	24	NUM
ajmri-3091	68	6	pa	pa	PROPN
ajmri-3091	68	7	ge	ge	PROPN
ajmri-3091	68	8	14	14	NUM
ajmri-3091	68	9	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	68	10	am	am	NOUN
ajmri-3091	68	11	.	.	PUNCT
ajmri-3091	69	1	j.	j.	PROPN
ajmri-3091	69	2	multidis	multidis	PROPN
ajmri-3091	69	3	.	.	PUNCT
ajmri-3091	70	1	res	re	NOUN
ajmri-3091	70	2	.	.	PUNCT
ajmri-3091	71	1	innov	innov	PROPN
ajmri-3091	71	2	.	.	PUNCT
ajmri-3091	72	1	3(6	3(6	PROPN
ajmri-3091	72	2	)	)	PUNCT
ajmri-3091	72	3	12	12	NUM
ajmri-3091	72	4	-	-	SYM
ajmri-3091	72	5	24	24	NUM
ajmri-3091	72	6	,	,	PUNCT
ajmri-3091	72	7	2024	2024	NUM
ajmri-3091	72	8	years	year	NOUN
ajmri-3091	72	9	were	be	AUX
ajmri-3091	72	10	two	two	NUM
ajmri-3091	72	11	times	time	NOUN
ajmri-3091	72	12	more	more	ADV
ajmri-3091	72	13	likely	likely	ADJ
ajmri-3091	72	14	to	to	PART
ajmri-3091	72	15	experience	experience	VERB
ajmri-3091	72	16	these	these	DET
ajmri-3091	72	17	changes	change	NOUN
ajmri-3091	72	18	,	,	PUNCT
ajmri-3091	72	19	indicating	indicate	VERB
ajmri-3091	72	20	a	a	DET
ajmri-3091	72	21	significant	significant	ADJ
ajmri-3091	72	22	impact	impact	NOUN
ajmri-3091	72	23	of	of	ADP
ajmri-3091	72	24	the	the	DET
ajmri-3091	72	25	vaccine	vaccine	NOUN
ajmri-3091	72	26	on	on	ADP
ajmri-3091	72	27	the	the	DET
ajmri-3091	72	28	menstrual	menstrual	ADJ
ajmri-3091	72	29	cycle	cycle	NOUN
ajmri-3091	72	30	(	(	PUNCT
ajmri-3091	72	31	almousa	almousa	NOUN
ajmri-3091	72	32	,	,	PUNCT
ajmri-3091	72	33	2022	2022	NUM
ajmri-3091	72	34	)	)	PUNCT
ajmri-3091	72	35	.	.	PUNCT
ajmri-3091	73	1	moreover	moreover	ADV
ajmri-3091	73	2	,	,	PUNCT
ajmri-3091	73	3	a	a	DET
ajmri-3091	73	4	study	study	NOUN
ajmri-3091	73	5	by	by	ADP
ajmri-3091	73	6	gibson	gibson	PROPN
ajmri-3091	73	7	et	et	PROPN
ajmri-3091	73	8	al	al	PROPN
ajmri-3091	73	9	.	.	PROPN
ajmri-3091	74	1	(	(	PUNCT
ajmri-3091	74	2	2022	2022	NUM
ajmri-3091	74	3	)	)	PUNCT
ajmri-3091	74	4	found	find	VERB
ajmri-3091	74	5	that	that	SCONJ
ajmri-3091	74	6	55	55	NUM
ajmri-3091	74	7	%	%	NOUN
ajmri-3091	74	8	of	of	ADP
ajmri-3091	74	9	participants	participant	NOUN
ajmri-3091	74	10	received	receive	VERB
ajmri-3091	74	11	the	the	DET
ajmri-3091	74	12	pfizer	pfizer	NOUN
ajmri-3091	74	13	vaccination	vaccination	NOUN
ajmri-3091	74	14	,	,	PUNCT
ajmri-3091	74	15	37	37	NUM
ajmri-3091	74	16	%	%	NOUN
ajmri-3091	74	17	received	receive	VERB
ajmri-3091	74	18	moderna	moderna	PROPN
ajmri-3091	74	19	’s	’s	PART
ajmri-3091	74	20	vaccine	vaccine	NOUN
ajmri-3091	74	21	,	,	PUNCT
ajmri-3091	74	22	and	and	CCONJ
ajmri-3091	74	23	8	8	NUM
ajmri-3091	74	24	%	%	NOUN
ajmri-3091	74	25	received	receive	VERB
ajmri-3091	74	26	the	the	DET
ajmri-3091	74	27	johnson	johnson	PROPN
ajmri-3091	74	28	and	and	CCONJ
ajmri-3091	74	29	janssen	janssen	PROPN
ajmri-3091	74	30	vaccine	vaccine	NOUN
ajmri-3091	74	31	(	(	PUNCT
ajmri-3091	74	32	gibson	gibson	PROPN
ajmri-3091	74	33	et	et	PROPN
ajmri-3091	74	34	al	al	PROPN
ajmri-3091	74	35	.	.	PROPN
ajmri-3091	74	36	,	,	PUNCT
ajmri-3091	74	37	2022	2022	NUM
ajmri-3091	74	38	)	)	PUNCT
ajmri-3091	74	39	.	.	PUNCT
ajmri-3091	75	1	this	this	DET
ajmri-3091	75	2	study	study	NOUN
ajmri-3091	75	3	found	find	VERB
ajmri-3091	75	4	a	a	DET
ajmri-3091	75	5	slight	slight	ADJ
ajmri-3091	75	6	increase	increase	NOUN
ajmri-3091	75	7	in	in	ADP
ajmri-3091	75	8	menstrual	menstrual	ADJ
ajmri-3091	75	9	cycle	cycle	NOUN
ajmri-3091	75	10	duration	duration	NOUN
ajmri-3091	75	11	following	follow	VERB
ajmri-3091	75	12	covid-19	covid-19	PROPN
ajmri-3091	75	13	vaccination	vaccination	NOUN
ajmri-3091	75	14	,	,	PUNCT
ajmri-3091	75	15	with	with	ADP
ajmri-3091	75	16	a	a	DET
ajmri-3091	75	17	significant	significant	ADJ
ajmri-3091	75	18	increase	increase	NOUN
ajmri-3091	75	19	in	in	ADP
ajmri-3091	75	20	the	the	DET
ajmri-3091	75	21	likelihood	likelihood	NOUN
ajmri-3091	75	22	of	of	ADP
ajmri-3091	75	23	a	a	DET
ajmri-3091	75	24	cycle	cycle	NOUN
ajmri-3091	75	25	lasting	last	VERB
ajmri-3091	75	26	over	over	ADP
ajmri-3091	75	27	38	38	NUM
ajmri-3091	75	28	days	day	NOUN
ajmri-3091	75	29	(	(	PUNCT
ajmri-3091	75	30	gibson	gibson	PROPN
ajmri-3091	75	31	et	et	PROPN
ajmri-3091	75	32	al	al	PROPN
ajmri-3091	75	33	.	.	PROPN
ajmri-3091	75	34	,	,	PUNCT
ajmri-3091	75	35	2022	2022	NUM
ajmri-3091	75	36	)	)	PUNCT
ajmri-3091	75	37	.	.	PUNCT
ajmri-3091	76	1	however	however	ADV
ajmri-3091	76	2	,	,	PUNCT
ajmri-3091	76	3	this	this	DET
ajmri-3091	76	4	effect	effect	NOUN
ajmri-3091	76	5	was	be	AUX
ajmri-3091	76	6	not	not	PART
ajmri-3091	76	7	persistent	persistent	ADJ
ajmri-3091	76	8	.	.	PUNCT
ajmri-3091	77	1	the	the	DET
ajmri-3091	77	2	duration	duration	NOUN
ajmri-3091	77	3	of	of	ADP
ajmri-3091	77	4	menstrual	menstrual	ADJ
ajmri-3091	77	5	cycles	cycle	NOUN
ajmri-3091	77	6	increased	increase	VERB
ajmri-3091	77	7	for	for	ADP
ajmri-3091	77	8	1	1	NUM
ajmri-3091	77	9	-	-	SYM
ajmri-3091	77	10	2	2	NUM
ajmri-3091	77	11	cycles	cycle	NOUN
ajmri-3091	77	12	after	after	ADP
ajmri-3091	77	13	vaccination	vaccination	NOUN
ajmri-3091	77	14	but	but	CCONJ
ajmri-3091	77	15	then	then	ADV
ajmri-3091	77	16	recovered	recover	VERB
ajmri-3091	77	17	to	to	ADP
ajmri-3091	77	18	their	their	PRON
ajmri-3091	77	19	original	original	ADJ
ajmri-3091	77	20	length	length	NOUN
ajmri-3091	77	21	.	.	PUNCT
ajmri-3091	78	1	the	the	DET
ajmri-3091	78	2	increase	increase	NOUN
ajmri-3091	78	3	was	be	AUX
ajmri-3091	78	4	associated	associate	VERB
ajmri-3091	78	5	with	with	ADP
ajmri-3091	78	6	dosages	dosage	NOUN
ajmri-3091	78	7	administered	administer	VERB
ajmri-3091	78	8	during	during	ADP
ajmri-3091	78	9	the	the	DET
ajmri-3091	78	10	early	early	ADJ
ajmri-3091	78	11	and	and	CCONJ
ajmri-3091	78	12	mid	mid	ADJ
ajmri-3091	78	13	-	-	ADJ
ajmri-3091	78	14	follicular	follicular	ADJ
ajmri-3091	78	15	phase	phase	NOUN
ajmri-3091	78	16	(	(	PUNCT
ajmri-3091	78	17	gibson	gibson	PROPN
ajmri-3091	78	18	et	et	PROPN
ajmri-3091	78	19	al	al	PROPN
ajmri-3091	78	20	.	.	PROPN
ajmri-3091	78	21	,	,	PUNCT
ajmri-3091	78	22	2022	2022	NUM
ajmri-3091	78	23	)	)	PUNCT
ajmri-3091	78	24	.	.	PUNCT
ajmri-3091	79	1	a	a	DET
ajmri-3091	79	2	second	second	ADJ
ajmri-3091	79	3	dosage	dosage	NOUN
ajmri-3091	79	4	within	within	ADP
ajmri-3091	79	5	the	the	DET
ajmri-3091	79	6	final	final	ADJ
ajmri-3091	79	7	14	14	NUM
ajmri-3091	79	8	days	day	NOUN
ajmri-3091	79	9	of	of	ADP
ajmri-3091	79	10	the	the	DET
ajmri-3091	79	11	cycle	cycle	NOUN
ajmri-3091	79	12	,	,	PUNCT
ajmri-3091	79	13	typically	typically	ADV
ajmri-3091	79	14	aligning	align	VERB
ajmri-3091	79	15	with	with	ADP
ajmri-3091	79	16	the	the	DET
ajmri-3091	79	17	luteal	luteal	ADJ
ajmri-3091	79	18	phase	phase	NOUN
ajmri-3091	79	19	,	,	PUNCT
ajmri-3091	79	20	shortened	shorten	VERB
ajmri-3091	79	21	the	the	DET
ajmri-3091	79	22	average	average	ADJ
ajmri-3091	79	23	cycle	cycle	NOUN
ajmri-3091	79	24	length	length	NOUN
ajmri-3091	79	25	.	.	PUNCT
ajmri-3091	80	1	the	the	DET
ajmri-3091	80	2	study	study	NOUN
ajmri-3091	80	3	suggests	suggest	VERB
ajmri-3091	80	4	that	that	SCONJ
ajmri-3091	80	5	the	the	DET
ajmri-3091	80	6	association	association	NOUN
ajmri-3091	80	7	between	between	ADP
ajmri-3091	80	8	vaccination	vaccination	NOUN
ajmri-3091	80	9	and	and	CCONJ
ajmri-3091	80	10	menstrual	menstrual	ADJ
ajmri-3091	80	11	cycle	cycle	NOUN
ajmri-3091	80	12	length	length	NOUN
ajmri-3091	80	13	depends	depend	VERB
ajmri-3091	80	14	on	on	ADP
ajmri-3091	80	15	the	the	DET
ajmri-3091	80	16	timing	timing	NOUN
ajmri-3091	80	17	of	of	ADP
ajmri-3091	80	18	the	the	DET
ajmri-3091	80	19	dosage	dosage	NOUN
ajmri-3091	80	20	and	and	CCONJ
ajmri-3091	80	21	may	may	AUX
ajmri-3091	80	22	align	align	VERB
ajmri-3091	80	23	with	with	ADP
ajmri-3091	80	24	specific	specific	ADJ
ajmri-3091	80	25	phases	phase	NOUN
ajmri-3091	80	26	of	of	ADP
ajmri-3091	80	27	the	the	DET
ajmri-3091	80	28	menstrual	menstrual	ADJ
ajmri-3091	80	29	cycle	cycle	NOUN
ajmri-3091	80	30	(	(	PUNCT
ajmri-3091	80	31	gibson	gibson	PROPN
ajmri-3091	80	32	et	et	PROPN
ajmri-3091	80	33	al	al	PROPN
ajmri-3091	80	34	.	.	PROPN
ajmri-3091	80	35	,	,	PUNCT
ajmri-3091	80	36	2022	2022	NUM
ajmri-3091	80	37	)	)	PUNCT
ajmri-3091	80	38	.	.	PUNCT
ajmri-3091	81	1	previous	previous	ADJ
ajmri-3091	81	2	studies	study	NOUN
ajmri-3091	81	3	demonstrated	demonstrate	VERB
ajmri-3091	81	4	a	a	DET
ajmri-3091	81	5	correlation	correlation	NOUN
ajmri-3091	81	6	between	between	ADP
ajmri-3091	81	7	the	the	DET
ajmri-3091	81	8	administration	administration	NOUN
ajmri-3091	81	9	of	of	ADP
ajmri-3091	81	10	the	the	DET
ajmri-3091	81	11	covid-19	covid-19	PROPN
ajmri-3091	81	12	vaccine	vaccine	NOUN
ajmri-3091	81	13	and	and	CCONJ
ajmri-3091	81	14	elongation	elongation	NOUN
ajmri-3091	81	15	of	of	ADP
ajmri-3091	81	16	the	the	DET
ajmri-3091	81	17	menstrual	menstrual	ADJ
ajmri-3091	81	18	cycle	cycle	NOUN
ajmri-3091	81	19	,	,	PUNCT
ajmri-3091	81	20	as	as	ADV
ajmri-3091	81	21	well	well	ADV
ajmri-3091	81	22	as	as	ADP
ajmri-3091	81	23	irregularities	irregularity	NOUN
ajmri-3091	81	24	in	in	ADP
ajmri-3091	81	25	its	its	PRON
ajmri-3091	81	26	pattern	pattern	NOUN
ajmri-3091	81	27	(	(	PUNCT
ajmri-3091	81	28	alghamdi	alghamdi	NOUN
ajmri-3091	81	29	et	et	PROPN
ajmri-3091	81	30	al	al	PROPN
ajmri-3091	81	31	.	.	PROPN
ajmri-3091	81	32	,	,	PUNCT
ajmri-3091	81	33	2021	2021	NUM
ajmri-3091	81	34	;	;	PUNCT
ajmri-3091	81	35	muhaidat	muhaidat	NOUN
ajmri-3091	81	36	et	et	PROPN
ajmri-3091	81	37	al	al	PROPN
ajmri-3091	81	38	.	.	PROPN
ajmri-3091	81	39	,	,	PUNCT
ajmri-3091	81	40	2022	2022	NUM
ajmri-3091	81	41	)	)	PUNCT
ajmri-3091	81	42	.	.	PUNCT
ajmri-3091	82	1	studies	study	NOUN
ajmri-3091	82	2	conducted	conduct	VERB
ajmri-3091	82	3	by	by	ADP
ajmri-3091	82	4	alvergne	alvergne	PROPN
ajmri-3091	82	5	et	et	PROPN
ajmri-3091	82	6	al	al	PROPN
ajmri-3091	82	7	.	.	PROPN
ajmri-3091	82	8	(	(	PUNCT
ajmri-3091	82	9	2022	2022	NUM
ajmri-3091	82	10	)	)	PUNCT
ajmri-3091	82	11	and	and	CCONJ
ajmri-3091	82	12	edelman	edelman	NOUN
ajmri-3091	82	13	et	et	PROPN
ajmri-3091	82	14	al	al	PROPN
ajmri-3091	82	15	.	.	PROPN
ajmri-3091	82	16	(	(	PUNCT
ajmri-3091	82	17	2022	2022	NUM
ajmri-3091	82	18	)	)	PUNCT
ajmri-3091	82	19	reported	report	VERB
ajmri-3091	82	20	a	a	DET
ajmri-3091	82	21	certain	certain	ADJ
ajmri-3091	82	22	degree	degree	NOUN
ajmri-3091	82	23	of	of	ADP
ajmri-3091	82	24	correlation	correlation	NOUN
ajmri-3091	82	25	between	between	ADP
ajmri-3091	82	26	vaccination	vaccination	NOUN
ajmri-3091	82	27	doses	dose	NOUN
ajmri-3091	82	28	and	and	CCONJ
ajmri-3091	82	29	menstrual	menstrual	ADJ
ajmri-3091	82	30	disturbances	disturbance	NOUN
ajmri-3091	82	31	(	(	PUNCT
ajmri-3091	82	32	alvergne	alvergne	NOUN
ajmri-3091	82	33	et	et	PROPN
ajmri-3091	82	34	al	al	PROPN
ajmri-3091	82	35	.	.	PROPN
ajmri-3091	82	36	,	,	PUNCT
ajmri-3091	82	37	2022	2022	NUM
ajmri-3091	82	38	)	)	PUNCT
ajmri-3091	82	39	.	.	PUNCT
ajmri-3091	83	1	consequently	consequently	ADV
ajmri-3091	83	2	,	,	PUNCT
ajmri-3091	83	3	the	the	DET
ajmri-3091	83	4	study	study	NOUN
ajmri-3091	83	5	by	by	ADP
ajmri-3091	83	6	farland	farland	PROPN
ajmri-3091	83	7	et	et	PROPN
ajmri-3091	83	8	al	al	PROPN
ajmri-3091	83	9	.	.	PROPN
ajmri-3091	84	1	(	(	PUNCT
ajmri-3091	84	2	2023	2023	NUM
ajmri-3091	84	3	)	)	PUNCT
ajmri-3091	84	4	found	find	VERB
ajmri-3091	84	5	that	that	SCONJ
ajmri-3091	84	6	25	25	NUM
ajmri-3091	84	7	%	%	NOUN
ajmri-3091	84	8	of	of	ADP
ajmri-3091	84	9	the	the	DET
ajmri-3091	84	10	participants	participant	NOUN
ajmri-3091	84	11	who	who	PRON
ajmri-3091	84	12	received	receive	VERB
ajmri-3091	84	13	vaccine	vaccine	NOUN
ajmri-3091	84	14	experienced	experience	VERB
ajmri-3091	84	15	menstrual	menstrual	ADJ
ajmri-3091	84	16	cycle	cycle	NOUN
ajmri-3091	84	17	disruptions	disruption	NOUN
ajmri-3091	84	18	,	,	PUNCT
ajmri-3091	84	19	with	with	ADP
ajmri-3091	84	20	the	the	DET
ajmri-3091	84	21	majority	majority	NOUN
ajmri-3091	84	22	occurring	occur	VERB
ajmri-3091	84	23	after	after	ADP
ajmri-3091	84	24	the	the	DET
ajmri-3091	84	25	second	second	ADJ
ajmri-3091	84	26	dose	dose	NOUN
ajmri-3091	84	27	(	(	PUNCT
ajmri-3091	84	28	56	56	NUM
ajmri-3091	84	29	%	%	NOUN
ajmri-3091	84	30	)	)	PUNCT
ajmri-3091	84	31	(	(	PUNCT
ajmri-3091	84	32	farland	farland	NOUN
ajmri-3091	84	33	et	et	PROPN
ajmri-3091	84	34	al	al	PROPN
ajmri-3091	84	35	.	.	PROPN
ajmri-3091	84	36	,	,	PUNCT
ajmri-3091	84	37	2023	2023	NUM
ajmri-3091	84	38	)	)	PUNCT
ajmri-3091	84	39	.	.	PUNCT
ajmri-3091	85	1	common	common	ADJ
ajmri-3091	85	2	issues	issue	NOUN
ajmri-3091	85	3	included	include	VERB
ajmri-3091	85	4	irregular	irregular	ADJ
ajmri-3091	85	5	menstruation	menstruation	NOUN
ajmri-3091	85	6	(	(	PUNCT
ajmri-3091	85	7	43	43	NUM
ajmri-3091	85	8	%	%	NOUN
ajmri-3091	85	9	)	)	PUNCT
ajmri-3091	85	10	,	,	PUNCT
ajmri-3091	85	11	heavy	heavy	ADJ
ajmri-3091	85	12	bleeding	bleeding	NOUN
ajmri-3091	85	13	(	(	PUNCT
ajmri-3091	85	14	31	31	NUM
ajmri-3091	85	15	%	%	NOUN
ajmri-3091	85	16	)	)	PUNCT
ajmri-3091	85	17	,	,	PUNCT
ajmri-3091	85	18	increased	increase	VERB
ajmri-3091	85	19	period	period	NOUN
ajmri-3091	85	20	discomfort	discomfort	NOUN
ajmri-3091	85	21	(	(	PUNCT
ajmri-3091	85	22	30	30	NUM
ajmri-3091	85	23	%	%	NOUN
ajmri-3091	85	24	)	)	PUNCT
ajmri-3091	85	25	,	,	PUNCT
ajmri-3091	85	26	and	and	CCONJ
ajmri-3091	85	27	intensified	intensify	VERB
ajmri-3091	85	28	premenstrual	premenstrual	ADJ
ajmri-3091	85	29	symptoms	symptom	NOUN
ajmri-3091	85	30	(	(	PUNCT
ajmri-3091	85	31	34	34	NUM
ajmri-3091	85	32	%	%	NOUN
ajmri-3091	85	33	)	)	PUNCT
ajmri-3091	85	34	.	.	PUNCT
ajmri-3091	86	1	the	the	DET
ajmri-3091	86	2	study	study	NOUN
ajmri-3091	86	3	results	result	NOUN
ajmri-3091	86	4	revealed	reveal	VERB
ajmri-3091	86	5	that	that	SCONJ
ajmri-3091	86	6	individuals	individual	NOUN
ajmri-3091	86	7	with	with	ADP
ajmri-3091	86	8	higher	high	ADJ
ajmri-3091	86	9	bmi	bmi	NOUN
ajmri-3091	86	10	and	and	CCONJ
ajmri-3091	86	11	higher	high	ADJ
ajmri-3091	86	12	self	self	NOUN
ajmri-3091	86	13	-	-	PUNCT
ajmri-3091	86	14	reported	report	VERB
ajmri-3091	86	15	perceived	perceive	VERB
ajmri-3091	86	16	stress	stress	NOUN
ajmri-3091	86	17	levels	level	NOUN
ajmri-3091	86	18	were	be	AUX
ajmri-3091	86	19	more	more	ADV
ajmri-3091	86	20	likely	likely	ADJ
ajmri-3091	86	21	to	to	PART
ajmri-3091	86	22	experience	experience	VERB
ajmri-3091	86	23	these	these	DET
ajmri-3091	86	24	changes	change	NOUN
ajmri-3091	86	25	after	after	ADP
ajmri-3091	86	26	vaccination	vaccination	NOUN
ajmri-3091	86	27	(	(	PUNCT
ajmri-3091	86	28	farland	farland	NOUN
ajmri-3091	86	29	et	et	PROPN
ajmri-3091	86	30	al	al	PROPN
ajmri-3091	86	31	.	.	PROPN
ajmri-3091	86	32	,	,	PUNCT
ajmri-3091	86	33	2023	2023	NUM
ajmri-3091	86	34	)	)	PUNCT
ajmri-3091	86	35	.	.	PUNCT
ajmri-3091	87	1	similarly	similarly	ADV
ajmri-3091	87	2	,	,	PUNCT
ajmri-3091	87	3	h.	h.	PROPN
ajmri-3091	87	4	m.	m.	PROPN
ajmri-3091	87	5	al	al	PROPN
ajmri-3091	87	6	kadri	kadri	PROPN
ajmri-3091	87	7	et	et	PROPN
ajmri-3091	87	8	al	al	PROPN
ajmri-3091	87	9	.	.	PROPN
ajmri-3091	87	10	(	(	PUNCT
ajmri-3091	87	11	2023	2023	NUM
ajmri-3091	87	12	)	)	PUNCT
ajmri-3091	87	13	found	find	VERB
ajmri-3091	87	14	menorrhagia	menorrhagia	NOUN
ajmri-3091	87	15	,	,	PUNCT
ajmri-3091	87	16	oligomenorrhea	oligomenorrhea	PROPN
ajmri-3091	87	17	,	,	PUNCT
ajmri-3091	87	18	and	and	CCONJ
ajmri-3091	87	19	polymenorrhea	polymenorrhea	PROPN
ajmri-3091	87	20	as	as	ADP
ajmri-3091	87	21	the	the	DET
ajmri-3091	87	22	most	most	ADV
ajmri-3091	87	23	common	common	ADJ
ajmri-3091	87	24	menstrual	menstrual	ADJ
ajmri-3091	87	25	irregularities	irregularity	NOUN
ajmri-3091	87	26	post	post	NOUN
ajmri-3091	87	27	-	-	NOUN
ajmri-3091	87	28	vaccination	vaccination	NOUN
ajmri-3091	87	29	,	,	PUNCT
ajmri-3091	87	30	highlighting	highlight	VERB
ajmri-3091	87	31	the	the	DET
ajmri-3091	87	32	significant	significant	ADJ
ajmri-3091	87	33	number	number	NOUN
ajmri-3091	87	34	of	of	ADP
ajmri-3091	87	35	women	woman	NOUN
ajmri-3091	87	36	experiencing	experience	VERB
ajmri-3091	87	37	irregular	irregular	ADJ
ajmri-3091	87	38	menstruation	menstruation	NOUN
ajmri-3091	87	39	(	(	PUNCT
ajmri-3091	87	40	al	al	PROPN
ajmri-3091	87	41	kadri	kadri	PROPN
ajmri-3091	87	42	et	et	PROPN
ajmri-3091	87	43	al	al	PROPN
ajmri-3091	87	44	.	.	PROPN
ajmri-3091	87	45	,	,	PUNCT
ajmri-3091	87	46	2023	2023	NUM
ajmri-3091	87	47	)	)	PUNCT
ajmri-3091	87	48	.	.	PUNCT
ajmri-3091	88	1	however	however	ADV
ajmri-3091	88	2	,	,	PUNCT
ajmri-3091	88	3	a	a	DET
ajmri-3091	88	4	study	study	NOUN
ajmri-3091	88	5	by	by	ADP
ajmri-3091	88	6	isılay	isılay	NOUN
ajmri-3091	88	7	taşkaldıran	taşkaldıran	VERB
ajmri-3091	88	8	et	et	PROPN
ajmri-3091	88	9	al	al	PROPN
ajmri-3091	88	10	.	.	PROPN
ajmri-3091	89	1	(	(	PUNCT
ajmri-3091	89	2	2022	2022	NUM
ajmri-3091	89	3	)	)	PUNCT
ajmri-3091	89	4	&	&	CCONJ
ajmri-3091	89	5	tayyab	tayyab	PROPN
ajmri-3091	89	6	et	et	PROPN
ajmri-3091	89	7	al	al	PROPN
ajmri-3091	89	8	.	.	PROPN
ajmri-3091	90	1	(	(	PUNCT
ajmri-3091	90	2	2022	2022	NUM
ajmri-3091	90	3	)	)	PUNCT
ajmri-3091	90	4	revealed	reveal	VERB
ajmri-3091	90	5	that	that	SCONJ
ajmri-3091	90	6	35.7	35.7	NUM
ajmri-3091	90	7	%	%	NOUN
ajmri-3091	90	8	of	of	ADP
ajmri-3091	90	9	241	241	NUM
ajmri-3091	90	10	covid-19	covid-19	PROPN
ajmri-3091	90	11	-	-	PUNCT
ajmri-3091	90	12	infected	infect	VERB
ajmri-3091	90	13	women	woman	NOUN
ajmri-3091	90	14	experienced	experience	VERB
ajmri-3091	90	15	menstrual	menstrual	ADJ
ajmri-3091	90	16	changes	change	NOUN
ajmri-3091	90	17	within	within	ADP
ajmri-3091	90	18	the	the	DET
ajmri-3091	90	19	first	first	ADJ
ajmri-3091	90	20	three	three	NUM
ajmri-3091	90	21	cycles	cycle	NOUN
ajmri-3091	90	22	.	.	PUNCT
ajmri-3091	91	1	among	among	ADP
ajmri-3091	91	2	537	537	NUM
ajmri-3091	91	3	individuals	individual	NOUN
ajmri-3091	91	4	who	who	PRON
ajmri-3091	91	5	received	receive	VERB
ajmri-3091	91	6	various	various	ADJ
ajmri-3091	91	7	covid-19	covid-19	PROPN
ajmri-3091	91	8	vaccinations	vaccination	NOUN
ajmri-3091	91	9	,	,	PUNCT
ajmri-3091	91	10	15.1	15.1	NUM
ajmri-3091	91	11	%	%	NOUN
ajmri-3091	91	12	reported	report	VERB
ajmri-3091	91	13	changes	change	NOUN
ajmri-3091	91	14	(	(	PUNCT
ajmri-3091	91	15	taşkaldıran	taşkaldıran	VERB
ajmri-3091	91	16	et	et	PROPN
ajmri-3091	91	17	al	al	PROPN
ajmri-3091	91	18	.	.	PROPN
ajmri-3091	91	19	,	,	PUNCT
ajmri-3091	91	20	2022	2022	NUM
ajmri-3091	91	21	)	)	PUNCT
ajmri-3091	91	22	.	.	PUNCT
ajmri-3091	92	1	women	woman	NOUN
ajmri-3091	92	2	who	who	PRON
ajmri-3091	92	3	received	receive	VERB
ajmri-3091	92	4	the	the	DET
ajmri-3091	92	5	sinovac	sinovac	NOUN
ajmri-3091	92	6	and	and	CCONJ
ajmri-3091	92	7	pfizer	pfizer	NOUN
ajmri-3091	92	8	vaccines	vaccine	NOUN
ajmri-3091	92	9	had	have	VERB
ajmri-3091	92	10	a	a	DET
ajmri-3091	92	11	higher	high	ADJ
ajmri-3091	92	12	incidence	incidence	NOUN
ajmri-3091	92	13	of	of	ADP
ajmri-3091	92	14	menstrual	menstrual	ADJ
ajmri-3091	92	15	irregularities	irregularity	NOUN
ajmri-3091	92	16	post	post	NOUN
ajmri-3091	92	17	-	-	NOUN
ajmri-3091	92	18	vaccination	vaccination	NOUN
ajmri-3091	92	19	(	(	PUNCT
ajmri-3091	92	20	tayyaba	tayyaba	NOUN
ajmri-3091	92	21	rehan	rehan	PROPN
ajmri-3091	92	22	et	et	PROPN
ajmri-3091	92	23	al	al	PROPN
ajmri-3091	92	24	.	.	PROPN
ajmri-3091	92	25	,	,	PUNCT
ajmri-3091	92	26	2022	2022	NUM
ajmri-3091	92	27	)	)	PUNCT
ajmri-3091	92	28	.	.	PUNCT
ajmri-3091	93	1	a	a	DET
ajmri-3091	93	2	study	study	NOUN
ajmri-3091	93	3	by	by	ADP
ajmri-3091	93	4	chavin	chavin	PROPN
ajmri-3091	93	5	d.	d.	PROPN
ajmri-3091	93	6	gopaul	gopaul	PROPN
ajmri-3091	93	7	et	et	PROPN
ajmri-3091	93	8	al	al	PROPN
ajmri-3091	93	9	.	.	PROPN
ajmri-3091	93	10	(	(	PUNCT
ajmri-3091	93	11	2023	2023	NUM
ajmri-3091	93	12	)	)	PUNCT
ajmri-3091	93	13	revealed	reveal	VERB
ajmri-3091	93	14	that	that	SCONJ
ajmri-3091	93	15	menstrual	menstrual	ADJ
ajmri-3091	93	16	cycle	cycle	NOUN
ajmri-3091	93	17	issues	issue	NOUN
ajmri-3091	93	18	were	be	AUX
ajmri-3091	93	19	common	common	ADJ
ajmri-3091	93	20	among	among	ADP
ajmri-3091	93	21	those	those	PRON
ajmri-3091	93	22	who	who	PRON
ajmri-3091	93	23	received	receive	VERB
ajmri-3091	93	24	the	the	DET
ajmri-3091	93	25	covid-19	covid-19	PROPN
ajmri-3091	93	26	vaccine	vaccine	NOUN
ajmri-3091	93	27	,	,	PUNCT
ajmri-3091	93	28	including	include	VERB
ajmri-3091	93	29	delayed	delay	VERB
ajmri-3091	93	30	menstruation	menstruation	NOUN
ajmri-3091	93	31	and	and	CCONJ
ajmri-3091	93	32	excessive	excessive	ADJ
ajmri-3091	93	33	bleeding	bleeding	NOUN
ajmri-3091	93	34	(	(	PUNCT
ajmri-3091	93	35	gopaul	gopaul	NOUN
ajmri-3091	93	36	et	et	PROPN
ajmri-3091	93	37	al	al	PROPN
ajmri-3091	93	38	.	.	PROPN
ajmri-3091	93	39	,	,	PUNCT
ajmri-3091	93	40	2023	2023	NUM
ajmri-3091	93	41	)	)	PUNCT
ajmri-3091	93	42	.	.	PUNCT
ajmri-3091	94	1	the	the	DET
ajmri-3091	94	2	results	result	NOUN
ajmri-3091	94	3	were	be	AUX
ajmri-3091	94	4	consistent	consistent	ADJ
ajmri-3091	94	5	with	with	ADP
ajmri-3091	94	6	a	a	DET
ajmri-3091	94	7	previous	previous	ADJ
ajmri-3091	94	8	study	study	NOUN
ajmri-3091	94	9	by	by	ADP
ajmri-3091	94	10	woon	woon	PROPN
ajmri-3091	94	11	&	&	CCONJ
ajmri-3091	94	12	male	male	PROPN
ajmri-3091	94	13	et	et	PROPN
ajmri-3091	94	14	al	al	PROPN
ajmri-3091	94	15	.	.	PROPN
ajmri-3091	95	1	(	(	PUNCT
ajmri-3091	95	2	2022	2022	NUM
ajmri-3091	95	3	)	)	PUNCT
ajmri-3091	95	4	,	,	PUNCT
ajmri-3091	95	5	who	who	PRON
ajmri-3091	95	6	observed	observe	VERB
ajmri-3091	95	7	a	a	DET
ajmri-3091	95	8	2.3	2.3	NUM
ajmri-3091	95	9	-	-	PUNCT
ajmri-3091	95	10	day	day	NOUN
ajmri-3091	95	11	delay	delay	NOUN
ajmri-3091	95	12	in	in	ADP
ajmri-3091	95	13	menstrual	menstrual	ADJ
ajmri-3091	95	14	cycles	cycle	NOUN
ajmri-3091	95	15	after	after	ADP
ajmri-3091	95	16	the	the	DET
ajmri-3091	95	17	first	first	ADJ
ajmri-3091	95	18	and	and	CCONJ
ajmri-3091	95	19	second	second	ADJ
ajmri-3091	95	20	doses	dose	NOUN
ajmri-3091	95	21	.	.	PUNCT
ajmri-3091	96	1	the	the	DET
ajmri-3091	96	2	norwegian	norwegian	PROPN
ajmri-3091	96	3	institute	institute	PROPN
ajmri-3091	96	4	of	of	ADP
ajmri-3091	96	5	public	public	ADJ
ajmri-3091	96	6	health	health	NOUN
ajmri-3091	96	7	also	also	ADV
ajmri-3091	96	8	found	find	VERB
ajmri-3091	96	9	increased	increase	VERB
ajmri-3091	96	10	menstrual	menstrual	ADJ
ajmri-3091	96	11	flow	flow	NOUN
ajmri-3091	96	12	in	in	ADP
ajmri-3091	96	13	young	young	ADJ
ajmri-3091	96	14	women	woman	NOUN
ajmri-3091	96	15	aged	age	VERB
ajmri-3091	96	16	18	18	NUM
ajmri-3091	96	17	-	-	SYM
ajmri-3091	96	18	30	30	NUM
ajmri-3091	96	19	after	after	ADP
ajmri-3091	96	20	receiving	receive	VERB
ajmri-3091	96	21	the	the	DET
ajmri-3091	96	22	first	first	ADJ
ajmri-3091	96	23	and	and	CCONJ
ajmri-3091	96	24	second	second	ADJ
ajmri-3091	96	25	doses	dose	NOUN
ajmri-3091	96	26	,	,	PUNCT
ajmri-3091	96	27	with	with	ADP
ajmri-3091	96	28	13.6	13.6	NUM
ajmri-3091	96	29	%	%	NOUN
ajmri-3091	96	30	and	and	CCONJ
ajmri-3091	96	31	15.3	15.3	NUM
ajmri-3091	96	32	%	%	NOUN
ajmri-3091	96	33	,	,	PUNCT
ajmri-3091	96	34	respectively	respectively	ADV
ajmri-3091	96	35	(	(	PUNCT
ajmri-3091	96	36	von	von	PROPN
ajmri-3091	96	37	woon	woon	PROPN
ajmri-3091	96	38	&	&	CCONJ
ajmri-3091	96	39	male	male	PROPN
ajmri-3091	96	40	,	,	PUNCT
ajmri-3091	96	41	2022	2022	NUM
ajmri-3091	96	42	)	)	PUNCT
ajmri-3091	96	43	.	.	PUNCT
ajmri-3091	97	1	however	however	ADV
ajmri-3091	97	2	,	,	PUNCT
ajmri-3091	97	3	no	no	DET
ajmri-3091	97	4	conclusive	conclusive	ADJ
ajmri-3091	97	5	evidence	evidence	NOUN
ajmri-3091	97	6	was	be	AUX
ajmri-3091	97	7	found	find	VERB
ajmri-3091	97	8	between	between	ADP
ajmri-3091	97	9	the	the	DET
ajmri-3091	97	10	covid-19	covid-19	PROPN
ajmri-3091	97	11	vaccination	vaccination	NOUN
ajmri-3091	97	12	and	and	CCONJ
ajmri-3091	97	13	other	other	ADJ
ajmri-3091	97	14	menstrual	menstrual	ADJ
ajmri-3091	97	15	irregularities	irregularity	NOUN
ajmri-3091	97	16	,	,	PUNCT
ajmri-3091	97	17	such	such	ADJ
ajmri-3091	97	18	as	as	ADP
ajmri-3091	97	19	missed	miss	VERB
ajmri-3091	97	20	periods	period	NOUN
ajmri-3091	97	21	(	(	PUNCT
ajmri-3091	97	22	gopaul	gopaul	NOUN
ajmri-3091	97	23	et	et	PROPN
ajmri-3091	97	24	al	al	PROPN
ajmri-3091	97	25	.	.	PROPN
ajmri-3091	97	26	,	,	PUNCT
ajmri-3091	97	27	2023	2023	NUM
ajmri-3091	97	28	)	)	PUNCT
ajmri-3091	97	29	.	.	PUNCT
ajmri-3091	98	1	therefore	therefore	ADV
ajmri-3091	98	2	,	,	PUNCT
ajmri-3091	98	3	this	this	DET
ajmri-3091	98	4	study	study	NOUN
ajmri-3091	98	5	aimed	aim	VERB
ajmri-3091	98	6	to	to	PART
ajmri-3091	98	7	demonstrate	demonstrate	VERB
ajmri-3091	98	8	the	the	DET
ajmri-3091	98	9	impact	impact	NOUN
ajmri-3091	98	10	of	of	ADP
ajmri-3091	98	11	covid-19	covid-19	PROPN
ajmri-3091	98	12	vaccines	vaccine	NOUN
ajmri-3091	98	13	on	on	ADP
ajmri-3091	98	14	women	woman	NOUN
ajmri-3091	98	15	’s	’s	PART
ajmri-3091	98	16	reproductive	reproductive	ADJ
ajmri-3091	98	17	health	health	NOUN
ajmri-3091	98	18	by	by	ADP
ajmri-3091	98	19	examining	examine	VERB
ajmri-3091	98	20	the	the	DET
ajmri-3091	98	21	association	association	NOUN
ajmri-3091	98	22	between	between	ADP
ajmri-3091	98	23	covid-19	covid-19	PROPN
ajmri-3091	98	24	vaccines	vaccine	NOUN
ajmri-3091	98	25	and	and	CCONJ
ajmri-3091	98	26	disturbed	disturb	VERB
ajmri-3091	98	27	menstrual	menstrual	ADJ
ajmri-3091	98	28	cycles	cycle	NOUN
ajmri-3091	98	29	.	.	PUNCT
ajmri-3091	99	1	materials	material	NOUN
ajmri-3091	99	2	and	and	CCONJ
ajmri-3091	99	3	methods	method	NOUN
ajmri-3091	99	4	study	study	NOUN
ajmri-3091	99	5	design	design	NOUN
ajmri-3091	99	6	and	and	CCONJ
ajmri-3091	99	7	population	population	NOUN
ajmri-3091	99	8	this	this	DET
ajmri-3091	99	9	cross	cross	ADJ
ajmri-3091	99	10	-	-	ADJ
ajmri-3091	99	11	sectional	sectional	ADJ
ajmri-3091	99	12	study	study	NOUN
ajmri-3091	99	13	was	be	AUX
ajmri-3091	99	14	conducted	conduct	VERB
ajmri-3091	99	15	among	among	ADP
ajmri-3091	99	16	adult	adult	NOUN
ajmri-3091	99	17	females	female	NOUN
ajmri-3091	99	18	at	at	ADP
ajmri-3091	99	19	king	king	PROPN
ajmri-3091	99	20	saud	saud	PROPN
ajmri-3091	99	21	university	university	PROPN
ajmri-3091	99	22	,	,	PUNCT
ajmri-3091	99	23	riyadh	riyadh	PROPN
ajmri-3091	99	24	,	,	PUNCT
ajmri-3091	99	25	from	from	ADP
ajmri-3091	99	26	april	april	PROPN
ajmri-3091	99	27	2022	2022	NUM
ajmri-3091	99	28	to	to	ADP
ajmri-3091	99	29	august	august	PROPN
ajmri-3091	99	30	2022	2022	NUM
ajmri-3091	99	31	.	.	PUNCT
ajmri-3091	100	1	the	the	DET
ajmri-3091	100	2	study	study	NOUN
ajmri-3091	100	3	population	population	NOUN
ajmri-3091	100	4	consists	consist	VERB
ajmri-3091	100	5	of	of	ADP
ajmri-3091	100	6	380	380	NUM
ajmri-3091	100	7	participants	participant	NOUN
ajmri-3091	100	8	who	who	PRON
ajmri-3091	100	9	experienced	experience	VERB
ajmri-3091	100	10	menstrual	menstrual	ADJ
ajmri-3091	100	11	cycle	cycle	NOUN
ajmri-3091	100	12	disturbances	disturbance	NOUN
ajmri-3091	100	13	after	after	ADP
ajmri-3091	100	14	receiving	receive	VERB
ajmri-3091	100	15	covid-19	covid-19	PROPN
ajmri-3091	100	16	vaccine	vaccine	NOUN
ajmri-3091	100	17	.	.	PUNCT
ajmri-3091	101	1	ethical	ethical	ADJ
ajmri-3091	101	2	approval	approval	NOUN
ajmri-3091	101	3	ethical	ethical	ADJ
ajmri-3091	101	4	approval	approval	NOUN
ajmri-3091	101	5	was	be	AUX
ajmri-3091	101	6	obtained	obtain	VERB
ajmri-3091	101	7	from	from	ADP
ajmri-3091	101	8	the	the	DET
ajmri-3091	101	9	deanship	deanship	NOUN
ajmri-3091	101	10	of	of	ADP
ajmri-3091	101	11	scientific	scientific	ADJ
ajmri-3091	101	12	research	research	NOUN
ajmri-3091	101	13	at	at	ADP
ajmri-3091	101	14	king	king	PROPN
ajmri-3091	101	15	saud	saud	PROPN
ajmri-3091	101	16	university	university	PROPN
ajmri-3091	101	17	(	(	PUNCT
ajmri-3091	101	18	ref	ref	VERB
ajmri-3091	101	19	no	no	INTJ
ajmri-3091	101	20	:	:	PUNCT
ajmri-3091	101	21	ksu	ksu	PROPN
ajmri-3091	101	22	-	-	PUNCT
ajmri-3091	101	23	he-22	he-22	NOUN
ajmri-3091	101	24	-	-	PUNCT
ajmri-3091	101	25	156	156	NUM
ajmri-3091	101	26	)	)	PUNCT
ajmri-3091	101	27	.	.	PUNCT
ajmri-3091	102	1	written	write	VERB
ajmri-3091	102	2	informed	informed	ADJ
ajmri-3091	102	3	consent	consent	NOUN
ajmri-3091	102	4	was	be	AUX
ajmri-3091	102	5	also	also	ADV
ajmri-3091	102	6	obtained	obtain	VERB
ajmri-3091	102	7	from	from	ADP
ajmri-3091	102	8	the	the	DET
ajmri-3091	102	9	participants	participant	NOUN
ajmri-3091	102	10	,	,	PUNCT
ajmri-3091	102	11	and	and	CCONJ
ajmri-3091	102	12	the	the	DET
ajmri-3091	102	13	study	study	NOUN
ajmri-3091	102	14	was	be	AUX
ajmri-3091	102	15	carried	carry	VERB
ajmri-3091	102	16	out	out	ADP
ajmri-3091	102	17	in	in	ADP
ajmri-3091	102	18	conformity	conformity	NOUN
ajmri-3091	102	19	with	with	ADP
ajmri-3091	102	20	the	the	DET
ajmri-3091	102	21	1964	1964	NUM
ajmri-3091	102	22	declaration	declaration	NOUN
ajmri-3091	102	23	of	of	ADP
ajmri-3091	102	24	helsinki	helsinki	PROPN
ajmri-3091	102	25	.	.	PUNCT
ajmri-3091	103	1	the	the	DET
ajmri-3091	103	2	strobe	strobe	PROPN
ajmri-3091	103	3	guidelines	guideline	NOUN
ajmri-3091	103	4	were	be	AUX
ajmri-3091	103	5	followed	follow	VERB
ajmri-3091	103	6	,	,	PUNCT
ajmri-3091	103	7	and	and	CCONJ
ajmri-3091	103	8	any	any	DET
ajmri-3091	103	9	subsequent	subsequent	ADJ
ajmri-3091	103	10	revisions	revision	NOUN
ajmri-3091	103	11	or	or	CCONJ
ajmri-3091	103	12	with	with	ADP
ajmri-3091	103	13	comparable	comparable	ADJ
ajmri-3091	103	14	ethical	ethical	ADJ
ajmri-3091	103	15	standards	standard	NOUN
ajmri-3091	103	16	.	.	PUNCT
ajmri-3091	104	1	inclusion	inclusion	NOUN
ajmri-3091	104	2	and	and	CCONJ
ajmri-3091	104	3	exclusion	exclusion	NOUN
ajmri-3091	104	4	criteria	criterion	NOUN
ajmri-3091	104	5	the	the	DET
ajmri-3091	104	6	study	study	NOUN
ajmri-3091	104	7	included	include	VERB
ajmri-3091	104	8	a	a	DET
ajmri-3091	104	9	clinically	clinically	ADV
ajmri-3091	104	10	suitable	suitable	ADJ
ajmri-3091	104	11	participant	participant	ADJ
ajmri-3091	104	12	cohort	cohort	NOUN
ajmri-3091	104	13	:	:	PUNCT
ajmri-3091	104	14	adult	adult	NOUN
ajmri-3091	104	15	females	female	NOUN
ajmri-3091	104	16	aged	age	VERB
ajmri-3091	104	17	18	18	NUM
ajmri-3091	104	18	to	to	PART
ajmri-3091	104	19	50	50	NUM
ajmri-3091	104	20	years	year	NOUN
ajmri-3091	104	21	.	.	PUNCT
ajmri-3091	105	1	participants	participant	NOUN
ajmri-3091	105	2	who	who	PRON
ajmri-3091	105	3	received	receive	VERB
ajmri-3091	105	4	the	the	DET
ajmri-3091	105	5	covid-19	covid-19	PROPN
ajmri-3091	105	6	vaccine	vaccine	NOUN
ajmri-3091	105	7	and	and	CCONJ
ajmri-3091	105	8	menstruating	menstruate	VERB
ajmri-3091	105	9	were	be	AUX
ajmri-3091	105	10	selected	select	VERB
ajmri-3091	105	11	for	for	ADP
ajmri-3091	105	12	the	the	DET
ajmri-3091	105	13	study	study	NOUN
ajmri-3091	105	14	.	.	PUNCT
ajmri-3091	106	1	conversely	conversely	ADV
ajmri-3091	106	2	,	,	PUNCT
ajmri-3091	106	3	the	the	DET
ajmri-3091	106	4	exclusion	exclusion	NOUN
ajmri-3091	106	5	criteria	criterion	NOUN
ajmri-3091	106	6	included	include	VERB
ajmri-3091	106	7	participants	participant	NOUN
ajmri-3091	106	8	aged	age	VERB
ajmri-3091	106	9	below	below	ADP
ajmri-3091	106	10	18	18	NUM
ajmri-3091	106	11	,	,	PUNCT
ajmri-3091	106	12	lactating	lactating	NOUN
ajmri-3091	106	13	and	and	CCONJ
ajmri-3091	106	14	pregnant	pregnant	ADJ
ajmri-3091	106	15	,	,	PUNCT
ajmri-3091	106	16	who	who	PRON
ajmri-3091	106	17	had	have	AUX
ajmri-3091	106	18	previously	previously	ADV
ajmri-3091	106	19	experienced	experience	VERB
ajmri-3091	106	20	ovarian	ovarian	ADJ
ajmri-3091	106	21	dysfunction	dysfunction	NOUN
ajmri-3091	106	22	,	,	PUNCT
ajmri-3091	106	23	who	who	PRON
ajmri-3091	106	24	used	use	VERB
ajmri-3091	106	25	intrauterine	intrauterine	NOUN
ajmri-3091	106	26	or	or	CCONJ
ajmri-3091	106	27	oral	oral	ADJ
ajmri-3091	106	28	contraceptives	contraceptive	NOUN
ajmri-3091	106	29	,	,	PUNCT
ajmri-3091	106	30	and	and	CCONJ
ajmri-3091	106	31	who	who	PRON
ajmri-3091	106	32	did	do	AUX
ajmri-3091	106	33	not	not	PART
ajmri-3091	106	34	receive	receive	VERB
ajmri-3091	106	35	the	the	DET
ajmri-3091	106	36	covid-19	covid-19	PROPN
ajmri-3091	106	37	vaccine	vaccine	NOUN
ajmri-3091	106	38	.	.	PUNCT
ajmri-3091	107	1	data	datum	NOUN
ajmri-3091	107	2	collection	collection	NOUN
ajmri-3091	107	3	and	and	CCONJ
ajmri-3091	107	4	sampling	sample	VERB
ajmri-3091	107	5	technique	technique	NOUN
ajmri-3091	107	6	the	the	DET
ajmri-3091	107	7	data	datum	NOUN
ajmri-3091	107	8	was	be	AUX
ajmri-3091	107	9	collected	collect	VERB
ajmri-3091	107	10	through	through	ADP
ajmri-3091	107	11	a	a	DET
ajmri-3091	107	12	structured	structured	ADJ
ajmri-3091	107	13	questionnaire	questionnaire	NOUN
ajmri-3091	107	14	consisting	consist	VERB
ajmri-3091	107	15	of	of	ADP
ajmri-3091	107	16	different	different	ADJ
ajmri-3091	107	17	components	component	NOUN
ajmri-3091	107	18	such	such	ADJ
ajmri-3091	107	19	as	as	ADP
ajmri-3091	107	20	demographics	demographic	NOUN
ajmri-3091	107	21	,	,	PUNCT
ajmri-3091	107	22	physical	physical	ADJ
ajmri-3091	107	23	exercise	exercise	NOUN
ajmri-3091	107	24	behaviour	behaviour	NOUN
ajmri-3091	107	25	,	,	PUNCT
ajmri-3091	107	26	menstrual	menstrual	ADJ
ajmri-3091	107	27	disorders	disorder	NOUN
ajmri-3091	107	28	,	,	PUNCT
ajmri-3091	107	29	the	the	DET
ajmri-3091	107	30	impact	impact	NOUN
ajmri-3091	107	31	of	of	ADP
ajmri-3091	107	32	the	the	DET
ajmri-3091	107	33	covid-19	covid-19	PROPN
ajmri-3091	107	34	vaccine	vaccine	NOUN
ajmri-3091	107	35	on	on	ADP
ajmri-3091	107	36	the	the	DET
ajmri-3091	107	37	menstrual	menstrual	ADJ
ajmri-3091	107	38	cycle	cycle	NOUN
ajmri-3091	107	39	,	,	PUNCT
ajmri-3091	107	40	and	and	CCONJ
ajmri-3091	107	41	side	side	NOUN
ajmri-3091	107	42	effects	effect	NOUN
ajmri-3091	107	43	associated	associate	VERB
ajmri-3091	107	44	with	with	ADP
ajmri-3091	107	45	the	the	DET
ajmri-3091	107	46	covid-19	covid-19	PROPN
ajmri-3091	107	47	vaccine	vaccine	NOUN
ajmri-3091	107	48	.	.	PUNCT
ajmri-3091	108	1	the	the	DET
ajmri-3091	108	2	questionnaire	questionnaire	NOUN
ajmri-3091	108	3	was	be	AUX
ajmri-3091	108	4	designed	design	VERB
ajmri-3091	108	5	using	use	VERB
ajmri-3091	108	6	google	google	PROPN
ajmri-3091	108	7	forms	form	NOUN
ajmri-3091	108	8	and	and	CCONJ
ajmri-3091	108	9	distributed	distribute	VERB
ajmri-3091	108	10	through	through	ADP
ajmri-3091	108	11	online	online	ADJ
ajmri-3091	108	12	social	social	ADJ
ajmri-3091	108	13	media	medium	NOUN
ajmri-3091	108	14	platforms	platform	NOUN
ajmri-3091	108	15	.	.	PUNCT
ajmri-3091	109	1	furthermore	furthermore	ADV
ajmri-3091	109	2	,	,	PUNCT
ajmri-3091	109	3	a	a	DET
ajmri-3091	109	4	stratified	stratified	ADJ
ajmri-3091	109	5	random	random	ADJ
ajmri-3091	109	6	sampling	sampling	NOUN
ajmri-3091	109	7	technique	technique	NOUN
ajmri-3091	109	8	was	be	AUX
ajmri-3091	109	9	employed	employ	VERB
ajmri-3091	109	10	to	to	PART
ajmri-3091	109	11	collect	collect	VERB
ajmri-3091	109	12	the	the	DET
ajmri-3091	109	13	data	datum	NOUN
ajmri-3091	109	14	.	.	PUNCT
ajmri-3091	110	1	data	datum	NOUN
ajmri-3091	110	2	analysis	analysis	NOUN
ajmri-3091	110	3	the	the	DET
ajmri-3091	110	4	data	datum	NOUN
ajmri-3091	110	5	was	be	AUX
ajmri-3091	110	6	analysed	analyse	VERB
ajmri-3091	110	7	using	use	VERB
ajmri-3091	110	8	statistical	statistical	ADJ
ajmri-3091	110	9	package	package	NOUN
ajmri-3091	110	10	for	for	ADP
ajmri-3091	110	11	social	social	ADJ
ajmri-3091	110	12	sciences	science	NOUN
ajmri-3091	110	13	(	(	PUNCT
ajmri-3091	110	14	spss	spss	PROPN
ajmri-3091	110	15	inc	inc	PROPN
ajmri-3091	110	16	.	.	PROPN
ajmri-3091	110	17	,	,	PUNCT
ajmri-3091	110	18	chicago	chicago	PROPN
ajmri-3091	110	19	,	,	PUNCT
ajmri-3091	110	20	il	il	PROPN
ajmri-3091	110	21	,	,	PUNCT
ajmri-3091	110	22	usa	usa	PROPN
ajmri-3091	110	23	)	)	PUNCT
ajmri-3091	110	24	version	version	NOUN
ajmri-3091	110	25	20.0	20.0	NUM
ajmri-3091	110	26	.	.	PUNCT
ajmri-3091	111	1	frequencies	frequency	NOUN
ajmri-3091	111	2	and	and	CCONJ
ajmri-3091	111	3	percentages	percentage	NOUN
ajmri-3091	111	4	were	be	AUX
ajmri-3091	111	5	calculated	calculate	VERB
ajmri-3091	111	6	using	use	VERB
ajmri-3091	111	7	descriptive	descriptive	ADJ
ajmri-3091	111	8	statistics	statistic	NOUN
ajmri-3091	111	9	,	,	PUNCT
ajmri-3091	111	10	and	and	CCONJ
ajmri-3091	111	11	association	association	NOUN
ajmri-3091	111	12	analysis	analysis	NOUN
ajmri-3091	111	13	was	be	AUX
ajmri-3091	111	14	done	do	VERB
ajmri-3091	111	15	to	to	ADP
ajmri-3091	111	16	pa	pa	PROPN
ajmri-3091	111	17	ge	ge	PROPN
ajmri-3091	111	18	15	15	NUM
ajmri-3091	111	19	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	111	20	am	am	NOUN
ajmri-3091	111	21	.	.	PUNCT
ajmri-3091	112	1	j.	j.	PROPN
ajmri-3091	112	2	multidis	multidis	PROPN
ajmri-3091	112	3	.	.	PUNCT
ajmri-3091	113	1	res	re	NOUN
ajmri-3091	113	2	.	.	PUNCT
ajmri-3091	114	1	innov	innov	PROPN
ajmri-3091	114	2	.	.	PUNCT
ajmri-3091	115	1	3(6	3(6	PROPN
ajmri-3091	115	2	)	)	PUNCT
ajmri-3091	115	3	12	12	NUM
ajmri-3091	115	4	-	-	SYM
ajmri-3091	115	5	24	24	NUM
ajmri-3091	115	6	,	,	PUNCT
ajmri-3091	115	7	2024	2024	NUM
ajmri-3091	115	8	evaluate	evaluate	VERB
ajmri-3091	115	9	the	the	DET
ajmri-3091	115	10	correlation	correlation	NOUN
ajmri-3091	115	11	between	between	ADP
ajmri-3091	115	12	variables	variable	NOUN
ajmri-3091	115	13	.	.	PUNCT
ajmri-3091	116	1	the	the	DET
ajmri-3091	116	2	p	p	NOUN
ajmri-3091	116	3	-	-	PUNCT
ajmri-3091	116	4	value	value	NOUN
ajmri-3091	116	5	of	of	ADP
ajmri-3091	116	6	<	<	X
ajmri-3091	116	7	0.05	0.05	NUM
ajmri-3091	116	8	was	be	AUX
ajmri-3091	116	9	considered	consider	VERB
ajmri-3091	116	10	statistically	statistically	ADV
ajmri-3091	116	11	significant	significant	ADJ
ajmri-3091	116	12	.	.	PUNCT
ajmri-3091	117	1	results	result	NOUN
ajmri-3091	117	2	and	and	CCONJ
ajmri-3091	117	3	discussion	discussion	NOUN
ajmri-3091	117	4	the	the	DET
ajmri-3091	117	5	results	result	NOUN
ajmri-3091	117	6	section	section	NOUN
ajmri-3091	117	7	presents	present	VERB
ajmri-3091	117	8	a	a	DET
ajmri-3091	117	9	comprehensive	comprehensive	ADJ
ajmri-3091	117	10	analysis	analysis	NOUN
ajmri-3091	117	11	and	and	CCONJ
ajmri-3091	117	12	statistical	statistical	ADJ
ajmri-3091	117	13	interpretations	interpretation	NOUN
ajmri-3091	117	14	based	base	VERB
ajmri-3091	117	15	on	on	ADP
ajmri-3091	117	16	data	datum	NOUN
ajmri-3091	117	17	collection	collection	NOUN
ajmri-3091	117	18	.	.	PUNCT
ajmri-3091	118	1	a	a	DET
ajmri-3091	118	2	total	total	NOUN
ajmri-3091	118	3	of	of	ADP
ajmri-3091	118	4	380	380	NUM
ajmri-3091	118	5	participants	participant	NOUN
ajmri-3091	118	6	were	be	AUX
ajmri-3091	118	7	included	include	VERB
ajmri-3091	118	8	in	in	ADP
ajmri-3091	118	9	the	the	DET
ajmri-3091	118	10	study	study	NOUN
ajmri-3091	118	11	.	.	PUNCT
ajmri-3091	119	1	table	table	NOUN
ajmri-3091	119	2	1	1	NUM
ajmri-3091	119	3	presents	present	VERB
ajmri-3091	119	4	the	the	DET
ajmri-3091	119	5	association	association	NOUN
ajmri-3091	119	6	between	between	ADP
ajmri-3091	119	7	menstrual	menstrual	ADJ
ajmri-3091	119	8	disorders	disorder	NOUN
ajmri-3091	119	9	and	and	CCONJ
ajmri-3091	119	10	the	the	DET
ajmri-3091	119	11	covid-19	covid-19	PROPN
ajmri-3091	119	12	vaccine	vaccine	NOUN
ajmri-3091	119	13	among	among	ADP
ajmri-3091	119	14	adult	adult	NOUN
ajmri-3091	119	15	females	female	NOUN
ajmri-3091	119	16	at	at	ADP
ajmri-3091	119	17	king	king	PROPN
ajmri-3091	119	18	saud	saud	PROPN
ajmri-3091	119	19	university	university	PROPN
ajmri-3091	119	20	.	.	PUNCT
ajmri-3091	120	1	notably	notably	ADV
ajmri-3091	120	2	,	,	PUNCT
ajmri-3091	120	3	59.5	59.5	NUM
ajmri-3091	120	4	%	%	NOUN
ajmri-3091	120	5	of	of	ADP
ajmri-3091	120	6	females	female	NOUN
ajmri-3091	120	7	aged	aged	ADJ
ajmri-3091	120	8	1825	1825	NUM
ajmri-3091	120	9	experienced	experience	VERB
ajmri-3091	120	10	menstrual	menstrual	ADJ
ajmri-3091	120	11	disorders	disorder	NOUN
ajmri-3091	120	12	,	,	PUNCT
ajmri-3091	120	13	with	with	ADP
ajmri-3091	120	14	a	a	DET
ajmri-3091	120	15	decreasing	decrease	VERB
ajmri-3091	120	16	percentage	percentage	NOUN
ajmri-3091	120	17	for	for	ADP
ajmri-3091	120	18	older	old	ADJ
ajmri-3091	120	19	age	age	NOUN
ajmri-3091	120	20	groups	group	NOUN
ajmri-3091	120	21	.	.	PUNCT
ajmri-3091	121	1	while	while	SCONJ
ajmri-3091	121	2	single	single	ADJ
ajmri-3091	121	3	women	woman	NOUN
ajmri-3091	121	4	exhibited	exhibit	VERB
ajmri-3091	121	5	a	a	DET
ajmri-3091	121	6	higher	high	ADJ
ajmri-3091	121	7	percentage	percentage	NOUN
ajmri-3091	121	8	(	(	PUNCT
ajmri-3091	121	9	71.8	71.8	NUM
ajmri-3091	121	10	%	%	NOUN
ajmri-3091	121	11	)	)	PUNCT
ajmri-3091	121	12	compared	compare	VERB
ajmri-3091	121	13	to	to	PART
ajmri-3091	121	14	married	married	ADJ
ajmri-3091	121	15	and	and	CCONJ
ajmri-3091	121	16	divorced	divorce	VERB
ajmri-3091	121	17	.	.	PUNCT
ajmri-3091	122	1	females	female	NOUN
ajmri-3091	122	2	with	with	ADP
ajmri-3091	122	3	normal	normal	ADJ
ajmri-3091	122	4	weight	weight	NOUN
ajmri-3091	122	5	showed	show	VERB
ajmri-3091	122	6	a	a	DET
ajmri-3091	122	7	higher	high	ADJ
ajmri-3091	122	8	percentage	percentage	NOUN
ajmri-3091	122	9	(	(	PUNCT
ajmri-3091	122	10	54.5	54.5	NUM
ajmri-3091	122	11	%	%	NOUN
ajmri-3091	122	12	)	)	PUNCT
ajmri-3091	122	13	compared	compare	VERB
ajmri-3091	122	14	to	to	ADP
ajmri-3091	122	15	obese	obese	ADJ
ajmri-3091	122	16	females	female	NOUN
ajmri-3091	122	17	.	.	PUNCT
ajmri-3091	123	1	tables	table	NOUN
ajmri-3091	123	2	2(a	2(a	NUM
ajmri-3091	123	3	)	)	PUNCT
ajmri-3091	123	4	,	,	PUNCT
ajmri-3091	123	5	2(b	2(b	NUM
ajmri-3091	123	6	)	)	PUNCT
ajmri-3091	123	7	,	,	PUNCT
ajmri-3091	123	8	and	and	CCONJ
ajmri-3091	123	9	2(c	2(c	NUM
ajmri-3091	123	10	)	)	PUNCT
ajmri-3091	123	11	present	present	ADJ
ajmri-3091	123	12	characteristics	characteristic	NOUN
ajmri-3091	123	13	of	of	ADP
ajmri-3091	123	14	female	female	ADJ
ajmri-3091	123	15	participants	participant	NOUN
ajmri-3091	123	16	,	,	PUNCT
ajmri-3091	123	17	covid-19	covid-19	PROPN
ajmri-3091	123	18	vaccination	vaccination	NOUN
ajmri-3091	123	19	,	,	PUNCT
ajmri-3091	123	20	infection	infection	NOUN
ajmri-3091	123	21	history	history	NOUN
ajmri-3091	123	22	,	,	PUNCT
ajmri-3091	123	23	and	and	CCONJ
ajmri-3091	123	24	impact	impact	NOUN
ajmri-3091	123	25	of	of	ADP
ajmri-3091	123	26	vaccination	vaccination	NOUN
ajmri-3091	123	27	on	on	ADP
ajmri-3091	123	28	menstrual	menstrual	ADJ
ajmri-3091	123	29	cycle	cycle	NOUN
ajmri-3091	123	30	,	,	PUNCT
ajmri-3091	123	31	respectively	respectively	ADV
ajmri-3091	123	32	.	.	PUNCT
ajmri-3091	123	33	table	table	NOUN
ajmri-3091	123	34	3	3	NUM
ajmri-3091	123	35	shows	show	VERB
ajmri-3091	123	36	an	an	DET
ajmri-3091	123	37	association	association	NOUN
ajmri-3091	123	38	between	between	ADP
ajmri-3091	123	39	diet	diet	PROPN
ajmri-3091	123	40	,	,	PUNCT
ajmri-3091	123	41	physical	physical	ADJ
ajmri-3091	123	42	exercise	exercise	NOUN
ajmri-3091	123	43	and	and	CCONJ
ajmri-3091	123	44	menstrual	menstrual	ADJ
ajmri-3091	123	45	disorders	disorder	NOUN
ajmri-3091	123	46	after	after	ADP
ajmri-3091	123	47	obtaining	obtain	VERB
ajmri-3091	123	48	the	the	DET
ajmri-3091	123	49	covid-19	covid-19	PROPN
ajmri-3091	123	50	vaccine	vaccine	NOUN
ajmri-3091	123	51	.	.	PUNCT
ajmri-3091	124	1	the	the	DET
ajmri-3091	124	2	highest	high	ADJ
ajmri-3091	124	3	number	number	NOUN
ajmri-3091	124	4	of	of	ADP
ajmri-3091	124	5	females	female	NOUN
ajmri-3091	124	6	with	with	ADP
ajmri-3091	124	7	unhealthy	unhealthy	ADJ
ajmri-3091	124	8	diets	diet	NOUN
ajmri-3091	124	9	(	(	PUNCT
ajmri-3091	124	10	54.5	54.5	NUM
ajmri-3091	124	11	%	%	NOUN
ajmri-3091	124	12	)	)	PUNCT
ajmri-3091	124	13	and	and	CCONJ
ajmri-3091	124	14	moderateintensity	moderateintensity	NOUN
ajmri-3091	124	15	exercise	exercise	NOUN
ajmri-3091	124	16	(	(	PUNCT
ajmri-3091	124	17	92.6	92.6	NUM
ajmri-3091	124	18	%	%	NOUN
ajmri-3091	124	19	)	)	PUNCT
ajmri-3091	124	20	had	have	VERB
ajmri-3091	124	21	menstrual	menstrual	ADJ
ajmri-3091	124	22	disorders	disorder	NOUN
ajmri-3091	124	23	.	.	PUNCT
ajmri-3091	125	1	among	among	ADP
ajmri-3091	125	2	participants	participant	NOUN
ajmri-3091	125	3	,	,	PUNCT
ajmri-3091	125	4	(	(	PUNCT
ajmri-3091	125	5	39.2	39.2	NUM
ajmri-3091	125	6	%	%	NOUN
ajmri-3091	125	7	)	)	PUNCT
ajmri-3091	125	8	of	of	ADP
ajmri-3091	125	9	females	female	NOUN
ajmri-3091	125	10	had	have	AUX
ajmri-3091	125	11	troubled	trouble	VERB
ajmri-3091	125	12	psychological	psychological	ADJ
ajmri-3091	125	13	health	health	NOUN
ajmri-3091	125	14	post	post	ADJ
ajmri-3091	125	15	-	-	ADJ
ajmri-3091	125	16	covid-19	covid-19	ADJ
ajmri-3091	125	17	vaccination	vaccination	NOUN
ajmri-3091	125	18	.	.	PUNCT
ajmri-3091	126	1	table	table	NOUN
ajmri-3091	126	2	4	4	NUM
ajmri-3091	126	3	reveals	reveal	VERB
ajmri-3091	126	4	an	an	DET
ajmri-3091	126	5	association	association	NOUN
ajmri-3091	126	6	between	between	ADP
ajmri-3091	126	7	menstrual	menstrual	ADJ
ajmri-3091	126	8	disorders	disorder	NOUN
ajmri-3091	126	9	post	post	ADJ
ajmri-3091	126	10	-	-	ADJ
ajmri-3091	126	11	covid-19	covid-19	ADJ
ajmri-3091	126	12	vaccination	vaccination	NOUN
ajmri-3091	126	13	and	and	CCONJ
ajmri-3091	126	14	chronic	chronic	ADJ
ajmri-3091	126	15	diseases	disease	NOUN
ajmri-3091	126	16	.	.	PUNCT
ajmri-3091	127	1	the	the	DET
ajmri-3091	127	2	highest	high	ADJ
ajmri-3091	127	3	number	number	NOUN
ajmri-3091	127	4	of	of	ADP
ajmri-3091	127	5	menstrual	menstrual	ADJ
ajmri-3091	127	6	disturbances	disturbance	NOUN
ajmri-3091	127	7	was	be	AUX
ajmri-3091	127	8	observed	observe	VERB
ajmri-3091	127	9	in	in	ADP
ajmri-3091	127	10	females	female	NOUN
ajmri-3091	127	11	with	with	ADP
ajmri-3091	127	12	chronic	chronic	ADJ
ajmri-3091	127	13	disease	disease	NOUN
ajmri-3091	127	14	(	(	PUNCT
ajmri-3091	127	15	14.6	14.6	NUM
ajmri-3091	127	16	%	%	NOUN
ajmri-3091	127	17	)	)	PUNCT
ajmri-3091	127	18	compared	compare	VERB
ajmri-3091	127	19	to	to	ADP
ajmri-3091	127	20	hormone	hormone	NOUN
ajmri-3091	127	21	imbalance	imbalance	NOUN
ajmri-3091	127	22	(	(	PUNCT
ajmri-3091	127	23	12.9	12.9	NUM
ajmri-3091	127	24	%	%	NOUN
ajmri-3091	127	25	)	)	PUNCT
ajmri-3091	127	26	.	.	PUNCT
ajmri-3091	128	1	however	however	ADV
ajmri-3091	128	2	,	,	PUNCT
ajmri-3091	128	3	the	the	DET
ajmri-3091	128	4	association	association	NOUN
ajmri-3091	128	5	analysis	analysis	NOUN
ajmri-3091	128	6	was	be	AUX
ajmri-3091	128	7	not	not	PART
ajmri-3091	128	8	significant	significant	ADJ
ajmri-3091	128	9	.	.	PUNCT
ajmri-3091	129	1	the	the	DET
ajmri-3091	129	2	correlation	correlation	NOUN
ajmri-3091	129	3	between	between	ADP
ajmri-3091	129	4	menstrual	menstrual	ADJ
ajmri-3091	129	5	disorders	disorder	NOUN
ajmri-3091	129	6	post	post	ADJ
ajmri-3091	129	7	-	-	ADJ
ajmri-3091	129	8	covid-19	covid-19	ADJ
ajmri-3091	129	9	vaccination	vaccination	NOUN
ajmri-3091	129	10	and	and	CCONJ
ajmri-3091	129	11	the	the	DET
ajmri-3091	129	12	health	health	NOUN
ajmri-3091	129	13	behaviours	behaviour	NOUN
ajmri-3091	129	14	and	and	CCONJ
ajmri-3091	129	15	practices	practice	NOUN
ajmri-3091	129	16	,	,	PUNCT
ajmri-3091	129	17	medical	medical	ADJ
ajmri-3091	129	18	treatments	treatment	NOUN
ajmri-3091	129	19	and	and	CCONJ
ajmri-3091	129	20	reproductive	reproductive	ADJ
ajmri-3091	129	21	health	health	NOUN
ajmri-3091	129	22	of	of	ADP
ajmri-3091	129	23	the	the	DET
ajmri-3091	129	24	participants	participant	NOUN
ajmri-3091	129	25	is	be	AUX
ajmri-3091	129	26	presented	present	VERB
ajmri-3091	129	27	in	in	ADP
ajmri-3091	129	28	table	table	NOUN
ajmri-3091	129	29	5	5	NUM
ajmri-3091	129	30	.	.	PUNCT
ajmri-3091	130	1	there	there	PRON
ajmri-3091	130	2	was	be	VERB
ajmri-3091	130	3	no	no	DET
ajmri-3091	130	4	significant	significant	ADJ
ajmri-3091	130	5	link	link	NOUN
ajmri-3091	130	6	between	between	ADP
ajmri-3091	130	7	infection	infection	NOUN
ajmri-3091	130	8	and	and	CCONJ
ajmri-3091	130	9	vaccination	vaccination	NOUN
ajmri-3091	130	10	,	,	PUNCT
ajmri-3091	130	11	but	but	CCONJ
ajmri-3091	130	12	higher	high	ADJ
ajmri-3091	130	13	rates	rate	NOUN
ajmri-3091	130	14	of	of	ADP
ajmri-3091	130	15	infection	infection	NOUN
ajmri-3091	130	16	were	be	AUX
ajmri-3091	130	17	observed	observe	VERB
ajmri-3091	130	18	after	after	ADP
ajmri-3091	130	19	vaccination	vaccination	NOUN
ajmri-3091	130	20	.	.	PUNCT
ajmri-3091	131	1	the	the	DET
ajmri-3091	131	2	analysis	analysis	NOUN
ajmri-3091	131	3	revealed	reveal	VERB
ajmri-3091	131	4	that	that	SCONJ
ajmri-3091	131	5	(	(	PUNCT
ajmri-3091	131	6	76.8	76.8	NUM
ajmri-3091	131	7	%	%	NOUN
ajmri-3091	131	8	)	)	PUNCT
ajmri-3091	131	9	females	female	NOUN
ajmri-3091	131	10	did	do	AUX
ajmri-3091	131	11	not	not	PART
ajmri-3091	131	12	use	use	VERB
ajmri-3091	131	13	any	any	DET
ajmri-3091	131	14	therapeutic	therapeutic	ADJ
ajmri-3091	131	15	drugs	drug	NOUN
ajmri-3091	131	16	;	;	PUNCT
ajmri-3091	131	17	reproductive	reproductive	ADJ
ajmri-3091	131	18	health	health	NOUN
ajmri-3091	131	19	was	be	AUX
ajmri-3091	131	20	better	well	ADJ
ajmri-3091	131	21	,	,	PUNCT
ajmri-3091	131	22	but	but	CCONJ
ajmri-3091	131	23	breastfeeding	breastfeeding	NOUN
ajmri-3091	131	24	was	be	AUX
ajmri-3091	131	25	less	less	ADV
ajmri-3091	131	26	common	common	ADJ
ajmri-3091	131	27	among	among	ADP
ajmri-3091	131	28	women	woman	NOUN
ajmri-3091	131	29	with	with	ADP
ajmri-3091	131	30	children	child	NOUN
ajmri-3091	131	31	.	.	PUNCT
ajmri-3091	132	1	further	far	ADV
ajmri-3091	132	2	,	,	PUNCT
ajmri-3091	132	3	there	there	PRON
ajmri-3091	132	4	was	be	VERB
ajmri-3091	132	5	no	no	DET
ajmri-3091	132	6	significant	significant	ADJ
ajmri-3091	132	7	association	association	NOUN
ajmri-3091	132	8	between	between	ADP
ajmri-3091	132	9	vaccination	vaccination	NOUN
ajmri-3091	132	10	stages	stage	NOUN
ajmri-3091	132	11	and	and	CCONJ
ajmri-3091	132	12	menstruation	menstruation	NOUN
ajmri-3091	132	13	issues	issue	NOUN
ajmri-3091	132	14	,	,	PUNCT
ajmri-3091	132	15	but	but	CCONJ
ajmri-3091	132	16	higher	high	ADJ
ajmri-3091	132	17	rates	rate	NOUN
ajmri-3091	132	18	were	be	AUX
ajmri-3091	132	19	observed	observe	VERB
ajmri-3091	132	20	for	for	ADP
ajmri-3091	132	21	those	those	PRON
ajmri-3091	132	22	receiving	receive	VERB
ajmri-3091	132	23	two	two	NUM
ajmri-3091	132	24	or	or	CCONJ
ajmri-3091	132	25	three	three	NUM
ajmri-3091	132	26	doses	dose	NOUN
ajmri-3091	132	27	.	.	PUNCT
ajmri-3091	133	1	figure	figure	NOUN
ajmri-3091	133	2	1	1	NUM
ajmri-3091	133	3	displays	display	VERB
ajmri-3091	133	4	the	the	DET
ajmri-3091	133	5	use	use	NOUN
ajmri-3091	133	6	of	of	ADP
ajmri-3091	133	7	therapeutic	therapeutic	ADJ
ajmri-3091	133	8	drugs	drug	NOUN
ajmri-3091	133	9	among	among	ADP
ajmri-3091	133	10	participants	participant	NOUN
ajmri-3091	133	11	,	,	PUNCT
ajmri-3091	133	12	whereas	whereas	SCONJ
ajmri-3091	133	13	figures	figure	NOUN
ajmri-3091	133	14	2	2	NUM
ajmri-3091	133	15	and	and	CCONJ
ajmri-3091	133	16	3	3	NUM
ajmri-3091	133	17	illustrate	illustrate	VERB
ajmri-3091	133	18	common	common	ADJ
ajmri-3091	133	19	types	type	NOUN
ajmri-3091	133	20	of	of	ADP
ajmri-3091	133	21	disturbances	disturbance	NOUN
ajmri-3091	133	22	during	during	ADP
ajmri-3091	133	23	the	the	DET
ajmri-3091	133	24	menstrual	menstrual	ADJ
ajmri-3091	133	25	cycle	cycle	NOUN
ajmri-3091	133	26	post	post	ADJ
ajmri-3091	133	27	-	-	ADJ
ajmri-3091	133	28	covid-19	covid-19	ADJ
ajmri-3091	133	29	vaccination	vaccination	NOUN
ajmri-3091	133	30	and	and	CCONJ
ajmri-3091	133	31	the	the	DET
ajmri-3091	133	32	duration	duration	NOUN
ajmri-3091	133	33	of	of	ADP
ajmri-3091	133	34	side	side	NOUN
ajmri-3091	133	35	effects	effect	NOUN
ajmri-3091	133	36	among	among	ADP
ajmri-3091	133	37	adult	adult	NOUN
ajmri-3091	133	38	females	female	NOUN
ajmri-3091	133	39	at	at	ADP
ajmri-3091	133	40	king	king	PROPN
ajmri-3091	133	41	saud	saud	PROPN
ajmri-3091	133	42	university	university	PROPN
ajmri-3091	133	43	.	.	PUNCT
ajmri-3091	134	1	table	table	NOUN
ajmri-3091	134	2	1	1	NUM
ajmri-3091	134	3	:	:	PUNCT
ajmri-3091	134	4	demographic	demographic	ADJ
ajmri-3091	134	5	characteristics	characteristic	NOUN
ajmri-3091	134	6	and	and	CCONJ
ajmri-3091	134	7	impact	impact	NOUN
ajmri-3091	134	8	of	of	ADP
ajmri-3091	134	9	covid-19	covid-19	PROPN
ajmri-3091	134	10	vaccine	vaccine	NOUN
ajmri-3091	134	11	on	on	ADP
ajmri-3091	134	12	menstrual	menstrual	ADJ
ajmri-3091	134	13	cycle	cycle	NOUN
ajmri-3091	134	14	frequency	frequency	NOUN
ajmri-3091	134	15	(	(	PUNCT
ajmri-3091	134	16	n	n	NOUN
ajmri-3091	134	17	=	=	SYM
ajmri-3091	134	18	380	380	NUM
ajmri-3091	134	19	)	)	PUNCT
ajmri-3091	134	20	percentage	percentage	NOUN
ajmri-3091	134	21	(	(	PUNCT
ajmri-3091	134	22	n	n	CCONJ
ajmri-3091	134	23	%	%	NOUN
ajmri-3091	134	24	)	)	PUNCT
ajmri-3091	135	1	participant	participant	NOUN
ajmri-3091	135	2	consent	consent	VERB
ajmri-3091	135	3	no	no	DET
ajmri-3091	135	4	4	4	NUM
ajmri-3091	135	5	1.1	1.1	NUM
ajmri-3091	135	6	yes	yes	NOUN
ajmri-3091	135	7	376	376	NUM
ajmri-3091	135	8	98.9	98.9	NUM
ajmri-3091	135	9	age	age	NOUN
ajmri-3091	135	10	18–25	18–25	NUM
ajmri-3091	135	11	226	226	NUM
ajmri-3091	135	12	59.5	59.5	NUM
ajmri-3091	135	13	26–35	26–35	NUM
ajmri-3091	135	14	87	87	NUM
ajmri-3091	135	15	22.9	22.9	NUM
ajmri-3091	135	16	36–49	36–49	NUM
ajmri-3091	135	17	67	67	NUM
ajmri-3091	135	18	17.6	17.6	NUM
ajmri-3091	135	19	nationality	nationality	NOUN
ajmri-3091	135	20	non	non	ADJ
ajmri-3091	135	21	-	-	ADJ
ajmri-3091	135	22	saudi	saudi	ADJ
ajmri-3091	135	23	15	15	NUM
ajmri-3091	135	24	3.9	3.9	NUM
ajmri-3091	135	25	saudi	saudi	ADJ
ajmri-3091	135	26	365	365	NUM
ajmri-3091	135	27	96.1	96.1	NUM
ajmri-3091	135	28	marital	marital	ADJ
ajmri-3091	135	29	status	status	NOUN
ajmri-3091	135	30	single	single	ADJ
ajmri-3091	135	31	273	273	NUM
ajmri-3091	135	32	71.8	71.8	NUM
ajmri-3091	135	33	married	marry	VERB
ajmri-3091	135	34	92	92	NUM
ajmri-3091	135	35	24.2	24.2	NUM
ajmri-3091	135	36	divorced	divorce	VERB
ajmri-3091	135	37	15	15	NUM
ajmri-3091	135	38	3.9	3.9	NUM
ajmri-3091	135	39	profession	profession	NOUN
ajmri-3091	135	40	bachelors	bachelor	NOUN
ajmri-3091	135	41	student	student	VERB
ajmri-3091	135	42	207	207	NUM
ajmri-3091	135	43	54.5	54.5	NUM
ajmri-3091	135	44	post	post	ADJ
ajmri-3091	135	45	-	-	ADJ
ajmri-3091	135	46	graduate	graduate	ADJ
ajmri-3091	135	47	student	student	NOUN
ajmri-3091	135	48	70	70	NUM
ajmri-3091	135	49	18.4	18.4	NUM
ajmri-3091	135	50	employee	employee	NOUN
ajmri-3091	135	51	71	71	NUM
ajmri-3091	135	52	18.7	18.7	NUM
ajmri-3091	135	53	faculty	faculty	NOUN
ajmri-3091	135	54	member	member	NOUN
ajmri-3091	135	55	32	32	NUM
ajmri-3091	135	56	8.4	8.4	NUM
ajmri-3091	135	57	body	body	NOUN
ajmri-3091	135	58	mass	mass	NOUN
ajmri-3091	135	59	index	index	NOUN
ajmri-3091	135	60	underweight	underweight	NOUN
ajmri-3091	135	61	40	40	NUM
ajmri-3091	135	62	10.5	10.5	NUM
ajmri-3091	135	63	normal	normal	ADJ
ajmri-3091	135	64	weight	weight	NOUN
ajmri-3091	135	65	207	207	NUM
ajmri-3091	135	66	54.5	54.5	NUM
ajmri-3091	135	67	overweight	overweight	NOUN
ajmri-3091	135	68	80	80	NUM
ajmri-3091	135	69	21.1	21.1	NUM
ajmri-3091	135	70	obese	obese	NOUN
ajmri-3091	135	71	class	class	NOUN
ajmri-3091	135	72	1	1	NUM
ajmri-3091	135	73	30	30	NUM
ajmri-3091	135	74	7.9	7.9	NUM
ajmri-3091	135	75	obese	obese	ADJ
ajmri-3091	135	76	class	class	NOUN
ajmri-3091	135	77	2	2	NUM
ajmri-3091	135	78	16	16	NUM
ajmri-3091	135	79	4.2	4.2	NUM
ajmri-3091	135	80	obese	obese	ADJ
ajmri-3091	135	81	class	class	NOUN
ajmri-3091	135	82	3	3	NUM
ajmri-3091	135	83	7	7	NUM
ajmri-3091	135	84	1.8	1.8	NUM
ajmri-3091	135	85	pa	pa	PROPN
ajmri-3091	135	86	ge	ge	PROPN
ajmri-3091	135	87	16	16	NUM
ajmri-3091	136	1	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	136	2	am	am	NOUN
ajmri-3091	136	3	.	.	PUNCT
ajmri-3091	137	1	j.	j.	PROPN
ajmri-3091	137	2	multidis	multidis	PROPN
ajmri-3091	137	3	.	.	PUNCT
ajmri-3091	138	1	res	re	NOUN
ajmri-3091	138	2	.	.	PUNCT
ajmri-3091	139	1	innov	innov	PROPN
ajmri-3091	139	2	.	.	PUNCT
ajmri-3091	140	1	3(6	3(6	PROPN
ajmri-3091	140	2	)	)	PUNCT
ajmri-3091	140	3	12	12	NUM
ajmri-3091	140	4	-	-	SYM
ajmri-3091	140	5	24	24	NUM
ajmri-3091	140	6	,	,	PUNCT
ajmri-3091	140	7	2024	2024	NUM
ajmri-3091	140	8	table	table	NOUN
ajmri-3091	140	9	1	1	NUM
ajmri-3091	140	10	shows	show	VERB
ajmri-3091	140	11	that	that	SCONJ
ajmri-3091	140	12	menstrual	menstrual	ADJ
ajmri-3091	140	13	problems	problem	NOUN
ajmri-3091	140	14	following	follow	VERB
ajmri-3091	140	15	the	the	DET
ajmri-3091	140	16	covid-19	covid-19	PROPN
ajmri-3091	140	17	vaccination	vaccination	NOUN
ajmri-3091	140	18	reduced	reduce	VERB
ajmri-3091	140	19	with	with	ADP
ajmri-3091	140	20	increasing	increase	VERB
ajmri-3091	140	21	age	age	NOUN
ajmri-3091	140	22	,	,	PUNCT
ajmri-3091	140	23	with	with	ADP
ajmri-3091	140	24	the	the	DET
ajmri-3091	140	25	association	association	NOUN
ajmri-3091	140	26	not	not	PART
ajmri-3091	140	27	being	be	AUX
ajmri-3091	140	28	statistically	statistically	ADV
ajmri-3091	140	29	significant	significant	ADJ
ajmri-3091	140	30	.	.	PUNCT
ajmri-3091	141	1	adult	adult	NOUN
ajmri-3091	141	2	females	female	NOUN
ajmri-3091	141	3	aged	age	VERB
ajmri-3091	141	4	18	18	NUM
ajmri-3091	141	5	to	to	PART
ajmri-3091	141	6	25	25	NUM
ajmri-3091	141	7	had	have	VERB
ajmri-3091	141	8	the	the	DET
ajmri-3091	141	9	highest	high	ADJ
ajmri-3091	141	10	rate	rate	NOUN
ajmri-3091	141	11	of	of	ADP
ajmri-3091	141	12	disorders	disorder	NOUN
ajmri-3091	141	13	following	follow	VERB
ajmri-3091	141	14	covid-19	covid-19	PROPN
ajmri-3091	141	15	vaccination	vaccination	NOUN
ajmri-3091	141	16	.	.	PUNCT
ajmri-3091	142	1	menstrual	menstrual	ADJ
ajmri-3091	142	2	disruptions	disruption	NOUN
ajmri-3091	142	3	were	be	AUX
ajmri-3091	142	4	substantially	substantially	ADV
ajmri-3091	142	5	correlated	correlate	VERB
ajmri-3091	142	6	with	with	ADP
ajmri-3091	142	7	marital	marital	ADJ
ajmri-3091	142	8	status	status	NOUN
ajmri-3091	142	9	with	with	ADP
ajmri-3091	142	10	single	single	ADJ
ajmri-3091	142	11	women	woman	NOUN
ajmri-3091	142	12	reporting	report	VERB
ajmri-3091	142	13	the	the	DET
ajmri-3091	142	14	highest	high	ADJ
ajmri-3091	142	15	occurrence	occurrence	NOUN
ajmri-3091	142	16	.	.	PUNCT
ajmri-3091	143	1	the	the	DET
ajmri-3091	143	2	comparison	comparison	NOUN
ajmri-3091	143	3	was	be	AUX
ajmri-3091	143	4	significant	significant	ADJ
ajmri-3091	143	5	,	,	PUNCT
ajmri-3091	143	6	with	with	ADP
ajmri-3091	143	7	p	p	NOUN
ajmri-3091	143	8	=	=	NOUN
ajmri-3091	143	9	0.05	0.05	NUM
ajmri-3091	143	10	.	.	PUNCT
ajmri-3091	144	1	there	there	PRON
ajmri-3091	144	2	was	be	VERB
ajmri-3091	144	3	no	no	DET
ajmri-3091	144	4	significant	significant	ADJ
ajmri-3091	144	5	correlation	correlation	NOUN
ajmri-3091	144	6	observed	observe	VERB
ajmri-3091	144	7	between	between	ADP
ajmri-3091	144	8	bmi	bmi	NOUN
ajmri-3091	144	9	levels	level	NOUN
ajmri-3091	144	10	and	and	CCONJ
ajmri-3091	144	11	disruptions	disruption	NOUN
ajmri-3091	144	12	in	in	ADP
ajmri-3091	144	13	the	the	DET
ajmri-3091	144	14	menstrual	menstrual	ADJ
ajmri-3091	144	15	cycle	cycle	NOUN
ajmri-3091	144	16	.	.	PUNCT
ajmri-3091	145	1	however	however	ADV
ajmri-3091	145	2	,	,	PUNCT
ajmri-3091	145	3	obese	obese	ADJ
ajmri-3091	145	4	females	female	NOUN
ajmri-3091	145	5	reported	report	VERB
ajmri-3091	145	6	fewer	few	ADJ
ajmri-3091	145	7	disorders	disorder	NOUN
ajmri-3091	145	8	than	than	ADP
ajmri-3091	145	9	normal	normal	ADJ
ajmri-3091	145	10	-	-	PUNCT
ajmri-3091	145	11	weight	weight	NOUN
ajmri-3091	145	12	females	female	NOUN
ajmri-3091	145	13	,	,	PUNCT
ajmri-3091	145	14	who	who	PRON
ajmri-3091	145	15	reported	report	VERB
ajmri-3091	145	16	the	the	DET
ajmri-3091	145	17	most	most	ADJ
ajmri-3091	145	18	disorders	disorder	NOUN
ajmri-3091	145	19	.	.	PUNCT
ajmri-3091	146	1	table	table	NOUN
ajmri-3091	146	2	2(a	2(a	NUM
ajmri-3091	146	3	):	):	PUNCT
ajmri-3091	146	4	characteristics	characteristic	NOUN
ajmri-3091	146	5	of	of	ADP
ajmri-3091	146	6	female	female	ADJ
ajmri-3091	146	7	participants	participant	NOUN
ajmri-3091	146	8	characteristics	characteristic	NOUN
ajmri-3091	146	9	frequency	frequency	NOUN
ajmri-3091	146	10	(	(	PUNCT
ajmri-3091	147	1	n	n	NOUN
ajmri-3091	147	2	=	=	SYM
ajmri-3091	147	3	380	380	NUM
ajmri-3091	147	4	)	)	PUNCT
ajmri-3091	147	5	percentage	percentage	NOUN
ajmri-3091	147	6	(	(	PUNCT
ajmri-3091	147	7	n	n	NOUN
ajmri-3091	147	8	%	%	NOUN
ajmri-3091	147	9	)	)	PUNCT
ajmri-3091	147	10	are	be	AUX
ajmri-3091	147	11	you	you	PRON
ajmri-3091	147	12	pregnant	pregnant	ADJ
ajmri-3091	147	13	?	?	PUNCT
ajmri-3091	148	1	no	no	DET
ajmri-3091	148	2	377	377	NUM
ajmri-3091	148	3	99.2	99.2	NUM
ajmri-3091	148	4	yes	yes	INTJ
ajmri-3091	148	5	3	3	NUM
ajmri-3091	148	6	0.8	0.8	NUM
ajmri-3091	148	7	are	be	AUX
ajmri-3091	148	8	you	you	PRON
ajmri-3091	148	9	breastfeeding	breastfeed	VERB
ajmri-3091	148	10	?	?	PUNCT
ajmri-3091	149	1	no	no	DET
ajmri-3091	149	2	374	374	NUM
ajmri-3091	149	3	98.4	98.4	NUM
ajmri-3091	149	4	yes	yes	NOUN
ajmri-3091	149	5	6	6	NUM
ajmri-3091	149	6	1.6	1.6	NUM
ajmri-3091	149	7	do	do	AUX
ajmri-3091	149	8	you	you	PRON
ajmri-3091	149	9	have	have	VERB
ajmri-3091	149	10	menstrual	menstrual	ADJ
ajmri-3091	149	11	disorders	disorder	NOUN
ajmri-3091	149	12	?	?	PUNCT
ajmri-3091	150	1	no	no	DET
ajmri-3091	150	2	181	181	NUM
ajmri-3091	150	3	47.6	47.6	NUM
ajmri-3091	150	4	yes	yes	INTJ
ajmri-3091	150	5	199	199	NUM
ajmri-3091	150	6	52.4	52.4	NUM
ajmri-3091	150	7	do	do	AUX
ajmri-3091	150	8	you	you	PRON
ajmri-3091	150	9	have	have	VERB
ajmri-3091	150	10	a	a	DET
ajmri-3091	150	11	thyroid	thyroid	NOUN
ajmri-3091	150	12	disorder	disorder	NOUN
ajmri-3091	150	13	?	?	PUNCT
ajmri-3091	151	1	no	no	DET
ajmri-3091	151	2	358	358	NUM
ajmri-3091	151	3	94.2	94.2	NUM
ajmri-3091	152	1	yes	yes	INTJ
ajmri-3091	152	2	22	22	NUM
ajmri-3091	152	3	5.8	5.8	NUM
ajmri-3091	152	4	do	do	AUX
ajmri-3091	152	5	you	you	PRON
ajmri-3091	152	6	have	have	VERB
ajmri-3091	152	7	a	a	DET
ajmri-3091	152	8	hormone	hormone	NOUN
ajmri-3091	152	9	imbalance	imbalance	NOUN
ajmri-3091	152	10	?	?	PUNCT
ajmri-3091	153	1	no	no	DET
ajmri-3091	153	2	331	331	NUM
ajmri-3091	153	3	87.1	87.1	NUM
ajmri-3091	153	4	yes	yes	INTJ
ajmri-3091	153	5	49	49	NUM
ajmri-3091	153	6	12.9	12.9	NUM
ajmri-3091	153	7	do	do	AUX
ajmri-3091	153	8	you	you	PRON
ajmri-3091	153	9	have	have	VERB
ajmri-3091	153	10	children	child	NOUN
ajmri-3091	153	11	?	?	PUNCT
ajmri-3091	154	1	no	no	DET
ajmri-3091	154	2	297	297	NUM
ajmri-3091	154	3	78.2	78.2	NUM
ajmri-3091	154	4	yes	yes	INTJ
ajmri-3091	154	5	83	83	NUM
ajmri-3091	154	6	21.8	21.8	NUM
ajmri-3091	154	7	do	do	AUX
ajmri-3091	154	8	you	you	PRON
ajmri-3091	154	9	use	use	VERB
ajmri-3091	154	10	any	any	PRON
ajmri-3091	154	11	of	of	ADP
ajmri-3091	154	12	these	these	DET
ajmri-3091	154	13	contraceptives	contraceptive	NOUN
ajmri-3091	154	14	?	?	PUNCT
ajmri-3091	155	1	nothing	nothing	PRON
ajmri-3091	155	2	354	354	NUM
ajmri-3091	155	3	93.2	93.2	NUM
ajmri-3091	155	4	the	the	DET
ajmri-3091	155	5	oral	oral	ADJ
ajmri-3091	155	6	contraceptive	contraceptive	ADJ
ajmri-3091	155	7	pill	pill	NOUN
ajmri-3091	155	8	21	21	NUM
ajmri-3091	155	9	5.5	5.5	NUM
ajmri-3091	155	10	intrauterine	intrauterine	ADJ
ajmri-3091	155	11	device	device	NOUN
ajmri-3091	155	12	5	5	NUM
ajmri-3091	155	13	1.3	1.3	NUM
ajmri-3091	155	14	table	table	NOUN
ajmri-3091	155	15	2(b	2(b	NUM
ajmri-3091	155	16	):	):	PUNCT
ajmri-3091	155	17	covid-19	covid-19	PROPN
ajmri-3091	155	18	vaccination	vaccination	NOUN
ajmri-3091	155	19	and	and	CCONJ
ajmri-3091	155	20	infection	infection	NOUN
ajmri-3091	155	21	history	history	NOUN
ajmri-3091	155	22	characteristics	characteristic	NOUN
ajmri-3091	155	23	frequency	frequency	NOUN
ajmri-3091	155	24	(	(	PUNCT
ajmri-3091	155	25	n	n	NOUN
ajmri-3091	155	26	=	=	SYM
ajmri-3091	155	27	380	380	NUM
ajmri-3091	155	28	)	)	PUNCT
ajmri-3091	155	29	percentage	percentage	NOUN
ajmri-3091	155	30	(	(	PUNCT
ajmri-3091	155	31	n	n	NOUN
ajmri-3091	155	32	%	%	NOUN
ajmri-3091	155	33	)	)	PUNCT
ajmri-3091	155	34	have	have	AUX
ajmri-3091	155	35	you	you	PRON
ajmri-3091	155	36	been	be	AUX
ajmri-3091	155	37	infected	infect	VERB
ajmri-3091	155	38	with	with	ADP
ajmri-3091	155	39	acute	acute	ADJ
ajmri-3091	155	40	respiratory	respiratory	ADJ
ajmri-3091	155	41	syndrome	syndrome	NOUN
ajmri-3091	155	42	coronavirus	coronavirus	NOUN
ajmri-3091	155	43	2	2	NUM
ajmri-3091	155	44	before	before	ADP
ajmri-3091	155	45	getting	get	VERB
ajmri-3091	155	46	covid-19	covid-19	PROPN
ajmri-3091	155	47	vaccination	vaccination	NOUN
ajmri-3091	155	48	?	?	PUNCT
ajmri-3091	156	1	no	no	DET
ajmri-3091	156	2	334	334	NUM
ajmri-3091	156	3	87.9	87.9	NUM
ajmri-3091	157	1	yes	yes	INTJ
ajmri-3091	157	2	46	46	NUM
ajmri-3091	157	3	12.1	12.1	NUM
ajmri-3091	157	4	have	have	AUX
ajmri-3091	157	5	you	you	PRON
ajmri-3091	157	6	been	be	AUX
ajmri-3091	157	7	infected	infect	VERB
ajmri-3091	157	8	with	with	ADP
ajmri-3091	157	9	acute	acute	ADJ
ajmri-3091	157	10	respiratory	respiratory	ADJ
ajmri-3091	157	11	syndrome	syndrome	NOUN
ajmri-3091	157	12	coronavirus	coronavirus	NOUN
ajmri-3091	157	13	2	2	NUM
ajmri-3091	157	14	after	after	ADP
ajmri-3091	157	15	getting	get	VERB
ajmri-3091	157	16	covid-19	covid-19	PROPN
ajmri-3091	157	17	vaccination	vaccination	NOUN
ajmri-3091	157	18	?	?	PUNCT
ajmri-3091	158	1	no	no	DET
ajmri-3091	158	2	286	286	NUM
ajmri-3091	158	3	75.3	75.3	NUM
ajmri-3091	159	1	yes	yes	NOUN
ajmri-3091	159	2	94	94	NUM
ajmri-3091	159	3	24.7	24.7	NUM
ajmri-3091	159	4	how	how	SCONJ
ajmri-3091	159	5	many	many	ADJ
ajmri-3091	159	6	doses	dose	NOUN
ajmri-3091	159	7	of	of	ADP
ajmri-3091	159	8	covid-19	covid-19	PROPN
ajmri-3091	159	9	vaccine	vaccine	NOUN
ajmri-3091	159	10	did	do	AUX
ajmri-3091	159	11	you	you	PRON
ajmri-3091	159	12	receive	receive	VERB
ajmri-3091	159	13	?	?	PUNCT
ajmri-3091	160	1	one	one	NUM
ajmri-3091	160	2	dose	dose	VERB
ajmri-3091	160	3	3	3	NUM
ajmri-3091	160	4	8	8	NUM
ajmri-3091	160	5	two	two	NUM
ajmri-3091	160	6	doses	dose	NOUN
ajmri-3091	160	7	129	129	NUM
ajmri-3091	160	8	33.9	33.9	NUM
ajmri-3091	160	9	three	three	NUM
ajmri-3091	160	10	doses	dose	NOUN
ajmri-3091	160	11	248	248	NUM
ajmri-3091	160	12	65.3	65.3	NUM
ajmri-3091	160	13	what	what	PRON
ajmri-3091	160	14	kind	kind	NOUN
ajmri-3091	160	15	of	of	ADP
ajmri-3091	160	16	vaccine	vaccine	NOUN
ajmri-3091	160	17	did	do	AUX
ajmri-3091	160	18	you	you	PRON
ajmri-3091	160	19	receive	receive	VERB
ajmri-3091	160	20	?	?	PUNCT
ajmri-3091	161	1	pfizer	pfizer	NOUN
ajmri-3091	161	2	biontec	biontec	ADV
ajmri-3091	161	3	316	316	NUM
ajmri-3091	161	4	83.2	83.2	NUM
ajmri-3091	161	5	oxford	oxford	PROPN
ajmri-3091	161	6	astrazeneca	astrazeneca	NOUN
ajmri-3091	161	7	64	64	NUM
ajmri-3091	161	8	16.8	16.8	NUM
ajmri-3091	161	9	what	what	PRON
ajmri-3091	161	10	kind	kind	NOUN
ajmri-3091	161	11	of	of	ADP
ajmri-3091	161	12	vaccine	vaccine	NOUN
ajmri-3091	161	13	did	do	AUX
ajmri-3091	161	14	you	you	PRON
ajmri-3091	161	15	receive	receive	VERB
ajmri-3091	161	16	for	for	ADP
ajmri-3091	161	17	the	the	DET
ajmri-3091	161	18	second	second	ADJ
ajmri-3091	161	19	time	time	NOUN
ajmri-3091	161	20	?	?	PUNCT
ajmri-3091	162	1	pa	pa	PROPN
ajmri-3091	162	2	ge	ge	PROPN
ajmri-3091	162	3	17	17	NUM
ajmri-3091	162	4	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	162	5	am	am	NOUN
ajmri-3091	162	6	.	.	PUNCT
ajmri-3091	163	1	j.	j.	PROPN
ajmri-3091	163	2	multidis	multidis	PROPN
ajmri-3091	163	3	.	.	PUNCT
ajmri-3091	164	1	res	re	NOUN
ajmri-3091	164	2	.	.	PUNCT
ajmri-3091	165	1	innov	innov	PROPN
ajmri-3091	165	2	.	.	PUNCT
ajmri-3091	166	1	3(6	3(6	PROPN
ajmri-3091	166	2	)	)	PUNCT
ajmri-3091	166	3	12	12	NUM
ajmri-3091	166	4	-	-	SYM
ajmri-3091	166	5	24	24	NUM
ajmri-3091	166	6	,	,	PUNCT
ajmri-3091	166	7	2024	2024	NUM
ajmri-3091	166	8	did	do	AUX
ajmri-3091	166	9	not	not	PART
ajmri-3091	166	10	receive	receive	VERB
ajmri-3091	166	11	the	the	DET
ajmri-3091	166	12	second	second	ADJ
ajmri-3091	166	13	dose	dose	NOUN
ajmri-3091	166	14	1	1	NUM
ajmri-3091	166	15	0.3	0.3	NUM
ajmri-3091	166	16	pfizer	pfizer	NOUN
ajmri-3091	166	17	biontec	biontec	ADV
ajmri-3091	166	18	334	334	NUM
ajmri-3091	166	19	87.9	87.9	NUM
ajmri-3091	166	20	oxford	oxford	ADJ
ajmri-3091	166	21	astrazeneca	astrazeneca	NOUN
ajmri-3091	166	22	40	40	NUM
ajmri-3091	166	23	10.5	10.5	NUM
ajmri-3091	166	24	moderna	moderna	NOUN
ajmri-3091	166	25	5	5	NUM
ajmri-3091	166	26	1.3	1.3	NUM
ajmri-3091	166	27	what	what	PRON
ajmri-3091	166	28	kind	kind	NOUN
ajmri-3091	166	29	of	of	ADP
ajmri-3091	166	30	vaccine	vaccine	NOUN
ajmri-3091	166	31	did	do	AUX
ajmri-3091	166	32	you	you	PRON
ajmri-3091	166	33	receive	receive	VERB
ajmri-3091	166	34	for	for	ADP
ajmri-3091	166	35	the	the	DET
ajmri-3091	166	36	third	third	ADJ
ajmri-3091	166	37	time	time	NOUN
ajmri-3091	166	38	?	?	PUNCT
ajmri-3091	167	1	did	do	AUX
ajmri-3091	167	2	not	not	PART
ajmri-3091	167	3	receive	receive	VERB
ajmri-3091	167	4	third	third	ADJ
ajmri-3091	167	5	dose	dose	NOUN
ajmri-3091	167	6	111	111	NUM
ajmri-3091	167	7	29.2	29.2	NUM
ajmri-3091	167	8	pfizer	pfizer	NOUN
ajmri-3091	167	9	biontec	biontec	ADV
ajmri-3091	167	10	214	214	NUM
ajmri-3091	167	11	56.3	56.3	NUM
ajmri-3091	167	12	oxford	oxford	ADJ
ajmri-3091	167	13	astrazeneca	astrazeneca	NOUN
ajmri-3091	167	14	9	9	NUM
ajmri-3091	167	15	2.4	2.4	NUM
ajmri-3091	167	16	moderna	moderna	NOUN
ajmri-3091	167	17	46	46	NUM
ajmri-3091	167	18	12.1	12.1	NUM
ajmri-3091	167	19	table	table	NOUN
ajmri-3091	167	20	2(c	2(c	NUM
ajmri-3091	167	21	):	):	PUNCT
ajmri-3091	167	22	impact	impact	NOUN
ajmri-3091	167	23	of	of	ADP
ajmri-3091	167	24	covid-19	covid-19	PROPN
ajmri-3091	167	25	vaccine	vaccine	NOUN
ajmri-3091	167	26	on	on	ADP
ajmri-3091	167	27	menstrual	menstrual	ADJ
ajmri-3091	167	28	cycle	cycle	NOUN
ajmri-3091	167	29	characteristics	characteristic	NOUN
ajmri-3091	167	30	frequency	frequency	NOUN
ajmri-3091	167	31	(	(	PUNCT
ajmri-3091	167	32	n	n	NOUN
ajmri-3091	167	33	=	=	SYM
ajmri-3091	167	34	380	380	NUM
ajmri-3091	167	35	)	)	PUNCT
ajmri-3091	167	36	percentage	percentage	NOUN
ajmri-3091	167	37	(	(	PUNCT
ajmri-3091	167	38	n	n	NOUN
ajmri-3091	167	39	%	%	NOUN
ajmri-3091	167	40	)	)	PUNCT
ajmri-3091	167	41	have	have	AUX
ajmri-3091	167	42	you	you	PRON
ajmri-3091	167	43	experienced	experience	VERB
ajmri-3091	167	44	any	any	DET
ajmri-3091	167	45	side	side	NOUN
ajmri-3091	167	46	effects	effect	NOUN
ajmri-3091	167	47	after	after	ADP
ajmri-3091	167	48	the	the	DET
ajmri-3091	167	49	vaccine	vaccine	NOUN
ajmri-3091	167	50	?	?	PUNCT
ajmri-3091	168	1	no	no	DET
ajmri-3091	168	2	111	111	NUM
ajmri-3091	168	3	29.2	29.2	NUM
ajmri-3091	168	4	yes	yes	NOUN
ajmri-3091	168	5	269	269	NUM
ajmri-3091	168	6	70.8	70.8	NUM
ajmri-3091	168	7	when	when	SCONJ
ajmri-3091	168	8	did	do	AUX
ajmri-3091	168	9	the	the	DET
ajmri-3091	168	10	side	side	NOUN
ajmri-3091	168	11	effects	effect	NOUN
ajmri-3091	168	12	appear	appear	VERB
ajmri-3091	168	13	?	?	PUNCT
ajmri-3091	169	1	immediately	immediately	ADV
ajmri-3091	169	2	after	after	ADP
ajmri-3091	169	3	the	the	DET
ajmri-3091	169	4	vaccine	vaccine	NOUN
ajmri-3091	169	5	49	49	NUM
ajmri-3091	169	6	12.9	12.9	NUM
ajmri-3091	169	7	within	within	ADP
ajmri-3091	169	8	24	24	NUM
ajmri-3091	169	9	hours	hour	NOUN
ajmri-3091	169	10	after	after	ADP
ajmri-3091	169	11	the	the	DET
ajmri-3091	169	12	vaccine	vaccine	NOUN
ajmri-3091	169	13	277	277	NUM
ajmri-3091	169	14	72.9	72.9	NUM
ajmri-3091	169	15	during	during	ADP
ajmri-3091	169	16	the	the	DET
ajmri-3091	169	17	first	first	ADJ
ajmri-3091	169	18	week	week	NOUN
ajmri-3091	169	19	17	17	NUM
ajmri-3091	169	20	4.5	4.5	NUM
ajmri-3091	169	21	after	after	ADP
ajmri-3091	169	22	more	more	ADJ
ajmri-3091	169	23	than	than	ADP
ajmri-3091	169	24	a	a	PRON
ajmri-3091	169	25	week	week	NOUN
ajmri-3091	169	26	37	37	NUM
ajmri-3091	169	27	9.7	9.7	NUM
ajmri-3091	169	28	how	how	SCONJ
ajmri-3091	169	29	long	long	ADV
ajmri-3091	169	30	did	do	AUX
ajmri-3091	169	31	the	the	DET
ajmri-3091	169	32	side	side	NOUN
ajmri-3091	169	33	effects	effect	NOUN
ajmri-3091	169	34	last	last	ADJ
ajmri-3091	169	35	?	?	PUNCT
ajmri-3091	170	1	after	after	ADP
ajmri-3091	170	2	few	few	ADJ
ajmri-3091	170	3	hours	hour	NOUN
ajmri-3091	170	4	of	of	ADP
ajmri-3091	170	5	vaccination	vaccination	NOUN
ajmri-3091	170	6	57	57	NUM
ajmri-3091	170	7	15	15	NUM
ajmri-3091	170	8	two	two	NUM
ajmri-3091	170	9	days	day	NOUN
ajmri-3091	170	10	or	or	CCONJ
ajmri-3091	170	11	less	less	ADJ
ajmri-3091	170	12	142	142	NUM
ajmri-3091	170	13	37.4	37.4	NUM
ajmri-3091	170	14	one	one	NUM
ajmri-3091	170	15	week	week	NOUN
ajmri-3091	170	16	50	50	NUM
ajmri-3091	170	17	13.2	13.2	NUM
ajmri-3091	170	18	a	a	DET
ajmri-3091	170	19	month	month	NOUN
ajmri-3091	170	20	or	or	CCONJ
ajmri-3091	170	21	less	less	ADJ
ajmri-3091	170	22	16	16	NUM
ajmri-3091	170	23	4.2	4.2	NUM
ajmri-3091	170	24	more	more	ADJ
ajmri-3091	170	25	than	than	ADP
ajmri-3091	170	26	a	a	DET
ajmri-3091	170	27	week	week	NOUN
ajmri-3091	170	28	115	115	NUM
ajmri-3091	170	29	30.3	30.3	NUM
ajmri-3091	170	30	did	do	AUX
ajmri-3091	170	31	you	you	PRON
ajmri-3091	170	32	receive	receive	VERB
ajmri-3091	170	33	the	the	DET
ajmri-3091	170	34	covid-19	covid-19	PROPN
ajmri-3091	170	35	vaccine	vaccine	NOUN
ajmri-3091	170	36	during	during	ADP
ajmri-3091	170	37	the	the	DET
ajmri-3091	170	38	menstrual	menstrual	ADJ
ajmri-3091	170	39	cycle	cycle	NOUN
ajmri-3091	170	40	?	?	PUNCT
ajmri-3091	171	1	no	no	DET
ajmri-3091	171	2	272	272	NUM
ajmri-3091	171	3	71.6	71.6	NUM
ajmri-3091	171	4	yes	yes	INTJ
ajmri-3091	171	5	108	108	NUM
ajmri-3091	171	6	28.4	28.4	NUM
ajmri-3091	171	7	have	have	AUX
ajmri-3091	171	8	you	you	PRON
ajmri-3091	171	9	experienced	experience	VERB
ajmri-3091	171	10	one	one	NUM
ajmri-3091	171	11	of	of	ADP
ajmri-3091	171	12	these	these	DET
ajmri-3091	171	13	symptoms	symptom	NOUN
ajmri-3091	171	14	related	relate	VERB
ajmri-3091	171	15	to	to	ADP
ajmri-3091	171	16	the	the	DET
ajmri-3091	171	17	menstrual	menstrual	ADJ
ajmri-3091	171	18	cycle	cycle	NOUN
ajmri-3091	171	19	after	after	ADP
ajmri-3091	171	20	the	the	DET
ajmri-3091	171	21	vaccine	vaccine	NOUN
ajmri-3091	171	22	?	?	PUNCT
ajmri-3091	172	1	not	not	PART
ajmri-3091	172	2	applicable	applicable	ADJ
ajmri-3091	172	3	181	181	NUM
ajmri-3091	172	4	47.6	47.6	NUM
ajmri-3091	172	5	amenorrhea	amenorrhea	NOUN
ajmri-3091	172	6	28	28	NUM
ajmri-3091	172	7	7.4	7.4	NUM
ajmri-3091	172	8	oligomenorrhea	oligomenorrhea	NOUN
ajmri-3091	172	9	56	56	NUM
ajmri-3091	172	10	14.7	14.7	NUM
ajmri-3091	172	11	menorrhagia	menorrhagia	NOUN
ajmri-3091	172	12	32	32	NUM
ajmri-3091	172	13	8.4	8.4	NUM
ajmri-3091	172	14	length	length	NOUN
ajmri-3091	172	15	of	of	ADP
ajmri-3091	172	16	menstruation	menstruation	NOUN
ajmri-3091	172	17	more	more	ADJ
ajmri-3091	172	18	than	than	ADP
ajmri-3091	172	19	8	8	NUM
ajmri-3091	172	20	days	day	NOUN
ajmri-3091	172	21	5	5	NUM
ajmri-3091	172	22	1.3	1.3	NUM
ajmri-3091	172	23	dysmenorrhea	dysmenorrhea	NOUN
ajmri-3091	172	24	25	25	NUM
ajmri-3091	172	25	6.6	6.6	NUM
ajmri-3091	172	26	polymenorrhea	polymenorrhea	NOUN
ajmri-3091	172	27	30	30	NUM
ajmri-3091	172	28	7.9	7.9	NUM
ajmri-3091	172	29	short	short	ADJ
ajmri-3091	172	30	period	period	NOUN
ajmri-3091	172	31	(	(	PUNCT
ajmri-3091	172	32	<	<	X
ajmri-3091	172	33	2	2	NUM
ajmri-3091	172	34	days	day	NOUN
ajmri-3091	172	35	)	)	PUNCT
ajmri-3091	172	36	17	17	NUM
ajmri-3091	172	37	4.5	4.5	NUM
ajmri-3091	172	38	bleeding	bleed	VERB
ajmri-3091	172	39	between	between	ADP
ajmri-3091	172	40	menstruation	menstruation	NOUN
ajmri-3091	172	41	cycles	cycle	VERB
ajmri-3091	172	42	6	6	NUM
ajmri-3091	172	43	1.6	1.6	NUM
ajmri-3091	172	44	how	how	SCONJ
ajmri-3091	172	45	long	long	ADV
ajmri-3091	172	46	have	have	AUX
ajmri-3091	172	47	you	you	PRON
ajmri-3091	172	48	had	have	VERB
ajmri-3091	172	49	symptoms	symptom	NOUN
ajmri-3091	172	50	of	of	ADP
ajmri-3091	172	51	menstrual	menstrual	ADJ
ajmri-3091	172	52	disorder	disorder	NOUN
ajmri-3091	172	53	after	after	ADP
ajmri-3091	172	54	the	the	DET
ajmri-3091	172	55	vaccine	vaccine	NOUN
ajmri-3091	172	56	?	?	PUNCT
ajmri-3091	173	1	not	not	PART
ajmri-3091	173	2	applicable	applicable	ADJ
ajmri-3091	173	3	159	159	NUM
ajmri-3091	173	4	41.8	41.8	NUM
ajmri-3091	173	5	one	one	NUM
ajmri-3091	173	6	month	month	NOUN
ajmri-3091	173	7	38	38	NUM
ajmri-3091	173	8	10.0	10.0	NUM
ajmri-3091	173	9	two	two	NUM
ajmri-3091	173	10	months	month	NOUN
ajmri-3091	173	11	43	43	NUM
ajmri-3091	173	12	11.3	11.3	NUM
ajmri-3091	173	13	three	three	NUM
ajmri-3091	173	14	months	month	NOUN
ajmri-3091	173	15	and	and	CCONJ
ajmri-3091	173	16	more	more	ADJ
ajmri-3091	173	17	140	140	NUM
ajmri-3091	173	18	36.8	36.8	NUM
ajmri-3091	173	19	do	do	AUX
ajmri-3091	173	20	you	you	PRON
ajmri-3091	173	21	think	think	VERB
ajmri-3091	173	22	these	these	DET
ajmri-3091	173	23	symptoms	symptom	NOUN
ajmri-3091	173	24	of	of	ADP
ajmri-3091	173	25	the	the	DET
ajmri-3091	173	26	menstrual	menstrual	ADJ
ajmri-3091	173	27	cycle	cycle	NOUN
ajmri-3091	173	28	that	that	PRON
ajmri-3091	173	29	you	you	PRON
ajmri-3091	173	30	experienced	experience	VERB
ajmri-3091	173	31	are	be	AUX
ajmri-3091	173	32	related	relate	VERB
ajmri-3091	173	33	to	to	ADP
ajmri-3091	173	34	the	the	DET
ajmri-3091	173	35	covid-19	covid-19	PROPN
ajmri-3091	173	36	vaccines	vaccine	NOUN
ajmri-3091	173	37	?	?	PUNCT
ajmri-3091	174	1	no	no	DET
ajmri-3091	174	2	175	175	NUM
ajmri-3091	174	3	46.1	46.1	NUM
ajmri-3091	174	4	pa	pa	PROPN
ajmri-3091	174	5	ge	ge	PROPN
ajmri-3091	174	6	18	18	NUM
ajmri-3091	174	7	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	174	8	am	am	NOUN
ajmri-3091	174	9	.	.	PUNCT
ajmri-3091	175	1	j.	j.	PROPN
ajmri-3091	175	2	multidis	multidis	PROPN
ajmri-3091	175	3	.	.	PUNCT
ajmri-3091	176	1	res	re	NOUN
ajmri-3091	176	2	.	.	PUNCT
ajmri-3091	177	1	innov	innov	PROPN
ajmri-3091	177	2	.	.	PUNCT
ajmri-3091	178	1	3(6	3(6	PROPN
ajmri-3091	178	2	)	)	PUNCT
ajmri-3091	178	3	12	12	NUM
ajmri-3091	178	4	-	-	SYM
ajmri-3091	178	5	24	24	NUM
ajmri-3091	178	6	,	,	PUNCT
ajmri-3091	178	7	2024	2024	NUM
ajmri-3091	178	8	yes	yes	NOUN
ajmri-3091	178	9	205	205	NUM
ajmri-3091	178	10	53.9	53.9	NUM
ajmri-3091	178	11	in	in	ADP
ajmri-3091	178	12	which	which	PRON
ajmri-3091	178	13	dose	dose	NOUN
ajmri-3091	178	14	did	do	AUX
ajmri-3091	178	15	you	you	PRON
ajmri-3091	178	16	get	get	VERB
ajmri-3091	178	17	the	the	DET
ajmri-3091	178	18	side	side	NOUN
ajmri-3091	178	19	effects	effect	NOUN
ajmri-3091	178	20	related	relate	VERB
ajmri-3091	178	21	to	to	ADP
ajmri-3091	178	22	the	the	DET
ajmri-3091	178	23	menstrual	menstrual	ADJ
ajmri-3091	178	24	cycle	cycle	NOUN
ajmri-3091	178	25	?	?	PUNCT
ajmri-3091	179	1	i	i	PRON
ajmri-3091	179	2	do	do	AUX
ajmri-3091	179	3	not	not	PART
ajmri-3091	179	4	know	know	VERB
ajmri-3091	179	5	216	216	NUM
ajmri-3091	179	6	56.8	56.8	NUM
ajmri-3091	179	7	first	first	ADV
ajmri-3091	179	8	dose	dose	VERB
ajmri-3091	179	9	64	64	NUM
ajmri-3091	179	10	16.8	16.8	NUM
ajmri-3091	179	11	second	second	NOUN
ajmri-3091	179	12	dose	dose	VERB
ajmri-3091	179	13	58	58	NUM
ajmri-3091	179	14	15.3	15.3	NUM
ajmri-3091	179	15	third	third	NOUN
ajmri-3091	179	16	dose	dose	NOUN
ajmri-3091	179	17	42	42	NUM
ajmri-3091	179	18	11.1	11.1	NUM
ajmri-3091	179	19	figure	figure	NOUN
ajmri-3091	179	20	1	1	NUM
ajmri-3091	179	21	:	:	PUNCT
ajmri-3091	179	22	use	use	NOUN
ajmri-3091	179	23	of	of	ADP
ajmri-3091	179	24	therapeutic	therapeutic	ADJ
ajmri-3091	179	25	drugs	drug	NOUN
ajmri-3091	179	26	in	in	ADP
ajmri-3091	179	27	between	between	ADP
ajmri-3091	179	28	covid-19	covid-19	PROPN
ajmri-3091	179	29	vaccination	vaccination	NOUN
ajmri-3091	179	30	or	or	CCONJ
ajmri-3091	179	31	menstrual	menstrual	ADJ
ajmri-3091	179	32	cycle	cycle	NOUN
ajmri-3091	179	33	period	period	NOUN
ajmri-3091	179	34	tables	table	NOUN
ajmri-3091	179	35	2(a	2(a	NUM
ajmri-3091	179	36	,	,	PUNCT
ajmri-3091	179	37	b	b	NOUN
ajmri-3091	179	38	,	,	PUNCT
ajmri-3091	179	39	and	and	CCONJ
ajmri-3091	179	40	c	c	X
ajmri-3091	179	41	)	)	PUNCT
ajmri-3091	179	42	show	show	VERB
ajmri-3091	179	43	female	female	ADJ
ajmri-3091	179	44	participant	participant	NOUN
ajmri-3091	179	45	’s	’s	PART
ajmri-3091	179	46	medical	medical	ADJ
ajmri-3091	179	47	history	history	NOUN
ajmri-3091	179	48	,	,	PUNCT
ajmri-3091	179	49	covid-19	covid-19	PROPN
ajmri-3091	179	50	vaccination	vaccination	NOUN
ajmri-3091	179	51	status	status	NOUN
ajmri-3091	179	52	,	,	PUNCT
ajmri-3091	179	53	and	and	CCONJ
ajmri-3091	179	54	the	the	DET
ajmri-3091	179	55	impact	impact	NOUN
ajmri-3091	179	56	of	of	ADP
ajmri-3091	179	57	the	the	DET
ajmri-3091	179	58	vaccine	vaccine	NOUN
ajmri-3091	179	59	on	on	ADP
ajmri-3091	179	60	their	their	PRON
ajmri-3091	179	61	menstrual	menstrual	ADJ
ajmri-3091	179	62	cycle	cycle	NOUN
ajmri-3091	179	63	.	.	PUNCT
ajmri-3091	180	1	most	most	ADJ
ajmri-3091	180	2	participants	participant	NOUN
ajmri-3091	180	3	did	do	AUX
ajmri-3091	180	4	not	not	PART
ajmri-3091	180	5	exhibit	exhibit	VERB
ajmri-3091	180	6	hormonal	hormonal	ADJ
ajmri-3091	180	7	abnormalities	abnormality	NOUN
ajmri-3091	180	8	,	,	PUNCT
ajmri-3091	180	9	were	be	AUX
ajmri-3091	180	10	not	not	PART
ajmri-3091	180	11	breastfeeding	breastfeed	VERB
ajmri-3091	180	12	,	,	PUNCT
ajmri-3091	180	13	and	and	CCONJ
ajmri-3091	180	14	were	be	AUX
ajmri-3091	180	15	pregnant	pregnant	ADJ
ajmri-3091	180	16	.	.	PUNCT
ajmri-3091	181	1	the	the	DET
ajmri-3091	181	2	majority	majority	NOUN
ajmri-3091	181	3	of	of	ADP
ajmri-3091	181	4	the	the	DET
ajmri-3091	181	5	participants	participant	NOUN
ajmri-3091	181	6	received	receive	VERB
ajmri-3091	181	7	three	three	NUM
ajmri-3091	181	8	doses	dose	NOUN
ajmri-3091	181	9	of	of	ADP
ajmri-3091	181	10	the	the	DET
ajmri-3091	181	11	vaccination	vaccination	NOUN
ajmri-3091	181	12	,	,	PUNCT
ajmri-3091	181	13	with	with	ADP
ajmri-3091	181	14	pfizzer	pfizzer	NOUN
ajmri-3091	181	15	being	be	AUX
ajmri-3091	181	16	the	the	DET
ajmri-3091	181	17	largest	large	ADJ
ajmri-3091	181	18	.	.	PUNCT
ajmri-3091	182	1	the	the	DET
ajmri-3091	182	2	majority	majority	NOUN
ajmri-3091	182	3	reported	report	VERB
ajmri-3091	182	4	negative	negative	ADJ
ajmri-3091	182	5	effects	effect	NOUN
ajmri-3091	182	6	on	on	ADP
ajmri-3091	182	7	their	their	PRON
ajmri-3091	182	8	menstrual	menstrual	ADJ
ajmri-3091	182	9	cycle	cycle	NOUN
ajmri-3091	182	10	,	,	PUNCT
ajmri-3091	182	11	with	with	ADP
ajmri-3091	182	12	72.9	72.9	NUM
ajmri-3091	182	13	%	%	NOUN
ajmri-3091	182	14	occurring	occur	VERB
ajmri-3091	182	15	within	within	ADP
ajmri-3091	182	16	24	24	NUM
ajmri-3091	182	17	hours	hour	NOUN
ajmri-3091	182	18	and	and	CCONJ
ajmri-3091	182	19	30.3	30.3	NUM
ajmri-3091	182	20	%	%	NOUN
ajmri-3091	182	21	lasting	last	VERB
ajmri-3091	182	22	over	over	ADP
ajmri-3091	182	23	a	a	DET
ajmri-3091	182	24	week	week	NOUN
ajmri-3091	182	25	(	(	PUNCT
ajmri-3091	182	26	ci	ci	NOUN
ajmri-3091	182	27	:	:	PUNCT
ajmri-3091	182	28	95	95	NUM
ajmri-3091	182	29	%	%	NOUN
ajmri-3091	182	30	)	)	PUNCT
ajmri-3091	182	31	.	.	PUNCT
ajmri-3091	183	1	however	however	ADV
ajmri-3091	183	2	,	,	PUNCT
ajmri-3091	183	3	269	269	NUM
ajmri-3091	183	4	participants	participant	NOUN
ajmri-3091	183	5	(	(	PUNCT
ajmri-3091	183	6	70.8	70.8	NUM
ajmri-3091	183	7	%	%	NOUN
ajmri-3091	183	8	)	)	PUNCT
ajmri-3091	183	9	responded	respond	VERB
ajmri-3091	183	10	that	that	SCONJ
ajmri-3091	183	11	they	they	PRON
ajmri-3091	183	12	experienced	experience	VERB
ajmri-3091	183	13	side	side	NOUN
ajmri-3091	183	14	effects	effect	NOUN
ajmri-3091	183	15	after	after	ADP
ajmri-3091	183	16	vaccine	vaccine	NOUN
ajmri-3091	183	17	.	.	PUNCT
ajmri-3091	184	1	side	side	NOUN
ajmri-3091	184	2	effects	effect	NOUN
ajmri-3091	184	3	like	like	ADP
ajmri-3091	184	4	fever	fever	NOUN
ajmri-3091	184	5	,	,	PUNCT
ajmri-3091	184	6	fatigue	fatigue	NOUN
ajmri-3091	184	7	,	,	PUNCT
ajmri-3091	184	8	headaches	headache	NOUN
ajmri-3091	184	9	,	,	PUNCT
ajmri-3091	184	10	muscle	muscle	NOUN
ajmri-3091	184	11	discomfort	discomfort	NOUN
ajmri-3091	184	12	,	,	PUNCT
ajmri-3091	184	13	and	and	CCONJ
ajmri-3091	184	14	injection	injection	NOUN
ajmri-3091	184	15	site	site	NOUN
ajmri-3091	184	16	pain	pain	NOUN
ajmri-3091	184	17	typically	typically	ADV
ajmri-3091	184	18	were	be	AUX
ajmri-3091	184	19	the	the	DET
ajmri-3091	184	20	most	most	ADV
ajmri-3091	184	21	common	common	ADJ
ajmri-3091	184	22	among	among	ADP
ajmri-3091	184	23	participants	participant	NOUN
ajmri-3091	184	24	.	.	PUNCT
ajmri-3091	185	1	table	table	NOUN
ajmri-3091	185	2	3	3	NUM
ajmri-3091	185	3	:	:	PUNCT
ajmri-3091	185	4	associations	association	NOUN
ajmri-3091	185	5	of	of	ADP
ajmri-3091	185	6	diet	diet	NOUN
ajmri-3091	185	7	and	and	CCONJ
ajmri-3091	185	8	physical	physical	ADJ
ajmri-3091	185	9	exercise	exercise	NOUN
ajmri-3091	185	10	behavior	behavior	NOUN
ajmri-3091	185	11	with	with	ADP
ajmri-3091	185	12	menstrual	menstrual	ADJ
ajmri-3091	185	13	disorders	disorder	NOUN
ajmri-3091	185	14	after	after	ADP
ajmri-3091	185	15	obtaining	obtain	VERB
ajmri-3091	185	16	a	a	DET
ajmri-3091	185	17	covid-19	covid-19	PROPN
ajmri-3091	185	18	vaccine	vaccine	NOUN
ajmri-3091	185	19	variables	variable	NOUN
ajmri-3091	185	20	frequency	frequency	NOUN
ajmri-3091	185	21	(	(	PUNCT
ajmri-3091	185	22	n	n	NOUN
ajmri-3091	185	23	=	=	SYM
ajmri-3091	185	24	380	380	NUM
ajmri-3091	185	25	)	)	PUNCT
ajmri-3091	185	26	percentage	percentage	NOUN
ajmri-3091	185	27	of	of	ADP
ajmri-3091	185	28	females	female	NOUN
ajmri-3091	185	29	who	who	PRON
ajmri-3091	185	30	had	have	VERB
ajmri-3091	185	31	menstrual	menstrual	ADJ
ajmri-3091	185	32	disorders	disorder	NOUN
ajmri-3091	185	33	after	after	ADP
ajmri-3091	185	34	vaccination	vaccination	NOUN
ajmri-3091	185	35	(	(	PUNCT
ajmri-3091	185	36	n	n	CCONJ
ajmri-3091	185	37	%	%	NOUN
ajmri-3091	185	38	)	)	PUNCT
ajmri-3091	185	39	association	association	NOUN
ajmri-3091	185	40	analysis	analysis	NOUN
ajmri-3091	185	41	value	value	NOUN
ajmri-3091	185	42	sig	sig	PROPN
ajmri-3091	185	43	.	.	PUNCT
ajmri-3091	186	1	diet	diet	PROPN
ajmri-3091	186	2	unhealthy	unhealthy	ADJ
ajmri-3091	186	3	and	and	CCONJ
ajmri-3091	186	4	unbalanced	unbalanced	ADJ
ajmri-3091	186	5	diet	diet	NOUN
ajmri-3091	186	6	207	207	NUM
ajmri-3091	186	7	54.5	54.5	NUM
ajmri-3091	186	8	10.229	10.229	NUM
ajmri-3091	186	9	.332	.332	NUM
ajmri-3091	186	10	healthy	healthy	ADJ
ajmri-3091	186	11	and	and	CCONJ
ajmri-3091	186	12	balanced	balanced	ADJ
ajmri-3091	186	13	diet	diet	NOUN
ajmri-3091	186	14	173	173	NUM
ajmri-3091	186	15	45.5	45.5	NUM
ajmri-3091	186	16	exercise	exercise	NOUN
ajmri-3091	186	17	practising	practise	VERB
ajmri-3091	186	18	daily	daily	ADJ
ajmri-3091	186	19	exercise	exercise	VERB
ajmri-3091	186	20	6.075	6.075	NUM
ajmri-3091	186	21	.732	.732	NUM
ajmri-3091	187	1	no	no	DET
ajmri-3091	187	2	255	255	NUM
ajmri-3091	187	3	67.1	67.1	NUM
ajmri-3091	187	4	yes	yes	NOUN
ajmri-3091	187	5	125	125	NUM
ajmri-3091	187	6	32.9	32.9	NUM
ajmri-3091	187	7	moderate	moderate	ADJ
ajmri-3091	187	8	-	-	PUNCT
ajmri-3091	187	9	intensity	intensity	NOUN
ajmri-3091	187	10	exercise	exercise	NOUN
ajmri-3091	187	11	352	352	NUM
ajmri-3091	187	12	92.6	92.6	NUM
ajmri-3091	187	13	17.634	17.634	NUM
ajmri-3091	187	14	.04	.04	NUM
ajmri-3091	187	15	vigorous	vigorous	ADJ
ajmri-3091	187	16	-	-	PUNCT
ajmri-3091	187	17	intensity	intensity	NOUN
ajmri-3091	187	18	exercise	exercise	NOUN
ajmri-3091	187	19	28	28	NUM
ajmri-3091	187	20	7.4	7.4	NUM
ajmri-3091	187	21	spent	spend	VERB
ajmri-3091	187	22	75	75	NUM
ajmri-3091	187	23	min	min	NOUN
ajmri-3091	187	24	or	or	CCONJ
ajmri-3091	187	25	less	less	ADJ
ajmri-3091	187	26	per	per	ADP
ajmri-3091	187	27	week	week	NOUN
ajmri-3091	187	28	277	277	NUM
ajmri-3091	187	29	72	72	NUM
ajmri-3091	187	30	15.212	15.212	NUM
ajmri-3091	187	31	.647	.647	NUM
ajmri-3091	187	32	spent	spend	VERB
ajmri-3091	187	33	76–150	76–150	NUM
ajmri-3091	187	34	min	min	NOUN
ajmri-3091	187	35	per	per	ADP
ajmri-3091	187	36	week	week	NOUN
ajmri-3091	187	37	84	84	NUM
ajmri-3091	187	38	22.1	22.1	NUM
ajmri-3091	187	39	spent	spend	VERB
ajmri-3091	187	40	151–300	151–300	NUM
ajmri-3091	187	41	min	min	NOUN
ajmri-3091	187	42	per	per	ADP
ajmri-3091	187	43	week	week	NOUN
ajmri-3091	187	44	19	19	NUM
ajmri-3091	187	45	5.0	5.0	NUM
ajmri-3091	187	46	psychological	psychological	ADJ
ajmri-3091	187	47	health	health	NOUN
ajmri-3091	187	48	troubled	trouble	VERB
ajmri-3091	187	49	psychological	psychological	ADJ
ajmri-3091	187	50	health	health	NOUN
ajmri-3091	187	51	149	149	NUM
ajmri-3091	187	52	39.2	39.2	NUM
ajmri-3091	187	53	20.345	20.345	NUM
ajmri-3091	187	54	.016	.016	NUM
ajmri-3091	187	55	balanced	balanced	ADJ
ajmri-3091	187	56	psychological	psychological	ADJ
ajmri-3091	187	57	health	health	NOUN
ajmri-3091	187	58	231	231	NUM
ajmri-3091	187	59	60.8	60.8	NUM
ajmri-3091	187	60	pa	pa	PROPN
ajmri-3091	187	61	ge	ge	PROPN
ajmri-3091	187	62	19	19	NUM
ajmri-3091	187	63	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	187	64	am	am	NOUN
ajmri-3091	187	65	.	.	PUNCT
ajmri-3091	188	1	j.	j.	PROPN
ajmri-3091	188	2	multidis	multidis	PROPN
ajmri-3091	188	3	.	.	PUNCT
ajmri-3091	189	1	res	re	NOUN
ajmri-3091	189	2	.	.	PUNCT
ajmri-3091	190	1	innov	innov	PROPN
ajmri-3091	190	2	.	.	PUNCT
ajmri-3091	191	1	3(6	3(6	PROPN
ajmri-3091	191	2	)	)	PUNCT
ajmri-3091	191	3	12	12	NUM
ajmri-3091	191	4	-	-	SYM
ajmri-3091	191	5	24	24	NUM
ajmri-3091	191	6	,	,	PUNCT
ajmri-3091	191	7	2024	2024	NUM
ajmri-3091	191	8	table	table	NOUN
ajmri-3091	191	9	4	4	NUM
ajmri-3091	191	10	:	:	PUNCT
ajmri-3091	191	11	associations	association	NOUN
ajmri-3091	191	12	between	between	ADP
ajmri-3091	191	13	menstrual	menstrual	ADJ
ajmri-3091	191	14	disorders	disorder	NOUN
ajmri-3091	191	15	after	after	ADP
ajmri-3091	191	16	obtaining	obtain	VERB
ajmri-3091	191	17	a	a	DET
ajmri-3091	191	18	covid-19	covid-19	PROPN
ajmri-3091	191	19	vaccine	vaccine	NOUN
ajmri-3091	191	20	and	and	CCONJ
ajmri-3091	191	21	adult	adult	NOUN
ajmri-3091	191	22	females	female	NOUN
ajmri-3091	191	23	suffering	suffer	VERB
ajmri-3091	191	24	from	from	ADP
ajmri-3091	191	25	chronic	chronic	ADJ
ajmri-3091	191	26	diseases	disease	NOUN
ajmri-3091	191	27	variables	variable	VERB
ajmri-3091	191	28	association	association	NOUN
ajmri-3091	191	29	analysis	analysis	NOUN
ajmri-3091	191	30	value	value	NOUN
ajmri-3091	191	31	sig	sig	PROPN
ajmri-3091	191	32	.	.	PUNCT
ajmri-3091	192	1	disorders	disorder	NOUN
ajmri-3091	192	2	chronic	chronic	ADJ
ajmri-3091	192	3	disease	disease	NOUN
ajmri-3091	192	4	106.356	106.356	NUM
ajmri-3091	192	5	.115	.115	NUM
ajmri-3091	192	6	thyroid	thyroid	NOUN
ajmri-3091	192	7	disorder	disorder	NOUN
ajmri-3091	192	8	4.212	4.212	NUM
ajmri-3091	192	9	.897	.897	NUM
ajmri-3091	192	10	hormone	hormone	NOUN
ajmri-3091	192	11	imbalance	imbalance	NOUN
ajmri-3091	192	12	8.734	8.734	NUM
ajmri-3091	192	13	.462	.462	NUM
ajmri-3091	192	14	menstrual	menstrual	ADJ
ajmri-3091	192	15	disorders	disorder	NOUN
ajmri-3091	192	16	before	before	ADP
ajmri-3091	192	17	the	the	DET
ajmri-3091	192	18	covid-19	covid-19	PROPN
ajmri-3091	192	19	vaccine	vaccine	NOUN
ajmri-3091	192	20	77.210	77.210	NUM
ajmri-3091	192	21	.001	.001	NUM
ajmri-3091	192	22	no	no	DET
ajmri-3091	192	23	reproductive	reproductive	ADJ
ajmri-3091	192	24	disease	disease	NOUN
ajmri-3091	192	25	61.179	61.179	NUM
ajmri-3091	192	26	.234	.234	NUM
ajmri-3091	192	27	polycystic	polycystic	ADJ
ajmri-3091	192	28	ovaries	ovary	NOUN
ajmri-3091	192	29	uterine	uterine	ADJ
ajmri-3091	192	30	fibrosis	fibrosis	NOUN
ajmri-3091	192	31	uterine	uterine	ADJ
ajmri-3091	192	32	tumours	tumours	PROPN
ajmri-3091	192	33	migratory	migratory	ADJ
ajmri-3091	192	34	endometrium	endometrium	NOUN
ajmri-3091	192	35	pelvic	pelvic	ADJ
ajmri-3091	192	36	inflammation	inflammation	NOUN
ajmri-3091	192	37	any	any	DET
ajmri-3091	192	38	other	other	ADJ
ajmri-3091	192	39	inflammation	inflammation	NOUN
ajmri-3091	192	40	covid-19	covid-19	PROPN
ajmri-3091	192	41	infection	infection	NOUN
ajmri-3091	192	42	infected	infect	VERB
ajmri-3091	192	43	with	with	ADP
ajmri-3091	192	44	sars	sar	NOUN
ajmri-3091	192	45	-	-	PUNCT
ajmri-3091	192	46	cov-2	cov-2	NOUN
ajmri-3091	192	47	before	before	ADP
ajmri-3091	192	48	vaccination	vaccination	NOUN
ajmri-3091	192	49	5.589	5.589	NUM
ajmri-3091	192	50	.78	.78	NUM
ajmri-3091	192	51	infected	infect	VERB
ajmri-3091	192	52	with	with	ADP
ajmri-3091	192	53	sars	sar	NOUN
ajmri-3091	192	54	-	-	PUNCT
ajmri-3091	192	55	cov-2	cov-2	NOUN
ajmri-3091	192	56	after	after	ADP
ajmri-3091	192	57	vaccination	vaccination	NOUN
ajmri-3091	192	58	10.234	10.234	NUM
ajmri-3091	192	59	.332	.332	NUM
ajmri-3091	192	60	table	table	NOUN
ajmri-3091	192	61	4	4	NUM
ajmri-3091	192	62	indicated	indicate	VERB
ajmri-3091	192	63	a	a	DET
ajmri-3091	192	64	significant	significant	ADJ
ajmri-3091	192	65	correlation	correlation	NOUN
ajmri-3091	192	66	(	(	PUNCT
ajmri-3091	192	67	p	p	NOUN
ajmri-3091	192	68	=	=	X
ajmri-3091	192	69	<	<	X
ajmri-3091	192	70	0.05	0.05	NUM
ajmri-3091	192	71	)	)	PUNCT
ajmri-3091	192	72	between	between	ADP
ajmri-3091	192	73	pre	pre	ADJ
ajmri-3091	192	74	-	-	ADJ
ajmri-3091	192	75	existing	exist	VERB
ajmri-3091	192	76	menstrual	menstrual	ADJ
ajmri-3091	192	77	problems	problem	NOUN
ajmri-3091	192	78	and	and	CCONJ
ajmri-3091	192	79	the	the	DET
ajmri-3091	192	80	occurrence	occurrence	NOUN
ajmri-3091	192	81	of	of	ADP
ajmri-3091	192	82	disorders	disorder	NOUN
ajmri-3091	192	83	after	after	ADP
ajmri-3091	192	84	receiving	receive	VERB
ajmri-3091	192	85	the	the	DET
ajmri-3091	192	86	covid-19	covid-19	PROPN
ajmri-3091	192	87	vaccine	vaccine	NOUN
ajmri-3091	192	88	(	(	PUNCT
ajmri-3091	192	89	p	p	X
ajmri-3091	192	90	<	<	X
ajmri-3091	192	91	0.05	0.05	NUM
ajmri-3091	192	92	)	)	PUNCT
ajmri-3091	192	93	.	.	PUNCT
ajmri-3091	193	1	while	while	SCONJ
ajmri-3091	193	2	certain	certain	ADJ
ajmri-3091	193	3	chronic	chronic	ADJ
ajmri-3091	193	4	diseases	disease	NOUN
ajmri-3091	193	5	and	and	CCONJ
ajmri-3091	193	6	other	other	ADJ
ajmri-3091	193	7	health	health	NOUN
ajmri-3091	193	8	-	-	PUNCT
ajmri-3091	193	9	related	relate	VERB
ajmri-3091	193	10	factors	factor	NOUN
ajmri-3091	193	11	were	be	AUX
ajmri-3091	193	12	linked	link	VERB
ajmri-3091	193	13	to	to	ADP
ajmri-3091	193	14	menstrual	menstrual	ADJ
ajmri-3091	193	15	irregularities	irregularity	NOUN
ajmri-3091	193	16	,	,	PUNCT
ajmri-3091	193	17	the	the	DET
ajmri-3091	193	18	p	p	NOUN
ajmri-3091	193	19	-	-	PUNCT
ajmri-3091	193	20	value	value	NOUN
ajmri-3091	193	21	showed	show	VERB
ajmri-3091	193	22	no	no	DET
ajmri-3091	193	23	statistical	statistical	ADJ
ajmri-3091	193	24	significance	significance	NOUN
ajmri-3091	193	25	(	(	PUNCT
ajmri-3091	193	26	p	p	X
ajmri-3091	193	27	=	=	NOUN
ajmri-3091	193	28	0.115	0.115	NUM
ajmri-3091	193	29	)	)	PUNCT
ajmri-3091	193	30	.	.	PUNCT
ajmri-3091	194	1	polycystic	polycystic	ADJ
ajmri-3091	194	2	ovaries	ovary	NOUN
ajmri-3091	194	3	had	have	VERB
ajmri-3091	194	4	a	a	DET
ajmri-3091	194	5	higher	high	ADJ
ajmri-3091	194	6	percentage	percentage	NOUN
ajmri-3091	194	7	(	(	PUNCT
ajmri-3091	194	8	14.16	14.16	NUM
ajmri-3091	194	9	%	%	NOUN
ajmri-3091	194	10	)	)	PUNCT
ajmri-3091	194	11	compared	compare	VERB
ajmri-3091	194	12	to	to	ADP
ajmri-3091	194	13	those	those	PRON
ajmri-3091	194	14	without	without	ADP
ajmri-3091	194	15	reproductive	reproductive	ADJ
ajmri-3091	194	16	diseases	disease	NOUN
ajmri-3091	194	17	(	(	PUNCT
ajmri-3091	194	18	80.53	80.53	NUM
ajmri-3091	194	19	%	%	NOUN
ajmri-3091	194	20	)	)	PUNCT
ajmri-3091	194	21	,	,	PUNCT
ajmri-3091	194	22	but	but	CCONJ
ajmri-3091	194	23	the	the	DET
ajmri-3091	194	24	association	association	NOUN
ajmri-3091	194	25	analysis	analysis	NOUN
ajmri-3091	194	26	lacks	lack	VERB
ajmri-3091	194	27	statistical	statistical	ADJ
ajmri-3091	194	28	significance	significance	NOUN
ajmri-3091	194	29	.	.	PUNCT
ajmri-3091	195	1	other	other	ADJ
ajmri-3091	195	2	reproductive	reproductive	ADJ
ajmri-3091	195	3	issues	issue	NOUN
ajmri-3091	195	4	showed	show	VERB
ajmri-3091	195	5	negligible	negligible	ADJ
ajmri-3091	195	6	associations	association	NOUN
ajmri-3091	195	7	.	.	PUNCT
ajmri-3091	196	1	the	the	DET
ajmri-3091	196	2	occurrence	occurrence	NOUN
ajmri-3091	196	3	of	of	ADP
ajmri-3091	196	4	menstrual	menstrual	ADJ
ajmri-3091	196	5	disturbances	disturbance	NOUN
ajmri-3091	196	6	was	be	AUX
ajmri-3091	196	7	associated	associate	VERB
ajmri-3091	196	8	with	with	ADP
ajmri-3091	196	9	sarscov-2	sarscov-2	NUM
ajmri-3091	196	10	infection	infection	NOUN
ajmri-3091	196	11	both	both	CCONJ
ajmri-3091	196	12	before	before	ADP
ajmri-3091	196	13	and	and	CCONJ
ajmri-3091	196	14	after	after	ADP
ajmri-3091	196	15	vaccination	vaccination	NOUN
ajmri-3091	196	16	,	,	PUNCT
ajmri-3091	196	17	with	with	ADP
ajmri-3091	196	18	respective	respective	ADJ
ajmri-3091	196	19	percentages	percentage	NOUN
ajmri-3091	196	20	of	of	ADP
ajmri-3091	196	21	(	(	PUNCT
ajmri-3091	196	22	12.1	12.1	NUM
ajmri-3091	196	23	%	%	NOUN
ajmri-3091	196	24	)	)	PUNCT
ajmri-3091	196	25	and	and	CCONJ
ajmri-3091	196	26	(	(	PUNCT
ajmri-3091	196	27	24.7	24.7	NUM
ajmri-3091	196	28	%	%	NOUN
ajmri-3091	196	29	)	)	PUNCT
ajmri-3091	196	30	.	.	PUNCT
ajmri-3091	197	1	however	however	ADV
ajmri-3091	197	2	,	,	PUNCT
ajmri-3091	197	3	the	the	DET
ajmri-3091	197	4	p	p	NOUN
ajmri-3091	197	5	-	-	PUNCT
ajmri-3091	197	6	value	value	NOUN
ajmri-3091	197	7	showed	show	VERB
ajmri-3091	197	8	no	no	DET
ajmri-3091	197	9	significant	significant	ADJ
ajmri-3091	197	10	correlation	correlation	NOUN
ajmri-3091	197	11	between	between	ADP
ajmri-3091	197	12	the	the	DET
ajmri-3091	197	13	variables	variable	NOUN
ajmri-3091	197	14	.	.	PUNCT
ajmri-3091	198	1	table	table	NOUN
ajmri-3091	198	2	3	3	NUM
ajmri-3091	198	3	shows	show	VERB
ajmri-3091	198	4	that	that	SCONJ
ajmri-3091	198	5	adult	adult	NOUN
ajmri-3091	198	6	females	female	NOUN
ajmri-3091	198	7	with	with	ADP
ajmri-3091	198	8	an	an	DET
ajmri-3091	198	9	unhealthy	unhealthy	ADJ
ajmri-3091	198	10	and	and	CCONJ
ajmri-3091	198	11	unbalanced	unbalanced	ADJ
ajmri-3091	198	12	diet	diet	NOUN
ajmri-3091	198	13	reported	report	VERB
ajmri-3091	198	14	the	the	DET
ajmri-3091	198	15	highest	high	ADJ
ajmri-3091	198	16	rate	rate	NOUN
ajmri-3091	198	17	of	of	ADP
ajmri-3091	198	18	disorders	disorder	NOUN
ajmri-3091	198	19	(	(	PUNCT
ajmri-3091	198	20	54.5	54.5	NUM
ajmri-3091	198	21	%	%	NOUN
ajmri-3091	198	22	)	)	PUNCT
ajmri-3091	198	23	,	,	PUNCT
ajmri-3091	198	24	and	and	CCONJ
ajmri-3091	198	25	the	the	DET
ajmri-3091	198	26	p	p	NOUN
ajmri-3091	198	27	-	-	PUNCT
ajmri-3091	198	28	value	value	NOUN
ajmri-3091	198	29	was	be	AUX
ajmri-3091	198	30	not	not	PART
ajmri-3091	198	31	statistically	statistically	ADV
ajmri-3091	198	32	significant	significant	ADJ
ajmri-3091	198	33	(	(	PUNCT
ajmri-3091	198	34	p	p	X
ajmri-3091	198	35	=	=	NOUN
ajmri-3091	198	36	0.332	0.332	NUM
ajmri-3091	198	37	)	)	PUNCT
ajmri-3091	198	38	.	.	PUNCT
ajmri-3091	199	1	menstrual	menstrual	ADJ
ajmri-3091	199	2	disorders	disorder	NOUN
ajmri-3091	199	3	were	be	AUX
ajmri-3091	199	4	reported	report	VERB
ajmri-3091	199	5	by	by	ADP
ajmri-3091	199	6	approximately	approximately	ADV
ajmri-3091	199	7	(	(	PUNCT
ajmri-3091	199	8	32.9	32.9	NUM
ajmri-3091	199	9	%	%	NOUN
ajmri-3091	199	10	)	)	PUNCT
ajmri-3091	199	11	of	of	ADP
ajmri-3091	199	12	females	female	NOUN
ajmri-3091	199	13	who	who	PRON
ajmri-3091	199	14	exercised	exercise	VERB
ajmri-3091	199	15	daily	daily	ADV
ajmri-3091	199	16	.	.	PUNCT
ajmri-3091	200	1	meanwhile	meanwhile	ADV
ajmri-3091	200	2	,	,	PUNCT
ajmri-3091	200	3	(	(	PUNCT
ajmri-3091	200	4	92.6	92.6	NUM
ajmri-3091	200	5	%	%	NOUN
ajmri-3091	200	6	)	)	PUNCT
ajmri-3091	200	7	of	of	ADP
ajmri-3091	200	8	adult	adult	NOUN
ajmri-3091	200	9	females	female	NOUN
ajmri-3091	200	10	who	who	PRON
ajmri-3091	200	11	engaged	engage	VERB
ajmri-3091	200	12	in	in	ADP
ajmri-3091	200	13	moderate	moderate	ADJ
ajmri-3091	200	14	exercise	exercise	NOUN
ajmri-3091	200	15	and	and	CCONJ
ajmri-3091	200	16	received	receive	VERB
ajmri-3091	200	17	the	the	DET
ajmri-3091	200	18	covid-19	covid-19	PROPN
ajmri-3091	200	19	vaccine	vaccine	NOUN
ajmri-3091	200	20	reported	report	VERB
ajmri-3091	200	21	suffering	suffer	VERB
ajmri-3091	200	22	from	from	ADP
ajmri-3091	200	23	a	a	DET
ajmri-3091	200	24	disorder	disorder	NOUN
ajmri-3091	200	25	with	with	ADP
ajmri-3091	200	26	a	a	DET
ajmri-3091	200	27	p	p	NOUN
ajmri-3091	200	28	-	-	PUNCT
ajmri-3091	200	29	value	value	NOUN
ajmri-3091	200	30	<	<	X
ajmri-3091	200	31	0.05	0.05	NUM
ajmri-3091	200	32	(	(	PUNCT
ajmri-3091	200	33	p	p	X
ajmri-3091	200	34	=	=	NOUN
ajmri-3091	200	35	0.04	0.04	NUM
ajmri-3091	200	36	)	)	PUNCT
ajmri-3091	200	37	,	,	PUNCT
ajmri-3091	200	38	considered	consider	VERB
ajmri-3091	200	39	statistically	statistically	ADV
ajmri-3091	200	40	significant	significant	ADJ
ajmri-3091	200	41	.	.	PUNCT
ajmri-3091	201	1	the	the	DET
ajmri-3091	201	2	exercise	exercise	NOUN
ajmri-3091	201	3	duration	duration	NOUN
ajmri-3091	201	4	,	,	PUNCT
ajmri-3091	201	5	75	75	NUM
ajmri-3091	201	6	minutes	minute	NOUN
ajmri-3091	201	7	or	or	CCONJ
ajmri-3091	201	8	less	less	ADJ
ajmri-3091	201	9	per	per	ADP
ajmri-3091	201	10	week	week	NOUN
ajmri-3091	201	11	,	,	PUNCT
ajmri-3091	201	12	was	be	AUX
ajmri-3091	201	13	associated	associate	VERB
ajmri-3091	201	14	with	with	ADP
ajmri-3091	201	15	the	the	DET
ajmri-3091	201	16	menstrual	menstrual	ADJ
ajmri-3091	201	17	cycle	cycle	NOUN
ajmri-3091	201	18	(	(	PUNCT
ajmri-3091	201	19	72	72	NUM
ajmri-3091	201	20	%	%	NOUN
ajmri-3091	201	21	)	)	PUNCT
ajmri-3091	201	22	compared	compare	VERB
ajmri-3091	201	23	to	to	ADP
ajmri-3091	201	24	150	150	NUM
ajmri-3091	201	25	-	-	SYM
ajmri-3091	201	26	300	300	NUM
ajmri-3091	201	27	mins	min	NOUN
ajmri-3091	201	28	per	per	ADP
ajmri-3091	201	29	week	week	NOUN
ajmri-3091	201	30	.	.	PUNCT
ajmri-3091	202	1	however	however	ADV
ajmri-3091	202	2	,	,	PUNCT
ajmri-3091	202	3	the	the	DET
ajmri-3091	202	4	p	p	NOUN
ajmri-3091	202	5	-	-	PUNCT
ajmri-3091	202	6	value	value	NOUN
ajmri-3091	202	7	(	(	PUNCT
ajmri-3091	202	8	p=	p=	NOUN
ajmri-3091	202	9	0.647	0.647	NUM
ajmri-3091	202	10	)	)	PUNCT
ajmri-3091	202	11	was	be	AUX
ajmri-3091	202	12	not	not	PART
ajmri-3091	202	13	statistically	statistically	ADV
ajmri-3091	202	14	significant	significant	ADJ
ajmri-3091	202	15	at	at	ADP
ajmri-3091	202	16	(	(	PUNCT
ajmri-3091	202	17	ci	ci	NOUN
ajmri-3091	202	18	;	;	PUNCT
ajmri-3091	202	19	95	95	NUM
ajmri-3091	202	20	%	%	NOUN
ajmri-3091	202	21	)	)	PUNCT
ajmri-3091	202	22	.	.	PUNCT
ajmri-3091	203	1	table	table	NOUN
ajmri-3091	203	2	5	5	NUM
ajmri-3091	203	3	:	:	PUNCT
ajmri-3091	203	4	associations	association	NOUN
ajmri-3091	203	5	between	between	ADP
ajmri-3091	203	6	menstrual	menstrual	ADJ
ajmri-3091	203	7	disorders	disorder	NOUN
ajmri-3091	203	8	after	after	ADP
ajmri-3091	203	9	obtaining	obtain	VERB
ajmri-3091	203	10	a	a	DET
ajmri-3091	203	11	covid-19	covid-19	PROPN
ajmri-3091	203	12	vaccine	vaccine	NOUN
ajmri-3091	203	13	and	and	CCONJ
ajmri-3091	203	14	health	health	NOUN
ajmri-3091	203	15	related	relate	VERB
ajmri-3091	203	16	behaviours	behaviour	NOUN
ajmri-3091	203	17	and	and	CCONJ
ajmri-3091	203	18	practices	practice	NOUN
ajmri-3091	203	19	variables	variable	NOUN
ajmri-3091	203	20	association	association	NOUN
ajmri-3091	203	21	analysis	analysis	NOUN
ajmri-3091	203	22	value	value	NOUN
ajmri-3091	203	23	sig	sig	PROPN
ajmri-3091	203	24	.	.	PUNCT
ajmri-3091	204	1	infected	infect	VERB
ajmri-3091	204	2	with	with	ADP
ajmri-3091	204	3	sars	sar	NOUN
ajmri-3091	204	4	-	-	PUNCT
ajmri-3091	204	5	cov-2	cov-2	NOUN
ajmri-3091	204	6	before	before	ADP
ajmri-3091	204	7	vaccination	vaccination	NOUN
ajmri-3091	204	8	5.589	5.589	NUM
ajmri-3091	204	9	.78	.78	NUM
ajmri-3091	204	10	infected	infect	VERB
ajmri-3091	204	11	with	with	ADP
ajmri-3091	204	12	sars	sar	NOUN
ajmri-3091	204	13	-	-	PUNCT
ajmri-3091	204	14	cov-2	cov-2	NOUN
ajmri-3091	204	15	after	after	ADP
ajmri-3091	204	16	vaccination	vaccination	NOUN
ajmri-3091	204	17	10.234	10.234	NUM
ajmri-3091	204	18	.332	.332	NUM
ajmri-3091	204	19	therapeutic	therapeutic	ADJ
ajmri-3091	204	20	drug	drug	NOUN
ajmri-3091	204	21	consumption	consumption	NOUN
ajmri-3091	204	22	84.485	84.485	NUM
ajmri-3091	204	23	.954	.954	NUM
ajmri-3091	204	24	have	have	VERB
ajmri-3091	204	25	children	child	NOUN
ajmri-3091	204	26	14.539	14.539	NUM
ajmri-3091	204	27	.104	.104	NUM
ajmri-3091	204	28	breastfeeding	breastfeed	VERB
ajmri-3091	204	29	19.599	19.599	NUM
ajmri-3091	204	30	.021	.021	NUM
ajmri-3091	204	31	no	no	DET
ajmri-3091	204	32	contraceptive	contraceptive	ADJ
ajmri-3091	204	33	use	use	NOUN
ajmri-3091	204	34	21.084	21.084	NUM
ajmri-3091	204	35	.275	.275	NUM
ajmri-3091	204	36	oral	oral	ADJ
ajmri-3091	204	37	contraceptive	contraceptive	ADJ
ajmri-3091	204	38	pill	pill	NOUN
ajmri-3091	204	39	use	use	VERB
ajmri-3091	204	40	intrauterine	intrauterine	ADJ
ajmri-3091	204	41	device	device	NOUN
ajmri-3091	204	42	use	use	NOUN
ajmri-3091	204	43	received	receive	VERB
ajmri-3091	204	44	one	one	NUM
ajmri-3091	204	45	dose	dose	VERB
ajmri-3091	204	46	66.620	66.620	NUM
ajmri-3091	204	47	<	<	X
ajmri-3091	204	48	.001	.001	NUM
ajmri-3091	204	49	received	receive	VERB
ajmri-3091	204	50	two	two	NUM
ajmri-3091	204	51	doses	dose	NOUN
ajmri-3091	204	52	received	receive	VERB
ajmri-3091	204	53	three	three	NUM
ajmri-3091	204	54	doses	dose	NOUN
ajmri-3091	204	55	obtained	obtain	VERB
ajmri-3091	204	56	a	a	DET
ajmri-3091	204	57	covid-19	covid-19	PROPN
ajmri-3091	204	58	vaccine	vaccine	NOUN
ajmri-3091	204	59	dose	dose	VERB
ajmri-3091	204	60	during	during	ADP
ajmri-3091	204	61	the	the	DET
ajmri-3091	204	62	menstrual	menstrual	ADJ
ajmri-3091	204	63	cycle	cycle	NOUN
ajmri-3091	204	64	11.787	11.787	NUM
ajmri-3091	204	65	.226	.226	NUM
ajmri-3091	204	66	pa	pa	PROPN
ajmri-3091	204	67	ge	ge	PROPN
ajmri-3091	204	68	20	20	NUM
ajmri-3091	205	1	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	205	2	am	am	NOUN
ajmri-3091	205	3	.	.	PUNCT
ajmri-3091	206	1	j.	j.	PROPN
ajmri-3091	206	2	multidis	multidis	PROPN
ajmri-3091	206	3	.	.	PUNCT
ajmri-3091	207	1	res	re	NOUN
ajmri-3091	207	2	.	.	PUNCT
ajmri-3091	208	1	innov	innov	PROPN
ajmri-3091	208	2	.	.	PUNCT
ajmri-3091	209	1	3(6	3(6	PROPN
ajmri-3091	209	2	)	)	PUNCT
ajmri-3091	209	3	12	12	NUM
ajmri-3091	209	4	-	-	SYM
ajmri-3091	209	5	24	24	NUM
ajmri-3091	209	6	,	,	PUNCT
ajmri-3091	209	7	2024	2024	NUM
ajmri-3091	209	8	figure	figure	NOUN
ajmri-3091	209	9	2	2	NUM
ajmri-3091	209	10	:	:	PUNCT
ajmri-3091	209	11	the	the	DET
ajmri-3091	209	12	most	most	ADV
ajmri-3091	209	13	common	common	ADJ
ajmri-3091	209	14	types	type	NOUN
ajmri-3091	209	15	of	of	ADP
ajmri-3091	209	16	disturbances	disturbance	NOUN
ajmri-3091	209	17	related	relate	VERB
ajmri-3091	209	18	to	to	ADP
ajmri-3091	209	19	menstrual	menstrual	ADJ
ajmri-3091	209	20	cycle	cycle	NOUN
ajmri-3091	209	21	disturbances	disturbance	NOUN
ajmri-3091	209	22	among	among	ADP
ajmri-3091	209	23	adult	adult	NOUN
ajmri-3091	209	24	females	female	NOUN
ajmri-3091	209	25	at	at	ADP
ajmri-3091	209	26	king	king	PROPN
ajmri-3091	209	27	saudi	saudi	PROPN
ajmri-3091	209	28	university	university	PROPN
ajmri-3091	209	29	after	after	ADP
ajmri-3091	209	30	covid-19	covid-19	PROPN
ajmri-3091	209	31	vaccination	vaccination	NOUN
ajmri-3091	209	32	discussion	discussion	NOUN
ajmri-3091	209	33	during	during	ADP
ajmri-3091	209	34	the	the	DET
ajmri-3091	209	35	covid-19	covid-19	PROPN
ajmri-3091	209	36	pandemic	pandemic	NOUN
ajmri-3091	209	37	,	,	PUNCT
ajmri-3091	209	38	various	various	ADJ
ajmri-3091	209	39	vaccines	vaccine	NOUN
ajmri-3091	209	40	were	be	AUX
ajmri-3091	209	41	introduced	introduce	VERB
ajmri-3091	209	42	worldwide	worldwide	ADV
ajmri-3091	209	43	to	to	PART
ajmri-3091	209	44	overcome	overcome	VERB
ajmri-3091	209	45	the	the	DET
ajmri-3091	209	46	symptoms	symptom	NOUN
ajmri-3091	209	47	of	of	ADP
ajmri-3091	209	48	infection	infection	NOUN
ajmri-3091	209	49	.	.	PUNCT
ajmri-3091	210	1	saudi	saudi	PROPN
ajmri-3091	210	2	arabia	arabia	PROPN
ajmri-3091	210	3	has	have	AUX
ajmri-3091	210	4	approved	approve	VERB
ajmri-3091	210	5	the	the	DET
ajmri-3091	210	6	use	use	NOUN
ajmri-3091	210	7	of	of	ADP
ajmri-3091	210	8	three	three	NUM
ajmri-3091	210	9	sars	sar	NOUN
ajmri-3091	210	10	-	-	PUNCT
ajmri-3091	210	11	cov-2	cov-2	NOUN
ajmri-3091	210	12	vaccines	vaccine	NOUN
ajmri-3091	210	13	:	:	PUNCT
ajmri-3091	210	14	pfizer	pfizer	NOUN
ajmri-3091	210	15	-	-	PUNCT
ajmri-3091	210	16	biontech	biontech	ADJ
ajmri-3091	210	17	,	,	PUNCT
ajmri-3091	210	18	oxfordastrazeneca	oxfordastrazeneca	NOUN
ajmri-3091	210	19	chadox1	chadox1	NOUN
ajmri-3091	210	20	chimpanzee	chimpanzee	NOUN
ajmri-3091	210	21	adenovirus	adenovirus	NOUN
ajmri-3091	210	22	vector	vector	NOUN
ajmri-3091	210	23	,	,	PUNCT
ajmri-3091	210	24	and	and	CCONJ
ajmri-3091	210	25	moderna	moderna	PROPN
ajmri-3091	210	26	.	.	PUNCT
ajmri-3091	211	1	the	the	DET
ajmri-3091	211	2	vaccines	vaccine	NOUN
ajmri-3091	211	3	were	be	AUX
ajmri-3091	211	4	approved	approve	VERB
ajmri-3091	211	5	in	in	ADP
ajmri-3091	211	6	december	december	PROPN
ajmri-3091	211	7	2020	2020	NUM
ajmri-3091	211	8	,	,	PUNCT
ajmri-3091	211	9	february	february	NOUN
ajmri-3091	211	10	2021	2021	NUM
ajmri-3091	211	11	,	,	PUNCT
ajmri-3091	211	12	and	and	CCONJ
ajmri-3091	211	13	july	july	PROPN
ajmri-3091	211	14	2021	2021	NUM
ajmri-3091	211	15	(	(	PUNCT
ajmri-3091	211	16	alhur	alhur	VERB
ajmri-3091	211	17	,	,	PUNCT
ajmri-3091	211	18	2023	2023	NUM
ajmri-3091	211	19	)	)	PUNCT
ajmri-3091	211	20	.	.	PUNCT
ajmri-3091	212	1	as	as	ADP
ajmri-3091	212	2	of	of	ADP
ajmri-3091	212	3	november	november	PROPN
ajmri-3091	212	4	2022	2022	NUM
ajmri-3091	212	5	,	,	PUNCT
ajmri-3091	212	6	saudi	saudi	PROPN
ajmri-3091	212	7	arabia	arabia	PROPN
ajmri-3091	212	8	had	have	AUX
ajmri-3091	212	9	administered	administer	VERB
ajmri-3091	212	10	around	around	ADV
ajmri-3091	212	11	67	67	NUM
ajmri-3091	212	12	million	million	NUM
ajmri-3091	212	13	vaccine	vaccine	NOUN
ajmri-3091	212	14	doses	dose	NOUN
ajmri-3091	212	15	,	,	PUNCT
ajmri-3091	212	16	with	with	ADP
ajmri-3091	212	17	15	15	NUM
ajmri-3091	212	18	million	million	NUM
ajmri-3091	212	19	individuals	individual	NOUN
ajmri-3091	212	20	receiving	receive	VERB
ajmri-3091	212	21	booster	booster	NOUN
ajmri-3091	212	22	doses	dose	NOUN
ajmri-3091	212	23	.	.	PUNCT
ajmri-3091	213	1	the	the	DET
ajmri-3091	213	2	vaccines	vaccine	NOUN
ajmri-3091	213	3	have	have	AUX
ajmri-3091	213	4	been	be	AUX
ajmri-3091	213	5	validated	validate	VERB
ajmri-3091	213	6	through	through	ADP
ajmri-3091	213	7	clinical	clinical	ADJ
ajmri-3091	213	8	trials	trial	NOUN
ajmri-3091	213	9	,	,	PUNCT
ajmri-3091	213	10	and	and	CCONJ
ajmri-3091	213	11	common	common	ADJ
ajmri-3091	213	12	side	side	NOUN
ajmri-3091	213	13	effects	effect	NOUN
ajmri-3091	213	14	like	like	ADP
ajmri-3091	213	15	fever	fever	NOUN
ajmri-3091	213	16	,	,	PUNCT
ajmri-3091	213	17	fatigue	fatigue	NOUN
ajmri-3091	213	18	,	,	PUNCT
ajmri-3091	213	19	headaches	headache	NOUN
ajmri-3091	213	20	,	,	PUNCT
ajmri-3091	213	21	muscle	muscle	NOUN
ajmri-3091	213	22	discomfort	discomfort	NOUN
ajmri-3091	213	23	,	,	PUNCT
ajmri-3091	213	24	and	and	CCONJ
ajmri-3091	213	25	injection	injection	NOUN
ajmri-3091	213	26	site	site	NOUN
ajmri-3091	213	27	pain	pain	NOUN
ajmri-3091	213	28	typically	typically	ADV
ajmri-3091	213	29	resolve	resolve	VERB
ajmri-3091	213	30	within	within	ADP
ajmri-3091	213	31	a	a	DET
ajmri-3091	213	32	few	few	ADJ
ajmri-3091	213	33	days	day	NOUN
ajmri-3091	213	34	(	(	PUNCT
ajmri-3091	213	35	alahmadi	alahmadi	VERB
ajmri-3091	213	36	et	et	PROPN
ajmri-3091	213	37	al	al	PROPN
ajmri-3091	213	38	.	.	PROPN
ajmri-3091	213	39	,	,	PUNCT
ajmri-3091	213	40	2022	2022	NUM
ajmri-3091	213	41	)	)	PUNCT
ajmri-3091	213	42	.	.	PUNCT
ajmri-3091	214	1	menstrual	menstrual	ADJ
ajmri-3091	214	2	irregularities	irregularity	NOUN
ajmri-3091	214	3	,	,	PUNCT
ajmri-3091	214	4	often	often	ADV
ajmri-3091	214	5	unnoticed	unnoticed	ADJ
ajmri-3091	214	6	symptoms	symptom	NOUN
ajmri-3091	214	7	,	,	PUNCT
ajmri-3091	214	8	have	have	AUX
ajmri-3091	214	9	become	become	VERB
ajmri-3091	214	10	more	more	ADV
ajmri-3091	214	11	prevalent	prevalent	ADJ
ajmri-3091	214	12	after	after	ADP
ajmri-3091	214	13	the	the	DET
ajmri-3091	214	14	covid-19	covid-19	PROPN
ajmri-3091	214	15	vaccination	vaccination	NOUN
ajmri-3091	214	16	(	(	PUNCT
ajmri-3091	214	17	alahmadi	alahmadi	VERB
ajmri-3091	214	18	et	et	PROPN
ajmri-3091	214	19	al	al	PROPN
ajmri-3091	214	20	.	.	PROPN
ajmri-3091	214	21	,	,	PUNCT
ajmri-3091	214	22	2022	2022	NUM
ajmri-3091	214	23	)	)	PUNCT
ajmri-3091	214	24	.	.	PUNCT
ajmri-3091	215	1	these	these	DET
ajmri-3091	215	2	irregularities	irregularity	NOUN
ajmri-3091	215	3	significantly	significantly	ADV
ajmri-3091	215	4	impact	impact	VERB
ajmri-3091	215	5	women	woman	NOUN
ajmri-3091	215	6	’s	’s	PART
ajmri-3091	215	7	quality	quality	NOUN
ajmri-3091	215	8	of	of	ADP
ajmri-3091	215	9	life	life	NOUN
ajmri-3091	215	10	and	and	CCONJ
ajmri-3091	215	11	have	have	AUX
ajmri-3091	215	12	sparked	spark	VERB
ajmri-3091	215	13	concerns	concern	NOUN
ajmri-3091	215	14	about	about	ADP
ajmri-3091	215	15	a	a	DET
ajmri-3091	215	16	potential	potential	ADJ
ajmri-3091	215	17	link	link	NOUN
ajmri-3091	215	18	between	between	ADP
ajmri-3091	215	19	the	the	DET
ajmri-3091	215	20	vaccine	vaccine	NOUN
ajmri-3091	215	21	and	and	CCONJ
ajmri-3091	215	22	menstruation	menstruation	NOUN
ajmri-3091	215	23	patterns	pattern	NOUN
ajmri-3091	215	24	.	.	PUNCT
ajmri-3091	216	1	furthermore	furthermore	ADV
ajmri-3091	216	2	,	,	PUNCT
ajmri-3091	216	3	the	the	DET
ajmri-3091	216	4	hesitance	hesitance	NOUN
ajmri-3091	216	5	of	of	ADP
ajmri-3091	216	6	young	young	ADJ
ajmri-3091	216	7	women	woman	NOUN
ajmri-3091	216	8	to	to	PART
ajmri-3091	216	9	receive	receive	VERB
ajmri-3091	216	10	the	the	DET
ajmri-3091	216	11	covid-19	covid-19	PROPN
ajmri-3091	216	12	vaccination	vaccination	NOUN
ajmri-3091	216	13	has	have	AUX
ajmri-3091	216	14	been	be	AUX
ajmri-3091	216	15	intensified	intensify	VERB
ajmri-3091	216	16	by	by	ADP
ajmri-3091	216	17	unfounded	unfounded	ADJ
ajmri-3091	216	18	claims	claim	NOUN
ajmri-3091	216	19	suggesting	suggest	VERB
ajmri-3091	216	20	that	that	SCONJ
ajmri-3091	216	21	the	the	DET
ajmri-3091	216	22	vaccine	vaccine	NOUN
ajmri-3091	216	23	could	could	AUX
ajmri-3091	216	24	have	have	VERB
ajmri-3091	216	25	adverse	adverse	ADJ
ajmri-3091	216	26	effects	effect	NOUN
ajmri-3091	216	27	on	on	ADP
ajmri-3091	216	28	their	their	PRON
ajmri-3091	216	29	future	future	ADJ
ajmri-3091	216	30	fertility	fertility	NOUN
ajmri-3091	216	31	(	(	PUNCT
ajmri-3091	216	32	male	male	NOUN
ajmri-3091	216	33	,	,	PUNCT
ajmri-3091	216	34	2021	2021	NUM
ajmri-3091	216	35	)	)	PUNCT
ajmri-3091	216	36	.	.	PUNCT
ajmri-3091	217	1	there	there	PRON
ajmri-3091	217	2	was	be	VERB
ajmri-3091	217	3	a	a	DET
ajmri-3091	217	4	global	global	ADJ
ajmri-3091	217	5	table	table	NOUN
ajmri-3091	217	6	5	5	NUM
ajmri-3091	217	7	demonstrates	demonstrate	VERB
ajmri-3091	217	8	a	a	DET
ajmri-3091	217	9	significant	significant	ADJ
ajmri-3091	217	10	correlation	correlation	NOUN
ajmri-3091	217	11	between	between	ADP
ajmri-3091	217	12	breastfeeding	breastfeeding	NOUN
ajmri-3091	217	13	and	and	CCONJ
ajmri-3091	217	14	menstrual	menstrual	ADJ
ajmri-3091	217	15	disturbances	disturbance	NOUN
ajmri-3091	217	16	(	(	PUNCT
ajmri-3091	217	17	p	p	X
ajmri-3091	217	18	=	=	PROPN
ajmri-3091	217	19	0.021	0.021	NUM
ajmri-3091	217	20	)	)	PUNCT
ajmri-3091	217	21	,	,	PUNCT
ajmri-3091	217	22	as	as	ADV
ajmri-3091	217	23	well	well	ADV
ajmri-3091	217	24	as	as	ADP
ajmri-3091	217	25	a	a	DET
ajmri-3091	217	26	significant	significant	ADJ
ajmri-3091	217	27	association	association	NOUN
ajmri-3091	217	28	between	between	ADP
ajmri-3091	217	29	the	the	DET
ajmri-3091	217	30	number	number	NOUN
ajmri-3091	217	31	of	of	ADP
ajmri-3091	217	32	covid-19	covid-19	PROPN
ajmri-3091	217	33	vaccine	vaccine	NOUN
ajmri-3091	217	34	doses	dose	NOUN
ajmri-3091	217	35	and	and	CCONJ
ajmri-3091	217	36	the	the	DET
ajmri-3091	217	37	occurrence	occurrence	NOUN
ajmri-3091	217	38	of	of	ADP
ajmri-3091	217	39	menstrual	menstrual	ADJ
ajmri-3091	217	40	disturbances	disturbance	NOUN
ajmri-3091	217	41	(	(	PUNCT
ajmri-3091	217	42	p	p	NOUN
ajmri-3091	217	43	=	=	NOUN
ajmri-3091	217	44	0.001	0.001	NUM
ajmri-3091	217	45	)	)	PUNCT
ajmri-3091	217	46	.	.	PUNCT
ajmri-3091	218	1	the	the	DET
ajmri-3091	218	2	administration	administration	NOUN
ajmri-3091	218	3	of	of	ADP
ajmri-3091	218	4	the	the	DET
ajmri-3091	218	5	vaccination	vaccination	NOUN
ajmri-3091	218	6	during	during	ADP
ajmri-3091	218	7	menstruation	menstruation	NOUN
ajmri-3091	218	8	was	be	AUX
ajmri-3091	218	9	linked	link	VERB
ajmri-3091	218	10	to	to	ADP
ajmri-3091	218	11	a	a	DET
ajmri-3091	218	12	notable	notable	ADJ
ajmri-3091	218	13	occurrence	occurrence	NOUN
ajmri-3091	218	14	of	of	ADP
ajmri-3091	218	15	menstrual	menstrual	ADJ
ajmri-3091	218	16	disturbances	disturbance	NOUN
ajmri-3091	218	17	,	,	PUNCT
ajmri-3091	218	18	although	although	SCONJ
ajmri-3091	218	19	the	the	DET
ajmri-3091	218	20	p	p	NOUN
ajmri-3091	218	21	-	-	PUNCT
ajmri-3091	218	22	value	value	NOUN
ajmri-3091	218	23	showed	show	VERB
ajmri-3091	218	24	no	no	DET
ajmri-3091	218	25	statistical	statistical	ADJ
ajmri-3091	218	26	significance	significance	NOUN
ajmri-3091	218	27	.	.	PUNCT
ajmri-3091	219	1	moreover	moreover	ADV
ajmri-3091	219	2	,	,	PUNCT
ajmri-3091	219	3	the	the	DET
ajmri-3091	219	4	prevalence	prevalence	NOUN
ajmri-3091	219	5	of	of	ADP
ajmri-3091	219	6	menstrual	menstrual	ADJ
ajmri-3091	219	7	disturbances	disturbance	NOUN
ajmri-3091	219	8	was	be	AUX
ajmri-3091	219	9	remarkably	remarkably	ADV
ajmri-3091	219	10	high	high	ADJ
ajmri-3091	219	11	(	(	PUNCT
ajmri-3091	219	12	93.2	93.2	NUM
ajmri-3091	219	13	%	%	NOUN
ajmri-3091	219	14	)	)	PUNCT
ajmri-3091	219	15	in	in	ADP
ajmri-3091	219	16	females	female	NOUN
ajmri-3091	219	17	who	who	PRON
ajmri-3091	219	18	did	do	AUX
ajmri-3091	219	19	not	not	PART
ajmri-3091	219	20	take	take	VERB
ajmri-3091	219	21	contraceptive	contraceptive	ADJ
ajmri-3091	219	22	pills	pill	NOUN
ajmri-3091	219	23	.	.	PUNCT
ajmri-3091	220	1	however	however	ADV
ajmri-3091	220	2	,	,	PUNCT
ajmri-3091	220	3	the	the	DET
ajmri-3091	220	4	correlation	correlation	NOUN
ajmri-3091	220	5	was	be	AUX
ajmri-3091	220	6	not	not	PART
ajmri-3091	220	7	statistically	statistically	ADV
ajmri-3091	220	8	significant	significant	ADJ
ajmri-3091	220	9	.	.	PUNCT
ajmri-3091	221	1	figure	figure	VERB
ajmri-3091	221	2	3	3	NUM
ajmri-3091	221	3	:	:	PUNCT
ajmri-3091	221	4	duration	duration	NOUN
ajmri-3091	221	5	of	of	ADP
ajmri-3091	221	6	side	side	NOUN
ajmri-3091	221	7	effects	effect	NOUN
ajmri-3091	221	8	associated	associate	VERB
ajmri-3091	221	9	with	with	ADP
ajmri-3091	221	10	the	the	DET
ajmri-3091	221	11	menstrual	menstrual	ADJ
ajmri-3091	221	12	cycle	cycle	NOUN
ajmri-3091	221	13	after	after	ADP
ajmri-3091	221	14	receiving	receive	VERB
ajmri-3091	221	15	a	a	DET
ajmri-3091	221	16	covid-19	covid-19	PROPN
ajmri-3091	221	17	vaccin	vaccin	NOUN
ajmri-3091	221	18	pa	pa	PROPN
ajmri-3091	221	19	ge	ge	PROPN
ajmri-3091	221	20	21	21	NUM
ajmri-3091	222	1	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	222	2	am	am	NOUN
ajmri-3091	222	3	.	.	PUNCT
ajmri-3091	223	1	j.	j.	PROPN
ajmri-3091	223	2	multidis	multidis	PROPN
ajmri-3091	223	3	.	.	PUNCT
ajmri-3091	224	1	res	re	NOUN
ajmri-3091	224	2	.	.	PUNCT
ajmri-3091	225	1	innov	innov	PROPN
ajmri-3091	225	2	.	.	PUNCT
ajmri-3091	226	1	3(6	3(6	PROPN
ajmri-3091	226	2	)	)	PUNCT
ajmri-3091	226	3	12	12	NUM
ajmri-3091	226	4	-	-	SYM
ajmri-3091	226	5	24	24	NUM
ajmri-3091	226	6	,	,	PUNCT
ajmri-3091	226	7	2024	2024	NUM
ajmri-3091	226	8	apprehension	apprehension	NOUN
ajmri-3091	226	9	about	about	ADP
ajmri-3091	226	10	the	the	DET
ajmri-3091	226	11	potential	potential	ADJ
ajmri-3091	226	12	correlation	correlation	NOUN
ajmri-3091	226	13	between	between	ADP
ajmri-3091	226	14	menstrual	menstrual	ADJ
ajmri-3091	226	15	irregularities	irregularity	NOUN
ajmri-3091	226	16	and	and	CCONJ
ajmri-3091	226	17	the	the	DET
ajmri-3091	226	18	covid-19	covid-19	PROPN
ajmri-3091	226	19	vaccine	vaccine	NOUN
ajmri-3091	226	20	,	,	PUNCT
ajmri-3091	226	21	with	with	ADP
ajmri-3091	226	22	women	woman	NOUN
ajmri-3091	226	23	concerned	concern	VERB
ajmri-3091	226	24	about	about	ADP
ajmri-3091	226	25	the	the	DET
ajmri-3091	226	26	duration	duration	NOUN
ajmri-3091	226	27	of	of	ADP
ajmri-3091	226	28	these	these	DET
ajmri-3091	226	29	negative	negative	ADJ
ajmri-3091	226	30	effects	effect	NOUN
ajmri-3091	226	31	and	and	CCONJ
ajmri-3091	226	32	hesitant	hesitant	ADJ
ajmri-3091	226	33	to	to	PART
ajmri-3091	226	34	receive	receive	VERB
ajmri-3091	226	35	more	more	ADJ
ajmri-3091	226	36	doses	dose	NOUN
ajmri-3091	226	37	(	(	PUNCT
ajmri-3091	226	38	alaamri	alaamri	NOUN
ajmri-3091	226	39	et	et	PROPN
ajmri-3091	226	40	al	al	PROPN
ajmri-3091	226	41	.	.	PROPN
ajmri-3091	226	42	,	,	PUNCT
ajmri-3091	226	43	2022	2022	NUM
ajmri-3091	226	44	)	)	PUNCT
ajmri-3091	226	45	.	.	PUNCT
ajmri-3091	227	1	a	a	DET
ajmri-3091	227	2	study	study	NOUN
ajmri-3091	227	3	by	by	ADP
ajmri-3091	227	4	fadi	fadi	PROPN
ajmri-3091	227	5	et	et	PROPN
ajmri-3091	227	6	al	al	PROPN
ajmri-3091	227	7	.	.	PROPN
ajmri-3091	227	8	(	(	PUNCT
ajmri-3091	227	9	2022	2022	NUM
ajmri-3091	227	10	)	)	PUNCT
ajmri-3091	227	11	identified	identify	VERB
ajmri-3091	227	12	a	a	DET
ajmri-3091	227	13	potential	potential	ADJ
ajmri-3091	227	14	correlation	correlation	NOUN
ajmri-3091	227	15	between	between	ADP
ajmri-3091	227	16	irregular	irregular	ADJ
ajmri-3091	227	17	menstrual	menstrual	ADJ
ajmri-3091	227	18	cycles	cycle	NOUN
ajmri-3091	227	19	and	and	CCONJ
ajmri-3091	227	20	the	the	DET
ajmri-3091	227	21	covid-19	covid-19	PROPN
ajmri-3091	227	22	vaccine	vaccine	NOUN
ajmri-3091	227	23	,	,	PUNCT
ajmri-3091	227	24	which	which	PRON
ajmri-3091	227	25	may	may	AUX
ajmri-3091	227	26	affect	affect	VERB
ajmri-3091	227	27	the	the	DET
ajmri-3091	227	28	overall	overall	ADJ
ajmri-3091	227	29	wellbeing	wellbeing	NOUN
ajmri-3091	227	30	of	of	ADP
ajmri-3091	227	31	women	woman	NOUN
ajmri-3091	227	32	(	(	PUNCT
ajmri-3091	227	33	qashqari	qashqari	PROPN
ajmri-3091	227	34	et	et	PROPN
ajmri-3091	227	35	al	al	PROPN
ajmri-3091	227	36	.	.	PROPN
ajmri-3091	227	37	,	,	PUNCT
ajmri-3091	227	38	2022	2022	NUM
ajmri-3091	227	39	)	)	PUNCT
ajmri-3091	227	40	.	.	PUNCT
ajmri-3091	228	1	the	the	DET
ajmri-3091	228	2	present	present	ADJ
ajmri-3091	228	3	study	study	NOUN
ajmri-3091	228	4	results	result	NOUN
ajmri-3091	228	5	revealed	reveal	VERB
ajmri-3091	228	6	that	that	SCONJ
ajmri-3091	228	7	71.8	71.8	NUM
ajmri-3091	228	8	%	%	NOUN
ajmri-3091	228	9	of	of	ADP
ajmri-3091	228	10	adult	adult	NOUN
ajmri-3091	228	11	females	female	NOUN
ajmri-3091	228	12	with	with	ADP
ajmri-3091	228	13	menstrual	menstrual	ADJ
ajmri-3091	228	14	disturbances	disturbance	NOUN
ajmri-3091	228	15	were	be	AUX
ajmri-3091	228	16	single	single	ADJ
ajmri-3091	228	17	,	,	PUNCT
ajmri-3091	228	18	54.5	54.5	NUM
ajmri-3091	228	19	%	%	NOUN
ajmri-3091	228	20	had	have	VERB
ajmri-3091	228	21	an	an	DET
ajmri-3091	228	22	average	average	ADJ
ajmri-3091	228	23	weight	weight	NOUN
ajmri-3091	228	24	,	,	PUNCT
ajmri-3091	228	25	and	and	CCONJ
ajmri-3091	228	26	were	be	AUX
ajmri-3091	228	27	between	between	ADP
ajmri-3091	228	28	the	the	DET
ajmri-3091	228	29	ages	age	NOUN
ajmri-3091	228	30	of	of	ADP
ajmri-3091	228	31	18	18	NUM
ajmri-3091	228	32	and	and	CCONJ
ajmri-3091	228	33	25	25	NUM
ajmri-3091	228	34	.	.	PUNCT
ajmri-3091	229	1	additionally	additionally	ADV
ajmri-3091	229	2	,	,	PUNCT
ajmri-3091	229	3	67.1	67.1	NUM
ajmri-3091	229	4	%	%	NOUN
ajmri-3091	229	5	of	of	ADP
ajmri-3091	229	6	the	the	DET
ajmri-3091	229	7	participants	participant	NOUN
ajmri-3091	229	8	did	do	AUX
ajmri-3091	229	9	not	not	PART
ajmri-3091	229	10	exercise	exercise	VERB
ajmri-3091	229	11	regularly	regularly	ADV
ajmri-3091	229	12	,	,	PUNCT
ajmri-3091	229	13	54.5	54.5	NUM
ajmri-3091	229	14	%	%	NOUN
ajmri-3091	229	15	had	have	VERB
ajmri-3091	229	16	unhealthy	unhealthy	ADJ
ajmri-3091	229	17	diet	diet	NOUN
ajmri-3091	229	18	patterns	pattern	NOUN
ajmri-3091	229	19	,	,	PUNCT
ajmri-3091	229	20	and	and	CCONJ
ajmri-3091	229	21	60.8	60.8	NUM
ajmri-3091	229	22	%	%	NOUN
ajmri-3091	229	23	reported	report	VERB
ajmri-3091	229	24	good	good	ADJ
ajmri-3091	229	25	psychological	psychological	ADJ
ajmri-3091	229	26	health	health	NOUN
ajmri-3091	229	27	.	.	PUNCT
ajmri-3091	230	1	further	far	ADV
ajmri-3091	230	2	,	,	PUNCT
ajmri-3091	230	3	only	only	ADV
ajmri-3091	230	4	12.9	12.9	NUM
ajmri-3091	230	5	%	%	NOUN
ajmri-3091	230	6	of	of	ADP
ajmri-3091	230	7	participants	participant	NOUN
ajmri-3091	230	8	had	have	VERB
ajmri-3091	230	9	an	an	DET
ajmri-3091	230	10	imbalance	imbalance	NOUN
ajmri-3091	230	11	in	in	ADP
ajmri-3091	230	12	hormones	hormone	NOUN
ajmri-3091	230	13	,	,	PUNCT
ajmri-3091	230	14	5.8	5.8	NUM
ajmri-3091	230	15	%	%	NOUN
ajmri-3091	230	16	had	have	VERB
ajmri-3091	230	17	a	a	DET
ajmri-3091	230	18	thyroid	thyroid	NOUN
ajmri-3091	230	19	gland	gland	NOUN
ajmri-3091	230	20	problem	problem	NOUN
ajmri-3091	230	21	,	,	PUNCT
ajmri-3091	230	22	and	and	CCONJ
ajmri-3091	230	23	13.72	13.72	NUM
ajmri-3091	230	24	%	%	NOUN
ajmri-3091	230	25	had	have	VERB
ajmri-3091	230	26	a	a	DET
ajmri-3091	230	27	chronic	chronic	ADJ
ajmri-3091	230	28	condition	condition	NOUN
ajmri-3091	230	29	.	.	PUNCT
ajmri-3091	231	1	among	among	ADP
ajmri-3091	231	2	participants	participant	NOUN
ajmri-3091	231	3	,	,	PUNCT
ajmri-3091	231	4	3.1	3.1	NUM
ajmri-3091	231	5	%	%	NOUN
ajmri-3091	231	6	had	have	VERB
ajmri-3091	231	7	uterine	uterine	ADJ
ajmri-3091	231	8	fibrosis	fibrosis	NOUN
ajmri-3091	231	9	,	,	PUNCT
ajmri-3091	231	10	14.16	14.16	NUM
ajmri-3091	231	11	%	%	NOUN
ajmri-3091	231	12	had	have	VERB
ajmri-3091	231	13	polycystic	polycystic	ADJ
ajmri-3091	231	14	ovaries	ovary	NOUN
ajmri-3091	231	15	,	,	PUNCT
ajmri-3091	231	16	3.2	3.2	NUM
ajmri-3091	231	17	%	%	NOUN
ajmri-3091	231	18	took	take	VERB
ajmri-3091	231	19	antidepressants	antidepressant	NOUN
ajmri-3091	231	20	,	,	PUNCT
ajmri-3091	231	21	and	and	CCONJ
ajmri-3091	231	22	7.4	7.4	NUM
ajmri-3091	231	23	%	%	NOUN
ajmri-3091	231	24	used	use	VERB
ajmri-3091	231	25	conventional	conventional	ADJ
ajmri-3091	231	26	analgesics	analgesic	NOUN
ajmri-3091	231	27	.	.	PUNCT
ajmri-3091	232	1	in	in	ADP
ajmri-3091	232	2	addition	addition	NOUN
ajmri-3091	232	3	,	,	PUNCT
ajmri-3091	232	4	93.2	93.2	NUM
ajmri-3091	232	5	%	%	NOUN
ajmri-3091	232	6	of	of	ADP
ajmri-3091	232	7	participants	participant	NOUN
ajmri-3091	232	8	did	do	AUX
ajmri-3091	232	9	not	not	PART
ajmri-3091	232	10	use	use	VERB
ajmri-3091	232	11	contraceptive	contraceptive	ADJ
ajmri-3091	232	12	pills	pill	NOUN
ajmri-3091	232	13	,	,	PUNCT
ajmri-3091	232	14	and	and	CCONJ
ajmri-3091	232	15	1.6	1.6	NUM
ajmri-3091	232	16	%	%	NOUN
ajmri-3091	232	17	of	of	ADP
ajmri-3091	232	18	participants	participant	NOUN
ajmri-3091	232	19	breastfed	breastfe	VERB
ajmri-3091	232	20	their	their	PRON
ajmri-3091	232	21	children	child	NOUN
ajmri-3091	232	22	.	.	PUNCT
ajmri-3091	233	1	these	these	DET
ajmri-3091	233	2	risk	risk	NOUN
ajmri-3091	233	3	factors	factor	NOUN
ajmri-3091	233	4	intensify	intensify	VERB
ajmri-3091	233	5	the	the	DET
ajmri-3091	233	6	effects	effect	NOUN
ajmri-3091	233	7	of	of	ADP
ajmri-3091	233	8	covid-19	covid-19	PROPN
ajmri-3091	233	9	vaccinations	vaccination	NOUN
ajmri-3091	233	10	on	on	ADP
ajmri-3091	233	11	menstrual	menstrual	ADJ
ajmri-3091	233	12	cycles	cycle	NOUN
ajmri-3091	233	13	,	,	PUNCT
ajmri-3091	233	14	as	as	SCONJ
ajmri-3091	233	15	the	the	DET
ajmri-3091	233	16	majority	majority	NOUN
ajmri-3091	233	17	did	do	AUX
ajmri-3091	233	18	not	not	PART
ajmri-3091	233	19	indicate	indicate	VERB
ajmri-3091	233	20	any	any	DET
ajmri-3091	233	21	irregularities	irregularity	NOUN
ajmri-3091	233	22	in	in	ADP
ajmri-3091	233	23	menstruation	menstruation	NOUN
ajmri-3091	233	24	.	.	PUNCT
ajmri-3091	234	1	however	however	ADV
ajmri-3091	234	2	,	,	PUNCT
ajmri-3091	234	3	the	the	DET
ajmri-3091	234	4	study	study	NOUN
ajmri-3091	234	5	found	find	VERB
ajmri-3091	234	6	minor	minor	ADJ
ajmri-3091	234	7	impacts	impact	NOUN
ajmri-3091	234	8	in	in	ADP
ajmri-3091	234	9	relation	relation	NOUN
ajmri-3091	234	10	to	to	PART
ajmri-3091	234	11	diet	diet	PROPN
ajmri-3091	234	12	quality	quality	NOUN
ajmri-3091	234	13	,	,	PUNCT
ajmri-3091	234	14	increased	increase	VERB
ajmri-3091	234	15	physical	physical	ADJ
ajmri-3091	234	16	activity	activity	NOUN
ajmri-3091	234	17	,	,	PUNCT
ajmri-3091	234	18	thyroid	thyroid	NOUN
ajmri-3091	234	19	issues	issue	NOUN
ajmri-3091	234	20	,	,	PUNCT
ajmri-3091	234	21	and	and	CCONJ
ajmri-3091	234	22	venereal	venereal	ADJ
ajmri-3091	234	23	illnesses	illness	NOUN
ajmri-3091	234	24	during	during	ADP
ajmri-3091	234	25	the	the	DET
ajmri-3091	234	26	menstrual	menstrual	ADJ
ajmri-3091	234	27	cycle	cycle	NOUN
ajmri-3091	234	28	.	.	PUNCT
ajmri-3091	235	1	a	a	DET
ajmri-3091	235	2	total	total	NOUN
ajmri-3091	235	3	of	of	ADP
ajmri-3091	235	4	33.9	33.9	NUM
ajmri-3091	235	5	%	%	NOUN
ajmri-3091	235	6	of	of	ADP
ajmri-3091	235	7	participants	participant	NOUN
ajmri-3091	235	8	received	receive	VERB
ajmri-3091	235	9	two	two	NUM
ajmri-3091	235	10	doses	dose	NOUN
ajmri-3091	235	11	of	of	ADP
ajmri-3091	235	12	covid-19	covid-19	PROPN
ajmri-3091	235	13	vaccination	vaccination	NOUN
ajmri-3091	235	14	,	,	PUNCT
ajmri-3091	235	15	while	while	SCONJ
ajmri-3091	235	16	65.3	65.3	NUM
ajmri-3091	235	17	%	%	NOUN
ajmri-3091	235	18	received	receive	VERB
ajmri-3091	235	19	three	three	NUM
ajmri-3091	235	20	doses	dose	NOUN
ajmri-3091	235	21	.	.	PUNCT
ajmri-3091	236	1	pfizer	pfizer	NOUN
ajmri-3091	236	2	was	be	AUX
ajmri-3091	236	3	the	the	DET
ajmri-3091	236	4	most	most	ADV
ajmri-3091	236	5	commonly	commonly	ADV
ajmri-3091	236	6	administered	administer	VERB
ajmri-3091	236	7	vaccine	vaccine	NOUN
ajmri-3091	236	8	,	,	PUNCT
ajmri-3091	236	9	with	with	ADP
ajmri-3091	236	10	83.2	83.2	NUM
ajmri-3091	236	11	%	%	NOUN
ajmri-3091	236	12	receiving	receive	VERB
ajmri-3091	236	13	the	the	DET
ajmri-3091	236	14	first	first	ADJ
ajmri-3091	236	15	dose	dose	NOUN
ajmri-3091	236	16	,	,	PUNCT
ajmri-3091	236	17	87.9	87.9	NUM
ajmri-3091	236	18	%	%	NOUN
ajmri-3091	236	19	receiving	receive	VERB
ajmri-3091	236	20	the	the	DET
ajmri-3091	236	21	second	second	ADJ
ajmri-3091	236	22	,	,	PUNCT
ajmri-3091	236	23	and	and	CCONJ
ajmri-3091	236	24	56.3	56.3	NUM
ajmri-3091	236	25	%	%	NOUN
ajmri-3091	236	26	receiving	receive	VERB
ajmri-3091	236	27	the	the	DET
ajmri-3091	236	28	third	third	ADJ
ajmri-3091	236	29	dose	dose	NOUN
ajmri-3091	236	30	.	.	PUNCT
ajmri-3091	237	1	these	these	DET
ajmri-3091	237	2	results	result	NOUN
ajmri-3091	237	3	are	be	AUX
ajmri-3091	237	4	consistent	consistent	ADJ
ajmri-3091	237	5	with	with	ADP
ajmri-3091	237	6	isılay	isılay	NOUN
ajmri-3091	237	7	tas	tas	PROPN
ajmri-3091	237	8	kaldıran	kaldıran	PROPN
ajmri-3091	237	9	et	et	PROPN
ajmri-3091	237	10	al	al	PROPN
ajmri-3091	237	11	.	.	PROPN
ajmri-3091	238	1	(	(	PUNCT
ajmri-3091	238	2	2022	2022	NUM
ajmri-3091	238	3	)	)	PUNCT
ajmri-3091	238	4	,	,	PUNCT
ajmri-3091	238	5	who	who	PRON
ajmri-3091	238	6	reported	report	VERB
ajmri-3091	238	7	that	that	SCONJ
ajmri-3091	238	8	women	woman	NOUN
ajmri-3091	238	9	who	who	PRON
ajmri-3091	238	10	received	receive	VERB
ajmri-3091	238	11	pfizer	pfizer	NOUN
ajmri-3091	238	12	and	and	CCONJ
ajmri-3091	238	13	sinovac	sinovac	NOUN
ajmri-3091	238	14	vaccinations	vaccination	NOUN
ajmri-3091	238	15	had	have	VERB
ajmri-3091	238	16	a	a	DET
ajmri-3091	238	17	higher	high	ADJ
ajmri-3091	238	18	incidence	incidence	NOUN
ajmri-3091	238	19	of	of	ADP
ajmri-3091	238	20	menstruation	menstruation	NOUN
ajmri-3091	238	21	changes	change	NOUN
ajmri-3091	238	22	postvaccination	postvaccination	NOUN
ajmri-3091	238	23	(	(	PUNCT
ajmri-3091	238	24	taşkaldıran	taşkaldıran	VERB
ajmri-3091	238	25	et	et	PROPN
ajmri-3091	238	26	al	al	PROPN
ajmri-3091	238	27	.	.	PROPN
ajmri-3091	238	28	,	,	PUNCT
ajmri-3091	238	29	2022	2022	NUM
ajmri-3091	238	30	)	)	PUNCT
ajmri-3091	238	31	.	.	PUNCT
ajmri-3091	239	1	gibson	gibson	PROPN
ajmri-3091	239	2	et	et	PROPN
ajmri-3091	239	3	al	al	PROPN
ajmri-3091	239	4	.	.	PROPN
ajmri-3091	240	1	(	(	PUNCT
ajmri-3091	240	2	2022	2022	NUM
ajmri-3091	240	3	)	)	PUNCT
ajmri-3091	240	4	similarly	similarly	ADV
ajmri-3091	240	5	documented	document	VERB
ajmri-3091	240	6	a	a	DET
ajmri-3091	240	7	consistent	consistent	ADJ
ajmri-3091	240	8	outcome	outcome	NOUN
ajmri-3091	240	9	,	,	PUNCT
ajmri-3091	240	10	revealing	reveal	VERB
ajmri-3091	240	11	that	that	SCONJ
ajmri-3091	240	12	58	58	NUM
ajmri-3091	240	13	%	%	NOUN
ajmri-3091	240	14	of	of	ADP
ajmri-3091	240	15	participants	participant	NOUN
ajmri-3091	240	16	who	who	PRON
ajmri-3091	240	17	received	receive	VERB
ajmri-3091	240	18	pfizer	pfizer	NOUN
ajmri-3091	240	19	vaccination	vaccination	NOUN
ajmri-3091	240	20	experienced	experience	VERB
ajmri-3091	240	21	this	this	DET
ajmri-3091	240	22	consequence	consequence	NOUN
ajmri-3091	240	23	(	(	PUNCT
ajmri-3091	240	24	gibson	gibson	PROPN
ajmri-3091	240	25	et	et	PROPN
ajmri-3091	240	26	al	al	PROPN
ajmri-3091	240	27	.	.	PROPN
ajmri-3091	240	28	,	,	PUNCT
ajmri-3091	240	29	2022	2022	NUM
ajmri-3091	240	30	)	)	PUNCT
ajmri-3091	240	31	.	.	PUNCT
ajmri-3091	241	1	moreover	moreover	ADV
ajmri-3091	241	2	,	,	PUNCT
ajmri-3091	241	3	28.4	28.4	NUM
ajmri-3091	241	4	%	%	NOUN
ajmri-3091	241	5	of	of	ADP
ajmri-3091	241	6	participants	participant	NOUN
ajmri-3091	241	7	had	have	VERB
ajmri-3091	241	8	the	the	DET
ajmri-3091	241	9	vaccination	vaccination	NOUN
ajmri-3091	241	10	while	while	SCONJ
ajmri-3091	241	11	they	they	PRON
ajmri-3091	241	12	were	be	AUX
ajmri-3091	241	13	menstruating	menstruate	VERB
ajmri-3091	241	14	.	.	PUNCT
ajmri-3091	242	1	the	the	DET
ajmri-3091	242	2	findings	finding	NOUN
ajmri-3091	242	3	of	of	ADP
ajmri-3091	242	4	the	the	DET
ajmri-3091	242	5	chi	chi	ADJ
ajmri-3091	242	6	-	-	PUNCT
ajmri-3091	242	7	square	square	ADJ
ajmri-3091	242	8	test	test	NOUN
ajmri-3091	242	9	indicated	indicate	VERB
ajmri-3091	242	10	that	that	SCONJ
ajmri-3091	242	11	there	there	PRON
ajmri-3091	242	12	was	be	VERB
ajmri-3091	242	13	a	a	DET
ajmri-3091	242	14	highly	highly	ADV
ajmri-3091	242	15	significant	significant	ADJ
ajmri-3091	242	16	association	association	NOUN
ajmri-3091	242	17	(	(	PUNCT
ajmri-3091	242	18	p	p	NOUN
ajmri-3091	242	19	=	=	NOUN
ajmri-3091	242	20	0.001	0.001	NUM
ajmri-3091	242	21	)	)	PUNCT
ajmri-3091	242	22	between	between	ADP
ajmri-3091	242	23	the	the	DET
ajmri-3091	242	24	number	number	NOUN
ajmri-3091	242	25	of	of	ADP
ajmri-3091	242	26	vaccine	vaccine	NOUN
ajmri-3091	242	27	doses	dose	NOUN
ajmri-3091	242	28	and	and	CCONJ
ajmri-3091	242	29	the	the	DET
ajmri-3091	242	30	effects	effect	NOUN
ajmri-3091	242	31	of	of	ADP
ajmri-3091	242	32	the	the	DET
ajmri-3091	242	33	vaccines	vaccine	NOUN
ajmri-3091	242	34	on	on	ADP
ajmri-3091	242	35	menstrual	menstrual	ADJ
ajmri-3091	242	36	disruptions	disruption	NOUN
ajmri-3091	242	37	.	.	PUNCT
ajmri-3091	243	1	the	the	DET
ajmri-3091	243	2	incidence	incidence	NOUN
ajmri-3091	243	3	of	of	ADP
ajmri-3091	243	4	menstrual	menstrual	ADJ
ajmri-3091	243	5	cycle	cycle	NOUN
ajmri-3091	243	6	disturbances	disturbance	NOUN
ajmri-3091	243	7	increased	increase	VERB
ajmri-3091	243	8	with	with	ADP
ajmri-3091	243	9	the	the	DET
ajmri-3091	243	10	number	number	NOUN
ajmri-3091	243	11	of	of	ADP
ajmri-3091	243	12	received	receive	VERB
ajmri-3091	243	13	vaccine	vaccine	NOUN
ajmri-3091	243	14	doses	dose	NOUN
ajmri-3091	243	15	,	,	PUNCT
ajmri-3091	243	16	with	with	ADP
ajmri-3091	243	17	the	the	DET
ajmri-3091	243	18	pfizer	pfizer	NOUN
ajmri-3091	243	19	and	and	CCONJ
ajmri-3091	243	20	astrazeneca	astrazeneca	NOUN
ajmri-3091	243	21	vaccination	vaccination	NOUN
ajmri-3091	243	22	participants	participant	NOUN
ajmri-3091	243	23	experiencing	experience	VERB
ajmri-3091	243	24	the	the	DET
ajmri-3091	243	25	highest	high	ADJ
ajmri-3091	243	26	incidence	incidence	NOUN
ajmri-3091	243	27	of	of	ADP
ajmri-3091	243	28	disturbances	disturbance	NOUN
ajmri-3091	243	29	.	.	PUNCT
ajmri-3091	244	1	these	these	DET
ajmri-3091	244	2	findings	finding	NOUN
ajmri-3091	244	3	are	be	AUX
ajmri-3091	244	4	in	in	ADP
ajmri-3091	244	5	line	line	NOUN
ajmri-3091	244	6	with	with	ADP
ajmri-3091	244	7	farland	farland	NOUN
ajmri-3091	244	8	et	et	PROPN
ajmri-3091	244	9	al	al	PROPN
ajmri-3091	244	10	.	.	PROPN
ajmri-3091	245	1	(	(	PUNCT
ajmri-3091	245	2	2023	2023	NUM
ajmri-3091	245	3	)	)	PUNCT
ajmri-3091	245	4	,	,	PUNCT
ajmri-3091	245	5	who	who	PRON
ajmri-3091	245	6	demonstrated	demonstrate	VERB
ajmri-3091	245	7	that	that	SCONJ
ajmri-3091	245	8	a	a	DET
ajmri-3091	245	9	slight	slight	ADJ
ajmri-3091	245	10	increase	increase	NOUN
ajmri-3091	245	11	in	in	ADP
ajmri-3091	245	12	menstrual	menstrual	ADJ
ajmri-3091	245	13	cycle	cycle	NOUN
ajmri-3091	245	14	length	length	NOUN
ajmri-3091	245	15	was	be	AUX
ajmri-3091	245	16	correlated	correlate	VERB
ajmri-3091	245	17	with	with	ADP
ajmri-3091	245	18	the	the	DET
ajmri-3091	245	19	number	number	NOUN
ajmri-3091	245	20	of	of	ADP
ajmri-3091	245	21	covid-19	covid-19	PROPN
ajmri-3091	245	22	vaccination	vaccination	NOUN
ajmri-3091	245	23	doses	dose	NOUN
ajmri-3091	245	24	(	(	PUNCT
ajmri-3091	245	25	farland	farland	NOUN
ajmri-3091	245	26	et	et	PROPN
ajmri-3091	245	27	al	al	PROPN
ajmri-3091	245	28	.	.	PROPN
ajmri-3091	245	29	,	,	PUNCT
ajmri-3091	245	30	2023	2023	NUM
ajmri-3091	245	31	)	)	PUNCT
ajmri-3091	245	32	.	.	PUNCT
ajmri-3091	246	1	trogstad	trogstad	NOUN
ajmri-3091	246	2	et	et	PROPN
ajmri-3091	246	3	al	al	PROPN
ajmri-3091	246	4	.	.	PROPN
ajmri-3091	247	1	(	(	PUNCT
ajmri-3091	247	2	2022	2022	NUM
ajmri-3091	247	3	)	)	PUNCT
ajmri-3091	247	4	reported	report	VERB
ajmri-3091	247	5	that	that	SCONJ
ajmri-3091	247	6	the	the	DET
ajmri-3091	247	7	most	most	ADV
ajmri-3091	247	8	common	common	ADJ
ajmri-3091	247	9	disturbances	disturbance	NOUN
ajmri-3091	247	10	related	relate	VERB
ajmri-3091	247	11	to	to	ADP
ajmri-3091	247	12	various	various	ADJ
ajmri-3091	247	13	menstrual	menstrual	ADJ
ajmri-3091	247	14	cycle	cycle	NOUN
ajmri-3091	247	15	changes	change	NOUN
ajmri-3091	247	16	following	follow	VERB
ajmri-3091	247	17	covid-19	covid-19	PROPN
ajmri-3091	247	18	vaccination	vaccination	NOUN
ajmri-3091	247	19	were	be	AUX
ajmri-3091	247	20	heavier	heavy	ADJ
ajmri-3091	247	21	than	than	ADP
ajmri-3091	247	22	usual	usual	ADJ
ajmri-3091	247	23	periods	period	NOUN
ajmri-3091	247	24	,	,	PUNCT
ajmri-3091	247	25	delayed	delay	VERB
ajmri-3091	247	26	periods	period	NOUN
ajmri-3091	247	27	,	,	PUNCT
ajmri-3091	247	28	and	and	CCONJ
ajmri-3091	247	29	unexpected	unexpected	ADJ
ajmri-3091	247	30	vaginal	vaginal	ADJ
ajmri-3091	247	31	bleeding	bleeding	NOUN
ajmri-3091	247	32	(	(	PUNCT
ajmri-3091	247	33	trogstad	trogstad	NOUN
ajmri-3091	247	34	et	et	PROPN
ajmri-3091	247	35	al	al	PROPN
ajmri-3091	247	36	.	.	PROPN
ajmri-3091	247	37	,	,	PUNCT
ajmri-3091	247	38	2022	2022	NUM
ajmri-3091	247	39	)	)	PUNCT
ajmri-3091	247	40	.	.	PUNCT
ajmri-3091	248	1	however	however	ADV
ajmri-3091	248	2	,	,	PUNCT
ajmri-3091	248	3	the	the	DET
ajmri-3091	248	4	present	present	ADJ
ajmri-3091	248	5	study	study	NOUN
ajmri-3091	248	6	results	result	NOUN
ajmri-3091	248	7	showed	show	VERB
ajmri-3091	248	8	that	that	SCONJ
ajmri-3091	248	9	menorrhagia	menorrhagia	NOUN
ajmri-3091	248	10	(	(	PUNCT
ajmri-3091	248	11	8.4	8.4	NUM
ajmri-3091	248	12	%	%	NOUN
ajmri-3091	248	13	)	)	PUNCT
ajmri-3091	248	14	,	,	PUNCT
ajmri-3091	248	15	polymenorrhagia	polymenorrhagia	NOUN
ajmri-3091	248	16	(	(	PUNCT
ajmri-3091	248	17	7.9	7.9	NUM
ajmri-3091	248	18	%	%	NOUN
ajmri-3091	248	19	)	)	PUNCT
ajmri-3091	248	20	,	,	PUNCT
ajmri-3091	248	21	and	and	CCONJ
ajmri-3091	248	22	amenorrhoea	amenorrhoea	NOUN
ajmri-3091	248	23	(	(	PUNCT
ajmri-3091	248	24	7.4	7.4	NUM
ajmri-3091	248	25	%	%	NOUN
ajmri-3091	248	26	)	)	PUNCT
ajmri-3091	248	27	were	be	AUX
ajmri-3091	248	28	the	the	DET
ajmri-3091	248	29	most	most	ADV
ajmri-3091	248	30	common	common	ADJ
ajmri-3091	248	31	disturbances	disturbance	NOUN
ajmri-3091	248	32	following	follow	VERB
ajmri-3091	248	33	oligomenorrhea	oligomenorrhea	PROPN
ajmri-3091	248	34	(	(	PUNCT
ajmri-3091	248	35	14.7	14.7	NUM
ajmri-3091	248	36	%	%	NOUN
ajmri-3091	248	37	)	)	PUNCT
ajmri-3091	248	38	.	.	PUNCT
ajmri-3091	249	1	conversely	conversely	ADV
ajmri-3091	249	2	,	,	PUNCT
ajmri-3091	249	3	47.6	47.6	NUM
ajmri-3091	249	4	%	%	NOUN
ajmri-3091	249	5	of	of	ADP
ajmri-3091	249	6	participants	participant	NOUN
ajmri-3091	249	7	reported	report	VERB
ajmri-3091	249	8	no	no	DET
ajmri-3091	249	9	menstrual	menstrual	ADJ
ajmri-3091	249	10	cycle	cycle	NOUN
ajmri-3091	249	11	-	-	PUNCT
ajmri-3091	249	12	related	relate	VERB
ajmri-3091	249	13	negative	negative	ADJ
ajmri-3091	249	14	effects	effect	NOUN
ajmri-3091	249	15	post	post	NOUN
ajmri-3091	249	16	-	-	NOUN
ajmri-3091	249	17	vaccination	vaccination	NOUN
ajmri-3091	249	18	.	.	PUNCT
ajmri-3091	250	1	according	accord	VERB
ajmri-3091	250	2	to	to	ADP
ajmri-3091	250	3	almousa	almousa	PROPN
ajmri-3091	250	4	et	et	PROPN
ajmri-3091	250	5	al	al	PROPN
ajmri-3091	250	6	.	.	PROPN
ajmri-3091	251	1	(	(	PUNCT
ajmri-3091	251	2	2022	2022	NUM
ajmri-3091	251	3	)	)	PUNCT
ajmri-3091	251	4	,	,	PUNCT
ajmri-3091	251	5	women	woman	NOUN
ajmri-3091	251	6	who	who	PRON
ajmri-3091	251	7	previously	previously	ADV
ajmri-3091	251	8	experienced	experience	VERB
ajmri-3091	251	9	irregular	irregular	ADJ
ajmri-3091	251	10	menstruation	menstruation	NOUN
ajmri-3091	251	11	were	be	AUX
ajmri-3091	251	12	less	less	ADV
ajmri-3091	251	13	likely	likely	ADJ
ajmri-3091	251	14	than	than	ADP
ajmri-3091	251	15	those	those	PRON
ajmri-3091	251	16	who	who	PRON
ajmri-3091	251	17	previously	previously	ADV
ajmri-3091	251	18	experienced	experience	VERB
ajmri-3091	251	19	normal	normal	ADJ
ajmri-3091	251	20	menstruation	menstruation	NOUN
ajmri-3091	251	21	to	to	PART
ajmri-3091	251	22	experience	experience	VERB
ajmri-3091	251	23	menstrual	menstrual	ADJ
ajmri-3091	251	24	disturbances	disturbance	NOUN
ajmri-3091	251	25	postvaccination	postvaccination	NOUN
ajmri-3091	251	26	.	.	PUNCT
ajmri-3091	252	1	however	however	ADV
ajmri-3091	252	2	,	,	PUNCT
ajmri-3091	252	3	this	this	DET
ajmri-3091	252	4	difference	difference	NOUN
ajmri-3091	252	5	was	be	AUX
ajmri-3091	252	6	not	not	PART
ajmri-3091	252	7	statistically	statistically	ADV
ajmri-3091	252	8	significant	significant	ADJ
ajmri-3091	252	9	(	(	PUNCT
ajmri-3091	252	10	almousa	almousa	NOUN
ajmri-3091	252	11	,	,	PUNCT
ajmri-3091	252	12	2022	2022	NUM
ajmri-3091	252	13	)	)	PUNCT
ajmri-3091	252	14	.	.	PUNCT
ajmri-3091	253	1	in	in	ADP
ajmri-3091	253	2	contrast	contrast	NOUN
ajmri-3091	253	3	,	,	PUNCT
ajmri-3091	253	4	a	a	DET
ajmri-3091	253	5	study	study	NOUN
ajmri-3091	253	6	by	by	ADP
ajmri-3091	253	7	chao	chao	PROPN
ajmri-3091	253	8	et	et	PROPN
ajmri-3091	253	9	al	al	PROPN
ajmri-3091	253	10	.	.	PROPN
ajmri-3091	254	1	(	(	PUNCT
ajmri-3091	254	2	2022	2022	NUM
ajmri-3091	254	3	)	)	PUNCT
ajmri-3091	254	4	demonstrated	demonstrate	VERB
ajmri-3091	254	5	a	a	DET
ajmri-3091	254	6	statistically	statistically	ADV
ajmri-3091	254	7	significant	significant	ADJ
ajmri-3091	254	8	(	(	PUNCT
ajmri-3091	254	9	p	p	X
ajmri-3091	254	10	<	<	X
ajmri-3091	254	11	0.0001	0.0001	NUM
ajmri-3091	254	12	)	)	PUNCT
ajmri-3091	254	13	correlation	correlation	NOUN
ajmri-3091	254	14	between	between	ADP
ajmri-3091	254	15	covid-19	covid-19	PROPN
ajmri-3091	254	16	vaccination	vaccination	NOUN
ajmri-3091	254	17	and	and	CCONJ
ajmri-3091	254	18	menstrual	menstrual	ADJ
ajmri-3091	254	19	disturbances	disturbance	NOUN
ajmri-3091	254	20	(	(	PUNCT
ajmri-3091	254	21	chao	chao	PROPN
ajmri-3091	254	22	et	et	PROPN
ajmri-3091	254	23	al	al	PROPN
ajmri-3091	254	24	.	.	PROPN
ajmri-3091	254	25	,	,	PUNCT
ajmri-3091	254	26	2022	2022	NUM
ajmri-3091	254	27	)	)	PUNCT
ajmri-3091	254	28	.	.	PUNCT
ajmri-3091	255	1	in	in	ADP
ajmri-3091	255	2	comparison	comparison	NOUN
ajmri-3091	255	3	,	,	PUNCT
ajmri-3091	255	4	alahmari	alahmari	PROPN
ajmri-3091	255	5	et	et	PROPN
ajmri-3091	255	6	al	al	PROPN
ajmri-3091	255	7	.	.	PROPN
ajmri-3091	255	8	(	(	PUNCT
ajmri-3091	255	9	2022	2022	NUM
ajmri-3091	255	10	)	)	PUNCT
ajmri-3091	255	11	evaluated	evaluate	VERB
ajmri-3091	255	12	that	that	SCONJ
ajmri-3091	255	13	there	there	PRON
ajmri-3091	255	14	was	be	VERB
ajmri-3091	255	15	no	no	DET
ajmri-3091	255	16	significant	significant	ADJ
ajmri-3091	255	17	correlation	correlation	NOUN
ajmri-3091	255	18	between	between	ADP
ajmri-3091	255	19	covid-19	covid-19	PROPN
ajmri-3091	255	20	vaccination	vaccination	NOUN
ajmri-3091	255	21	and	and	CCONJ
ajmri-3091	255	22	menstruation	menstruation	NOUN
ajmri-3091	255	23	problems	problem	NOUN
ajmri-3091	255	24	.	.	PUNCT
ajmri-3091	256	1	the	the	DET
ajmri-3091	256	2	side	side	NOUN
ajmri-3091	256	3	effects	effect	NOUN
ajmri-3091	256	4	can	can	AUX
ajmri-3091	256	5	be	be	AUX
ajmri-3091	256	6	the	the	DET
ajmri-3091	256	7	result	result	NOUN
ajmri-3091	256	8	of	of	ADP
ajmri-3091	256	9	an	an	DET
ajmri-3091	256	10	immunological	immunological	ADJ
ajmri-3091	256	11	response	response	NOUN
ajmri-3091	256	12	rather	rather	ADV
ajmri-3091	256	13	than	than	ADP
ajmri-3091	256	14	the	the	DET
ajmri-3091	256	15	vaccine	vaccine	NOUN
ajmri-3091	256	16	or	or	CCONJ
ajmri-3091	256	17	any	any	PRON
ajmri-3091	256	18	of	of	ADP
ajmri-3091	256	19	its	its	PRON
ajmri-3091	256	20	elements	element	NOUN
ajmri-3091	256	21	(	(	PUNCT
ajmri-3091	256	22	alahmari	alahmari	PROPN
ajmri-3091	256	23	&	&	CCONJ
ajmri-3091	256	24	el	el	PROPN
ajmri-3091	256	25	,	,	PUNCT
ajmri-3091	256	26	2022	2022	NUM
ajmri-3091	256	27	)	)	PUNCT
ajmri-3091	256	28	.	.	PUNCT
ajmri-3091	257	1	this	this	DET
ajmri-3091	257	2	study	study	NOUN
ajmri-3091	257	3	’s	’s	PART
ajmri-3091	257	4	findings	finding	NOUN
ajmri-3091	257	5	suggest	suggest	VERB
ajmri-3091	257	6	that	that	SCONJ
ajmri-3091	257	7	covid-19	covid-19	PROPN
ajmri-3091	257	8	vaccination	vaccination	NOUN
ajmri-3091	257	9	impacted	impact	VERB
ajmri-3091	257	10	women	woman	NOUN
ajmri-3091	257	11	’s	’s	PART
ajmri-3091	257	12	menstrual	menstrual	ADJ
ajmri-3091	257	13	cycles	cycle	NOUN
ajmri-3091	257	14	and	and	CCONJ
ajmri-3091	257	15	reproductive	reproductive	ADJ
ajmri-3091	257	16	health	health	NOUN
ajmri-3091	257	17	.	.	PUNCT
ajmri-3091	258	1	the	the	DET
ajmri-3091	258	2	interaction	interaction	NOUN
ajmri-3091	258	3	between	between	ADP
ajmri-3091	258	4	the	the	DET
ajmri-3091	258	5	immune	immune	ADJ
ajmri-3091	258	6	system	system	NOUN
ajmri-3091	258	7	and	and	CCONJ
ajmri-3091	258	8	endocrine	endocrine	NOUN
ajmri-3091	258	9	system	system	NOUN
ajmri-3091	258	10	was	be	AUX
ajmri-3091	258	11	likely	likely	ADV
ajmri-3091	258	12	responsible	responsible	ADJ
ajmri-3091	258	13	for	for	ADP
ajmri-3091	258	14	the	the	DET
ajmri-3091	258	15	negative	negative	ADJ
ajmri-3091	258	16	effects	effect	NOUN
ajmri-3091	258	17	of	of	ADP
ajmri-3091	258	18	these	these	DET
ajmri-3091	258	19	vaccinations	vaccination	NOUN
ajmri-3091	258	20	.	.	PUNCT
ajmri-3091	259	1	however	however	ADV
ajmri-3091	259	2	,	,	PUNCT
ajmri-3091	259	3	the	the	DET
ajmri-3091	259	4	findings	finding	NOUN
ajmri-3091	259	5	by	by	ADP
ajmri-3091	259	6	chavin	chavin	PROPN
ajmri-3091	259	7	et	et	PROPN
ajmri-3091	259	8	al	al	PROPN
ajmri-3091	259	9	.	.	PROPN
ajmri-3091	260	1	(	(	PUNCT
ajmri-3091	260	2	2023	2023	NUM
ajmri-3091	260	3	)	)	PUNCT
ajmri-3091	260	4	partially	partially	ADV
ajmri-3091	260	5	supported	support	VERB
ajmri-3091	260	6	previous	previous	ADJ
ajmri-3091	260	7	studies	study	NOUN
ajmri-3091	260	8	indicating	indicate	VERB
ajmri-3091	260	9	an	an	DET
ajmri-3091	260	10	association	association	NOUN
ajmri-3091	260	11	between	between	ADP
ajmri-3091	260	12	covid-19	covid-19	PROPN
ajmri-3091	260	13	vaccination	vaccination	NOUN
ajmri-3091	260	14	and	and	CCONJ
ajmri-3091	260	15	subsequent	subsequent	ADJ
ajmri-3091	260	16	irregular	irregular	ADJ
ajmri-3091	260	17	menstrual	menstrual	ADJ
ajmri-3091	260	18	periods	period	NOUN
ajmri-3091	260	19	(	(	PUNCT
ajmri-3091	260	20	gopaul	gopaul	NOUN
ajmri-3091	260	21	et	et	PROPN
ajmri-3091	260	22	al	al	PROPN
ajmri-3091	260	23	.	.	PROPN
ajmri-3091	260	24	,	,	PUNCT
ajmri-3091	260	25	2023	2023	NUM
ajmri-3091	260	26	)	)	PUNCT
ajmri-3091	260	27	.	.	PUNCT
ajmri-3091	261	1	with	with	ADP
ajmri-3091	261	2	the	the	DET
ajmri-3091	261	3	exception	exception	NOUN
ajmri-3091	261	4	of	of	ADP
ajmri-3091	261	5	delayed	delay	VERB
ajmri-3091	261	6	periods	period	NOUN
ajmri-3091	261	7	and	and	CCONJ
ajmri-3091	261	8	other	other	ADJ
ajmri-3091	261	9	menstrual	menstrual	ADJ
ajmri-3091	261	10	issues	issue	NOUN
ajmri-3091	261	11	like	like	ADP
ajmri-3091	261	12	abnormal	abnormal	ADJ
ajmri-3091	261	13	bleeding	bleeding	NOUN
ajmri-3091	261	14	,	,	PUNCT
ajmri-3091	261	15	severe	severe	ADJ
ajmri-3091	261	16	symptoms	symptom	NOUN
ajmri-3091	261	17	,	,	PUNCT
ajmri-3091	261	18	and	and	CCONJ
ajmri-3091	261	19	miscellaneous	miscellaneous	ADJ
ajmri-3091	261	20	symptoms	symptom	NOUN
ajmri-3091	261	21	,	,	PUNCT
ajmri-3091	261	22	this	this	DET
ajmri-3091	261	23	study	study	NOUN
ajmri-3091	261	24	found	find	VERB
ajmri-3091	261	25	that	that	SCONJ
ajmri-3091	261	26	self	self	NOUN
ajmri-3091	261	27	-	-	PUNCT
ajmri-3091	261	28	reported	report	VERB
ajmri-3091	261	29	menstrual	menstrual	ADJ
ajmri-3091	261	30	cycle	cycle	NOUN
ajmri-3091	261	31	disturbances	disturbance	NOUN
ajmri-3091	261	32	such	such	ADJ
ajmri-3091	261	33	as	as	ADP
ajmri-3091	261	34	missed	miss	VERB
ajmri-3091	261	35	periods	period	NOUN
ajmri-3091	261	36	,	,	PUNCT
ajmri-3091	261	37	spotting	spot	VERB
ajmri-3091	261	38	,	,	PUNCT
ajmri-3091	261	39	irregular	irregular	ADJ
ajmri-3091	261	40	cycles	cycle	NOUN
ajmri-3091	261	41	,	,	PUNCT
ajmri-3091	261	42	and	and	CCONJ
ajmri-3091	261	43	flow	flow	NOUN
ajmri-3091	261	44	fluctuations	fluctuation	NOUN
ajmri-3091	261	45	did	do	AUX
ajmri-3091	261	46	not	not	PART
ajmri-3091	261	47	show	show	VERB
ajmri-3091	261	48	significant	significant	ADJ
ajmri-3091	261	49	differences	difference	NOUN
ajmri-3091	261	50	after	after	ADP
ajmri-3091	261	51	the	the	DET
ajmri-3091	261	52	first	first	ADJ
ajmri-3091	261	53	and	and	CCONJ
ajmri-3091	261	54	second	second	ADJ
ajmri-3091	261	55	dose	dose	NOUN
ajmri-3091	261	56	of	of	ADP
ajmri-3091	261	57	vaccination	vaccination	NOUN
ajmri-3091	261	58	(	(	PUNCT
ajmri-3091	261	59	gopaul	gopaul	NOUN
ajmri-3091	261	60	et	et	PROPN
ajmri-3091	261	61	al	al	PROPN
ajmri-3091	261	62	.	.	PROPN
ajmri-3091	261	63	,	,	PUNCT
ajmri-3091	261	64	2023	2023	NUM
ajmri-3091	261	65	)	)	PUNCT
ajmri-3091	261	66	.	.	PUNCT
ajmri-3091	262	1	consequently	consequently	ADV
ajmri-3091	262	2	,	,	PUNCT
ajmri-3091	262	3	the	the	DET
ajmri-3091	262	4	study	study	NOUN
ajmri-3091	262	5	indicated	indicate	VERB
ajmri-3091	262	6	that	that	SCONJ
ajmri-3091	262	7	the	the	DET
ajmri-3091	262	8	irregularities	irregularity	NOUN
ajmri-3091	262	9	in	in	ADP
ajmri-3091	262	10	the	the	DET
ajmri-3091	262	11	menstrual	menstrual	ADJ
ajmri-3091	262	12	cycle	cycle	NOUN
ajmri-3091	262	13	post	post	ADJ
ajmri-3091	262	14	-	-	ADJ
ajmri-3091	262	15	covid-19	covid-19	ADJ
ajmri-3091	262	16	vaccination	vaccination	NOUN
ajmri-3091	262	17	were	be	AUX
ajmri-3091	262	18	temporary	temporary	ADJ
ajmri-3091	262	19	and	and	CCONJ
ajmri-3091	262	20	returned	return	VERB
ajmri-3091	262	21	to	to	ADP
ajmri-3091	262	22	normal	normal	ADJ
ajmri-3091	262	23	after	after	ADP
ajmri-3091	262	24	a	a	DET
ajmri-3091	262	25	short	short	ADJ
ajmri-3091	262	26	period	period	NOUN
ajmri-3091	262	27	(	(	PUNCT
ajmri-3091	262	28	gopaul	gopaul	NOUN
ajmri-3091	262	29	et	et	PROPN
ajmri-3091	262	30	al	al	PROPN
ajmri-3091	262	31	.	.	PROPN
ajmri-3091	262	32	,	,	PUNCT
ajmri-3091	262	33	2023	2023	NUM
ajmri-3091	262	34	)	)	PUNCT
ajmri-3091	262	35	.	.	PUNCT
ajmri-3091	263	1	this	this	DET
ajmri-3091	263	2	information	information	NOUN
ajmri-3091	263	3	is	be	AUX
ajmri-3091	263	4	crucial	crucial	ADJ
ajmri-3091	263	5	for	for	ADP
ajmri-3091	263	6	reducing	reduce	VERB
ajmri-3091	263	7	young	young	ADJ
ajmri-3091	263	8	women	woman	NOUN
ajmri-3091	263	9	’s	’s	PART
ajmri-3091	263	10	vaccine	vaccine	NOUN
ajmri-3091	263	11	reluctance	reluctance	NOUN
ajmri-3091	263	12	and	and	CCONJ
ajmri-3091	263	13	improving	improve	VERB
ajmri-3091	263	14	the	the	DET
ajmri-3091	263	15	effectiveness	effectiveness	NOUN
ajmri-3091	263	16	of	of	ADP
ajmri-3091	263	17	the	the	DET
ajmri-3091	263	18	vaccination	vaccination	NOUN
ajmri-3091	263	19	campaign	campaign	NOUN
ajmri-3091	263	20	.	.	PUNCT
ajmri-3091	264	1	understanding	understand	VERB
ajmri-3091	264	2	the	the	DET
ajmri-3091	264	3	link	link	NOUN
ajmri-3091	264	4	between	between	ADP
ajmri-3091	264	5	vaccination	vaccination	NOUN
ajmri-3091	264	6	and	and	CCONJ
ajmri-3091	264	7	post	post	ADJ
ajmri-3091	264	8	-	-	ADJ
ajmri-3091	264	9	vaccination	vaccination	ADJ
ajmri-3091	264	10	changes	change	NOUN
ajmri-3091	264	11	can	can	AUX
ajmri-3091	264	12	help	help	VERB
ajmri-3091	264	13	young	young	ADJ
ajmri-3091	264	14	women	woman	NOUN
ajmri-3091	264	15	prepare	prepare	VERB
ajmri-3091	264	16	for	for	ADP
ajmri-3091	264	17	potential	potential	ADJ
ajmri-3091	264	18	changes	change	NOUN
ajmri-3091	264	19	in	in	ADP
ajmri-3091	264	20	their	their	PRON
ajmri-3091	264	21	menstrual	menstrual	ADJ
ajmri-3091	264	22	cycles	cycle	NOUN
ajmri-3091	264	23	.	.	PUNCT
ajmri-3091	265	1	conclusion	conclusion	NOUN
ajmri-3091	265	2	in	in	ADP
ajmri-3091	265	3	conclusion	conclusion	NOUN
ajmri-3091	265	4	,	,	PUNCT
ajmri-3091	265	5	the	the	DET
ajmri-3091	265	6	study	study	NOUN
ajmri-3091	265	7	showed	show	VERB
ajmri-3091	265	8	the	the	DET
ajmri-3091	265	9	impact	impact	NOUN
ajmri-3091	265	10	of	of	ADP
ajmri-3091	265	11	covid-19	covid-19	PROPN
ajmri-3091	265	12	vaccination	vaccination	NOUN
ajmri-3091	265	13	on	on	ADP
ajmri-3091	265	14	menstrual	menstrual	ADJ
ajmri-3091	265	15	disturbances	disturbance	NOUN
ajmri-3091	265	16	in	in	ADP
ajmri-3091	265	17	adult	adult	NOUN
ajmri-3091	265	18	females	female	NOUN
ajmri-3091	265	19	in	in	ADP
ajmri-3091	265	20	ksu	ksu	PROPN
ajmri-3091	265	21	.	.	PUNCT
ajmri-3091	266	1	over	over	ADP
ajmri-3091	266	2	half	half	NOUN
ajmri-3091	266	3	of	of	ADP
ajmri-3091	266	4	the	the	DET
ajmri-3091	266	5	females	female	NOUN
ajmri-3091	266	6	experienced	experience	VERB
ajmri-3091	266	7	at	at	ADV
ajmri-3091	266	8	least	least	ADV
ajmri-3091	266	9	one	one	NUM
ajmri-3091	266	10	issue	issue	NOUN
ajmri-3091	266	11	related	relate	VERB
ajmri-3091	266	12	to	to	ADP
ajmri-3091	266	13	the	the	DET
ajmri-3091	266	14	menstrual	menstrual	ADJ
ajmri-3091	266	15	cycle	cycle	NOUN
ajmri-3091	266	16	after	after	ADP
ajmri-3091	266	17	receiving	receive	VERB
ajmri-3091	266	18	the	the	DET
ajmri-3091	266	19	vaccine	vaccine	NOUN
ajmri-3091	266	20	.	.	PUNCT
ajmri-3091	267	1	the	the	DET
ajmri-3091	267	2	study	study	NOUN
ajmri-3091	267	3	suggests	suggest	VERB
ajmri-3091	267	4	that	that	SCONJ
ajmri-3091	267	5	people	people	NOUN
ajmri-3091	267	6	receiving	receive	VERB
ajmri-3091	267	7	covid-19	covid-19	PROPN
ajmri-3091	267	8	vaccines	vaccine	NOUN
ajmri-3091	267	9	engage	engage	VERB
ajmri-3091	267	10	in	in	ADP
ajmri-3091	267	11	more	more	ADV
ajmri-3091	267	12	beneficial	beneficial	ADJ
ajmri-3091	267	13	interventions	intervention	NOUN
ajmri-3091	267	14	,	,	PUNCT
ajmri-3091	267	15	but	but	CCONJ
ajmri-3091	267	16	the	the	DET
ajmri-3091	267	17	precipitating	precipitating	NOUN
ajmri-3091	267	18	factors	factor	NOUN
ajmri-3091	267	19	should	should	AUX
ajmri-3091	267	20	be	be	AUX
ajmri-3091	267	21	considered	consider	VERB
ajmri-3091	267	22	when	when	SCONJ
ajmri-3091	267	23	administering	administer	VERB
ajmri-3091	267	24	the	the	DET
ajmri-3091	267	25	vaccine	vaccine	NOUN
ajmri-3091	267	26	to	to	PART
ajmri-3091	267	27	mitigate	mitigate	VERB
ajmri-3091	267	28	disruption	disruption	NOUN
ajmri-3091	267	29	.	.	PUNCT
ajmri-3091	268	1	the	the	DET
ajmri-3091	268	2	pfizer	pfizer	NOUN
ajmri-3091	268	3	-	-	PUNCT
ajmri-3091	268	4	biontech	biontech	ADJ
ajmri-3091	268	5	vaccine	vaccine	NOUN
ajmri-3091	268	6	was	be	AUX
ajmri-3091	268	7	among	among	ADP
ajmri-3091	268	8	the	the	DET
ajmri-3091	268	9	most	most	ADV
ajmri-3091	268	10	widely	widely	ADV
ajmri-3091	268	11	used	use	VERB
ajmri-3091	268	12	and	and	CCONJ
ajmri-3091	268	13	induced	induce	VERB
ajmri-3091	268	14	changes	change	NOUN
ajmri-3091	268	15	in	in	ADP
ajmri-3091	268	16	menstrual	menstrual	ADJ
ajmri-3091	268	17	disturbances	disturbance	NOUN
ajmri-3091	268	18	after	after	ADP
ajmri-3091	268	19	vaccination	vaccination	NOUN
ajmri-3091	268	20	.	.	PUNCT
ajmri-3091	269	1	further	further	ADJ
ajmri-3091	269	2	research	research	NOUN
ajmri-3091	269	3	is	be	AUX
ajmri-3091	269	4	needed	need	VERB
ajmri-3091	269	5	on	on	ADP
ajmri-3091	269	6	the	the	DET
ajmri-3091	269	7	long	long	ADJ
ajmri-3091	269	8	-	-	PUNCT
ajmri-3091	269	9	term	term	NOUN
ajmri-3091	269	10	safety	safety	NOUN
ajmri-3091	269	11	of	of	ADP
ajmri-3091	269	12	covid-19	covid-19	PROPN
ajmri-3091	269	13	vaccines	vaccine	NOUN
ajmri-3091	269	14	on	on	ADP
ajmri-3091	269	15	females	female	NOUN
ajmri-3091	269	16	and	and	CCONJ
ajmri-3091	269	17	the	the	DET
ajmri-3091	269	18	overall	overall	ADJ
ajmri-3091	269	19	population	population	NOUN
ajmri-3091	269	20	’s	’s	PART
ajmri-3091	269	21	health	health	NOUN
ajmri-3091	269	22	.	.	PUNCT
ajmri-3091	270	1	pa	pa	PROPN
ajmri-3091	270	2	ge	ge	PROPN
ajmri-3091	270	3	22	22	NUM
ajmri-3091	270	4	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	270	5	am	am	NOUN
ajmri-3091	270	6	.	.	PUNCT
ajmri-3091	271	1	j.	j.	PROPN
ajmri-3091	271	2	multidis	multidis	PROPN
ajmri-3091	271	3	.	.	PUNCT
ajmri-3091	272	1	res	re	NOUN
ajmri-3091	272	2	.	.	PUNCT
ajmri-3091	273	1	innov	innov	PROPN
ajmri-3091	273	2	.	.	PUNCT
ajmri-3091	274	1	3(6	3(6	PROPN
ajmri-3091	274	2	)	)	PUNCT
ajmri-3091	274	3	12	12	NUM
ajmri-3091	274	4	-	-	SYM
ajmri-3091	274	5	24	24	NUM
ajmri-3091	274	6	,	,	PUNCT
ajmri-3091	274	7	2024	2024	NUM
ajmri-3091	274	8	limitation	limitation	NOUN
ajmri-3091	274	9	and	and	CCONJ
ajmri-3091	274	10	strengths	strength	NOUN
ajmri-3091	274	11	•	•	ADP
ajmri-3091	274	12	the	the	DET
ajmri-3091	274	13	study	study	NOUN
ajmri-3091	274	14	’s	’s	PART
ajmri-3091	274	15	limitations	limitation	NOUN
ajmri-3091	274	16	may	may	AUX
ajmri-3091	274	17	include	include	VERB
ajmri-3091	274	18	a	a	DET
ajmri-3091	274	19	small	small	ADJ
ajmri-3091	274	20	sample	sample	NOUN
ajmri-3091	274	21	size	size	NOUN
ajmri-3091	274	22	and	and	CCONJ
ajmri-3091	274	23	cross	cross	ADJ
ajmri-3091	274	24	-	-	ADJ
ajmri-3091	274	25	sectional	sectional	ADJ
ajmri-3091	274	26	design	design	NOUN
ajmri-3091	274	27	,	,	PUNCT
ajmri-3091	274	28	which	which	PRON
ajmri-3091	274	29	can	can	AUX
ajmri-3091	274	30	hinder	hinder	VERB
ajmri-3091	274	31	the	the	DET
ajmri-3091	274	32	ability	ability	NOUN
ajmri-3091	274	33	to	to	PART
ajmri-3091	274	34	establish	establish	VERB
ajmri-3091	274	35	causality	causality	NOUN
ajmri-3091	274	36	and	and	CCONJ
ajmri-3091	274	37	generalizability	generalizability	NOUN
ajmri-3091	274	38	.	.	PUNCT
ajmri-3091	275	1	selection	selection	NOUN
ajmri-3091	275	2	bias	bias	NOUN
ajmri-3091	275	3	may	may	AUX
ajmri-3091	275	4	be	be	AUX
ajmri-3091	275	5	introduced	introduce	VERB
ajmri-3091	275	6	due	due	ADP
ajmri-3091	275	7	to	to	ADP
ajmri-3091	275	8	the	the	DET
ajmri-3091	275	9	online	online	ADJ
ajmri-3091	275	10	distribution	distribution	NOUN
ajmri-3091	275	11	of	of	ADP
ajmri-3091	275	12	the	the	DET
ajmri-3091	275	13	questionnaire	questionnaire	NOUN
ajmri-3091	275	14	.	.	PUNCT
ajmri-3091	276	1	•	•	NUM
ajmri-3091	276	2	however	however	ADV
ajmri-3091	276	3	,	,	PUNCT
ajmri-3091	276	4	the	the	DET
ajmri-3091	276	5	study	study	NOUN
ajmri-3091	276	6	provided	provide	VERB
ajmri-3091	276	7	valuable	valuable	ADJ
ajmri-3091	276	8	insights	insight	NOUN
ajmri-3091	276	9	into	into	ADP
ajmri-3091	276	10	the	the	DET
ajmri-3091	276	11	association	association	NOUN
ajmri-3091	276	12	between	between	ADP
ajmri-3091	276	13	menstrual	menstrual	ADJ
ajmri-3091	276	14	cycle	cycle	NOUN
ajmri-3091	276	15	disturbances	disturbance	NOUN
ajmri-3091	276	16	and	and	CCONJ
ajmri-3091	276	17	covid-19	covid-19	PROPN
ajmri-3091	276	18	vaccination	vaccination	NOUN
ajmri-3091	276	19	,	,	PUNCT
ajmri-3091	276	20	highlighting	highlight	VERB
ajmri-3091	276	21	areas	area	NOUN
ajmri-3091	276	22	for	for	ADP
ajmri-3091	276	23	further	further	ADJ
ajmri-3091	276	24	research	research	NOUN
ajmri-3091	276	25	and	and	CCONJ
ajmri-3091	276	26	emphasising	emphasise	VERB
ajmri-3091	276	27	public	public	ADJ
ajmri-3091	276	28	health	health	NOUN
ajmri-3091	276	29	concerns	concern	NOUN
ajmri-3091	276	30	.	.	PUNCT
ajmri-3091	277	1	recommendations	recommendation	NOUN
ajmri-3091	277	2	•	•	VERB
ajmri-3091	277	3	future	future	ADJ
ajmri-3091	277	4	studies	study	NOUN
ajmri-3091	277	5	and	and	CCONJ
ajmri-3091	277	6	clinical	clinical	ADJ
ajmri-3091	277	7	trials	trial	NOUN
ajmri-3091	277	8	should	should	AUX
ajmri-3091	277	9	investigate	investigate	VERB
ajmri-3091	277	10	the	the	DET
ajmri-3091	277	11	menstrual	menstrual	ADV
ajmri-3091	277	12	-	-	PUNCT
ajmri-3091	277	13	related	relate	VERB
ajmri-3091	277	14	adverse	adverse	ADJ
ajmri-3091	277	15	effects	effect	NOUN
ajmri-3091	277	16	to	to	PART
ajmri-3091	277	17	develop	develop	VERB
ajmri-3091	277	18	vaccines	vaccine	NOUN
ajmri-3091	277	19	.	.	PUNCT
ajmri-3091	278	1	•	•	NUM
ajmri-3091	278	2	education	education	NOUN
ajmri-3091	278	3	programs	program	NOUN
ajmri-3091	278	4	should	should	AUX
ajmri-3091	278	5	be	be	AUX
ajmri-3091	278	6	developed	develop	VERB
ajmri-3091	278	7	to	to	PART
ajmri-3091	278	8	enhance	enhance	VERB
ajmri-3091	278	9	understanding	understanding	NOUN
ajmri-3091	278	10	of	of	ADP
ajmri-3091	278	11	the	the	DET
ajmri-3091	278	12	impact	impact	NOUN
ajmri-3091	278	13	of	of	ADP
ajmri-3091	278	14	covid-19	covid-19	PROPN
ajmri-3091	278	15	vaccination	vaccination	NOUN
ajmri-3091	278	16	on	on	ADP
ajmri-3091	278	17	menstrual	menstrual	ADJ
ajmri-3091	278	18	cycles	cycle	NOUN
ajmri-3091	278	19	.	.	PUNCT
ajmri-3091	279	1	•	•	NUM
ajmri-3091	279	2	establishing	establish	VERB
ajmri-3091	279	3	a	a	DET
ajmri-3091	279	4	systematic	systematic	ADJ
ajmri-3091	279	5	health	health	NOUN
ajmri-3091	279	6	monitoring	monitoring	NOUN
ajmri-3091	279	7	system	system	NOUN
ajmri-3091	279	8	is	be	AUX
ajmri-3091	279	9	necessary	necessary	ADJ
ajmri-3091	279	10	in	in	ADP
ajmri-3091	279	11	order	order	NOUN
ajmri-3091	279	12	to	to	PART
ajmri-3091	279	13	monitor	monitor	VERB
ajmri-3091	279	14	and	and	CCONJ
ajmri-3091	279	15	report	report	VERB
ajmri-3091	279	16	adverse	adverse	ADJ
ajmri-3091	279	17	events	event	NOUN
ajmri-3091	279	18	.	.	PUNCT
ajmri-3091	280	1	•	•	NUM
ajmri-3091	280	2	future	future	ADJ
ajmri-3091	280	3	research	research	NOUN
ajmri-3091	280	4	should	should	AUX
ajmri-3091	280	5	include	include	VERB
ajmri-3091	280	6	a	a	DET
ajmri-3091	280	7	comprehensive	comprehensive	ADJ
ajmri-3091	280	8	assessment	assessment	NOUN
ajmri-3091	280	9	of	of	ADP
ajmri-3091	280	10	mental	mental	ADJ
ajmri-3091	280	11	health	health	NOUN
ajmri-3091	280	12	status	status	NOUN
ajmri-3091	280	13	in	in	ADP
ajmri-3091	280	14	order	order	NOUN
ajmri-3091	280	15	to	to	PART
ajmri-3091	280	16	understand	understand	VERB
ajmri-3091	280	17	the	the	DET
ajmri-3091	280	18	association	association	NOUN
ajmri-3091	280	19	between	between	ADP
ajmri-3091	280	20	menstrual	menstrual	ADJ
ajmri-3091	280	21	health	health	NOUN
ajmri-3091	280	22	and	and	CCONJ
ajmri-3091	280	23	psychological	psychological	ADJ
ajmri-3091	280	24	well	well	ADV
ajmri-3091	280	25	-	-	PUNCT
ajmri-3091	280	26	being	being	NOUN
ajmri-3091	280	27	.	.	PUNCT
ajmri-3091	281	1	•	•	INTJ
ajmri-3091	281	2	it	it	PRON
ajmri-3091	281	3	is	be	AUX
ajmri-3091	281	4	essential	essential	ADJ
ajmri-3091	281	5	to	to	PART
ajmri-3091	281	6	improve	improve	VERB
ajmri-3091	281	7	public	public	ADJ
ajmri-3091	281	8	health	health	NOUN
ajmri-3091	281	9	communication	communication	NOUN
ajmri-3091	281	10	strategies	strategy	NOUN
ajmri-3091	281	11	and	and	CCONJ
ajmri-3091	281	12	update	update	NOUN
ajmri-3091	281	13	guidelines	guideline	NOUN
ajmri-3091	281	14	for	for	ADP
ajmri-3091	281	15	healthcare	healthcare	NOUN
ajmri-3091	281	16	professionals	professional	NOUN
ajmri-3091	281	17	managing	manage	VERB
ajmri-3091	281	18	menstruation	menstruation	NOUN
ajmri-3091	281	19	disorders	disorder	NOUN
ajmri-3091	281	20	.	.	PUNCT
ajmri-3091	282	1	•	•	NUM
ajmri-3091	282	2	policymakers	policymaker	NOUN
ajmri-3091	282	3	should	should	AUX
ajmri-3091	282	4	include	include	VERB
ajmri-3091	282	5	menstrual	menstrual	ADJ
ajmri-3091	282	6	health	health	NOUN
ajmri-3091	282	7	when	when	SCONJ
ajmri-3091	282	8	implementing	implement	VERB
ajmri-3091	282	9	vaccination	vaccination	NOUN
ajmri-3091	282	10	safety	safety	NOUN
ajmri-3091	282	11	monitoring	monitoring	NOUN
ajmri-3091	282	12	activities	activity	NOUN
ajmri-3091	282	13	.	.	PUNCT
ajmri-3091	283	1	acknowledgement	acknowledgement	NOUN
ajmri-3091	283	2	the	the	DET
ajmri-3091	283	3	authors	author	NOUN
ajmri-3091	283	4	are	be	AUX
ajmri-3091	283	5	thankful	thankful	ADJ
ajmri-3091	283	6	to	to	ADP
ajmri-3091	283	7	king	king	PROPN
ajmri-3091	283	8	saud	saud	PROPN
ajmri-3091	283	9	university	university	PROPN
ajmri-3091	283	10	for	for	ADP
ajmri-3091	283	11	their	their	PRON
ajmri-3091	283	12	continuous	continuous	ADJ
ajmri-3091	283	13	support	support	NOUN
ajmri-3091	283	14	throughout	throughout	ADP
ajmri-3091	283	15	the	the	DET
ajmri-3091	283	16	study	study	NOUN
ajmri-3091	283	17	.	.	PUNCT
ajmri-3091	284	1	the	the	DET
ajmri-3091	284	2	authors	author	NOUN
ajmri-3091	284	3	also	also	ADV
ajmri-3091	284	4	appreciate	appreciate	VERB
ajmri-3091	284	5	the	the	DET
ajmri-3091	284	6	public	public	ADJ
ajmri-3091	284	7	health	health	PROPN
ajmri-3091	284	8	department	department	PROPN
ajmri-3091	284	9	at	at	ADP
ajmri-3091	284	10	imam	imam	PROPN
ajmri-3091	284	11	abdurrahman	abdurrahman	PROPN
ajmri-3091	284	12	bin	bin	PROPN
ajmri-3091	284	13	faisal	faisal	PROPN
ajmri-3091	284	14	university	university	PROPN
ajmri-3091	284	15	for	for	ADP
ajmri-3091	284	16	supervising	supervise	VERB
ajmri-3091	284	17	this	this	DET
ajmri-3091	284	18	study	study	NOUN
ajmri-3091	284	19	.	.	PUNCT
ajmri-3091	285	1	references	reference	NOUN
ajmri-3091	285	2	al	al	PROPN
ajmri-3091	285	3	kadri	kadri	PROPN
ajmri-3091	285	4	,	,	PUNCT
ajmri-3091	285	5	h.	h.	PROPN
ajmri-3091	285	6	m.	m.	PROPN
ajmri-3091	285	7	,	,	PUNCT
ajmri-3091	285	8	al	al	PROPN
ajmri-3091	285	9	sudairy	sudairy	NOUN
ajmri-3091	285	10	,	,	PUNCT
ajmri-3091	285	11	a.	a.	NOUN
ajmri-3091	285	12	a.	a.	PROPN
ajmri-3091	285	13	,	,	PUNCT
ajmri-3091	285	14	alangari	alangari	PROPN
ajmri-3091	285	15	,	,	PUNCT
ajmri-3091	285	16	a.	a.	PROPN
ajmri-3091	285	17	s.	s.	PROPN
ajmri-3091	285	18	,	,	PUNCT
ajmri-3091	285	19	al	al	PROPN
ajmri-3091	285	20	khateeb	khateeb	PROPN
ajmri-3091	285	21	,	,	PUNCT
ajmri-3091	285	22	b.	b.	PROPN
ajmri-3091	285	23	f.	f.	PROPN
ajmri-3091	285	24	,	,	PUNCT
ajmri-3091	285	25	&	&	CCONJ
ajmri-3091	285	26	el	el	PROPN
ajmri-3091	285	27	-	-	PROPN
ajmri-3091	285	28	metwally	metwally	ADV
ajmri-3091	285	29	,	,	PUNCT
ajmri-3091	285	30	a.	a.	NOUN
ajmri-3091	285	31	a.	a.	NOUN
ajmri-3091	285	32	(	(	PUNCT
ajmri-3091	285	33	2023	2023	NUM
ajmri-3091	285	34	)	)	PUNCT
ajmri-3091	285	35	.	.	PUNCT
ajmri-3091	286	1	covid-19	covid-19	PROPN
ajmri-3091	286	2	vaccination	vaccination	NOUN
ajmri-3091	286	3	and	and	CCONJ
ajmri-3091	286	4	menstrual	menstrual	ADJ
ajmri-3091	286	5	disorders	disorder	NOUN
ajmri-3091	286	6	among	among	ADP
ajmri-3091	286	7	women	woman	NOUN
ajmri-3091	286	8	:	:	PUNCT
ajmri-3091	286	9	findings	finding	NOUN
ajmri-3091	286	10	from	from	ADP
ajmri-3091	286	11	a	a	DET
ajmri-3091	286	12	meta	meta	ADJ
ajmri-3091	286	13	-	-	PUNCT
ajmri-3091	286	14	analysis	analysis	NOUN
ajmri-3091	286	15	study	study	NOUN
ajmri-3091	286	16	.	.	PUNCT
ajmri-3091	287	1	journal	journal	NOUN
ajmri-3091	287	2	of	of	ADP
ajmri-3091	287	3	infection	infection	NOUN
ajmri-3091	287	4	and	and	CCONJ
ajmri-3091	287	5	public	public	ADJ
ajmri-3091	287	6	health	health	NOUN
ajmri-3091	287	7	.	.	PUNCT
ajmri-3091	288	1	alaamri	alaamri	PROPN
ajmri-3091	288	2	,	,	PUNCT
ajmri-3091	288	3	o.	o.	PROPN
ajmri-3091	288	4	,	,	PUNCT
ajmri-3091	288	5	okmi	okmi	PROPN
ajmri-3091	288	6	,	,	PUNCT
ajmri-3091	288	7	e.	e.	PROPN
ajmri-3091	288	8	a.	a.	PROPN
ajmri-3091	288	9	,	,	PUNCT
ajmri-3091	288	10	&	&	CCONJ
ajmri-3091	288	11	suliman	suliman	PROPN
ajmri-3091	288	12	,	,	PUNCT
ajmri-3091	288	13	y.	y.	PROPN
ajmri-3091	288	14	(	(	PUNCT
ajmri-3091	288	15	2022	2022	NUM
ajmri-3091	288	16	)	)	PUNCT
ajmri-3091	288	17	.	.	PUNCT
ajmri-3091	289	1	vaccine	vaccine	NOUN
ajmri-3091	289	2	hesitancy	hesitancy	NOUN
ajmri-3091	289	3	in	in	ADP
ajmri-3091	289	4	saudi	saudi	PROPN
ajmri-3091	289	5	arabia	arabia	PROPN
ajmri-3091	289	6	:	:	PUNCT
ajmri-3091	289	7	a	a	DET
ajmri-3091	289	8	cross	cross	ADJ
ajmri-3091	289	9	-	-	ADJ
ajmri-3091	289	10	sectional	sectional	ADJ
ajmri-3091	289	11	study	study	NOUN
ajmri-3091	289	12	.	.	PUNCT
ajmri-3091	290	1	tropical	tropical	ADJ
ajmri-3091	290	2	medicine	medicine	NOUN
ajmri-3091	290	3	and	and	CCONJ
ajmri-3091	290	4	infectious	infectious	ADJ
ajmri-3091	290	5	disease	disease	NOUN
ajmri-3091	290	6	,	,	PUNCT
ajmri-3091	290	7	7(4	7(4	NUM
ajmri-3091	290	8	)	)	PUNCT
ajmri-3091	290	9	,	,	PUNCT
ajmri-3091	290	10	60	60	NUM
ajmri-3091	290	11	.	.	PUNCT
ajmri-3091	291	1	alahmadi	alahmadi	PROPN
ajmri-3091	291	2	,	,	PUNCT
ajmri-3091	291	3	a.	a.	NOUN
ajmri-3091	291	4	m.	m.	NOUN
ajmri-3091	291	5	,	,	PUNCT
ajmri-3091	291	6	aljohani	aljohani	PROPN
ajmri-3091	291	7	,	,	PUNCT
ajmri-3091	291	8	a.	a.	PROPN
ajmri-3091	291	9	h.	h.	PROPN
ajmri-3091	291	10	,	,	PUNCT
ajmri-3091	291	11	fadhloun	fadhloun	PROPN
ajmri-3091	291	12	,	,	PUNCT
ajmri-3091	291	13	r.	r.	PROPN
ajmri-3091	291	14	a.	a.	PROPN
ajmri-3091	291	15	,	,	PUNCT
ajmri-3091	291	16	almohammadi	almohammadi	PROPN
ajmri-3091	291	17	,	,	PUNCT
ajmri-3091	291	18	a.	a.	PROPN
ajmri-3091	291	19	s.	s.	PROPN
ajmri-3091	291	20	,	,	PUNCT
ajmri-3091	291	21	alharbi	alharbi	PROPN
ajmri-3091	291	22	,	,	PUNCT
ajmri-3091	291	23	d.	d.	PROPN
ajmri-3091	291	24	f.	f.	PROPN
ajmri-3091	291	25	,	,	PUNCT
ajmri-3091	291	26	alrefai	alrefai	PROPN
ajmri-3091	291	27	,	,	PUNCT
ajmri-3091	291	28	l.	l.	PROPN
ajmri-3091	291	29	s.	s.	PROPN
ajmri-3091	291	30	,	,	PUNCT
ajmri-3091	291	31	fadhloun	fadhloun	PROPN
ajmri-3091	291	32	,	,	PUNCT
ajmri-3091	291	33	r.	r.	PROPN
ajmri-3091	291	34	,	,	PUNCT
ajmri-3091	291	35	almohammadi	almohammadi	PROPN
ajmri-3091	291	36	,	,	PUNCT
ajmri-3091	291	37	a.	a.	NOUN
ajmri-3091	291	38	,	,	PUNCT
ajmri-3091	291	39	&	&	CCONJ
ajmri-3091	291	40	alharbi	alharbi	PROPN
ajmri-3091	291	41	,	,	PUNCT
ajmri-3091	291	42	d.	d.	PROPN
ajmri-3091	291	43	(	(	PUNCT
ajmri-3091	291	44	2022	2022	NUM
ajmri-3091	291	45	)	)	PUNCT
ajmri-3091	291	46	.	.	PUNCT
ajmri-3091	292	1	the	the	DET
ajmri-3091	292	2	effect	effect	NOUN
ajmri-3091	292	3	of	of	ADP
ajmri-3091	292	4	the	the	DET
ajmri-3091	292	5	covid-19	covid-19	PROPN
ajmri-3091	292	6	vaccine	vaccine	NOUN
ajmri-3091	292	7	on	on	ADP
ajmri-3091	292	8	the	the	DET
ajmri-3091	292	9	menstrual	menstrual	ADJ
ajmri-3091	292	10	cycle	cycle	NOUN
ajmri-3091	292	11	among	among	ADP
ajmri-3091	292	12	reproductive	reproductive	NOUN
ajmri-3091	292	13	-	-	PUNCT
ajmri-3091	292	14	aged	age	VERB
ajmri-3091	292	15	females	female	NOUN
ajmri-3091	292	16	in	in	ADP
ajmri-3091	292	17	saudi	saudi	PROPN
ajmri-3091	292	18	arabia	arabia	PROPN
ajmri-3091	292	19	.	.	PUNCT
ajmri-3091	293	1	cureus	cureus	NOUN
ajmri-3091	293	2	,	,	PUNCT
ajmri-3091	293	3	14(12	14(12	NUM
ajmri-3091	293	4	)	)	PUNCT
ajmri-3091	293	5	.	.	PUNCT
ajmri-3091	294	1	alahmari	alahmari	NOUN
ajmri-3091	294	2	,	,	PUNCT
ajmri-3091	294	3	a.	a.	NOUN
ajmri-3091	294	4	m.	m.	NOUN
ajmri-3091	294	5	,	,	PUNCT
ajmri-3091	294	6	&	&	CCONJ
ajmri-3091	294	7	rahman	rahman	PROPN
ajmri-3091	294	8	,	,	PUNCT
ajmri-3091	294	9	s.	s.	PROPN
ajmri-3091	294	10	k.	k.	PROPN
ajmri-3091	294	11	a.	a.	PROPN
ajmri-3091	294	12	e.	e.	PROPN
ajmri-3091	294	13	(	(	PUNCT
ajmri-3091	294	14	2022	2022	NUM
ajmri-3091	294	15	)	)	PUNCT
ajmri-3091	294	16	.	.	PUNCT
ajmri-3091	295	1	relationship	relationship	NOUN
ajmri-3091	295	2	between	between	ADP
ajmri-3091	295	3	menstrual	menstrual	ADJ
ajmri-3091	295	4	cycle	cycle	NOUN
ajmri-3091	295	5	changes	change	NOUN
ajmri-3091	295	6	and	and	CCONJ
ajmri-3091	295	7	types	type	NOUN
ajmri-3091	295	8	of	of	ADP
ajmri-3091	295	9	covid-19	covid-19	PROPN
ajmri-3091	295	10	vaccines	vaccine	NOUN
ajmri-3091	295	11	among	among	ADP
ajmri-3091	295	12	women	woman	NOUN
ajmri-3091	295	13	living	live	VERB
ajmri-3091	295	14	in	in	ADP
ajmri-3091	295	15	riyadh	riyadh	PROPN
ajmri-3091	295	16	,	,	PUNCT
ajmri-3091	295	17	saudi	saudi	PROPN
ajmri-3091	295	18	arabia	arabia	PROPN
ajmri-3091	295	19	2022	2022	NUM
ajmri-3091	295	20	.	.	PUNCT
ajmri-3091	296	1	medical	medical	ADJ
ajmri-3091	296	2	science	science	PROPN
ajmri-3091	296	3	,	,	PUNCT
ajmri-3091	296	4	26(126	26(126	PROPN
ajmri-3091	296	5	)	)	PUNCT
ajmri-3091	296	6	,	,	PUNCT
ajmri-3091	296	7	1–9	1–9	NOUN
ajmri-3091	296	8	.	.	PUNCT
ajmri-3091	296	9	https://doi.org/10.54905/disssi/v26i126/	https://doi.org/10.54905/disssi/v26i126/	PROPN
ajmri-3091	296	10	ms340e2306	ms340e2306	PROPN
ajmri-3091	296	11	alghamdi	alghamdi	NOUN
ajmri-3091	296	12	,	,	PUNCT
ajmri-3091	296	13	a.	a.	NOUN
ajmri-3091	296	14	n.	n.	PROPN
ajmri-3091	296	15	,	,	PUNCT
ajmri-3091	296	16	alotaibi	alotaibi	NOUN
ajmri-3091	296	17	,	,	PUNCT
ajmri-3091	296	18	m.	m.	NOUN
ajmri-3091	296	19	i.	i.	PROPN
ajmri-3091	296	20	,	,	PUNCT
ajmri-3091	296	21	alqahtani	alqahtani	PROPN
ajmri-3091	296	22	,	,	PUNCT
ajmri-3091	296	23	a.	a.	PROPN
ajmri-3091	296	24	s.	s.	PROPN
ajmri-3091	296	25	,	,	PUNCT
ajmri-3091	296	26	al	al	PROPN
ajmri-3091	296	27	aboud	aboud	PROPN
ajmri-3091	296	28	,	,	PUNCT
ajmri-3091	296	29	d.	d.	PROPN
ajmri-3091	296	30	,	,	PUNCT
ajmri-3091	296	31	&	&	CCONJ
ajmri-3091	296	32	abdel	abdel	PROPN
ajmri-3091	296	33	-	-	PUNCT
ajmri-3091	296	34	moneim	moneim	PROPN
ajmri-3091	296	35	,	,	PUNCT
ajmri-3091	296	36	a.	a.	PROPN
ajmri-3091	296	37	s.	s.	PROPN
ajmri-3091	296	38	(	(	PUNCT
ajmri-3091	296	39	2021	2021	NUM
ajmri-3091	296	40	)	)	PUNCT
ajmri-3091	296	41	.	.	PUNCT
ajmri-3091	297	1	bnt162b2	bnt162b2	NOUN
ajmri-3091	297	2	and	and	CCONJ
ajmri-3091	297	3	chadox1	chadox1	ADJ
ajmri-3091	297	4	sars	sar	NOUN
ajmri-3091	297	5	-	-	PUNCT
ajmri-3091	297	6	cov-2	cov-2	PART
ajmri-3091	297	7	post	post	ADJ
ajmri-3091	297	8	-	-	ADJ
ajmri-3091	297	9	vaccination	vaccination	ADJ
ajmri-3091	297	10	sideeffects	sideeffect	NOUN
ajmri-3091	297	11	among	among	ADP
ajmri-3091	297	12	saudi	saudi	ADJ
ajmri-3091	297	13	vaccinees	vaccinee	NOUN
ajmri-3091	297	14	.	.	PUNCT
ajmri-3091	298	1	frontiers	frontier	NOUN
ajmri-3091	298	2	in	in	ADP
ajmri-3091	298	3	medicine	medicine	NOUN
ajmri-3091	298	4	,	,	PUNCT
ajmri-3091	298	5	8	8	NUM
ajmri-3091	298	6	,	,	PUNCT
ajmri-3091	298	7	760047	760047	NUM
ajmri-3091	298	8	.	.	PUNCT
ajmri-3091	299	1	alhazmi	alhazmi	PROPN
ajmri-3091	299	2	,	,	PUNCT
ajmri-3091	299	3	a.	a.	NOUN
ajmri-3091	299	4	,	,	PUNCT
ajmri-3091	299	5	alamer	alamer	NOUN
ajmri-3091	299	6	,	,	PUNCT
ajmri-3091	299	7	e.	e.	PROPN
ajmri-3091	299	8	,	,	PUNCT
ajmri-3091	299	9	daws	daws	PROPN
ajmri-3091	299	10	,	,	PUNCT
ajmri-3091	299	11	d.	d.	PROPN
ajmri-3091	299	12	,	,	PUNCT
ajmri-3091	299	13	hakami	hakami	PROPN
ajmri-3091	299	14	,	,	PUNCT
ajmri-3091	299	15	m.	m.	NOUN
ajmri-3091	299	16	,	,	PUNCT
ajmri-3091	299	17	darraj	darraj	VERB
ajmri-3091	299	18	,	,	PUNCT
ajmri-3091	299	19	m.	m.	NOUN
ajmri-3091	299	20	,	,	PUNCT
ajmri-3091	299	21	abdelwahab	abdelwahab	PROPN
ajmri-3091	299	22	,	,	PUNCT
ajmri-3091	299	23	s.	s.	PROPN
ajmri-3091	299	24	,	,	PUNCT
ajmri-3091	299	25	maghfuri	maghfuri	PROPN
ajmri-3091	299	26	,	,	PUNCT
ajmri-3091	299	27	a.	a.	PROPN
ajmri-3091	299	28	,	,	PUNCT
ajmri-3091	299	29	&	&	CCONJ
ajmri-3091	299	30	algaissi	algaissi	PROPN
ajmri-3091	299	31	,	,	PUNCT
ajmri-3091	299	32	a.	a.	NOUN
ajmri-3091	299	33	(	(	PUNCT
ajmri-3091	299	34	2021	2021	NUM
ajmri-3091	299	35	)	)	PUNCT
ajmri-3091	299	36	.	.	PUNCT
ajmri-3091	300	1	evaluation	evaluation	NOUN
ajmri-3091	300	2	of	of	ADP
ajmri-3091	300	3	side	side	NOUN
ajmri-3091	300	4	effects	effect	NOUN
ajmri-3091	300	5	associated	associate	VERB
ajmri-3091	300	6	with	with	ADP
ajmri-3091	300	7	covid-19	covid-19	PROPN
ajmri-3091	300	8	vaccines	vaccine	NOUN
ajmri-3091	300	9	in	in	ADP
ajmri-3091	300	10	saudi	saudi	PROPN
ajmri-3091	300	11	arabia	arabia	PROPN
ajmri-3091	300	12	.	.	PUNCT
ajmri-3091	301	1	vaccines	vaccine	NOUN
ajmri-3091	301	2	,	,	PUNCT
ajmri-3091	301	3	9(6	9(6	NUM
ajmri-3091	301	4	)	)	PUNCT
ajmri-3091	301	5	,	,	PUNCT
ajmri-3091	301	6	674	674	NUM
ajmri-3091	301	7	.	.	PUNCT
ajmri-3091	302	1	alhur	alhur	VERB
ajmri-3091	302	2	,	,	PUNCT
ajmri-3091	302	3	a.	a.	NOUN
ajmri-3091	302	4	a.	a.	NOUN
ajmri-3091	302	5	(	(	PUNCT
ajmri-3091	302	6	2023	2023	NUM
ajmri-3091	302	7	)	)	PUNCT
ajmri-3091	302	8	.	.	PUNCT
ajmri-3091	303	1	public	public	ADJ
ajmri-3091	303	2	health	health	NOUN
ajmri-3091	303	3	informatics	informatic	NOUN
ajmri-3091	303	4	:	:	PUNCT
ajmri-3091	303	5	the	the	DET
ajmri-3091	303	6	importance	importance	NOUN
ajmri-3091	303	7	of	of	ADP
ajmri-3091	303	8	covid-19	covid-19	PROPN
ajmri-3091	303	9	dashboard	dashboard	NOUN
ajmri-3091	303	10	in	in	ADP
ajmri-3091	303	11	ksa	ksa	PROPN
ajmri-3091	303	12	for	for	ADP
ajmri-3091	303	13	sharing	share	VERB
ajmri-3091	303	14	and	and	CCONJ
ajmri-3091	303	15	visualizing	visualize	VERB
ajmri-3091	303	16	health	health	NOUN
ajmri-3091	303	17	information	information	NOUN
ajmri-3091	303	18	.	.	PUNCT
ajmri-3091	304	1	journal	journal	NOUN
ajmri-3091	304	2	of	of	ADP
ajmri-3091	304	3	information	information	NOUN
ajmri-3091	304	4	systems	system	NOUN
ajmri-3091	304	5	and	and	CCONJ
ajmri-3091	304	6	digital	digital	ADJ
ajmri-3091	304	7	technologies	technology	NOUN
ajmri-3091	304	8	,	,	PUNCT
ajmri-3091	304	9	5(1	5(1	NUM
ajmri-3091	304	10	)	)	PUNCT
ajmri-3091	304	11	,	,	PUNCT
ajmri-3091	304	12	4359	4359	NUM
ajmri-3091	304	13	.	.	PUNCT
ajmri-3091	305	1	almousa	almousa	NOUN
ajmri-3091	305	2	,	,	PUNCT
ajmri-3091	305	3	i.	i.	NOUN
ajmri-3091	305	4	a.	a.	PROPN
ajmri-3091	305	5	(	(	PUNCT
ajmri-3091	305	6	2022	2022	NUM
ajmri-3091	305	7	)	)	PUNCT
ajmri-3091	305	8	.	.	PUNCT
ajmri-3091	306	1	changes	change	NOUN
ajmri-3091	306	2	in	in	ADP
ajmri-3091	306	3	the	the	DET
ajmri-3091	306	4	menstrual	menstrual	ADJ
ajmri-3091	306	5	cycle	cycle	NOUN
ajmri-3091	306	6	among	among	ADP
ajmri-3091	306	7	the	the	DET
ajmri-3091	306	8	covid-19	covid-19	PROPN
ajmri-3091	306	9	vaccinated	vaccinate	VERB
ajmri-3091	306	10	women	woman	NOUN
ajmri-3091	306	11	in	in	ADP
ajmri-3091	306	12	the	the	DET
ajmri-3091	306	13	eastern	eastern	ADJ
ajmri-3091	306	14	province	province	NOUN
ajmri-3091	306	15	of	of	ADP
ajmri-3091	306	16	saudi	saudi	PROPN
ajmri-3091	306	17	arabia	arabia	PROPN
ajmri-3091	306	18	:	:	PUNCT
ajmri-3091	306	19	a	a	DET
ajmri-3091	306	20	cross	cross	ADJ
ajmri-3091	306	21	-	-	ADJ
ajmri-3091	306	22	sectional	sectional	ADJ
ajmri-3091	306	23	survey	survey	NOUN
ajmri-3091	306	24	,	,	PUNCT
ajmri-3091	306	25	2022	2022	NUM
ajmri-3091	306	26	.	.	PUNCT
ajmri-3091	307	1	the	the	DET
ajmri-3091	307	2	egyptian	egyptian	ADJ
ajmri-3091	307	3	journal	journal	PROPN
ajmri-3091	307	4	of	of	ADP
ajmri-3091	307	5	hospital	hospital	NOUN
ajmri-3091	307	6	medicine	medicine	NOUN
ajmri-3091	307	7	,	,	PUNCT
ajmri-3091	307	8	89(1	89(1	NUM
ajmri-3091	307	9	)	)	PUNCT
ajmri-3091	307	10	,	,	PUNCT
ajmri-3091	307	11	4260	4260	NUM
ajmri-3091	307	12	-	-	SYM
ajmri-3091	307	13	4264	4264	NUM
ajmri-3091	307	14	.	.	PUNCT
ajmri-3091	308	1	alvergne	alvergne	ADJ
ajmri-3091	308	2	,	,	PUNCT
ajmri-3091	308	3	a.	a.	NOUN
ajmri-3091	308	4	,	,	PUNCT
ajmri-3091	308	5	kountourides	kountourides	PROPN
ajmri-3091	308	6	,	,	PUNCT
ajmri-3091	308	7	g.	g.	PROPN
ajmri-3091	308	8	,	,	PUNCT
ajmri-3091	308	9	argentieri	argentieri	PROPN
ajmri-3091	308	10	,	,	PUNCT
ajmri-3091	308	11	m.	m.	NOUN
ajmri-3091	308	12	a.	a.	PROPN
ajmri-3091	308	13	,	,	PUNCT
ajmri-3091	308	14	agyen	agyen	NOUN
ajmri-3091	308	15	,	,	PUNCT
ajmri-3091	308	16	l.	l.	PROPN
ajmri-3091	308	17	,	,	PUNCT
ajmri-3091	308	18	rogers	rogers	PROPN
ajmri-3091	308	19	,	,	PUNCT
ajmri-3091	308	20	n.	n.	NOUN
ajmri-3091	308	21	,	,	PUNCT
ajmri-3091	308	22	knight	knight	PROPN
ajmri-3091	308	23	,	,	PUNCT
ajmri-3091	308	24	d.	d.	PROPN
ajmri-3091	308	25	,	,	PUNCT
ajmri-3091	308	26	sharp	sharp	ADJ
ajmri-3091	308	27	,	,	PUNCT
ajmri-3091	308	28	g.	g.	PROPN
ajmri-3091	308	29	c.	c.	PROPN
ajmri-3091	308	30	,	,	PUNCT
ajmri-3091	308	31	maybin	maybin	PROPN
ajmri-3091	308	32	,	,	PUNCT
ajmri-3091	308	33	j.	j.	PROPN
ajmri-3091	308	34	a.	a.	PROPN
ajmri-3091	308	35	,	,	PUNCT
ajmri-3091	308	36	&	&	CCONJ
ajmri-3091	308	37	olszewska	olszewska	PROPN
ajmri-3091	308	38	,	,	PUNCT
ajmri-3091	308	39	z.	z.	PROPN
ajmri-3091	308	40	(	(	PUNCT
ajmri-3091	308	41	2021	2021	NUM
ajmri-3091	308	42	)	)	PUNCT
ajmri-3091	308	43	.	.	PUNCT
ajmri-3091	309	1	covid-19	covid-19	PROPN
ajmri-3091	309	2	vaccination	vaccination	NOUN
ajmri-3091	309	3	and	and	CCONJ
ajmri-3091	309	4	menstrual	menstrual	ADJ
ajmri-3091	309	5	cycle	cycle	NOUN
ajmri-3091	309	6	changes	change	NOUN
ajmri-3091	309	7	:	:	PUNCT
ajmri-3091	309	8	a	a	DET
ajmri-3091	309	9	united	united	ADJ
ajmri-3091	309	10	kingdom	kingdom	NOUN
ajmri-3091	309	11	(	(	PUNCT
ajmri-3091	309	12	uk	uk	PROPN
ajmri-3091	309	13	)	)	PUNCT
ajmri-3091	309	14	retrospective	retrospective	ADJ
ajmri-3091	309	15	case	case	NOUN
ajmri-3091	309	16	-	-	PUNCT
ajmri-3091	309	17	control	control	NOUN
ajmri-3091	309	18	study	study	NOUN
ajmri-3091	309	19	.	.	PUNCT
ajmri-3091	310	1	medrxiv	medrxiv	X
ajmri-3091	310	2	(	(	PUNCT
ajmri-3091	310	3	cold	cold	ADJ
ajmri-3091	310	4	spring	spring	NOUN
ajmri-3091	310	5	harbor	harbor	NOUN
ajmri-3091	310	6	laboratory	laboratory	NOUN
ajmri-3091	310	7	)	)	PUNCT
ajmri-3091	310	8	.	.	PUNCT
ajmri-3091	311	1	https://doi	https://doi	PROPN
ajmri-3091	311	2	.	.	PUNCT
ajmri-3091	312	1	org/10.1101/2021.11.23.21266709	org/10.1101/2021.11.23.21266709	PROPN
ajmri-3091	312	2	alvergne	alvergne	ADJ
ajmri-3091	312	3	,	,	PUNCT
ajmri-3091	312	4	a.	a.	PROPN
ajmri-3091	312	5	,	,	PUNCT
ajmri-3091	312	6	woon	woon	PROPN
ajmri-3091	312	7	,	,	PUNCT
ajmri-3091	312	8	e.	e.	PROPN
ajmri-3091	312	9	v.	v.	PROPN
ajmri-3091	312	10	,	,	PUNCT
ajmri-3091	312	11	&	&	CCONJ
ajmri-3091	312	12	male	male	NOUN
ajmri-3091	312	13	,	,	PUNCT
ajmri-3091	312	14	v.	v.	PROPN
ajmri-3091	312	15	(	(	PUNCT
ajmri-3091	312	16	2022	2022	NUM
ajmri-3091	312	17	)	)	PUNCT
ajmri-3091	312	18	.	.	PUNCT
ajmri-3091	313	1	effect	effect	NOUN
ajmri-3091	313	2	of	of	ADP
ajmri-3091	313	3	covid-19	covid-19	PROPN
ajmri-3091	313	4	vaccination	vaccination	NOUN
ajmri-3091	313	5	on	on	ADP
ajmri-3091	313	6	the	the	DET
ajmri-3091	313	7	timing	timing	NOUN
ajmri-3091	313	8	and	and	CCONJ
ajmri-3091	313	9	flow	flow	NOUN
ajmri-3091	313	10	of	of	ADP
ajmri-3091	313	11	menstrual	menstrual	ADJ
ajmri-3091	313	12	periods	period	NOUN
ajmri-3091	313	13	in	in	ADP
ajmri-3091	313	14	two	two	NUM
ajmri-3091	313	15	cohorts	cohort	NOUN
ajmri-3091	313	16	.	.	PUNCT
ajmri-3091	314	1	frontiers	frontier	NOUN
ajmri-3091	314	2	in	in	ADP
ajmri-3091	314	3	reproductive	reproductive	ADJ
ajmri-3091	314	4	health	health	NOUN
ajmri-3091	314	5	,	,	PUNCT
ajmri-3091	314	6	4	4	NUM
ajmri-3091	314	7	.	.	PUNCT
ajmri-3091	314	8	barbieri	barbieri	PROPN
ajmri-3091	314	9	,	,	PUNCT
ajmri-3091	314	10	r.	r.	PROPN
ajmri-3091	314	11	l.	l.	PROPN
ajmri-3091	314	12	(	(	PUNCT
ajmri-3091	314	13	2014	2014	NUM
ajmri-3091	314	14	)	)	PUNCT
ajmri-3091	314	15	.	.	PUNCT
ajmri-3091	315	1	the	the	DET
ajmri-3091	315	2	endocrinology	endocrinology	NOUN
ajmri-3091	315	3	of	of	ADP
ajmri-3091	315	4	the	the	DET
ajmri-3091	315	5	menstrual	menstrual	ADJ
ajmri-3091	315	6	cycle	cycle	NOUN
ajmri-3091	315	7	.	.	PUNCT
ajmri-3091	316	1	human	human	ADJ
ajmri-3091	316	2	fertility	fertility	NOUN
ajmri-3091	316	3	:	:	PUNCT
ajmri-3091	316	4	methods	method	NOUN
ajmri-3091	316	5	and	and	CCONJ
ajmri-3091	316	6	protocols	protocol	NOUN
ajmri-3091	316	7	,	,	PUNCT
ajmri-3091	316	8	145	145	NUM
ajmri-3091	316	9	-	-	SYM
ajmri-3091	316	10	169	169	NUM
ajmri-3091	316	11	.	.	PUNCT
ajmri-3091	317	1	beatty	beatty	PROPN
ajmri-3091	317	2	,	,	PUNCT
ajmri-3091	317	3	a.	a.	PROPN
ajmri-3091	317	4	l.	l.	PROPN
ajmri-3091	317	5	,	,	PUNCT
ajmri-3091	317	6	peyser	peyser	NOUN
ajmri-3091	317	7	,	,	PUNCT
ajmri-3091	317	8	n.	n.	PROPN
ajmri-3091	317	9	d.	d.	PROPN
ajmri-3091	317	10	,	,	PUNCT
ajmri-3091	317	11	butcher	butcher	NOUN
ajmri-3091	317	12	,	,	PUNCT
ajmri-3091	317	13	x.	x.	PROPN
ajmri-3091	317	14	e.	e.	PROPN
ajmri-3091	317	15	,	,	PUNCT
ajmri-3091	317	16	cocohoba	cocohoba	PROPN
ajmri-3091	317	17	,	,	PUNCT
ajmri-3091	317	18	j.	j.	PROPN
ajmri-3091	317	19	m.	m.	PROPN
ajmri-3091	317	20	,	,	PUNCT
ajmri-3091	317	21	lin	lin	PROPN
ajmri-3091	317	22	,	,	PUNCT
ajmri-3091	317	23	f.	f.	PROPN
ajmri-3091	317	24	,	,	PUNCT
ajmri-3091	317	25	olgin	olgin	VERB
ajmri-3091	317	26	,	,	PUNCT
ajmri-3091	317	27	j.	j.	PROPN
ajmri-3091	317	28	e.	e.	PROPN
ajmri-3091	317	29	,	,	PUNCT
ajmri-3091	317	30	pletcher	pletcher	NOUN
ajmri-3091	317	31	,	,	PUNCT
ajmri-3091	317	32	m.	m.	NOUN
ajmri-3091	317	33	j.	j.	PROPN
ajmri-3091	317	34	,	,	PUNCT
ajmri-3091	317	35	&	&	CCONJ
ajmri-3091	317	36	marcus	marcus	PROPN
ajmri-3091	317	37	,	,	PUNCT
ajmri-3091	317	38	g.	g.	PROPN
ajmri-3091	317	39	m.	m.	PROPN
ajmri-3091	317	40	(	(	PUNCT
ajmri-3091	317	41	2021	2021	NUM
ajmri-3091	317	42	)	)	PUNCT
ajmri-3091	317	43	.	.	PUNCT
ajmri-3091	318	1	analysis	analysis	NOUN
ajmri-3091	318	2	of	of	ADP
ajmri-3091	318	3	covid-19	covid-19	PROPN
ajmri-3091	318	4	vaccine	vaccine	NOUN
ajmri-3091	318	5	type	type	NOUN
ajmri-3091	318	6	and	and	CCONJ
ajmri-3091	318	7	adverse	adverse	ADJ
ajmri-3091	318	8	effects	effect	NOUN
ajmri-3091	318	9	following	follow	VERB
ajmri-3091	318	10	vaccination	vaccination	NOUN
ajmri-3091	318	11	.	.	PUNCT
ajmri-3091	319	1	jama	jama	PROPN
ajmri-3091	319	2	network	network	PROPN
ajmri-3091	319	3	open	open	VERB
ajmri-3091	319	4	,	,	PUNCT
ajmri-3091	319	5	4(12	4(12	NUM
ajmri-3091	319	6	)	)	PUNCT
ajmri-3091	319	7	,	,	PUNCT
ajmri-3091	319	8	e2140364	e2140364	NOUN
ajmri-3091	319	9	-	-	PUNCT
ajmri-3091	319	10	e2140364	e2140364	NOUN
ajmri-3091	319	11	.	.	PUNCT
ajmri-3091	320	1	berga	berga	PROPN
ajmri-3091	320	2	,	,	PUNCT
ajmri-3091	320	3	s.	s.	PROPN
ajmri-3091	320	4	l.	l.	PROPN
ajmri-3091	320	5	(	(	PUNCT
ajmri-3091	320	6	2020	2020	NUM
ajmri-3091	320	7	)	)	PUNCT
ajmri-3091	320	8	.	.	PUNCT
ajmri-3091	321	1	the	the	DET
ajmri-3091	321	2	menstrual	menstrual	ADJ
ajmri-3091	321	3	cycle	cycle	NOUN
ajmri-3091	321	4	and	and	CCONJ
ajmri-3091	321	5	related	related	ADJ
ajmri-3091	321	6	disorders	disorder	NOUN
ajmri-3091	321	7	.	.	PUNCT
ajmri-3091	322	1	female	female	ADJ
ajmri-3091	322	2	reproductive	reproductive	ADJ
ajmri-3091	322	3	dysfunction	dysfunction	NOUN
ajmri-3091	322	4	,	,	PUNCT
ajmri-3091	322	5	23	23	NUM
ajmri-3091	322	6	-	-	SYM
ajmri-3091	322	7	37	37	NUM
ajmri-3091	322	8	.	.	PUNCT
ajmri-3091	323	1	bull	bull	PROPN
ajmri-3091	323	2	,	,	PUNCT
ajmri-3091	323	3	j.	j.	PROPN
ajmri-3091	323	4	r.	r.	PROPN
ajmri-3091	323	5	,	,	PUNCT
ajmri-3091	323	6	rowland	rowland	PROPN
ajmri-3091	323	7	,	,	PUNCT
ajmri-3091	323	8	s.	s.	PROPN
ajmri-3091	323	9	p.	p.	PROPN
ajmri-3091	323	10	,	,	PUNCT
ajmri-3091	323	11	scherwitzl	scherwitzl	NOUN
ajmri-3091	323	12	,	,	PUNCT
ajmri-3091	323	13	e.	e.	PROPN
ajmri-3091	323	14	b.	b.	PROPN
ajmri-3091	323	15	,	,	PUNCT
ajmri-3091	323	16	scherwitzl	scherwitzl	PROPN
ajmri-3091	323	17	,	,	PUNCT
ajmri-3091	323	18	r.	r.	PROPN
ajmri-3091	323	19	,	,	PUNCT
ajmri-3091	323	20	danielsson	danielsson	PROPN
ajmri-3091	323	21	,	,	PUNCT
ajmri-3091	323	22	k.	k.	PROPN
ajmri-3091	323	23	g.	g.	PROPN
ajmri-3091	323	24	,	,	PUNCT
ajmri-3091	323	25	&	&	CCONJ
ajmri-3091	323	26	harper	harper	PROPN
ajmri-3091	323	27	,	,	PUNCT
ajmri-3091	323	28	j.	j.	PROPN
ajmri-3091	323	29	(	(	PUNCT
ajmri-3091	323	30	2019	2019	NUM
ajmri-3091	323	31	)	)	PUNCT
ajmri-3091	323	32	.	.	PUNCT
ajmri-3091	324	1	real	real	ADJ
ajmri-3091	324	2	-	-	PUNCT
ajmri-3091	324	3	world	world	NOUN
ajmri-3091	324	4	menstrual	menstrual	ADJ
ajmri-3091	324	5	cycle	cycle	NOUN
ajmri-3091	324	6	characteristics	characteristic	NOUN
ajmri-3091	324	7	of	of	ADP
ajmri-3091	324	8	more	more	ADJ
ajmri-3091	324	9	than	than	ADP
ajmri-3091	324	10	600,000	600,000	NUM
ajmri-3091	324	11	menstrual	menstrual	ADJ
ajmri-3091	324	12	cycles	cycle	NOUN
ajmri-3091	324	13	.	.	PUNCT
ajmri-3091	325	1	npj	npj	PROPN
ajmri-3091	325	2	digital	digital	ADJ
ajmri-3091	325	3	medicine	medicine	NOUN
ajmri-3091	325	4	,	,	PUNCT
ajmri-3091	325	5	2(1	2(1	NUM
ajmri-3091	325	6	)	)	PUNCT
ajmri-3091	325	7	,	,	PUNCT
ajmri-3091	325	8	83	83	NUM
ajmri-3091	325	9	.	.	PUNCT
ajmri-3091	326	1	about	about	ADP
ajmri-3091	326	2	v	v	NOUN
ajmri-3091	326	3	-	-	ADV
ajmri-3091	326	4	safe	safe	ADJ
ajmri-3091	326	5	.	.	PUNCT
ajmri-3091	327	1	(	(	PUNCT
ajmri-3091	327	2	2024	2024	NUM
ajmri-3091	327	3	,	,	PUNCT
ajmri-3091	327	4	august	august	PROPN
ajmri-3091	327	5	8)	8)	NUM
ajmri-3091	327	6	.	.	PUNCT
ajmri-3091	327	7	vaccine	vaccine	NOUN
ajmri-3091	327	8	safety	safety	NOUN
ajmri-3091	327	9	systems	system	NOUN
ajmri-3091	327	10	.	.	PUNCT
ajmri-3091	328	1	https://www.cdc.gov/vaccine-safety-systems/vsafe/index.html	https://www.cdc.gov/vaccine-safety-systems/vsafe/index.html	X
ajmri-3091	328	2	chao	chao	PROPN
ajmri-3091	328	3	,	,	PUNCT
ajmri-3091	328	4	m.	m.	PROPN
ajmri-3091	328	5	j.	j.	PROPN
ajmri-3091	328	6	,	,	PUNCT
ajmri-3091	328	7	menon	menon	PROPN
ajmri-3091	328	8	,	,	PUNCT
ajmri-3091	328	9	c.	c.	PROPN
ajmri-3091	328	10	,	,	PUNCT
ajmri-3091	328	11	&	&	CCONJ
ajmri-3091	328	12	elgendi	elgendi	PROPN
ajmri-3091	328	13	,	,	PUNCT
ajmri-3091	328	14	m.	m.	NOUN
ajmri-3091	328	15	(	(	PUNCT
ajmri-3091	328	16	2022	2022	NUM
ajmri-3091	328	17	)	)	PUNCT
ajmri-3091	328	18	.	.	PUNCT
ajmri-3091	329	1	effect	effect	NOUN
ajmri-3091	329	2	of	of	ADP
ajmri-3091	329	3	covid-19	covid-19	PROPN
ajmri-3091	329	4	vaccination	vaccination	NOUN
ajmri-3091	329	5	on	on	ADP
ajmri-3091	329	6	the	the	DET
ajmri-3091	329	7	menstrual	menstrual	ADJ
ajmri-3091	329	8	cycle	cycle	NOUN
ajmri-3091	329	9	.	.	PUNCT
ajmri-3091	330	1	frontiers	frontier	NOUN
ajmri-3091	330	2	in	in	ADP
ajmri-3091	330	3	medicine	medicine	NOUN
ajmri-3091	330	4	,	,	PUNCT
ajmri-3091	330	5	9	9	NUM
ajmri-3091	330	6	,	,	PUNCT
ajmri-3091	330	7	1065421	1065421	NUM
ajmri-3091	330	8	.	.	PUNCT
ajmri-3091	331	1	critchley	critchley	PROPN
ajmri-3091	331	2	,	,	PUNCT
ajmri-3091	331	3	h.	h.	PROPN
ajmri-3091	331	4	o.	o.	PROPN
ajmri-3091	331	5	,	,	PUNCT
ajmri-3091	331	6	babayev	babayev	PROPN
ajmri-3091	331	7	,	,	PUNCT
ajmri-3091	331	8	e.	e.	PROPN
ajmri-3091	331	9	,	,	PUNCT
ajmri-3091	331	10	bulun	bulun	PROPN
ajmri-3091	331	11	,	,	PUNCT
ajmri-3091	331	12	s.	s.	PROPN
ajmri-3091	331	13	e.	e.	PROPN
ajmri-3091	331	14	,	,	PUNCT
ajmri-3091	331	15	clark	clark	PROPN
ajmri-3091	331	16	,	,	PUNCT
ajmri-3091	331	17	s.	s.	PROPN
ajmri-3091	331	18	,	,	PUNCT
ajmri-3091	331	19	garcia	garcia	PROPN
ajmri-3091	331	20	-	-	PUNCT
ajmri-3091	331	21	grau	grau	PROPN
ajmri-3091	331	22	,	,	PUNCT
ajmri-3091	331	23	i.	i.	PROPN
ajmri-3091	331	24	,	,	PUNCT
ajmri-3091	331	25	gregersen	gregersen	PROPN
ajmri-3091	331	26	,	,	PUNCT
ajmri-3091	331	27	p.	p.	PROPN
ajmri-3091	331	28	k.	k.	PROPN
ajmri-3091	331	29	,	,	PUNCT
ajmri-3091	331	30	kilcoyne	kilcoyne	PROPN
ajmri-3091	331	31	,	,	PUNCT
ajmri-3091	331	32	a.	a.	PROPN
ajmri-3091	331	33	,	,	PUNCT
ajmri-3091	331	34	kim	kim	PROPN
ajmri-3091	331	35	,	,	PUNCT
ajmri-3091	331	36	j.	j.	PROPN
ajmri-3091	331	37	y.	y.	PROPN
ajmri-3091	331	38	j.	j.	PROPN
ajmri-3091	331	39	,	,	PUNCT
ajmri-3091	331	40	lavender	lavender	NOUN
ajmri-3091	331	41	,	,	PUNCT
ajmri-3091	331	42	m.	m.	NOUN
ajmri-3091	331	43	,	,	PUNCT
ajmri-3091	331	44	&	&	CCONJ
ajmri-3091	331	45	marsh	marsh	PROPN
ajmri-3091	331	46	,	,	PUNCT
ajmri-3091	331	47	e.	e.	PROPN
ajmri-3091	331	48	e.	e.	PROPN
ajmri-3091	331	49	(	(	PUNCT
ajmri-3091	331	50	2020	2020	NUM
ajmri-3091	331	51	)	)	PUNCT
ajmri-3091	331	52	.	.	PUNCT
ajmri-3091	332	1	menstruation	menstruation	NOUN
ajmri-3091	332	2	:	:	PUNCT
ajmri-3091	332	3	science	science	NOUN
ajmri-3091	332	4	and	and	CCONJ
ajmri-3091	332	5	society	society	NOUN
ajmri-3091	332	6	.	.	PUNCT
ajmri-3091	333	1	american	american	ADJ
ajmri-3091	333	2	journal	journal	PROPN
ajmri-3091	333	3	of	of	ADP
ajmri-3091	333	4	obstetrics	obstetric	NOUN
ajmri-3091	333	5	and	and	CCONJ
ajmri-3091	333	6	gynecology	gynecology	NOUN
ajmri-3091	333	7	,	,	PUNCT
ajmri-3091	333	8	223(5	223(5	NUM
ajmri-3091	333	9	)	)	PUNCT
ajmri-3091	333	10	,	,	PUNCT
ajmri-3091	333	11	624	624	NUM
ajmri-3091	333	12	-	-	PUNCT
ajmri-3091	333	13	664	664	NUM
ajmri-3091	333	14	.	.	PUNCT
ajmri-3091	333	15	de	de	X
ajmri-3091	333	16	sanctis	sanctis	PROPN
ajmri-3091	333	17	,	,	PUNCT
ajmri-3091	333	18	v.	v.	PROPN
ajmri-3091	333	19	,	,	PUNCT
ajmri-3091	333	20	bernasconi	bernasconi	PROPN
ajmri-3091	333	21	,	,	PUNCT
ajmri-3091	333	22	s.	s.	PROPN
ajmri-3091	333	23	,	,	PUNCT
ajmri-3091	333	24	bianchin	bianchin	PROPN
ajmri-3091	333	25	,	,	PUNCT
ajmri-3091	333	26	l.	l.	PROPN
ajmri-3091	333	27	,	,	PUNCT
ajmri-3091	333	28	bona	bona	PROPN
ajmri-3091	333	29	,	,	PUNCT
ajmri-3091	333	30	g.	g.	PROPN
ajmri-3091	333	31	,	,	PUNCT
ajmri-3091	333	32	bozzola	bozzola	PROPN
ajmri-3091	333	33	,	,	PUNCT
ajmri-3091	333	34	m.	m.	NOUN
ajmri-3091	333	35	,	,	PUNCT
ajmri-3091	333	36	buzi	buzi	PROPN
ajmri-3091	333	37	,	,	PUNCT
ajmri-3091	333	38	f.	f.	PROPN
ajmri-3091	333	39	,	,	PUNCT
ajmri-3091	333	40	de	de	PROPN
ajmri-3091	333	41	sanctis	sanctis	PROPN
ajmri-3091	333	42	,	,	PUNCT
ajmri-3091	333	43	c.	c.	PROPN
ajmri-3091	333	44	,	,	PUNCT
ajmri-3091	333	45	rigon	rigon	PROPN
ajmri-3091	333	46	,	,	PUNCT
ajmri-3091	333	47	f.	f.	PROPN
ajmri-3091	333	48	,	,	PUNCT
ajmri-3091	333	49	tatò	tatò	PROPN
ajmri-3091	333	50	,	,	PUNCT
ajmri-3091	333	51	l.	l.	PROPN
ajmri-3091	333	52	,	,	PUNCT
ajmri-3091	333	53	&	&	CCONJ
ajmri-3091	333	54	tonini	tonini	PROPN
ajmri-3091	333	55	,	,	PUNCT
ajmri-3091	333	56	g.	g.	PROPN
ajmri-3091	333	57	(	(	PUNCT
ajmri-3091	333	58	2014	2014	NUM
ajmri-3091	333	59	)	)	PUNCT
ajmri-3091	333	60	.	.	PUNCT
ajmri-3091	334	1	onset	onset	NOUN
ajmri-3091	334	2	of	of	ADP
ajmri-3091	334	3	menstrual	menstrual	ADJ
ajmri-3091	334	4	cycle	cycle	NOUN
ajmri-3091	334	5	and	and	CCONJ
ajmri-3091	334	6	menses	mense	NOUN
ajmri-3091	334	7	features	feature	VERB
ajmri-3091	334	8	among	among	ADP
ajmri-3091	334	9	secondary	secondary	ADJ
ajmri-3091	334	10	school	school	NOUN
ajmri-3091	334	11	girls	girl	NOUN
ajmri-3091	334	12	in	in	ADP
ajmri-3091	334	13	italy	italy	PROPN
ajmri-3091	334	14	:	:	PUNCT
ajmri-3091	334	15	pa	pa	PROPN
ajmri-3091	334	16	ge	ge	PROPN
ajmri-3091	334	17	23	23	NUM
ajmri-3091	335	1	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	335	2	am	am	NOUN
ajmri-3091	335	3	.	.	PUNCT
ajmri-3091	336	1	j.	j.	PROPN
ajmri-3091	336	2	multidis	multidis	PROPN
ajmri-3091	336	3	.	.	PUNCT
ajmri-3091	337	1	res	re	NOUN
ajmri-3091	337	2	.	.	PUNCT
ajmri-3091	338	1	innov	innov	PROPN
ajmri-3091	338	2	.	.	PUNCT
ajmri-3091	339	1	3(6	3(6	PROPN
ajmri-3091	339	2	)	)	PUNCT
ajmri-3091	339	3	12	12	NUM
ajmri-3091	339	4	-	-	SYM
ajmri-3091	339	5	24	24	NUM
ajmri-3091	339	6	,	,	PUNCT
ajmri-3091	339	7	2024	2024	NUM
ajmri-3091	339	8	a	a	DET
ajmri-3091	339	9	questionnaire	questionnaire	NOUN
ajmri-3091	339	10	study	study	NOUN
ajmri-3091	339	11	on	on	ADP
ajmri-3091	339	12	3,783	3,783	NUM
ajmri-3091	339	13	students	student	NOUN
ajmri-3091	339	14	.	.	PUNCT
ajmri-3091	340	1	indian	indian	ADJ
ajmri-3091	340	2	journal	journal	PROPN
ajmri-3091	340	3	of	of	ADP
ajmri-3091	340	4	endocrinology	endocrinology	NOUN
ajmri-3091	340	5	and	and	CCONJ
ajmri-3091	340	6	metabolism	metabolism	NOUN
ajmri-3091	340	7	,	,	PUNCT
ajmri-3091	340	8	18(suppl	18(suppl	NUM
ajmri-3091	340	9	1	1	NUM
ajmri-3091	340	10	)	)	PUNCT
ajmri-3091	340	11	,	,	PUNCT
ajmri-3091	340	12	s84	s84	NOUN
ajmri-3091	340	13	.	.	PUNCT
ajmri-3091	341	1	demir	demir	PROPN
ajmri-3091	341	2	,	,	PUNCT
ajmri-3091	341	3	o.	o.	PROPN
ajmri-3091	341	4	,	,	PUNCT
ajmri-3091	341	5	sal	sal	PROPN
ajmri-3091	341	6	,	,	PUNCT
ajmri-3091	341	7	h.	h.	PROPN
ajmri-3091	341	8	,	,	PUNCT
ajmri-3091	341	9	&	&	CCONJ
ajmri-3091	341	10	comba	comba	PROPN
ajmri-3091	341	11	,	,	PUNCT
ajmri-3091	341	12	c.	c.	PROPN
ajmri-3091	341	13	(	(	PUNCT
ajmri-3091	341	14	2021	2021	NUM
ajmri-3091	341	15	)	)	PUNCT
ajmri-3091	341	16	.	.	PUNCT
ajmri-3091	342	1	triangle	triangle	NOUN
ajmri-3091	342	2	of	of	ADP
ajmri-3091	342	3	covid	covid	PROPN
ajmri-3091	342	4	,	,	PUNCT
ajmri-3091	342	5	anxiety	anxiety	NOUN
ajmri-3091	342	6	and	and	CCONJ
ajmri-3091	342	7	menstrual	menstrual	ADJ
ajmri-3091	342	8	cycle	cycle	NOUN
ajmri-3091	342	9	.	.	PUNCT
ajmri-3091	343	1	journal	journal	NOUN
ajmri-3091	343	2	of	of	ADP
ajmri-3091	343	3	obstetrics	obstetric	NOUN
ajmri-3091	343	4	and	and	CCONJ
ajmri-3091	343	5	gynaecology	gynaecology	NOUN
ajmri-3091	343	6	,	,	PUNCT
ajmri-3091	343	7	41(8	41(8	PROPN
ajmri-3091	343	8	)	)	PUNCT
ajmri-3091	343	9	,	,	PUNCT
ajmri-3091	343	10	1257	1257	NUM
ajmri-3091	343	11	-	-	SYM
ajmri-3091	343	12	1261	1261	NUM
ajmri-3091	343	13	.	.	PUNCT
ajmri-3091	344	1	farland	farland	NOUN
ajmri-3091	344	2	,	,	PUNCT
ajmri-3091	344	3	l.	l.	PROPN
ajmri-3091	344	4	v.	v.	PROPN
ajmri-3091	344	5	,	,	PUNCT
ajmri-3091	344	6	khan	khan	PROPN
ajmri-3091	344	7	,	,	PUNCT
ajmri-3091	344	8	s.	s.	PROPN
ajmri-3091	344	9	m.	m.	PROPN
ajmri-3091	344	10	,	,	PUNCT
ajmri-3091	344	11	shilen	shilen	PROPN
ajmri-3091	344	12	,	,	PUNCT
ajmri-3091	344	13	a.	a.	NOUN
ajmri-3091	344	14	,	,	PUNCT
ajmri-3091	344	15	heslin	heslin	PROPN
ajmri-3091	344	16	,	,	PUNCT
ajmri-3091	344	17	k.	k.	PROPN
ajmri-3091	344	18	m.	m.	PROPN
ajmri-3091	344	19	,	,	PUNCT
ajmri-3091	344	20	ishimwe	ishimwe	PROPN
ajmri-3091	344	21	,	,	PUNCT
ajmri-3091	344	22	p.	p.	PROPN
ajmri-3091	344	23	,	,	PUNCT
ajmri-3091	344	24	allen	allen	PROPN
ajmri-3091	344	25	,	,	PUNCT
ajmri-3091	344	26	a.	a.	NOUN
ajmri-3091	344	27	m.	m.	NOUN
ajmri-3091	344	28	,	,	PUNCT
ajmri-3091	344	29	herbst	herbst	PROPN
ajmri-3091	344	30	-	-	PUNCT
ajmri-3091	344	31	kralovetz	kralovetz	ADJ
ajmri-3091	344	32	,	,	PUNCT
ajmri-3091	344	33	m.	m.	NOUN
ajmri-3091	344	34	m.	m.	NOUN
ajmri-3091	344	35	,	,	PUNCT
ajmri-3091	344	36	mahnert	mahnert	NOUN
ajmri-3091	344	37	,	,	PUNCT
ajmri-3091	344	38	n.	n.	PROPN
ajmri-3091	344	39	d.	d.	PROPN
ajmri-3091	344	40	,	,	PUNCT
ajmri-3091	344	41	pogreba	pogreba	NOUN
ajmri-3091	344	42	-	-	PUNCT
ajmri-3091	344	43	brown	brown	NOUN
ajmri-3091	344	44	,	,	PUNCT
ajmri-3091	344	45	k.	k.	PROPN
ajmri-3091	344	46	,	,	PUNCT
ajmri-3091	344	47	&	&	CCONJ
ajmri-3091	344	48	ernst	ernst	PROPN
ajmri-3091	344	49	,	,	PUNCT
ajmri-3091	344	50	k.	k.	PROPN
ajmri-3091	344	51	c.	c.	PROPN
ajmri-3091	344	52	(	(	PUNCT
ajmri-3091	344	53	2023	2023	NUM
ajmri-3091	344	54	)	)	PUNCT
ajmri-3091	344	55	.	.	PUNCT
ajmri-3091	345	1	covid-19	covid-19	PROPN
ajmri-3091	345	2	vaccination	vaccination	NOUN
ajmri-3091	345	3	and	and	CCONJ
ajmri-3091	345	4	changes	change	NOUN
ajmri-3091	345	5	in	in	ADP
ajmri-3091	345	6	the	the	DET
ajmri-3091	345	7	menstrual	menstrual	ADJ
ajmri-3091	345	8	cycle	cycle	NOUN
ajmri-3091	345	9	among	among	ADP
ajmri-3091	345	10	vaccinated	vaccinated	ADJ
ajmri-3091	345	11	persons	person	NOUN
ajmri-3091	345	12	.	.	PUNCT
ajmri-3091	346	1	fertility	fertility	NOUN
ajmri-3091	346	2	and	and	CCONJ
ajmri-3091	346	3	sterility	sterility	NOUN
ajmri-3091	346	4	,	,	PUNCT
ajmri-3091	346	5	119(3	119(3	NUM
ajmri-3091	346	6	)	)	PUNCT
ajmri-3091	346	7	,	,	PUNCT
ajmri-3091	346	8	392	392	NUM
ajmri-3091	346	9	-	-	SYM
ajmri-3091	346	10	400	400	NUM
ajmri-3091	346	11	.	.	PUNCT
ajmri-3091	347	1	gibson	gibson	PROPN
ajmri-3091	347	2	,	,	PUNCT
ajmri-3091	347	3	e.	e.	PROPN
ajmri-3091	347	4	a.	a.	PROPN
ajmri-3091	347	5	,	,	PUNCT
ajmri-3091	347	6	li	li	PROPN
ajmri-3091	347	7	,	,	PUNCT
ajmri-3091	347	8	h.	h.	PROPN
ajmri-3091	347	9	,	,	PUNCT
ajmri-3091	347	10	fruh	fruh	NOUN
ajmri-3091	347	11	,	,	PUNCT
ajmri-3091	347	12	v.	v.	PROPN
ajmri-3091	347	13	,	,	PUNCT
ajmri-3091	347	14	gabra	gabra	PROPN
ajmri-3091	347	15	,	,	PUNCT
ajmri-3091	347	16	m.	m.	NOUN
ajmri-3091	347	17	,	,	PUNCT
ajmri-3091	347	18	asokan	asokan	ADJ
ajmri-3091	347	19	,	,	PUNCT
ajmri-3091	347	20	g.	g.	PROPN
ajmri-3091	347	21	,	,	PUNCT
ajmri-3091	347	22	jukic	jukic	PROPN
ajmri-3091	347	23	,	,	PUNCT
ajmri-3091	347	24	a.	a.	PROPN
ajmri-3091	347	25	m.	m.	PROPN
ajmri-3091	347	26	z.	z.	PROPN
ajmri-3091	347	27	,	,	PUNCT
ajmri-3091	347	28	baird	baird	PROPN
ajmri-3091	347	29	,	,	PUNCT
ajmri-3091	347	30	d.	d.	PROPN
ajmri-3091	347	31	d.	d.	PROPN
ajmri-3091	347	32	,	,	PUNCT
ajmri-3091	347	33	curry	curry	PROPN
ajmri-3091	347	34	,	,	PUNCT
ajmri-3091	347	35	c.	c.	PROPN
ajmri-3091	347	36	l.	l.	PROPN
ajmri-3091	347	37	,	,	PUNCT
ajmri-3091	347	38	fischercolbrie	fischercolbrie	PROPN
ajmri-3091	347	39	,	,	PUNCT
ajmri-3091	347	40	t.	t.	PROPN
ajmri-3091	347	41	,	,	PUNCT
ajmri-3091	347	42	&	&	CCONJ
ajmri-3091	347	43	onnela	onnela	PROPN
ajmri-3091	347	44	,	,	PUNCT
ajmri-3091	347	45	j.	j.	PROPN
ajmri-3091	347	46	p.	p.	PROPN
ajmri-3091	347	47	(	(	PUNCT
ajmri-3091	347	48	2022	2022	NUM
ajmri-3091	347	49	)	)	PUNCT
ajmri-3091	347	50	.	.	PUNCT
ajmri-3091	348	1	covid-19	covid-19	PROPN
ajmri-3091	348	2	vaccination	vaccination	NOUN
ajmri-3091	348	3	and	and	CCONJ
ajmri-3091	348	4	menstrual	menstrual	ADJ
ajmri-3091	348	5	cycle	cycle	NOUN
ajmri-3091	348	6	length	length	NOUN
ajmri-3091	348	7	in	in	ADP
ajmri-3091	348	8	the	the	DET
ajmri-3091	348	9	apple	apple	NOUN
ajmri-3091	348	10	women	woman	NOUN
ajmri-3091	348	11	’s	’s	PART
ajmri-3091	348	12	health	health	NOUN
ajmri-3091	348	13	study	study	NOUN
ajmri-3091	348	14	.	.	PUNCT
ajmri-3091	349	1	npj	npj	PROPN
ajmri-3091	349	2	digital	digital	ADJ
ajmri-3091	349	3	medicine	medicine	NOUN
ajmri-3091	349	4	,	,	PUNCT
ajmri-3091	349	5	5(1	5(1	NUM
ajmri-3091	349	6	)	)	PUNCT
ajmri-3091	349	7	,	,	PUNCT
ajmri-3091	349	8	165	165	NUM
ajmri-3091	349	9	.	.	PUNCT
ajmri-3091	350	1	gopaul	gopaul	PROPN
ajmri-3091	350	2	,	,	PUNCT
ajmri-3091	350	3	c.	c.	PROPN
ajmri-3091	350	4	d.	d.	PROPN
ajmri-3091	350	5	,	,	PUNCT
ajmri-3091	350	6	bassaw	bassaw	PROPN
ajmri-3091	350	7	,	,	PUNCT
ajmri-3091	350	8	b.	b.	PROPN
ajmri-3091	350	9	,	,	PUNCT
ajmri-3091	350	10	ventour	ventour	PROPN
ajmri-3091	350	11	,	,	PUNCT
ajmri-3091	350	12	d.	d.	PROPN
ajmri-3091	350	13	,	,	PUNCT
ajmri-3091	350	14	&	&	CCONJ
ajmri-3091	350	15	thomas	thomas	PROPN
ajmri-3091	350	16	,	,	PUNCT
ajmri-3091	350	17	d.	d.	PROPN
ajmri-3091	350	18	(	(	PUNCT
ajmri-3091	350	19	2023	2023	NUM
ajmri-3091	350	20	)	)	PUNCT
ajmri-3091	350	21	.	.	PUNCT
ajmri-3091	351	1	effects	effect	NOUN
ajmri-3091	351	2	of	of	ADP
ajmri-3091	351	3	covid-19	covid-19	PROPN
ajmri-3091	351	4	vaccines	vaccine	NOUN
ajmri-3091	351	5	on	on	ADP
ajmri-3091	351	6	the	the	DET
ajmri-3091	351	7	menstrual	menstrual	ADJ
ajmri-3091	351	8	cycle	cycle	NOUN
ajmri-3091	351	9	:	:	PUNCT
ajmri-3091	351	10	a	a	DET
ajmri-3091	351	11	cross	cross	ADJ
ajmri-3091	351	12	-	-	ADJ
ajmri-3091	351	13	sectional	sectional	ADJ
ajmri-3091	351	14	study	study	NOUN
ajmri-3091	351	15	.	.	PUNCT
ajmri-3091	352	1	the	the	DET
ajmri-3091	352	2	open	open	ADJ
ajmri-3091	352	3	public	public	ADJ
ajmri-3091	352	4	health	health	NOUN
ajmri-3091	352	5	journal	journal	NOUN
ajmri-3091	352	6	,	,	PUNCT
ajmri-3091	352	7	16(1	16(1	NUM
ajmri-3091	352	8	)	)	PUNCT
ajmri-3091	352	9	.	.	PUNCT
ajmri-3091	353	1	gray	gray	ADJ
ajmri-3091	353	2	,	,	PUNCT
ajmri-3091	353	3	s.	s.	PROPN
ajmri-3091	353	4	h.	h.	PROPN
ajmri-3091	353	5	(	(	PUNCT
ajmri-3091	353	6	2013	2013	NUM
ajmri-3091	353	7	)	)	PUNCT
ajmri-3091	353	8	.	.	PUNCT
ajmri-3091	354	1	menstrual	menstrual	ADJ
ajmri-3091	354	2	disorders	disorder	NOUN
ajmri-3091	354	3	.	.	PUNCT
ajmri-3091	355	1	pediatrics	pediatric	NOUN
ajmri-3091	355	2	in	in	ADP
ajmri-3091	355	3	review	review	NOUN
ajmri-3091	355	4	,	,	PUNCT
ajmri-3091	355	5	34(1	34(1	NUM
ajmri-3091	355	6	)	)	PUNCT
ajmri-3091	355	7	,	,	PUNCT
ajmri-3091	355	8	6	6	NUM
ajmri-3091	355	9	-	-	SYM
ajmri-3091	355	10	18	18	NUM
ajmri-3091	355	11	.	.	PUNCT
ajmri-3091	356	1	hatmal	hatmal	ADJ
ajmri-3091	356	2	,	,	PUNCT
ajmri-3091	356	3	m.	m.	NOUN
ajmri-3091	356	4	m.	m.	NOUN
ajmri-3091	356	5	,	,	PUNCT
ajmri-3091	356	6	al	al	PROPN
ajmri-3091	356	7	-	-	PUNCT
ajmri-3091	356	8	hatamleh	hatamleh	ADJ
ajmri-3091	356	9	,	,	PUNCT
ajmri-3091	356	10	m.	m.	NOUN
ajmri-3091	356	11	a.	a.	PROPN
ajmri-3091	356	12	i.	i.	PROPN
ajmri-3091	356	13	,	,	PUNCT
ajmri-3091	356	14	olaimat	olaimat	PROPN
ajmri-3091	356	15	,	,	PUNCT
ajmri-3091	356	16	a.	a.	NOUN
ajmri-3091	356	17	n.	n.	NOUN
ajmri-3091	356	18	,	,	PUNCT
ajmri-3091	356	19	hatmal	hatmal	ADJ
ajmri-3091	356	20	,	,	PUNCT
ajmri-3091	356	21	m.	m.	NOUN
ajmri-3091	356	22	,	,	PUNCT
ajmri-3091	356	23	alhaj	alhaj	PROPN
ajmri-3091	356	24	-	-	PUNCT
ajmri-3091	356	25	qasem	qasem	PROPN
ajmri-3091	356	26	,	,	PUNCT
ajmri-3091	356	27	d.	d.	PROPN
ajmri-3091	356	28	m.	m.	PROPN
ajmri-3091	356	29	,	,	PUNCT
ajmri-3091	356	30	olaimat	olaimat	PROPN
ajmri-3091	356	31	,	,	PUNCT
ajmri-3091	356	32	t.	t.	NOUN
ajmri-3091	356	33	m.	m.	NOUN
ajmri-3091	356	34	,	,	PUNCT
ajmri-3091	356	35	&	&	CCONJ
ajmri-3091	356	36	mohamud	mohamud	PROPN
ajmri-3091	356	37	,	,	PUNCT
ajmri-3091	356	38	r.	r.	PROPN
ajmri-3091	356	39	(	(	PUNCT
ajmri-3091	356	40	2021	2021	NUM
ajmri-3091	356	41	)	)	PUNCT
ajmri-3091	356	42	.	.	PUNCT
ajmri-3091	357	1	side	side	NOUN
ajmri-3091	357	2	effects	effect	NOUN
ajmri-3091	357	3	and	and	CCONJ
ajmri-3091	357	4	perceptions	perception	NOUN
ajmri-3091	357	5	following	follow	VERB
ajmri-3091	357	6	covid-19	covid-19	PROPN
ajmri-3091	357	7	vaccination	vaccination	NOUN
ajmri-3091	357	8	in	in	ADP
ajmri-3091	357	9	jordan	jordan	PROPN
ajmri-3091	357	10	:	:	PUNCT
ajmri-3091	357	11	a	a	DET
ajmri-3091	357	12	randomized	randomized	ADJ
ajmri-3091	357	13	,	,	PUNCT
ajmri-3091	357	14	cross	cross	ADJ
ajmri-3091	357	15	-	-	ADJ
ajmri-3091	357	16	sectional	sectional	ADJ
ajmri-3091	357	17	study	study	NOUN
ajmri-3091	357	18	implementing	implement	VERB
ajmri-3091	357	19	machine	machine	NOUN
ajmri-3091	357	20	learning	learning	NOUN
ajmri-3091	357	21	for	for	ADP
ajmri-3091	357	22	predicting	predict	VERB
ajmri-3091	357	23	severity	severity	NOUN
ajmri-3091	357	24	of	of	ADP
ajmri-3091	357	25	side	side	NOUN
ajmri-3091	357	26	effects	effect	NOUN
ajmri-3091	357	27	.	.	PUNCT
ajmri-3091	358	1	vaccines	vaccine	NOUN
ajmri-3091	358	2	,	,	PUNCT
ajmri-3091	358	3	9(6	9(6	NUM
ajmri-3091	358	4	)	)	PUNCT
ajmri-3091	358	5	,	,	PUNCT
ajmri-3091	358	6	556	556	NUM
ajmri-3091	358	7	.	.	PUNCT
ajmri-3091	359	1	https://doi.org/10.3390/	https://doi.org/10.3390/	PROPN
ajmri-3091	359	2	vaccines9060556	vaccines9060556	PROPN
ajmri-3091	359	3	huhmann	huhmann	PROPN
ajmri-3091	359	4	,	,	PUNCT
ajmri-3091	359	5	k.	k.	PROPN
ajmri-3091	359	6	(	(	PUNCT
ajmri-3091	359	7	2020	2020	NUM
ajmri-3091	359	8	)	)	PUNCT
ajmri-3091	359	9	.	.	PUNCT
ajmri-3091	360	1	menses	mense	NOUN
ajmri-3091	360	2	requires	require	VERB
ajmri-3091	360	3	energy	energy	NOUN
ajmri-3091	360	4	:	:	PUNCT
ajmri-3091	360	5	a	a	DET
ajmri-3091	360	6	review	review	NOUN
ajmri-3091	360	7	of	of	ADP
ajmri-3091	360	8	how	how	SCONJ
ajmri-3091	360	9	disordered	disordered	ADJ
ajmri-3091	360	10	eating	eating	NOUN
ajmri-3091	360	11	,	,	PUNCT
ajmri-3091	360	12	excessive	excessive	ADJ
ajmri-3091	360	13	exercise	exercise	NOUN
ajmri-3091	360	14	,	,	PUNCT
ajmri-3091	360	15	and	and	CCONJ
ajmri-3091	360	16	high	high	ADJ
ajmri-3091	360	17	stress	stress	NOUN
ajmri-3091	360	18	lead	lead	NOUN
ajmri-3091	360	19	to	to	ADP
ajmri-3091	360	20	menstrual	menstrual	ADJ
ajmri-3091	360	21	irregularities	irregularity	NOUN
ajmri-3091	360	22	.	.	PUNCT
ajmri-3091	361	1	clinical	clinical	ADJ
ajmri-3091	361	2	therapeutics	therapeutic	NOUN
ajmri-3091	361	3	,	,	PUNCT
ajmri-3091	361	4	42(3	42(3	NUM
ajmri-3091	361	5	)	)	PUNCT
ajmri-3091	361	6	,	,	PUNCT
ajmri-3091	361	7	401	401	NUM
ajmri-3091	361	8	-	-	SYM
ajmri-3091	361	9	407	407	NUM
ajmri-3091	361	10	.	.	PUNCT
ajmri-3091	362	1	jung	jung	PROPN
ajmri-3091	362	2	,	,	PUNCT
ajmri-3091	362	3	e.	e.	PROPN
ajmri-3091	362	4	k.	k.	PROPN
ajmri-3091	362	5	,	,	PUNCT
ajmri-3091	362	6	kim	kim	PROPN
ajmri-3091	362	7	,	,	PUNCT
ajmri-3091	362	8	s.	s.	PROPN
ajmri-3091	362	9	w.	w.	PROPN
ajmri-3091	362	10	,	,	PUNCT
ajmri-3091	362	11	ock	ock	PROPN
ajmri-3091	362	12	,	,	PUNCT
ajmri-3091	362	13	s.	s.	PROPN
ajmri-3091	362	14	m.	m.	PROPN
ajmri-3091	362	15	,	,	PUNCT
ajmri-3091	362	16	jung	jung	PROPN
ajmri-3091	362	17	,	,	PUNCT
ajmri-3091	362	18	k.	k.	PROPN
ajmri-3091	362	19	i.	i.	PROPN
ajmri-3091	362	20	,	,	PUNCT
ajmri-3091	362	21	&	&	CCONJ
ajmri-3091	362	22	song	song	PROPN
ajmri-3091	362	23	,	,	PUNCT
ajmri-3091	362	24	c.	c.	PROPN
ajmri-3091	362	25	h.	h.	PROPN
ajmri-3091	362	26	(	(	PUNCT
ajmri-3091	362	27	2018	2018	NUM
ajmri-3091	362	28	)	)	PUNCT
ajmri-3091	362	29	.	.	PUNCT
ajmri-3091	363	1	prevalence	prevalence	NOUN
ajmri-3091	363	2	and	and	CCONJ
ajmri-3091	363	3	related	related	ADJ
ajmri-3091	363	4	factors	factor	NOUN
ajmri-3091	363	5	of	of	ADP
ajmri-3091	363	6	irregular	irregular	ADJ
ajmri-3091	363	7	menstrual	menstrual	ADJ
ajmri-3091	363	8	cycles	cycle	NOUN
ajmri-3091	363	9	in	in	ADP
ajmri-3091	363	10	korean	korean	ADJ
ajmri-3091	363	11	women	woman	NOUN
ajmri-3091	363	12	:	:	PUNCT
ajmri-3091	363	13	the	the	DET
ajmri-3091	363	14	5th	5th	ADJ
ajmri-3091	363	15	korean	korean	ADJ
ajmri-3091	363	16	national	national	ADJ
ajmri-3091	363	17	health	health	PROPN
ajmri-3091	363	18	and	and	CCONJ
ajmri-3091	363	19	nutrition	nutrition	NOUN
ajmri-3091	363	20	examination	examination	NOUN
ajmri-3091	363	21	survey	survey	NOUN
ajmri-3091	363	22	(	(	PUNCT
ajmri-3091	363	23	knhanes	knhane	NOUN
ajmri-3091	363	24	-	-	PUNCT
ajmri-3091	363	25	v	v	NOUN
ajmri-3091	363	26	,	,	PUNCT
ajmri-3091	363	27	2010–2012	2010–2012	NUM
ajmri-3091	363	28	)	)	PUNCT
ajmri-3091	363	29	.	.	PUNCT
ajmri-3091	364	1	journal	journal	NOUN
ajmri-3091	364	2	of	of	ADP
ajmri-3091	364	3	psychosomatic	psychosomatic	ADJ
ajmri-3091	364	4	obstetrics	obstetric	NOUN
ajmri-3091	364	5	&	&	CCONJ
ajmri-3091	364	6	gynecology	gynecology	NOUN
ajmri-3091	364	7	,	,	PUNCT
ajmri-3091	364	8	39(3	39(3	NUM
ajmri-3091	364	9	)	)	PUNCT
ajmri-3091	364	10	,	,	PUNCT
ajmri-3091	364	11	196	196	NUM
ajmri-3091	364	12	-	-	SYM
ajmri-3091	364	13	202	202	NUM
ajmri-3091	364	14	.	.	PUNCT
ajmri-3091	365	1	kumar	kumar	PROPN
ajmri-3091	365	2	,	,	PUNCT
ajmri-3091	365	3	n.	n.	PROPN
ajmri-3091	365	4	,	,	PUNCT
ajmri-3091	365	5	gangane	gangane	NOUN
ajmri-3091	365	6	,	,	PUNCT
ajmri-3091	365	7	n.	n.	PROPN
ajmri-3091	365	8	,	,	PUNCT
ajmri-3091	365	9	mohapatra	mohapatra	PROPN
ajmri-3091	365	10	,	,	PUNCT
ajmri-3091	365	11	i.	i.	PROPN
ajmri-3091	365	12	,	,	PUNCT
ajmri-3091	365	13	rukadikar	rukadikar	PROPN
ajmri-3091	365	14	,	,	PUNCT
ajmri-3091	365	15	c.	c.	PROPN
ajmri-3091	365	16	,	,	PUNCT
ajmri-3091	365	17	sharmila	sharmila	PROPN
ajmri-3091	365	18	,	,	PUNCT
ajmri-3091	365	19	v.	v.	PROPN
ajmri-3091	365	20	,	,	PUNCT
ajmri-3091	365	21	pushpalatha	pushpalatha	PROPN
ajmri-3091	365	22	,	,	PUNCT
ajmri-3091	365	23	k.	k.	PROPN
ajmri-3091	365	24	,	,	PUNCT
ajmri-3091	365	25	eerike	eerike	INTJ
ajmri-3091	365	26	,	,	PUNCT
ajmri-3091	365	27	m.	m.	NOUN
ajmri-3091	365	28	,	,	PUNCT
ajmri-3091	365	29	santhoshi	santhoshi	PROPN
ajmri-3091	365	30	,	,	PUNCT
ajmri-3091	365	31	g.	g.	PROPN
ajmri-3091	365	32	,	,	PUNCT
ajmri-3091	365	33	samantaray	samantaray	VERB
ajmri-3091	365	34	,	,	PUNCT
ajmri-3091	365	35	s.	s.	PROPN
ajmri-3091	365	36	r.	r.	PROPN
ajmri-3091	365	37	,	,	PUNCT
ajmri-3091	365	38	seth	seth	PROPN
ajmri-3091	365	39	,	,	PUNCT
ajmri-3091	365	40	s.	s.	PROPN
ajmri-3091	365	41	,	,	PUNCT
ajmri-3091	365	42	trigunait	trigunait	PROPN
ajmri-3091	365	43	,	,	PUNCT
ajmri-3091	365	44	p.	p.	NOUN
ajmri-3091	365	45	,	,	PUNCT
ajmri-3091	365	46	reddy	reddy	PROPN
ajmri-3091	365	47	,	,	PUNCT
ajmri-3091	365	48	n.	n.	PROPN
ajmri-3091	365	49	j.	j.	PROPN
ajmri-3091	365	50	,	,	PUNCT
ajmri-3091	365	51	patel	patel	PROPN
ajmri-3091	365	52	,	,	PUNCT
ajmri-3091	365	53	s.	s.	PROPN
ajmri-3091	365	54	,	,	PUNCT
ajmri-3091	365	55	rani	rani	PROPN
ajmri-3091	365	56	,	,	PUNCT
ajmri-3091	365	57	s.	s.	PROPN
ajmri-3091	365	58	,	,	PUNCT
ajmri-3091	365	59	mishra	mishra	PROPN
ajmri-3091	365	60	,	,	PUNCT
ajmri-3091	365	61	r.	r.	PROPN
ajmri-3091	365	62	,	,	PUNCT
ajmri-3091	365	63	&	&	CCONJ
ajmri-3091	365	64	negi	negi	PROPN
ajmri-3091	365	65	,	,	PUNCT
ajmri-3091	365	66	k.	k.	PROPN
ajmri-3091	365	67	(	(	PUNCT
ajmri-3091	365	68	2023	2023	NUM
ajmri-3091	365	69	)	)	PUNCT
ajmri-3091	365	70	.	.	PUNCT
ajmri-3091	366	1	effect	effect	NOUN
ajmri-3091	366	2	of	of	ADP
ajmri-3091	366	3	covid-19	covid-19	PROPN
ajmri-3091	366	4	vaccination	vaccination	NOUN
ajmri-3091	366	5	on	on	ADP
ajmri-3091	366	6	menstrual	menstrual	ADJ
ajmri-3091	366	7	cycle	cycle	NOUN
ajmri-3091	366	8	patterns	pattern	NOUN
ajmri-3091	366	9	of	of	ADP
ajmri-3091	366	10	reproductiveage	reproductiveage	NOUN
ajmri-3091	366	11	women	woman	NOUN
ajmri-3091	366	12	:	:	PUNCT
ajmri-3091	366	13	a	a	DET
ajmri-3091	366	14	multi	multi	ADJ
ajmri-3091	366	15	-	-	ADJ
ajmri-3091	366	16	centric	centric	ADJ
ajmri-3091	366	17	observational	observational	ADJ
ajmri-3091	366	18	study	study	NOUN
ajmri-3091	366	19	.	.	PUNCT
ajmri-3091	367	1	current	current	ADJ
ajmri-3091	367	2	drug	drug	NOUN
ajmri-3091	367	3	research	research	NOUN
ajmri-3091	367	4	reviews	review	NOUN
ajmri-3091	367	5	,	,	PUNCT
ajmri-3091	367	6	16(2	16(2	NUM
ajmri-3091	367	7	)	)	PUNCT
ajmri-3091	367	8	,	,	PUNCT
ajmri-3091	367	9	237–248	237–248	NUM
ajmri-3091	367	10	.	.	PUNCT
ajmri-3091	368	1	https://doi.org/10.2174/258997751	https://doi.org/10.2174/258997751	NUM
ajmri-3091	368	2	5666230608140606	5666230608140606	NUM
ajmri-3091	368	3	li	li	PROPN
ajmri-3091	368	4	,	,	PUNCT
ajmri-3091	368	5	k.	k.	PROPN
ajmri-3091	368	6	,	,	PUNCT
ajmri-3091	368	7	chen	chen	PROPN
ajmri-3091	368	8	,	,	PUNCT
ajmri-3091	368	9	g.	g.	PROPN
ajmri-3091	368	10	,	,	PUNCT
ajmri-3091	368	11	hou	hou	PROPN
ajmri-3091	368	12	,	,	PUNCT
ajmri-3091	368	13	h.	h.	PROPN
ajmri-3091	368	14	,	,	PUNCT
ajmri-3091	368	15	liao	liao	PROPN
ajmri-3091	368	16	,	,	PUNCT
ajmri-3091	368	17	q.	q.	PROPN
ajmri-3091	368	18	,	,	PUNCT
ajmri-3091	368	19	chen	chen	PROPN
ajmri-3091	368	20	,	,	PUNCT
ajmri-3091	368	21	j.	j.	PROPN
ajmri-3091	368	22	,	,	PUNCT
ajmri-3091	368	23	bai	bai	PROPN
ajmri-3091	368	24	,	,	PUNCT
ajmri-3091	368	25	h.	h.	PROPN
ajmri-3091	368	26	,	,	PUNCT
ajmri-3091	368	27	lee	lee	PROPN
ajmri-3091	368	28	,	,	PUNCT
ajmri-3091	368	29	s.	s.	PROPN
ajmri-3091	368	30	,	,	PUNCT
ajmri-3091	368	31	wang	wang	PROPN
ajmri-3091	368	32	,	,	PUNCT
ajmri-3091	368	33	c.	c.	PROPN
ajmri-3091	368	34	,	,	PUNCT
ajmri-3091	368	35	li	li	PROPN
ajmri-3091	368	36	,	,	PUNCT
ajmri-3091	368	37	h.	h.	PROPN
ajmri-3091	368	38	,	,	PUNCT
ajmri-3091	368	39	&	&	CCONJ
ajmri-3091	368	40	cheng	cheng	PROPN
ajmri-3091	368	41	,	,	PUNCT
ajmri-3091	368	42	l.	l.	PROPN
ajmri-3091	368	43	(	(	PUNCT
ajmri-3091	368	44	2021	2021	NUM
ajmri-3091	368	45	)	)	PUNCT
ajmri-3091	368	46	.	.	PUNCT
ajmri-3091	369	1	analysis	analysis	NOUN
ajmri-3091	369	2	of	of	ADP
ajmri-3091	369	3	sex	sex	NOUN
ajmri-3091	369	4	hormones	hormone	NOUN
ajmri-3091	369	5	and	and	CCONJ
ajmri-3091	369	6	menstruation	menstruation	NOUN
ajmri-3091	369	7	in	in	ADP
ajmri-3091	369	8	covid-19	covid-19	PROPN
ajmri-3091	369	9	women	woman	NOUN
ajmri-3091	369	10	of	of	ADP
ajmri-3091	369	11	child	child	NOUN
ajmri-3091	369	12	-	-	PUNCT
ajmri-3091	369	13	bearing	bear	VERB
ajmri-3091	369	14	age	age	NOUN
ajmri-3091	369	15	.	.	PUNCT
ajmri-3091	370	1	reproductive	reproductive	ADJ
ajmri-3091	370	2	biomedicine	biomedicine	NOUN
ajmri-3091	370	3	online	online	NOUN
ajmri-3091	370	4	,	,	PUNCT
ajmri-3091	370	5	42(1	42(1	NOUN
ajmri-3091	370	6	)	)	PUNCT
ajmri-3091	370	7	,	,	PUNCT
ajmri-3091	370	8	260	260	NUM
ajmri-3091	370	9	-	-	SYM
ajmri-3091	370	10	267	267	NUM
ajmri-3091	370	11	.	.	PUNCT
ajmri-3091	371	1	male	male	NOUN
ajmri-3091	371	2	,	,	PUNCT
ajmri-3091	371	3	v.	v.	CCONJ
ajmri-3091	371	4	(	(	PUNCT
ajmri-3091	371	5	2021	2021	NUM
ajmri-3091	371	6	)	)	PUNCT
ajmri-3091	371	7	.	.	PUNCT
ajmri-3091	372	1	menstrual	menstrual	ADJ
ajmri-3091	372	2	changes	change	NOUN
ajmri-3091	372	3	after	after	ADP
ajmri-3091	372	4	covid-19	covid-19	PROPN
ajmri-3091	372	5	vaccination	vaccination	NOUN
ajmri-3091	372	6	.	.	PUNCT
ajmri-3091	373	1	bmj	bmj	PROPN
ajmri-3091	373	2	,	,	PUNCT
ajmri-3091	373	3	n2211	n2211	PROPN
ajmri-3091	373	4	.	.	PUNCT
ajmri-3091	374	1	https://doi.org/10.1136/	https://doi.org/10.1136/	PROPN
ajmri-3091	374	2	bmj.n2211	bmj.n2211	PROPN
ajmri-3091	374	3	moreira	moreira	PROPN
ajmri-3091	374	4	jr	jr	PROPN
ajmri-3091	374	5	,	,	PUNCT
ajmri-3091	374	6	e.	e.	PROPN
ajmri-3091	374	7	d.	d.	PROPN
ajmri-3091	374	8	,	,	PUNCT
ajmri-3091	374	9	kitchin	kitchin	PROPN
ajmri-3091	374	10	,	,	PUNCT
ajmri-3091	374	11	n.	n.	PROPN
ajmri-3091	374	12	,	,	PUNCT
ajmri-3091	374	13	xu	xu	PROPN
ajmri-3091	374	14	,	,	PUNCT
ajmri-3091	374	15	x.	x.	NOUN
ajmri-3091	374	16	,	,	PUNCT
ajmri-3091	374	17	dychter	dychter	PROPN
ajmri-3091	374	18	,	,	PUNCT
ajmri-3091	374	19	s.	s.	PROPN
ajmri-3091	374	20	s.	s.	PROPN
ajmri-3091	374	21	,	,	PUNCT
ajmri-3091	374	22	lockhart	lockhart	PROPN
ajmri-3091	374	23	,	,	PUNCT
ajmri-3091	374	24	s.	s.	PROPN
ajmri-3091	374	25	,	,	PUNCT
ajmri-3091	374	26	gurtman	gurtman	NOUN
ajmri-3091	374	27	,	,	PUNCT
ajmri-3091	374	28	a.	a.	NOUN
ajmri-3091	374	29	,	,	PUNCT
ajmri-3091	374	30	perez	perez	PROPN
ajmri-3091	374	31	,	,	PUNCT
ajmri-3091	374	32	j.	j.	PROPN
ajmri-3091	374	33	l.	l.	PROPN
ajmri-3091	374	34	,	,	PUNCT
ajmri-3091	374	35	zerbini	zerbini	PROPN
ajmri-3091	374	36	,	,	PUNCT
ajmri-3091	374	37	c.	c.	PROPN
ajmri-3091	374	38	,	,	PUNCT
ajmri-3091	374	39	dever	dever	PROPN
ajmri-3091	374	40	,	,	PUNCT
ajmri-3091	374	41	m.	m.	PROPN
ajmri-3091	374	42	e.	e.	PROPN
ajmri-3091	374	43	,	,	PUNCT
ajmri-3091	374	44	&	&	CCONJ
ajmri-3091	374	45	jennings	jennings	PROPN
ajmri-3091	374	46	,	,	PUNCT
ajmri-3091	374	47	t.	t.	PROPN
ajmri-3091	374	48	w.	w.	PROPN
ajmri-3091	374	49	(	(	PUNCT
ajmri-3091	374	50	2022	2022	NUM
ajmri-3091	374	51	)	)	PUNCT
ajmri-3091	374	52	.	.	PUNCT
ajmri-3091	375	1	safety	safety	NOUN
ajmri-3091	375	2	and	and	CCONJ
ajmri-3091	375	3	efficacy	efficacy	NOUN
ajmri-3091	375	4	of	of	ADP
ajmri-3091	375	5	a	a	DET
ajmri-3091	375	6	third	third	ADJ
ajmri-3091	375	7	dose	dose	NOUN
ajmri-3091	375	8	of	of	ADP
ajmri-3091	375	9	bnt162b2	bnt162b2	PROPN
ajmri-3091	375	10	covid-19	covid-19	PROPN
ajmri-3091	375	11	vaccine	vaccine	NOUN
ajmri-3091	375	12	.	.	PUNCT
ajmri-3091	376	1	new	new	PROPN
ajmri-3091	376	2	england	england	PROPN
ajmri-3091	376	3	journal	journal	PROPN
ajmri-3091	376	4	of	of	ADP
ajmri-3091	376	5	medicine	medicine	NOUN
ajmri-3091	376	6	,	,	PUNCT
ajmri-3091	376	7	386(20	386(20	NUM
ajmri-3091	376	8	)	)	PUNCT
ajmri-3091	376	9	,	,	PUNCT
ajmri-3091	376	10	19101921	19101921	NUM
ajmri-3091	376	11	.	.	PUNCT
ajmri-3091	377	1	muhaidat	muhaidat	NOUN
ajmri-3091	377	2	,	,	PUNCT
ajmri-3091	377	3	n.	n.	NOUN
ajmri-3091	377	4	,	,	PUNCT
ajmri-3091	377	5	alshrouf	alshrouf	PROPN
ajmri-3091	377	6	,	,	PUNCT
ajmri-3091	377	7	m.	m.	NOUN
ajmri-3091	377	8	a.	a.	PROPN
ajmri-3091	377	9	,	,	PUNCT
ajmri-3091	377	10	azzam	azzam	PROPN
ajmri-3091	377	11	,	,	PUNCT
ajmri-3091	377	12	m.	m.	NOUN
ajmri-3091	377	13	i.	i.	PROPN
ajmri-3091	377	14	,	,	PUNCT
ajmri-3091	377	15	karam	karam	PROPN
ajmri-3091	377	16	,	,	PUNCT
ajmri-3091	377	17	a.	a.	NOUN
ajmri-3091	377	18	m.	m.	NOUN
ajmri-3091	377	19	,	,	PUNCT
ajmri-3091	377	20	al	al	PROPN
ajmri-3091	377	21	-	-	PUNCT
ajmri-3091	377	22	nazer	nazer	PROPN
ajmri-3091	377	23	,	,	PUNCT
ajmri-3091	377	24	m.	m.	NOUN
ajmri-3091	377	25	w.	w.	PROPN
ajmri-3091	377	26	,	,	PUNCT
ajmri-3091	377	27	&	&	CCONJ
ajmri-3091	377	28	al	al	PROPN
ajmri-3091	377	29	-	-	PUNCT
ajmri-3091	377	30	ani	ani	PROPN
ajmri-3091	377	31	,	,	PUNCT
ajmri-3091	377	32	a.	a.	NOUN
ajmri-3091	377	33	(	(	PUNCT
ajmri-3091	377	34	2022	2022	NUM
ajmri-3091	377	35	)	)	PUNCT
ajmri-3091	377	36	.	.	PUNCT
ajmri-3091	378	1	menstrual	menstrual	ADJ
ajmri-3091	378	2	symptoms	symptom	NOUN
ajmri-3091	378	3	after	after	ADP
ajmri-3091	378	4	covid-19	covid-19	PROPN
ajmri-3091	378	5	vaccine	vaccine	NOUN
ajmri-3091	378	6	:	:	PUNCT
ajmri-3091	378	7	a	a	DET
ajmri-3091	378	8	cross	cross	ADJ
ajmri-3091	378	9	-	-	ADJ
ajmri-3091	378	10	sectional	sectional	ADJ
ajmri-3091	378	11	investigation	investigation	NOUN
ajmri-3091	378	12	in	in	ADP
ajmri-3091	378	13	the	the	DET
ajmri-3091	378	14	mena	mena	PROPN
ajmri-3091	378	15	region	region	PROPN
ajmri-3091	378	16	.	.	PUNCT
ajmri-3091	379	1	international	international	ADJ
ajmri-3091	379	2	journal	journal	PROPN
ajmri-3091	379	3	of	of	ADP
ajmri-3091	379	4	women	woman	NOUN
ajmri-3091	379	5	’s	’s	PART
ajmri-3091	379	6	health	health	NOUN
ajmri-3091	379	7	,	,	PUNCT
ajmri-3091	379	8	395	395	NUM
ajmri-3091	379	9	-	-	SYM
ajmri-3091	379	10	404	404	NUM
ajmri-3091	379	11	.	.	PUNCT
ajmri-3091	380	1	murray	murray	PROPN
ajmri-3091	380	2	,	,	PUNCT
ajmri-3091	380	3	c.	c.	PROPN
ajmri-3091	380	4	m.	m.	PROPN
ajmri-3091	380	5	,	,	PUNCT
ajmri-3091	380	6	&	&	CCONJ
ajmri-3091	380	7	orr	orr	PROPN
ajmri-3091	380	8	,	,	PUNCT
ajmri-3091	380	9	c.	c.	PROPN
ajmri-3091	380	10	j.	j.	PROPN
ajmri-3091	380	11	(	(	PUNCT
ajmri-3091	380	12	2019	2019	NUM
ajmri-3091	380	13	)	)	PUNCT
ajmri-3091	380	14	.	.	PUNCT
ajmri-3091	381	1	hormonal	hormonal	ADJ
ajmri-3091	381	2	regulation	regulation	NOUN
ajmri-3091	381	3	of	of	ADP
ajmri-3091	381	4	the	the	DET
ajmri-3091	381	5	menstrual	menstrual	ADJ
ajmri-3091	381	6	cycle	cycle	NOUN
ajmri-3091	381	7	and	and	CCONJ
ajmri-3091	381	8	ovulation	ovulation	NOUN
ajmri-3091	381	9	.	.	PUNCT
ajmri-3091	382	1	in	in	ADP
ajmri-3091	382	2	elsevier	elsevier	PROPN
ajmri-3091	382	3	ebooks	ebooks	PROPN
ajmri-3091	382	4	(	(	PUNCT
ajmri-3091	382	5	pp	pp	ADJ
ajmri-3091	382	6	.	.	PUNCT
ajmri-3091	382	7	159–167	159–167	NUM
ajmri-3091	382	8	)	)	PUNCT
ajmri-3091	382	9	.	.	PUNCT
ajmri-3091	383	1	https://doi.org/10.1016/b9780-12-814823-5.00012-x	https://doi.org/10.1016/b9780-12-814823-5.00012-x	PROPN
ajmri-3091	383	2	world	world	PROPN
ajmri-3091	383	3	health	health	PROPN
ajmri-3091	383	4	organization	organization	NOUN
ajmri-3091	383	5	:	:	PUNCT
ajmri-3091	383	6	who	who	PRON
ajmri-3091	383	7	.	.	PUNCT
ajmri-3091	384	1	(	(	PUNCT
ajmri-3091	384	2	2021	2021	NUM
ajmri-3091	384	3	,	,	PUNCT
ajmri-3091	384	4	july	july	PROPN
ajmri-3091	384	5	9	9	NUM
ajmri-3091	384	6	)	)	PUNCT
ajmri-3091	384	7	.	.	PUNCT
ajmri-3091	385	1	covid-19	covid-19	PROPN
ajmri-3091	385	2	subcommittee	subcommittee	NOUN
ajmri-3091	385	3	of	of	ADP
ajmri-3091	385	4	the	the	DET
ajmri-3091	385	5	who	who	PRON
ajmri-3091	385	6	global	global	ADJ
ajmri-3091	385	7	advisory	advisory	PROPN
ajmri-3091	385	8	committee	committee	NOUN
ajmri-3091	385	9	on	on	ADP
ajmri-3091	385	10	vaccine	vaccine	NOUN
ajmri-3091	385	11	safety	safety	NOUN
ajmri-3091	385	12	(	(	PUNCT
ajmri-3091	385	13	gacvs	gacvs	PROPN
ajmri-3091	385	14	):	):	PUNCT
ajmri-3091	385	15	updated	update	VERB
ajmri-3091	385	16	guidance	guidance	NOUN
ajmri-3091	385	17	regarding	regard	VERB
ajmri-3091	385	18	myocarditis	myocarditis	ADJ
ajmri-3091	385	19	and	and	CCONJ
ajmri-3091	385	20	pericarditis	pericarditis	PROPN
ajmri-3091	385	21	reported	report	VERB
ajmri-3091	385	22	with	with	ADP
ajmri-3091	385	23	covid-19	covid-19	PROPN
ajmri-3091	385	24	mrna	mrna	PROPN
ajmri-3091	385	25	vaccines	vaccine	NOUN
ajmri-3091	385	26	.	.	PUNCT
ajmri-3091	386	1	in	in	ADP
ajmri-3091	386	2	.	.	PUNCT
ajmri-3091	387	1	https://www.who.int/news/item/0907-2021-gacvs-guidance-myocarditis-pericarditiscovid-19-mrna-vaccines	https://www.who.int/news/item/0907-2021-gacvs-guidance-myocarditis-pericarditiscovid-19-mrna-vaccine	NOUN
ajmri-3091	387	2	patricio	patricio	PROPN
ajmri-3091	387	3	,	,	PUNCT
ajmri-3091	387	4	b.-p	b.-p	PROPN
ajmri-3091	387	5	.	.	PUNCT
ajmri-3091	387	6	,	,	PUNCT
ajmri-3091	387	7	&	&	CCONJ
ajmri-3091	387	8	sergio	sergio	PROPN
ajmri-3091	387	9	,	,	PUNCT
ajmri-3091	387	10	b.-g	b.-g	PROPN
ajmri-3091	387	11	.	.	PUNCT
ajmri-3091	388	1	(	(	PUNCT
ajmri-3091	388	2	2019	2019	NUM
ajmri-3091	388	3	)	)	PUNCT
ajmri-3091	388	4	.	.	PUNCT
ajmri-3091	389	1	normal	normal	ADJ
ajmri-3091	389	2	menstrual	menstrual	ADJ
ajmri-3091	389	3	cycle	cycle	NOUN
ajmri-3091	389	4	.	.	PUNCT
ajmri-3091	390	1	menstrual	menstrual	ADJ
ajmri-3091	390	2	cycle	cycle	NOUN
ajmri-3091	390	3	,	,	PUNCT
ajmri-3091	390	4	15	15	NUM
ajmri-3091	390	5	.	.	PUNCT
ajmri-3091	390	6	polack	polack	PROPN
ajmri-3091	390	7	,	,	PUNCT
ajmri-3091	390	8	f.	f.	PROPN
ajmri-3091	390	9	p.	p.	PROPN
ajmri-3091	390	10	,	,	PUNCT
ajmri-3091	390	11	thomas	thomas	PROPN
ajmri-3091	390	12	,	,	PUNCT
ajmri-3091	390	13	s.	s.	PROPN
ajmri-3091	390	14	j.	j.	PROPN
ajmri-3091	390	15	,	,	PUNCT
ajmri-3091	390	16	kitchin	kitchin	PROPN
ajmri-3091	390	17	,	,	PUNCT
ajmri-3091	390	18	n.	n.	NOUN
ajmri-3091	390	19	,	,	PUNCT
ajmri-3091	390	20	absalon	absalon	PROPN
ajmri-3091	390	21	,	,	PUNCT
ajmri-3091	390	22	j.	j.	PROPN
ajmri-3091	390	23	,	,	PUNCT
ajmri-3091	390	24	gurtman	gurtman	NOUN
ajmri-3091	390	25	,	,	PUNCT
ajmri-3091	390	26	a.	a.	NOUN
ajmri-3091	390	27	,	,	PUNCT
ajmri-3091	390	28	lockhart	lockhart	PROPN
ajmri-3091	390	29	,	,	PUNCT
ajmri-3091	390	30	s.	s.	PROPN
ajmri-3091	390	31	,	,	PUNCT
ajmri-3091	390	32	perez	perez	PROPN
ajmri-3091	390	33	,	,	PUNCT
ajmri-3091	390	34	j.	j.	PROPN
ajmri-3091	390	35	l.	l.	PROPN
ajmri-3091	390	36	,	,	PUNCT
ajmri-3091	390	37	pérez	pérez	NOUN
ajmri-3091	390	38	marc	marc	PROPN
ajmri-3091	390	39	,	,	PUNCT
ajmri-3091	390	40	g.	g.	PROPN
ajmri-3091	390	41	,	,	PUNCT
ajmri-3091	390	42	moreira	moreira	PROPN
ajmri-3091	390	43	,	,	PUNCT
ajmri-3091	390	44	e.	e.	PROPN
ajmri-3091	390	45	d.	d.	PROPN
ajmri-3091	390	46	,	,	PUNCT
ajmri-3091	390	47	&	&	CCONJ
ajmri-3091	390	48	zerbini	zerbini	PROPN
ajmri-3091	390	49	,	,	PUNCT
ajmri-3091	390	50	c.	c.	PROPN
ajmri-3091	390	51	(	(	PUNCT
ajmri-3091	390	52	2020	2020	NUM
ajmri-3091	390	53	)	)	PUNCT
ajmri-3091	390	54	.	.	PUNCT
ajmri-3091	391	1	safety	safety	NOUN
ajmri-3091	391	2	and	and	CCONJ
ajmri-3091	391	3	efficacy	efficacy	NOUN
ajmri-3091	391	4	of	of	ADP
ajmri-3091	391	5	the	the	DET
ajmri-3091	391	6	bnt162b2	bnt162b2	PROPN
ajmri-3091	391	7	mrna	mrna	PROPN
ajmri-3091	391	8	covid-19	covid-19	PROPN
ajmri-3091	391	9	vaccine	vaccine	NOUN
ajmri-3091	391	10	.	.	PUNCT
ajmri-3091	392	1	new	new	PROPN
ajmri-3091	392	2	england	england	PROPN
ajmri-3091	392	3	journal	journal	PROPN
ajmri-3091	392	4	of	of	ADP
ajmri-3091	392	5	medicine	medicine	NOUN
ajmri-3091	392	6	,	,	PUNCT
ajmri-3091	392	7	383(27	383(27	NUM
ajmri-3091	392	8	)	)	PUNCT
ajmri-3091	392	9	,	,	PUNCT
ajmri-3091	392	10	2603	2603	NUM
ajmri-3091	392	11	-	-	SYM
ajmri-3091	392	12	2615	2615	NUM
ajmri-3091	392	13	.	.	PUNCT
ajmri-3091	393	1	qashqari	qashqari	PROPN
ajmri-3091	393	2	,	,	PUNCT
ajmri-3091	393	3	f.	f.	PROPN
ajmri-3091	393	4	s.	s.	PROPN
ajmri-3091	393	5	,	,	PUNCT
ajmri-3091	393	6	dahlawi	dahlawi	PROPN
ajmri-3091	393	7	,	,	PUNCT
ajmri-3091	393	8	m.	m.	NOUN
ajmri-3091	393	9	,	,	PUNCT
ajmri-3091	393	10	assaggaf	assaggaf	PROPN
ajmri-3091	393	11	,	,	PUNCT
ajmri-3091	393	12	h.	h.	PROPN
ajmri-3091	393	13	m.	m.	PROPN
ajmri-3091	393	14	,	,	PUNCT
ajmri-3091	393	15	alsafi	alsafi	PROPN
ajmri-3091	393	16	,	,	PUNCT
ajmri-3091	393	17	r.	r.	PROPN
ajmri-3091	393	18	,	,	PUNCT
ajmri-3091	393	19	gari	gari	PROPN
ajmri-3091	393	20	,	,	PUNCT
ajmri-3091	393	21	a.	a.	NOUN
ajmri-3091	393	22	,	,	PUNCT
ajmri-3091	393	23	abudawood	abudawood	PROPN
ajmri-3091	393	24	,	,	PUNCT
ajmri-3091	393	25	a.	a.	PROPN
ajmri-3091	393	26	,	,	PUNCT
ajmri-3091	393	27	al	al	PROPN
ajmri-3091	393	28	-	-	PUNCT
ajmri-3091	393	29	doboke	doboke	PROPN
ajmri-3091	393	30	,	,	PUNCT
ajmri-3091	393	31	a.	a.	NOUN
ajmri-3091	393	32	,	,	PUNCT
ajmri-3091	393	33	alsulami	alsulami	PROPN
ajmri-3091	393	34	,	,	PUNCT
ajmri-3091	393	35	s.	s.	PROPN
ajmri-3091	393	36	,	,	PUNCT
ajmri-3091	393	37	bukhari	bukhari	PROPN
ajmri-3091	393	38	,	,	PUNCT
ajmri-3091	393	39	r.	r.	PROPN
ajmri-3091	393	40	,	,	PUNCT
ajmri-3091	393	41	&	&	CCONJ
ajmri-3091	393	42	majeed	majeed	PROPN
ajmri-3091	393	43	,	,	PUNCT
ajmri-3091	393	44	s.	s.	PROPN
ajmri-3091	393	45	a.	a.	PROPN
ajmri-3091	393	46	(	(	PUNCT
ajmri-3091	393	47	2022	2022	NUM
ajmri-3091	393	48	)	)	PUNCT
ajmri-3091	393	49	.	.	PUNCT
ajmri-3091	394	1	effect	effect	NOUN
ajmri-3091	394	2	of	of	ADP
ajmri-3091	394	3	the	the	DET
ajmri-3091	394	4	covid-19	covid-19	PROPN
ajmri-3091	394	5	vaccine	vaccine	NOUN
ajmri-3091	394	6	on	on	ADP
ajmri-3091	394	7	the	the	DET
ajmri-3091	394	8	menstrual	menstrual	ADJ
ajmri-3091	394	9	cycle	cycle	NOUN
ajmri-3091	394	10	among	among	ADP
ajmri-3091	394	11	females	female	NOUN
ajmri-3091	394	12	in	in	ADP
ajmri-3091	394	13	saudi	saudi	PROPN
ajmri-3091	394	14	arabia	arabia	PROPN
ajmri-3091	394	15	.	.	PUNCT
ajmri-3091	395	1	ethiopian	ethiopian	PROPN
ajmri-3091	395	2	journal	journal	PROPN
ajmri-3091	395	3	of	of	ADP
ajmri-3091	395	4	health	health	PROPN
ajmri-3091	395	5	sciences	sciences	PROPN
ajmri-3091	395	6	,	,	PUNCT
ajmri-3091	395	7	32(6	32(6	NUM
ajmri-3091	395	8	)	)	PUNCT
ajmri-3091	395	9	.	.	PUNCT
ajmri-3091	396	1	reed	reed	PROPN
ajmri-3091	396	2	,	,	PUNCT
ajmri-3091	396	3	b.	b.	PROPN
ajmri-3091	396	4	g.	g.	PROPN
ajmri-3091	396	5	,	,	PUNCT
ajmri-3091	396	6	&	&	CCONJ
ajmri-3091	396	7	carr	carr	PROPN
ajmri-3091	396	8	,	,	PUNCT
ajmri-3091	396	9	b.	b.	PROPN
ajmri-3091	396	10	r.	r.	PROPN
ajmri-3091	396	11	(	(	PUNCT
ajmri-3091	396	12	2018	2018	NUM
ajmri-3091	396	13	,	,	PUNCT
ajmri-3091	396	14	august	august	PROPN
ajmri-3091	396	15	5	5	NUM
ajmri-3091	396	16	)	)	PUNCT
ajmri-3091	396	17	.	.	PUNCT
ajmri-3091	397	1	the	the	DET
ajmri-3091	397	2	normal	normal	ADJ
ajmri-3091	397	3	menstrual	menstrual	ADJ
ajmri-3091	397	4	cycle	cycle	NOUN
ajmri-3091	397	5	and	and	CCONJ
ajmri-3091	397	6	the	the	DET
ajmri-3091	397	7	control	control	NOUN
ajmri-3091	397	8	of	of	ADP
ajmri-3091	397	9	ovulation	ovulation	NOUN
ajmri-3091	397	10	.	.	PUNCT
ajmri-3091	398	1	endotext	endotext	NOUN
ajmri-3091	398	2	ncbi	ncbi	PROPN
ajmri-3091	398	3	bookshelf	bookshelf	PROPN
ajmri-3091	398	4	.	.	PUNCT
ajmri-3091	399	1	https://www.ncbi.nlm.nih.gov/	https://www.ncbi.nlm.nih.gov/	PROPN
ajmri-3091	399	2	books	books	PROPN
ajmri-3091	399	3	/	/	SYM
ajmri-3091	399	4	nbk279054/	nbk279054/	PROPN
ajmri-3091	399	5	roos	roo	NOUN
ajmri-3091	399	6	,	,	PUNCT
ajmri-3091	399	7	e.	e.	PROPN
ajmri-3091	399	8	j.	j.	PROPN
ajmri-3091	399	9	,	,	PUNCT
ajmri-3091	399	10	simms	simms	PROPN
ajmri-3091	399	11	-	-	PUNCT
ajmri-3091	399	12	cendan	cendan	PROPN
ajmri-3091	399	13	,	,	PUNCT
ajmri-3091	399	14	j.	j.	PROPN
ajmri-3091	399	15	,	,	PUNCT
ajmri-3091	399	16	cheung	cheung	PROPN
ajmri-3091	399	17	,	,	PUNCT
ajmri-3091	399	18	c.	c.	PROPN
ajmri-3091	399	19	,	,	PUNCT
ajmri-3091	399	20	laufer	laufer	NOUN
ajmri-3091	399	21	,	,	PUNCT
ajmri-3091	399	22	d.	d.	PROPN
ajmri-3091	399	23	,	,	PUNCT
ajmri-3091	399	24	&	&	CCONJ
ajmri-3091	399	25	grover	grover	PROPN
ajmri-3091	399	26	,	,	PUNCT
ajmri-3091	399	27	s.	s.	PROPN
ajmri-3091	399	28	r.	r.	PROPN
ajmri-3091	399	29	(	(	PUNCT
ajmri-3091	399	30	2021	2021	NUM
ajmri-3091	399	31	)	)	PUNCT
ajmri-3091	399	32	.	.	PUNCT
ajmri-3091	400	1	pediatric	pediatric	ADJ
ajmri-3091	400	2	and	and	CCONJ
ajmri-3091	400	3	adolescent	adolescent	ADJ
ajmri-3091	400	4	gynecology	gynecology	NOUN
ajmri-3091	400	5	through	through	ADP
ajmri-3091	400	6	a	a	DET
ajmri-3091	400	7	global	global	ADJ
ajmri-3091	400	8	lens	len	NOUN
ajmri-3091	400	9	.	.	PUNCT
ajmri-3091	401	1	international	international	ADJ
ajmri-3091	401	2	journal	journal	PROPN
ajmri-3091	401	3	of	of	ADP
ajmri-3091	401	4	gynecology	gynecology	NOUN
ajmri-3091	401	5	&	&	CCONJ
ajmri-3091	401	6	obstetrics	obstetric	NOUN
ajmri-3091	401	7	,	,	PUNCT
ajmri-3091	401	8	156(2	156(2	NUM
ajmri-3091	401	9	)	)	PUNCT
ajmri-3091	401	10	,	,	PUNCT
ajmri-3091	401	11	189–196	189–196	NUM
ajmri-3091	401	12	.	.	PUNCT
ajmri-3091	402	1	https://	https://	PROPN
ajmri-3091	402	2	doi.org/10.1002/ijgo.13723	doi.org/10.1002/ijgo.13723	PROPN
ajmri-3091	402	3	saleh	saleh	PROPN
ajmri-3091	402	4	alzahrani	alzahrani	PROPN
ajmri-3091	402	5	,	,	PUNCT
ajmri-3091	402	6	h.	h.	PROPN
ajmri-3091	402	7	,	,	PUNCT
ajmri-3091	402	8	ali	ali	PROPN
ajmri-3091	402	9	algashami	algashami	PROPN
ajmri-3091	402	10	,	,	PUNCT
ajmri-3091	402	11	s.	s.	PROPN
ajmri-3091	402	12	,	,	PUNCT
ajmri-3091	402	13	abdulaziz	abdulaziz	PROPN
ajmri-3091	402	14	alharkan	alharkan	PROPN
ajmri-3091	402	15	,	,	PUNCT
ajmri-3091	402	16	a.	a.	NOUN
ajmri-3091	402	17	,	,	PUNCT
ajmri-3091	402	18	sultan	sultan	PROPN
ajmri-3091	402	19	alotaibi	alotaibi	NOUN
ajmri-3091	402	20	,	,	PUNCT
ajmri-3091	402	21	n.	n.	NOUN
ajmri-3091	402	22	,	,	PUNCT
ajmri-3091	402	23	&	&	CCONJ
ajmri-3091	402	24	waseem	waseem	PROPN
ajmri-3091	402	25	algahs	algahs	PROPN
ajmri-3091	402	26	,	,	PUNCT
ajmri-3091	402	27	n.	n.	NOUN
ajmri-3091	402	28	(	(	PUNCT
ajmri-3091	402	29	2023	2023	NUM
ajmri-3091	402	30	)	)	PUNCT
ajmri-3091	402	31	.	.	PUNCT
ajmri-3091	403	1	the	the	DET
ajmri-3091	403	2	effect	effect	NOUN
ajmri-3091	403	3	of	of	ADP
ajmri-3091	403	4	covid-19	covid-19	PROPN
ajmri-3091	403	5	vaccination	vaccination	NOUN
ajmri-3091	403	6	on	on	ADP
ajmri-3091	403	7	the	the	DET
ajmri-3091	403	8	menstrual	menstrual	ADJ
ajmri-3091	403	9	cycle	cycle	NOUN
ajmri-3091	403	10	in	in	ADP
ajmri-3091	403	11	female	female	NOUN
ajmri-3091	403	12	in	in	ADP
ajmri-3091	403	13	riyadh	riyadh	PROPN
ajmri-3091	403	14	,	,	PUNCT
ajmri-3091	403	15	saudi	saudi	PROPN
ajmri-3091	403	16	arabia	arabia	PROPN
ajmri-3091	403	17	.	.	PUNCT
ajmri-3091	404	1	saudi	saudi	ADJ
ajmri-3091	404	2	pharmaceutical	pharmaceutical	PROPN
ajmri-3091	404	3	journal	journal	NOUN
ajmri-3091	404	4	,	,	PUNCT
ajmri-3091	404	5	31(5	31(5	NUM
ajmri-3091	404	6	)	)	PUNCT
ajmri-3091	404	7	,	,	PUNCT
ajmri-3091	404	8	746	746	NUM
ajmri-3091	404	9	-	-	SYM
ajmri-3091	404	10	751	751	NUM
ajmri-3091	404	11	.	.	PUNCT
ajmri-3091	405	1	https://doi	https://doi	PROPN
ajmri-3091	405	2	.	.	PUNCT
ajmri-3091	405	3	org	org	PROPN
ajmri-3091	405	4	/	/	SYM
ajmri-3091	405	5	https://doi.org/10.1016	https://doi.org/10.1016	PROPN
ajmri-3091	405	6	/	/	SYM
ajmri-3091	405	7	j.jsps.2023.03.015	j.jsps.2023.03.015	PROPN
ajmri-3091	405	8	schmalenberger	schmalenberger	NOUN
ajmri-3091	405	9	,	,	PUNCT
ajmri-3091	405	10	k.	k.	PROPN
ajmri-3091	405	11	m.	m.	PROPN
ajmri-3091	405	12	,	,	PUNCT
ajmri-3091	405	13	tauseef	tauseef	PROPN
ajmri-3091	405	14	,	,	PUNCT
ajmri-3091	405	15	h.	h.	PROPN
ajmri-3091	405	16	a.	a.	PROPN
ajmri-3091	405	17	,	,	PUNCT
ajmri-3091	405	18	barone	barone	PROPN
ajmri-3091	405	19	,	,	PUNCT
ajmri-3091	405	20	j.	j.	PROPN
ajmri-3091	405	21	c.	c.	PROPN
ajmri-3091	405	22	,	,	PUNCT
ajmri-3091	405	23	owens	owens	PROPN
ajmri-3091	405	24	,	,	PUNCT
ajmri-3091	405	25	s.	s.	PROPN
ajmri-3091	405	26	a.	a.	PROPN
ajmri-3091	405	27	,	,	PUNCT
ajmri-3091	405	28	lieberman	lieberman	PROPN
ajmri-3091	405	29	,	,	PUNCT
ajmri-3091	405	30	l.	l.	PROPN
ajmri-3091	405	31	,	,	PUNCT
ajmri-3091	405	32	jarczok	jarczok	PROPN
ajmri-3091	405	33	,	,	PUNCT
ajmri-3091	405	34	m.	m.	PROPN
ajmri-3091	405	35	n.	n.	PROPN
ajmri-3091	405	36	,	,	PUNCT
ajmri-3091	405	37	girdler	girdler	PROPN
ajmri-3091	405	38	,	,	PUNCT
ajmri-3091	405	39	s.	s.	PROPN
ajmri-3091	405	40	s.	s.	PROPN
ajmri-3091	405	41	,	,	PUNCT
ajmri-3091	405	42	kiesner	kiesner	PROPN
ajmri-3091	405	43	,	,	PUNCT
ajmri-3091	405	44	j.	j.	PROPN
ajmri-3091	405	45	,	,	PUNCT
ajmri-3091	405	46	ditzen	ditzen	PROPN
ajmri-3091	405	47	,	,	PUNCT
ajmri-3091	405	48	b.	b.	PROPN
ajmri-3091	405	49	,	,	PUNCT
ajmri-3091	405	50	&	&	CCONJ
ajmri-3091	405	51	eisenlohr	eisenlohr	NOUN
ajmri-3091	405	52	-	-	PUNCT
ajmri-3091	405	53	moul	moul	NOUN
ajmri-3091	405	54	,	,	PUNCT
ajmri-3091	405	55	t.	t.	NOUN
ajmri-3091	405	56	a.	a.	NOUN
ajmri-3091	405	57	(	(	PUNCT
ajmri-3091	405	58	2020	2020	NUM
ajmri-3091	405	59	)	)	PUNCT
ajmri-3091	405	60	.	.	PUNCT
ajmri-3091	406	1	how	how	SCONJ
ajmri-3091	406	2	to	to	PART
ajmri-3091	406	3	study	study	VERB
ajmri-3091	406	4	the	the	DET
ajmri-3091	406	5	menstrual	menstrual	ADJ
ajmri-3091	406	6	cycle	cycle	NOUN
ajmri-3091	406	7	:	:	PUNCT
ajmri-3091	406	8	practical	practical	ADJ
ajmri-3091	406	9	tools	tool	NOUN
ajmri-3091	406	10	and	and	CCONJ
ajmri-3091	406	11	recommendations	recommendation	NOUN
ajmri-3091	406	12	.	.	PUNCT
ajmri-3091	407	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
ajmri-3091	407	2	,	,	PUNCT
ajmri-3091	407	3	123	123	NUM
ajmri-3091	407	4	,	,	PUNCT
ajmri-3091	407	5	104895	104895	NUM
ajmri-3091	407	6	.	.	PUNCT
ajmri-3091	408	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
ajmri-3091	408	2	.	.	PUNCT
ajmri-3091	409	1	psyneuen.2020.104895	psyneuen.2020.104895	PROPN
ajmri-3091	409	2	pa	pa	PROPN
ajmri-3091	409	3	ge	ge	PROPN
ajmri-3091	409	4	24	24	NUM
ajmri-3091	410	1	https://journals.e-palli.com/home/index.php/ajmri	https://journals.e-palli.com/home/index.php/ajmri	PROPN
ajmri-3091	410	2	am	am	NOUN
ajmri-3091	410	3	.	.	PUNCT
ajmri-3091	411	1	j.	j.	PROPN
ajmri-3091	411	2	multidis	multidis	PROPN
ajmri-3091	411	3	.	.	PUNCT
ajmri-3091	412	1	res	re	NOUN
ajmri-3091	412	2	.	.	PUNCT
ajmri-3091	413	1	innov	innov	PROPN
ajmri-3091	413	2	.	.	PUNCT
ajmri-3091	414	1	3(6	3(6	PROPN
ajmri-3091	414	2	)	)	PUNCT
ajmri-3091	414	3	12	12	NUM
ajmri-3091	414	4	-	-	SYM
ajmri-3091	414	5	24	24	NUM
ajmri-3091	414	6	,	,	PUNCT
ajmri-3091	414	7	2024	2024	NUM
ajmri-3091	414	8	schmalenberger	schmalenberger	NOUN
ajmri-3091	414	9	,	,	PUNCT
ajmri-3091	414	10	k.	k.	PROPN
ajmri-3091	414	11	m.	m.	PROPN
ajmri-3091	414	12	,	,	PUNCT
ajmri-3091	414	13	tauseef	tauseef	PROPN
ajmri-3091	414	14	,	,	PUNCT
ajmri-3091	414	15	h.	h.	PROPN
ajmri-3091	414	16	a.	a.	PROPN
ajmri-3091	414	17	,	,	PUNCT
ajmri-3091	414	18	barone	barone	PROPN
ajmri-3091	414	19	,	,	PUNCT
ajmri-3091	414	20	j.	j.	PROPN
ajmri-3091	414	21	c.	c.	PROPN
ajmri-3091	414	22	,	,	PUNCT
ajmri-3091	414	23	owens	owens	PROPN
ajmri-3091	414	24	,	,	PUNCT
ajmri-3091	414	25	s.	s.	PROPN
ajmri-3091	414	26	a.	a.	PROPN
ajmri-3091	414	27	,	,	PUNCT
ajmri-3091	414	28	lieberman	lieberman	PROPN
ajmri-3091	414	29	,	,	PUNCT
ajmri-3091	414	30	l.	l.	PROPN
ajmri-3091	414	31	,	,	PUNCT
ajmri-3091	414	32	jarczok	jarczok	PROPN
ajmri-3091	414	33	,	,	PUNCT
ajmri-3091	414	34	m.	m.	PROPN
ajmri-3091	414	35	n.	n.	PROPN
ajmri-3091	414	36	,	,	PUNCT
ajmri-3091	414	37	girdler	girdler	PROPN
ajmri-3091	414	38	,	,	PUNCT
ajmri-3091	414	39	s.	s.	PROPN
ajmri-3091	414	40	s.	s.	PROPN
ajmri-3091	414	41	,	,	PUNCT
ajmri-3091	414	42	kiesner	kiesner	PROPN
ajmri-3091	414	43	,	,	PUNCT
ajmri-3091	414	44	j.	j.	PROPN
ajmri-3091	414	45	,	,	PUNCT
ajmri-3091	414	46	ditzen	ditzen	PROPN
ajmri-3091	414	47	,	,	PUNCT
ajmri-3091	414	48	b.	b.	PROPN
ajmri-3091	414	49	,	,	PUNCT
ajmri-3091	414	50	&	&	CCONJ
ajmri-3091	414	51	eisenlohr	eisenlohr	NOUN
ajmri-3091	414	52	-	-	PUNCT
ajmri-3091	414	53	moul	moul	NOUN
ajmri-3091	414	54	,	,	PUNCT
ajmri-3091	414	55	t.	t.	NOUN
ajmri-3091	414	56	a.	a.	NOUN
ajmri-3091	414	57	(	(	PUNCT
ajmri-3091	414	58	2021	2021	NUM
ajmri-3091	414	59	)	)	PUNCT
ajmri-3091	414	60	.	.	PUNCT
ajmri-3091	415	1	how	how	SCONJ
ajmri-3091	415	2	to	to	PART
ajmri-3091	415	3	study	study	VERB
ajmri-3091	415	4	the	the	DET
ajmri-3091	415	5	menstrual	menstrual	ADJ
ajmri-3091	415	6	cycle	cycle	NOUN
ajmri-3091	415	7	:	:	PUNCT
ajmri-3091	415	8	practical	practical	ADJ
ajmri-3091	415	9	tools	tool	NOUN
ajmri-3091	415	10	and	and	CCONJ
ajmri-3091	415	11	recommendations	recommendation	NOUN
ajmri-3091	415	12	.	.	PUNCT
ajmri-3091	416	1	psychoneuroendocrinology	psychoneuroendocrinology	NOUN
ajmri-3091	416	2	,	,	PUNCT
ajmri-3091	416	3	123	123	NUM
ajmri-3091	416	4	,	,	PUNCT
ajmri-3091	416	5	104895	104895	NUM
ajmri-3091	416	6	.	.	PUNCT
ajmri-3091	417	1	https://doi.org/https://doi	https://doi.org/https://doi	X
ajmri-3091	417	2	.	.	X
ajmri-3091	418	1	org/10.1016	org/10.1016	PROPN
ajmri-3091	418	2	/	/	SYM
ajmri-3091	418	3	j.psyneuen.2020.104895	j.psyneuen.2020.104895	PROPN
ajmri-3091	418	4	sualeh	sualeh	NOUN
ajmri-3091	418	5	,	,	PUNCT
ajmri-3091	418	6	m.	m.	NOUN
ajmri-3091	418	7	,	,	PUNCT
ajmri-3091	418	8	uddin	uddin	PROPN
ajmri-3091	418	9	,	,	PUNCT
ajmri-3091	418	10	m.	m.	PROPN
ajmri-3091	418	11	r.	r.	PROPN
ajmri-3091	418	12	,	,	PUNCT
ajmri-3091	418	13	junaid	junaid	PROPN
ajmri-3091	418	14	,	,	PUNCT
ajmri-3091	418	15	n.	n.	PROPN
ajmri-3091	418	16	,	,	PUNCT
ajmri-3091	418	17	khan	khan	PROPN
ajmri-3091	418	18	,	,	PUNCT
ajmri-3091	418	19	m.	m.	NOUN
ajmri-3091	418	20	,	,	PUNCT
ajmri-3091	418	21	pario	pario	PROPN
ajmri-3091	418	22	,	,	PUNCT
ajmri-3091	418	23	a.	a.	PROPN
ajmri-3091	418	24	,	,	PUNCT
ajmri-3091	418	25	&	&	CCONJ
ajmri-3091	418	26	ain	ain	PROPN
ajmri-3091	418	27	,	,	PUNCT
ajmri-3091	418	28	q.	q.	PROPN
ajmri-3091	418	29	(	(	PUNCT
ajmri-3091	418	30	2022	2022	NUM
ajmri-3091	418	31	)	)	PUNCT
ajmri-3091	418	32	.	.	PUNCT
ajmri-3091	419	1	impact	impact	NOUN
ajmri-3091	419	2	of	of	ADP
ajmri-3091	419	3	covid-19	covid-19	PROPN
ajmri-3091	419	4	vaccination	vaccination	NOUN
ajmri-3091	419	5	on	on	ADP
ajmri-3091	419	6	menstrual	menstrual	ADJ
ajmri-3091	419	7	cycle	cycle	NOUN
ajmri-3091	419	8	:	:	PUNCT
ajmri-3091	419	9	a	a	DET
ajmri-3091	419	10	cross	cross	ADJ
ajmri-3091	419	11	-	-	ADJ
ajmri-3091	419	12	sectional	sectional	ADJ
ajmri-3091	419	13	study	study	NOUN
ajmri-3091	419	14	from	from	ADP
ajmri-3091	419	15	karachi	karachi	PROPN
ajmri-3091	419	16	,	,	PUNCT
ajmri-3091	419	17	pakistan	pakistan	PROPN
ajmri-3091	419	18	.	.	PUNCT
ajmri-3091	420	1	cureus	cureus	PROPN
ajmri-3091	420	2	,	,	PUNCT
ajmri-3091	420	3	14(8	14(8	NUM
ajmri-3091	420	4	)	)	PUNCT
ajmri-3091	420	5	.	.	PUNCT
ajmri-3091	421	1	taşkaldıran	taşkaldıran	PROPN
ajmri-3091	421	2	,	,	PUNCT
ajmri-3091	421	3	i.	i.	PROPN
ajmri-3091	421	4	,	,	PUNCT
ajmri-3091	421	5	vuraloğlu	vuraloğlu	PROPN
ajmri-3091	421	6	,	,	PUNCT
ajmri-3091	421	7	e.	e.	PROPN
ajmri-3091	421	8	,	,	PUNCT
ajmri-3091	421	9	bozkuş	bozkuş	PROPN
ajmri-3091	421	10	,	,	PUNCT
ajmri-3091	421	11	y.	y.	PROPN
ajmri-3091	421	12	,	,	PUNCT
ajmri-3091	421	13	i̇yidir	i̇yidir	PROPN
ajmri-3091	421	14	,	,	PUNCT
ajmri-3091	421	15	ö.	ö.	PROPN
ajmri-3091	421	16	t.	t.	PROPN
ajmri-3091	421	17	,	,	PUNCT
ajmri-3091	421	18	nar	nar	NOUN
ajmri-3091	421	19	,	,	PUNCT
ajmri-3091	421	20	a.	a.	NOUN
ajmri-3091	421	21	,	,	PUNCT
ajmri-3091	421	22	&	&	CCONJ
ajmri-3091	421	23	tütüncü	tütüncü	PROPN
ajmri-3091	421	24	,	,	PUNCT
ajmri-3091	421	25	n.	n.	PROPN
ajmri-3091	421	26	b.	b.	PROPN
ajmri-3091	421	27	(	(	PUNCT
ajmri-3091	421	28	2022	2022	NUM
ajmri-3091	421	29	)	)	PUNCT
ajmri-3091	421	30	.	.	PUNCT
ajmri-3091	422	1	menstrual	menstrual	ADJ
ajmri-3091	422	2	changes	change	NOUN
ajmri-3091	422	3	after	after	ADP
ajmri-3091	422	4	covid-19	covid-19	PROPN
ajmri-3091	422	5	infection	infection	NOUN
ajmri-3091	422	6	and	and	CCONJ
ajmri-3091	422	7	covid-19	covid-19	PROPN
ajmri-3091	422	8	vaccination	vaccination	NOUN
ajmri-3091	422	9	.	.	PUNCT
ajmri-3091	423	1	international	international	ADJ
ajmri-3091	423	2	journal	journal	NOUN
ajmri-3091	423	3	of	of	ADP
ajmri-3091	423	4	clinical	clinical	ADJ
ajmri-3091	423	5	practice	practice	NOUN
ajmri-3091	423	6	,	,	PUNCT
ajmri-3091	423	7	2022	2022	NUM
ajmri-3091	423	8	,	,	PUNCT
ajmri-3091	423	9	1–5	1–5	NUM
ajmri-3091	423	10	.	.	PUNCT
ajmri-3091	423	11	https://doi.org/10.1155/2022/3199758	https://doi.org/10.1155/2022/3199758	PROPN
ajmri-3091	423	12	tayyaba	tayyaba	PROPN
ajmri-3091	423	13	rehan	rehan	PROPN
ajmri-3091	423	14	,	,	PUNCT
ajmri-3091	423	15	s.	s.	PROPN
ajmri-3091	423	16	,	,	PUNCT
ajmri-3091	423	17	imran	imran	PROPN
ajmri-3091	423	18	,	,	PUNCT
ajmri-3091	423	19	l.	l.	PROPN
ajmri-3091	423	20	,	,	PUNCT
ajmri-3091	423	21	mansoor	mansoor	PROPN
ajmri-3091	423	22	,	,	PUNCT
ajmri-3091	423	23	h.	h.	PROPN
ajmri-3091	423	24	,	,	PUNCT
ajmri-3091	423	25	sayyeda	sayyeda	PROPN
ajmri-3091	423	26	,	,	PUNCT
ajmri-3091	423	27	q.	q.	PROPN
ajmri-3091	423	28	,	,	PUNCT
ajmri-3091	423	29	hussain	hussain	PROPN
ajmri-3091	423	30	,	,	PUNCT
ajmri-3091	423	31	h.	h.	PROPN
ajmri-3091	423	32	u.	u.	PROPN
ajmri-3091	423	33	,	,	PUNCT
ajmri-3091	423	34	cheema	cheema	PROPN
ajmri-3091	423	35	,	,	PUNCT
ajmri-3091	423	36	m.	m.	NOUN
ajmri-3091	423	37	s.	s.	PROPN
ajmri-3091	423	38	,	,	PUNCT
ajmri-3091	423	39	tahir	tahir	PROPN
ajmri-3091	423	40	,	,	PUNCT
ajmri-3091	423	41	m.	m.	PROPN
ajmri-3091	423	42	j.	j.	PROPN
ajmri-3091	423	43	,	,	PUNCT
ajmri-3091	423	44	asghar	asghar	PROPN
ajmri-3091	423	45	,	,	PUNCT
ajmri-3091	423	46	m.	m.	PROPN
ajmri-3091	423	47	s.	s.	PROPN
ajmri-3091	423	48	,	,	PUNCT
ajmri-3091	423	49	mahmmoud	mahmmoud	VERB
ajmri-3091	423	50	fadelallah	fadelallah	ADJ
ajmri-3091	423	51	eljack	eljack	NOUN
ajmri-3091	423	52	,	,	PUNCT
ajmri-3091	423	53	m.	m.	NOUN
ajmri-3091	423	54	,	,	PUNCT
ajmri-3091	423	55	&	&	CCONJ
ajmri-3091	423	56	islam	islam	PROPN
ajmri-3091	423	57	,	,	PUNCT
ajmri-3091	423	58	m.	m.	PROPN
ajmri-3091	423	59	s.	s.	PROPN
ajmri-3091	423	60	(	(	PUNCT
ajmri-3091	423	61	2022	2022	NUM
ajmri-3091	423	62	)	)	PUNCT
ajmri-3091	423	63	.	.	PUNCT
ajmri-3091	424	1	effects	effect	NOUN
ajmri-3091	424	2	of	of	ADP
ajmri-3091	424	3	sars	sar	NOUN
ajmri-3091	424	4	-	-	PUNCT
ajmri-3091	424	5	cov-2	cov-2	PART
ajmri-3091	424	6	infection	infection	NOUN
ajmri-3091	424	7	and	and	CCONJ
ajmri-3091	424	8	covid-19	covid-19	PROPN
ajmri-3091	424	9	pandemic	pandemic	NOUN
ajmri-3091	424	10	on	on	ADP
ajmri-3091	424	11	menstrual	menstrual	ADJ
ajmri-3091	424	12	health	health	NOUN
ajmri-3091	424	13	of	of	ADP
ajmri-3091	424	14	women	woman	NOUN
ajmri-3091	424	15	:	:	PUNCT
ajmri-3091	424	16	a	a	DET
ajmri-3091	424	17	systematic	systematic	ADJ
ajmri-3091	424	18	review	review	NOUN
ajmri-3091	424	19	.	.	PUNCT
ajmri-3091	425	1	health	health	NOUN
ajmri-3091	425	2	science	science	PROPN
ajmri-3091	425	3	reports	report	NOUN
ajmri-3091	425	4	,	,	PUNCT
ajmri-3091	425	5	5(6	5(6	NUM
ajmri-3091	425	6	)	)	PUNCT
ajmri-3091	425	7	,	,	PUNCT
ajmri-3091	425	8	e881	e881	PROPN
ajmri-3091	425	9	.	.	PUNCT
ajmri-3091	425	10	thiyagarajan	thiyagarajan	PROPN
ajmri-3091	425	11	,	,	PUNCT
ajmri-3091	425	12	d.	d.	PROPN
ajmri-3091	425	13	k.	k.	PROPN
ajmri-3091	425	14	,	,	PUNCT
ajmri-3091	425	15	basit	basit	PROPN
ajmri-3091	425	16	,	,	PUNCT
ajmri-3091	425	17	h.	h.	PROPN
ajmri-3091	425	18	,	,	PUNCT
ajmri-3091	425	19	&	&	CCONJ
ajmri-3091	425	20	jeanmonod	jeanmonod	PROPN
ajmri-3091	425	21	,	,	PUNCT
ajmri-3091	425	22	r.	r.	PROPN
ajmri-3091	425	23	(	(	PUNCT
ajmri-3091	425	24	2024	2024	NUM
ajmri-3091	425	25	,	,	PUNCT
ajmri-3091	425	26	september	september	PROPN
ajmri-3091	425	27	27	27	NUM
ajmri-3091	425	28	)	)	PUNCT
ajmri-3091	425	29	.	.	PUNCT
ajmri-3091	426	1	physiology	physiology	NOUN
ajmri-3091	426	2	,	,	PUNCT
ajmri-3091	426	3	menstrual	menstrual	ADJ
ajmri-3091	426	4	cycle	cycle	NOUN
ajmri-3091	426	5	.	.	PUNCT
ajmri-3091	427	1	statpearlsncbi	statpearlsncbi	VERB
ajmri-3091	427	2	bookshelf	bookshelf	PROPN
ajmri-3091	427	3	.	.	PUNCT
ajmri-3091	428	1	https://www.ncbi.nlm.nih.gov/	https://www.ncbi.nlm.nih.gov/	PROPN
ajmri-3091	428	2	books	books	PROPN
ajmri-3091	428	3	/	/	SYM
ajmri-3091	428	4	nbk500020/	nbk500020/	PROPN
ajmri-3091	428	5	trogstad	trogstad	NOUN
ajmri-3091	428	6	,	,	PUNCT
ajmri-3091	428	7	l.	l.	PROPN
ajmri-3091	428	8	,	,	PUNCT
ajmri-3091	428	9	juvet	juvet	PROPN
ajmri-3091	428	10	,	,	PUNCT
ajmri-3091	428	11	l.	l.	PROPN
ajmri-3091	428	12	,	,	PUNCT
ajmri-3091	428	13	feiring	feiring	NOUN
ajmri-3091	428	14	,	,	PUNCT
ajmri-3091	428	15	b.	b.	PROPN
ajmri-3091	428	16	,	,	PUNCT
ajmri-3091	428	17	&	&	CCONJ
ajmri-3091	428	18	blix	blix	PROPN
ajmri-3091	428	19	,	,	PUNCT
ajmri-3091	428	20	k.	k.	PROPN
ajmri-3091	428	21	(	(	PUNCT
ajmri-3091	428	22	2022	2022	NUM
ajmri-3091	428	23	)	)	PUNCT
ajmri-3091	428	24	.	.	PUNCT
ajmri-3091	429	1	covid-19	covid-19	PROPN
ajmri-3091	429	2	vaccines	vaccine	NOUN
ajmri-3091	429	3	and	and	CCONJ
ajmri-3091	429	4	menstrual	menstrual	ADJ
ajmri-3091	429	5	changes	change	NOUN
ajmri-3091	429	6	.	.	PUNCT
ajmri-3091	430	1	bmj	bmj	PROPN
ajmri-3091	430	2	medicine	medicine	NOUN
ajmri-3091	430	3	,	,	PUNCT
ajmri-3091	430	4	1(1	1(1	NUM
ajmri-3091	430	5	)	)	PUNCT
ajmri-3091	430	6	.	.	PUNCT
ajmri-3091	431	1	vladimirovna	vladimirovna	PROPN
ajmri-3091	431	2	,	,	PUNCT
ajmri-3091	431	3	s.	s.	PROPN
ajmri-3091	431	4	v.	v.	PROPN
ajmri-3091	431	5	,	,	PUNCT
ajmri-3091	431	6	anvarovna	anvarovna	NOUN
ajmri-3091	431	7	,	,	PUNCT
ajmri-3091	431	8	s.	s.	PROPN
ajmri-3091	431	9	l.	l.	PROPN
ajmri-3091	431	10	,	,	PUNCT
ajmri-3091	431	11	vladimirovna	vladimirovna	NOUN
ajmri-3091	431	12	,	,	PUNCT
ajmri-3091	431	13	m.	m.	PROPN
ajmri-3091	431	14	e.	e.	PROPN
ajmri-3091	431	15	,	,	PUNCT
ajmri-3091	431	16	&	&	CCONJ
ajmri-3091	431	17	khidirovna	khidirovna	PROPN
ajmri-3091	431	18	,	,	PUNCT
ajmri-3091	431	19	l.	l.	PROPN
ajmri-3091	431	20	z.	z.	PROPN
ajmri-3091	431	21	(	(	PUNCT
ajmri-3091	431	22	2023	2023	NUM
ajmri-3091	431	23	)	)	PUNCT
ajmri-3091	431	24	.	.	PUNCT
ajmri-3091	432	1	menstrual	menstrual	ADJ
ajmri-3091	432	2	cycle	cycle	NOUN
ajmri-3091	432	3	disturbances	disturbance	NOUN
ajmri-3091	432	4	in	in	ADP
ajmri-3091	432	5	the	the	DET
ajmri-3091	432	6	reproductive	reproductive	ADJ
ajmri-3091	432	7	period	period	NOUN
ajmri-3091	432	8	.	.	PUNCT
ajmri-3091	433	1	central	central	ADJ
ajmri-3091	433	2	asian	asian	ADJ
ajmri-3091	433	3	journal	journal	NOUN
ajmri-3091	433	4	of	of	ADP
ajmri-3091	433	5	medical	medical	ADJ
ajmri-3091	433	6	and	and	CCONJ
ajmri-3091	433	7	natural	natural	ADJ
ajmri-3091	433	8	science	science	NOUN
ajmri-3091	433	9	,	,	PUNCT
ajmri-3091	433	10	4(2	4(2	NUM
ajmri-3091	433	11	)	)	PUNCT
ajmri-3091	433	12	,	,	PUNCT
ajmri-3091	433	13	389397	389397	NUM
ajmri-3091	433	14	.	.	PUNCT
ajmri-3091	434	1	vogazianou	vogazianou	ADJ
ajmri-3091	434	2	,	,	PUNCT
ajmri-3091	434	3	a.	a.	NOUN
ajmri-3091	434	4	(	(	PUNCT
ajmri-3091	434	5	2019	2019	NUM
ajmri-3091	434	6	)	)	PUNCT
ajmri-3091	434	7	.	.	PUNCT
ajmri-3091	435	1	anatomy	anatomy	NOUN
ajmri-3091	435	2	and	and	CCONJ
ajmri-3091	435	3	physiology	physiology	NOUN
ajmri-3091	435	4	of	of	ADP
ajmri-3091	435	5	the	the	DET
ajmri-3091	435	6	female	female	ADJ
ajmri-3091	435	7	reproductive	reproductive	ADJ
ajmri-3091	435	8	system	system	NOUN
ajmri-3091	435	9	.	.	PUNCT
ajmri-3091	436	1	advanced	advanced	ADJ
ajmri-3091	436	2	practice	practice	NOUN
ajmri-3091	436	3	in	in	ADP
ajmri-3091	436	4	endocrinology	endocrinology	NOUN
ajmri-3091	436	5	nursing	nursing	NOUN
ajmri-3091	436	6	,	,	PUNCT
ajmri-3091	436	7	739	739	NUM
ajmri-3091	436	8	-	-	SYM
ajmri-3091	436	9	752	752	NUM
ajmri-3091	436	10	.	.	PUNCT
ajmri-3091	437	1	von	von	PROPN
ajmri-3091	437	2	woon	woon	PROPN
ajmri-3091	437	3	,	,	PUNCT
ajmri-3091	437	4	e.	e.	PROPN
ajmri-3091	437	5	,	,	PUNCT
ajmri-3091	437	6	&	&	CCONJ
ajmri-3091	437	7	male	male	PROPN
ajmri-3091	437	8	,	,	PUNCT
ajmri-3091	437	9	v.	v.	PROPN
ajmri-3091	437	10	(	(	PUNCT
ajmri-3091	437	11	2022	2022	NUM
ajmri-3091	437	12	)	)	PUNCT
ajmri-3091	437	13	.	.	PUNCT
ajmri-3091	438	1	effect	effect	NOUN
ajmri-3091	438	2	of	of	ADP
ajmri-3091	438	3	covid-19	covid-19	PROPN
ajmri-3091	438	4	vaccination	vaccination	NOUN
ajmri-3091	438	5	on	on	ADP
ajmri-3091	438	6	menstrual	menstrual	ADJ
ajmri-3091	438	7	periods	period	NOUN
ajmri-3091	438	8	in	in	ADP
ajmri-3091	438	9	a	a	DET
ajmri-3091	438	10	prospectively	prospectively	ADV
ajmri-3091	438	11	recruited	recruit	VERB
ajmri-3091	438	12	cohort	cohort	NOUN
ajmri-3091	438	13	.	.	PUNCT
ajmri-3091	439	1	medrxiv	medrxiv	X
ajmri-3091	439	2	(	(	PUNCT
ajmri-3091	439	3	cold	cold	ADJ
ajmri-3091	439	4	spring	spring	NOUN
ajmri-3091	439	5	harbor	harbor	NOUN
ajmri-3091	439	6	laboratory	laboratory	NOUN
ajmri-3091	439	7	)	)	PUNCT
ajmri-3091	439	8	.	.	PUNCT
ajmri-3091	440	1	https://doi.org/10.1101/2022.03.30.22273165	https://doi.org/10.1101/2022.03.30.22273165	PROPN
ajmri-3091	440	2	wei	wei	PROPN
ajmri-3091	440	3	,	,	PUNCT
ajmri-3091	440	4	s.-m	s.-m	PROPN
ajmri-3091	440	5	.	.	PROPN
ajmri-3091	440	6	,	,	PUNCT
ajmri-3091	440	7	schiller	schiller	PROPN
ajmri-3091	440	8	,	,	PUNCT
ajmri-3091	440	9	c.	c.	PROPN
ajmri-3091	440	10	e.	e.	PROPN
ajmri-3091	440	11	,	,	PUNCT
ajmri-3091	440	12	schmidt	schmidt	PROPN
ajmri-3091	440	13	,	,	PUNCT
ajmri-3091	440	14	p.	p.	PROPN
ajmri-3091	440	15	j.	j.	PROPN
ajmri-3091	440	16	,	,	PUNCT
ajmri-3091	440	17	&	&	CCONJ
ajmri-3091	440	18	rubinow	rubinow	PROPN
ajmri-3091	440	19	,	,	PUNCT
ajmri-3091	440	20	d.	d.	PROPN
ajmri-3091	440	21	r.	r.	PROPN
ajmri-3091	440	22	(	(	PUNCT
ajmri-3091	440	23	2018	2018	NUM
ajmri-3091	440	24	)	)	PUNCT
ajmri-3091	440	25	.	.	PUNCT
ajmri-3091	441	1	the	the	DET
ajmri-3091	441	2	role	role	NOUN
ajmri-3091	441	3	of	of	ADP
ajmri-3091	441	4	ovarian	ovarian	ADJ
ajmri-3091	441	5	steroids	steroid	NOUN
ajmri-3091	441	6	in	in	ADP
ajmri-3091	441	7	affective	affective	ADJ
ajmri-3091	441	8	disorders	disorder	NOUN
ajmri-3091	441	9	.	.	PUNCT
ajmri-3091	442	1	current	current	ADJ
ajmri-3091	442	2	opinion	opinion	NOUN
ajmri-3091	442	3	in	in	ADP
ajmri-3091	442	4	behavioral	behavioral	ADJ
ajmri-3091	442	5	sciences	science	NOUN
ajmri-3091	442	6	,	,	PUNCT
ajmri-3091	442	7	23	23	NUM
ajmri-3091	442	8	,	,	PUNCT
ajmri-3091	442	9	103112	103112	NUM
ajmri-3091	442	10	.	.	PUNCT